id sid tid token lemma pos work_jyzsgzx6ozemtdrfjlhthibtsm 1 1 Four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 1 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 1 3 Year Year NNP work_jyzsgzx6ozemtdrfjlhthibtsm 1 4 Results Results NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 1 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 1 6 Low Low NNP work_jyzsgzx6ozemtdrfjlhthibtsm 1 7 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 1 8 Dose Dose NNP work_jyzsgzx6ozemtdrfjlhthibtsm 1 9 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 1 10 Screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 1 11 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 1 12 Nodule Nodule NNP work_jyzsgzx6ozemtdrfjlhthibtsm 1 13 Management Management NNP work_jyzsgzx6ozemtdrfjlhthibtsm 1 14 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 1 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 1 16 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 1 17 Trial Trial NNP work_jyzsgzx6ozemtdrfjlhthibtsm 1 18 866 866 CD work_jyzsgzx6ozemtdrfjlhthibtsm 1 19 Journal Journal NNP work_jyzsgzx6ozemtdrfjlhthibtsm 1 20 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 1 21 Thoracic Thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 1 22 Oncology Oncology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 1 23 ® ® NNP work_jyzsgzx6ozemtdrfjlhthibtsm 1 24     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 1 25 • • NN work_jyzsgzx6ozemtdrfjlhthibtsm 1 26     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 1 27 Volume volume NN work_jyzsgzx6ozemtdrfjlhthibtsm 1 28     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 1 29 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 1 30 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 1 31     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 1 32 Number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 1 33     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 1 34 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 1 35 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 1 36     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 1 37 July July NNP work_jyzsgzx6ozemtdrfjlhthibtsm 1 38     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 1 39 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 1 40 Introduction introduction NN work_jyzsgzx6ozemtdrfjlhthibtsm 1 41 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 1 42 Recruitment recruitment NN work_jyzsgzx6ozemtdrfjlhthibtsm 1 43 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 1 44 nodule nodule VB work_jyzsgzx6ozemtdrfjlhthibtsm 1 45 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 1 46 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 1 47 critical critical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 1 48 issues issue NNS work_jyzsgzx6ozemtdrfjlhthibtsm 1 49 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 1 50 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 1 51 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 1 52 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 1 53 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 1 54 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 1 55 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 1 56 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 1 57 computed compute VBN work_jyzsgzx6ozemtdrfjlhthibtsm 1 58 tomog- tomog- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 1 59 raphy raphy NN work_jyzsgzx6ozemtdrfjlhthibtsm 1 60 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 1 61 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 1 62 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 1 63 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 2 1 We -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 2 2 report report VBP work_jyzsgzx6ozemtdrfjlhthibtsm 2 3 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 2 4 ’ ’ POS work_jyzsgzx6ozemtdrfjlhthibtsm 2 5 compliance compliance NN work_jyzsgzx6ozemtdrfjlhthibtsm 2 6 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 2 7 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 2 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 2 9 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 2 10 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 2 11 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 2 12 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 2 13 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 2 14 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 2 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 2 16 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 2 17 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 2 18 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 2 19 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 2 20 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 2 21 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 2 22 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 3 1 Methods method NNS work_jyzsgzx6ozemtdrfjlhthibtsm 3 2 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 3 3 Three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 3 4 thousand thousand CD work_jyzsgzx6ozemtdrfjlhthibtsm 3 5 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 3 6 hundred hundred CD work_jyzsgzx6ozemtdrfjlhthibtsm 3 7 six six CD work_jyzsgzx6ozemtdrfjlhthibtsm 3 8 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 3 9 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 3 10 former former JJ work_jyzsgzx6ozemtdrfjlhthibtsm 3 11 smok- smok- NN work_jyzsgzx6ozemtdrfjlhthibtsm 3 12 ers ers NNP work_jyzsgzx6ozemtdrfjlhthibtsm 3 13 invited invite VBN work_jyzsgzx6ozemtdrfjlhthibtsm 3 14 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 3 15 mail mail NN work_jyzsgzx6ozemtdrfjlhthibtsm 3 16 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 3 17 randomized randomize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 3 18 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 3 19 receive receive VB work_jyzsgzx6ozemtdrfjlhthibtsm 3 20 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 3 21 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 3 22 LDCT ldct NN work_jyzsgzx6ozemtdrfjlhthibtsm 3 23 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 3 24 n n NNP work_jyzsgzx6ozemtdrfjlhthibtsm 3 25 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 3 26 1613 1613 CD work_jyzsgzx6ozemtdrfjlhthibtsm 3 27 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 3 28 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 3 29 usual usual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 3 30 care care NN work_jyzsgzx6ozemtdrfjlhthibtsm 3 31 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 3 32 n n NN work_jyzsgzx6ozemtdrfjlhthibtsm 3 33 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 3 34 1593 1593 CD work_jyzsgzx6ozemtdrfjlhthibtsm 3 35 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 3 36 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 4 1 Management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 4 2 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 4 3 included include VBD work_jyzsgzx6ozemtdrfjlhthibtsm 4 4 follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 4 5 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 4 6 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 4 7 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 4 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 4 9 2-[18F]fluoro-2-deoxy 2-[18f]fluoro-2-deoxy CD work_jyzsgzx6ozemtdrfjlhthibtsm 4 10 - - SYM work_jyzsgzx6ozemtdrfjlhthibtsm 4 11 D D NNP work_jyzsgzx6ozemtdrfjlhthibtsm 4 12 glucose glucose NN work_jyzsgzx6ozemtdrfjlhthibtsm 4 13 positron positron NNP work_jyzsgzx6ozemtdrfjlhthibtsm 4 14 emis- emis- XX work_jyzsgzx6ozemtdrfjlhthibtsm 4 15 sion sion NN work_jyzsgzx6ozemtdrfjlhthibtsm 4 16 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 4 17 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 4 18 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 4 19 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 4 20 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 4 21 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 4 22 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 4 23 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 4 24 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 4 25 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 4 26 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 4 27 fine fine JJ work_jyzsgzx6ozemtdrfjlhthibtsm 4 28 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 4 29 needle needle NN work_jyzsgzx6ozemtdrfjlhthibtsm 4 30 aspiration aspiration NN work_jyzsgzx6ozemtdrfjlhthibtsm 4 31 biopsy biopsy NN work_jyzsgzx6ozemtdrfjlhthibtsm 4 32 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 4 33 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 4 34 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 4 35 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 5 1 Results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 5 2 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 5 3 One one CD work_jyzsgzx6ozemtdrfjlhthibtsm 5 4 thousand thousand CD work_jyzsgzx6ozemtdrfjlhthibtsm 5 5 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 5 6 hundred hundred CD work_jyzsgzx6ozemtdrfjlhthibtsm 5 7 six six CD work_jyzsgzx6ozemtdrfjlhthibtsm 5 8 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 5 9 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 5 10 87 87 CD work_jyzsgzx6ozemtdrfjlhthibtsm 5 11 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 5 12 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 5 13 underwent undergo VBD work_jyzsgzx6ozemtdrfjlhthibtsm 5 14 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 5 15 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 5 16 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 5 17 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 5 18 1263 1263 CD work_jyzsgzx6ozemtdrfjlhthibtsm 5 19 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 5 20 79 79 CD work_jyzsgzx6ozemtdrfjlhthibtsm 5 21 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 5 22 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 5 23 completed complete VBD work_jyzsgzx6ozemtdrfjlhthibtsm 5 24 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 5 25 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 5 26 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 5 27 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 6 1 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 6 2 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 6 3 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 6 4 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 6 5 30.3 30.3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 6 6 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 6 7 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 6 8 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 6 9 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 6 10 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 6 11 baseline baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 6 12 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 6 13 15.8 15.8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 6 14 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 6 15 sub- sub- RB work_jyzsgzx6ozemtdrfjlhthibtsm 6 16 sequently sequently RB work_jyzsgzx6ozemtdrfjlhthibtsm 6 17 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 7 1 Twenty twenty CD work_jyzsgzx6ozemtdrfjlhthibtsm 7 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 7 3 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 7 4 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 7 5 tumors tumor NNS work_jyzsgzx6ozemtdrfjlhthibtsm 7 6 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 7 7 20 20 CD work_jyzsgzx6ozemtdrfjlhthibtsm 7 8 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 7 9 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 7 10 1.5 1.5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 7 11 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 7 12 detection detection NN work_jyzsgzx6ozemtdrfjlhthibtsm 7 13 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 7 14 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 7 15 found find VBN work_jyzsgzx6ozemtdrfjlhthibtsm 7 16 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 7 17 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 7 18 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 7 19 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 7 20 20 20 CD work_jyzsgzx6ozemtdrfjlhthibtsm 7 21 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 7 22 tumors tumor NNS work_jyzsgzx6ozemtdrfjlhthibtsm 7 23 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 7 24 18 18 CD work_jyzsgzx6ozemtdrfjlhthibtsm 7 25 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 7 26 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 7 27 0.5 0.5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 7 28 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 7 29 detection detection NN work_jyzsgzx6ozemtdrfjlhthibtsm 7 30 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 7 31 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 7 32 subsequent subsequent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 7 33 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 7 34 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 7 35 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 8 1 Ten ten CD work_jyzsgzx6ozemtdrfjlhthibtsm 8 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 8 3 18 18 CD work_jyzsgzx6ozemtdrfjlhthibtsm 8 4 prevalent prevalent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 8 5 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 8 6 55 55 CD work_jyzsgzx6ozemtdrfjlhthibtsm 8 7 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 8 8 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 8 9 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 8 10 13 13 CD work_jyzsgzx6ozemtdrfjlhthibtsm 8 11 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 8 12 17 17 CD work_jyzsgzx6ozemtdrfjlhthibtsm 8 13 incident incident NN work_jyzsgzx6ozemtdrfjlhthibtsm 8 14 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 8 15 76 76 CD work_jyzsgzx6ozemtdrfjlhthibtsm 8 16 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 8 17 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 8 18 non non JJ work_jyzsgzx6ozemtdrfjlhthibtsm 8 19 – – : work_jyzsgzx6ozemtdrfjlhthibtsm 8 20 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 8 21 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 8 22 cell cell NN work_jyzsgzx6ozemtdrfjlhthibtsm 8 23 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 8 24 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 8 25 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 8 26 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 8 27 I. I. NNP work_jyzsgzx6ozemtdrfjlhthibtsm 8 28 Interval Interval NNP work_jyzsgzx6ozemtdrfjlhthibtsm 8 29 growth growth NN work_jyzsgzx6ozemtdrfjlhthibtsm 8 30 enabled enable VBD work_jyzsgzx6ozemtdrfjlhthibtsm 8 31 diagnosis diagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 8 32 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 8 33 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 8 34 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 8 35 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 8 36 16 16 CD work_jyzsgzx6ozemtdrfjlhthibtsm 8 37 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 8 38 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 8 39 42 42 CD work_jyzsgzx6ozemtdrfjlhthibtsm 8 40 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 8 41 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 8 42 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 8 43 but but CC work_jyzsgzx6ozemtdrfjlhthibtsm 8 44 at at RB work_jyzsgzx6ozemtdrfjlhthibtsm 8 45 least least RBS work_jyzsgzx6ozemtdrfjlhthibtsm 8 46 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 8 47 follow follow VB work_jyzsgzx6ozemtdrfjlhthibtsm 8 48 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 8 49 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 8 50 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 8 51 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 8 52 obtained obtain VBN work_jyzsgzx6ozemtdrfjlhthibtsm 8 53 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 8 54 741 741 CD work_jyzsgzx6ozemtdrfjlhthibtsm 8 55 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 8 56 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 8 57 52.7 52.7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 8 58 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 8 59 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 8 60 over over IN work_jyzsgzx6ozemtdrfjlhthibtsm 8 61 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 8 62 screen- screen- NN work_jyzsgzx6ozemtdrfjlhthibtsm 8 63 ing ing NN work_jyzsgzx6ozemtdrfjlhthibtsm 8 64 period period NN work_jyzsgzx6ozemtdrfjlhthibtsm 8 65 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 9 1 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 9 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 9 3 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 9 4 obtained obtain VBD work_jyzsgzx6ozemtdrfjlhthibtsm 9 5 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 9 6 6.5 6.5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 9 7 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 9 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 9 9 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 9 10 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 9 11 84 84 CD work_jyzsgzx6ozemtdrfjlhthibtsm 9 12 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 9 13 sensitiv- sensitiv- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 9 14 ity ity NN work_jyzsgzx6ozemtdrfjlhthibtsm 9 15 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 9 16 90 90 CD work_jyzsgzx6ozemtdrfjlhthibtsm 9 17 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 9 18 specificity specificity NN work_jyzsgzx6ozemtdrfjlhthibtsm 9 19 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 9 20 malignant malignant JJ work_jyzsgzx6ozemtdrfjlhthibtsm 9 21 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 9 22 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 10 1 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 10 2 obtained obtain VBD work_jyzsgzx6ozemtdrfjlhthibtsm 10 3 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 10 4 2.4 2.4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 10 5 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 10 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 10 7 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 10 8 showed show VBD work_jyzsgzx6ozemtdrfjlhthibtsm 10 9 90 90 CD work_jyzsgzx6ozemtdrfjlhthibtsm 10 10 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 10 11 sensitivity sensitivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 10 12 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 10 13 88 88 CD work_jyzsgzx6ozemtdrfjlhthibtsm 10 14 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 10 15 specificity specificity NN work_jyzsgzx6ozemtdrfjlhthibtsm 10 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 11 1 Positivity positivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 11 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 11 3 both both CC work_jyzsgzx6ozemtdrfjlhthibtsm 11 4 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 11 5 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 11 6 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 11 7 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 11 8 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 11 9 invariably invariably RB work_jyzsgzx6ozemtdrfjlhthibtsm 11 10 predicted predict VBD work_jyzsgzx6ozemtdrfjlhthibtsm 11 11 malignancy malignancy NN work_jyzsgzx6ozemtdrfjlhthibtsm 11 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 12 1 Surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 12 2 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 12 3 benign benign JJ work_jyzsgzx6ozemtdrfjlhthibtsm 12 4 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 12 5 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 12 6 performed perform VBN work_jyzsgzx6ozemtdrfjlhthibtsm 12 7 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 12 8 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 12 9 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 12 10 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 12 11 10 10 CD work_jyzsgzx6ozemtdrfjlhthibtsm 12 12 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 12 13 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 12 14 procedures procedure NNS work_jyzsgzx6ozemtdrfjlhthibtsm 12 15 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 12 16 but but CC work_jyzsgzx6ozemtdrfjlhthibtsm 12 17 followed follow VBD work_jyzsgzx6ozemtdrfjlhthibtsm 12 18 protocol protocol JJ work_jyzsgzx6ozemtdrfjlhthibtsm 12 19 violations violation NNS work_jyzsgzx6ozemtdrfjlhthibtsm 12 20 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 12 21 three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 12 22 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 12 23 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 13 1 Conclusions conclusion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 13 2 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 13 3 High high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 13 4 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 13 5 risk risk NN work_jyzsgzx6ozemtdrfjlhthibtsm 13 6 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 13 7 recruited recruit VBN work_jyzsgzx6ozemtdrfjlhthibtsm 13 8 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 13 9 mail mail NN work_jyzsgzx6ozemtdrfjlhthibtsm 13 10 who who WP work_jyzsgzx6ozemtdrfjlhthibtsm 13 11 entered enter VBD work_jyzsgzx6ozemtdrfjlhthibtsm 13 12 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 13 13 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 13 14 showed show VBD work_jyzsgzx6ozemtdrfjlhthibtsm 13 15 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 13 16 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 13 17 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 13 18 stable stable JJ work_jyzsgzx6ozemtdrfjlhthibtsm 13 19 compliance compliance NN work_jyzsgzx6ozemtdrfjlhthibtsm 13 20 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 14 1 Efficacy efficacy NN work_jyzsgzx6ozemtdrfjlhthibtsm 14 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 14 3 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 14 4 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 14 5 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 14 6 however however RB work_jyzsgzx6ozemtdrfjlhthibtsm 14 7 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 14 8 weakened weaken VBN work_jyzsgzx6ozemtdrfjlhthibtsm 14 9 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 14 10 low low JJ work_jyzsgzx6ozemtdrfjlhthibtsm 14 11 detection detection NN work_jyzsgzx6ozemtdrfjlhthibtsm 14 12 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 14 13 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 14 14 specificity specificity NN work_jyzsgzx6ozemtdrfjlhthibtsm 14 15 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 15 1 Adhesion adhesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 15 2 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 15 3 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 15 4 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 15 5 might may MD work_jyzsgzx6ozemtdrfjlhthibtsm 15 6 lessen lessen VB work_jyzsgzx6ozemtdrfjlhthibtsm 15 7 surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 15 8 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 15 9 benign benign JJ work_jyzsgzx6ozemtdrfjlhthibtsm 15 10 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 15 11 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 16 1 Key key JJ work_jyzsgzx6ozemtdrfjlhthibtsm 16 2 Words word NNS work_jyzsgzx6ozemtdrfjlhthibtsm 16 3 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 16 4 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 16 5 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 16 6 Computed computed JJ work_jyzsgzx6ozemtdrfjlhthibtsm 16 7 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 16 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 16 9 Nuclear nuclear JJ work_jyzsgzx6ozemtdrfjlhthibtsm 16 10 medicine medicine NN work_jyzsgzx6ozemtdrfjlhthibtsm 16 11 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 16 12 Pulmonary pulmonary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 16 13 biopsy biopsy NN work_jyzsgzx6ozemtdrfjlhthibtsm 16 14 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 17 1 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 17 2 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 17 3 Thorac Thorac NNP work_jyzsgzx6ozemtdrfjlhthibtsm 17 4 Oncol Oncol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 17 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 18 1 2013;8 2013;8 LS work_jyzsgzx6ozemtdrfjlhthibtsm 18 2 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 18 3 866 866 CD work_jyzsgzx6ozemtdrfjlhthibtsm 18 4 - - SYM work_jyzsgzx6ozemtdrfjlhthibtsm 18 5 875 875 CD work_jyzsgzx6ozemtdrfjlhthibtsm 18 6 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 18 7 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 8 Western western JJ work_jyzsgzx6ozemtdrfjlhthibtsm 18 9 countries country NNS work_jyzsgzx6ozemtdrfjlhthibtsm 18 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 11 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 12 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 13 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 18 14 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 18 15 most most RBS work_jyzsgzx6ozemtdrfjlhthibtsm 18 16 common common JJ work_jyzsgzx6ozemtdrfjlhthibtsm 18 17 malignant malignant JJ work_jyzsgzx6ozemtdrfjlhthibtsm 18 18 neoplasm neoplasm NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 19 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 20 men man NNS work_jyzsgzx6ozemtdrfjlhthibtsm 18 21 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 22 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 18 23 its -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 18 24 frequency frequency NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 25 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 18 26 constantly constantly RB work_jyzsgzx6ozemtdrfjlhthibtsm 18 27 increasing increase VBG work_jyzsgzx6ozemtdrfjlhthibtsm 18 28 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 29 women.1 women.1 JJ work_jyzsgzx6ozemtdrfjlhthibtsm 18 30 Non non NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 31 – – : work_jyzsgzx6ozemtdrfjlhthibtsm 18 32 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 18 33 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 18 34 cell cell NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 35 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 36 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 37 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 18 38 NSCLC NSCLC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 39 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 18 40 accounts account VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 18 41 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 42 approximately approximately RB work_jyzsgzx6ozemtdrfjlhthibtsm 18 43 85 85 CD work_jyzsgzx6ozemtdrfjlhthibtsm 18 44 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 45 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 46 these these DT work_jyzsgzx6ozemtdrfjlhthibtsm 18 47 neoplasms.2,3 neoplasms.2,3 . work_jyzsgzx6ozemtdrfjlhthibtsm 18 48 Although although IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 49 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 18 50 age age NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 51 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 18 52 adjusted adjust VBN work_jyzsgzx6ozemtdrfjlhthibtsm 18 53 trends trend NNS work_jyzsgzx6ozemtdrfjlhthibtsm 18 54 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 55 mortality mortality NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 56 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 18 57 decreasing decrease VBG work_jyzsgzx6ozemtdrfjlhthibtsm 18 58 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 59 survival survival NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 60 rates rate NNS work_jyzsgzx6ozemtdrfjlhthibtsm 18 61 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 62 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 63 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 64 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 18 65 still still RB work_jyzsgzx6ozemtdrfjlhthibtsm 18 66 10 10 CD work_jyzsgzx6ozemtdrfjlhthibtsm 18 67 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 68 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 69 16%.4,5 16%.4,5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 18 70 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 71 par- par- NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 72 ticular ticular NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 73 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 74 only only RB work_jyzsgzx6ozemtdrfjlhthibtsm 18 75 15 15 CD work_jyzsgzx6ozemtdrfjlhthibtsm 18 76 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 77 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 18 78 20 20 CD work_jyzsgzx6ozemtdrfjlhthibtsm 18 79 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 80 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 81 symptomatic symptomatic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 18 82 patients patient NNS work_jyzsgzx6ozemtdrfjlhthibtsm 18 83 have have VBP work_jyzsgzx6ozemtdrfjlhthibtsm 18 84 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 18 85 amenable amenable JJ work_jyzsgzx6ozemtdrfjlhthibtsm 18 86 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 87 radical radical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 18 88 surgical surgical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 18 89 resection.6 resection.6 NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 90 Copyright copyright NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 91 © © NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 92 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 18 93 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 94 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 18 95 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 96 Association Association NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 97 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 98 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 18 99 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 100 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 101 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 102 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 103 ISSN ISSN NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 104 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 18 105 1556 1556 CD work_jyzsgzx6ozemtdrfjlhthibtsm 18 106 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 18 107 0864/13/0807 0864/13/0807 CD work_jyzsgzx6ozemtdrfjlhthibtsm 18 108 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 18 109 0866 0866 CD work_jyzsgzx6ozemtdrfjlhthibtsm 18 110 Four Four NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 111 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 18 112 Year Year NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 113     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 18 114 Results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 18 115     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 18 116 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 117     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 18 118 Low Low NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 119 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 18 120 Dose Dose NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 121     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 18 122 CT ct NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 123     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 18 124 Screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 125     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 18 126 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 18 127     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 18 128 Nodule Nodule NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 129     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 18 130 Management Management NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 131     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 18 132 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 133     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 18 134 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 18 135     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 18 136 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 137     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 18 138 Trial Trial NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 139 Andrea Andrea NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 140 Lopes Lopes NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 141 Pegna Pegna NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 18 142 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 143 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 144 * * NFP work_jyzsgzx6ozemtdrfjlhthibtsm 18 145 Giulia Giulia NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 146 Picozzi Picozzi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 147 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 148 MD,† MD,† NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 149 Fabio Fabio NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 150 Falaschi Falaschi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 151 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 152 MD,‡ MD,‡ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 153 Laura Laura NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 154 Carrozzi Carrozzi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 155 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 156 MD,§ MD,§ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 157 Massimo Massimo NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 158 Falchini Falchini NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 159 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 160 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 161 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 162 ║ ║ -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 18 163 Francesca Francesca NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 164 Maria Maria NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 165 Carozzi Carozzi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 166 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 167 MD,¶ md,¶ CD work_jyzsgzx6ozemtdrfjlhthibtsm 18 168 Francesco Francesco NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 169 Pistelli Pistelli NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 170 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 171 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 172 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 173 § § ADD work_jyzsgzx6ozemtdrfjlhthibtsm 18 174 Camilla Camilla NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 175 Comin Comin NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 176 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 177 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 178 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 179 # # NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 180 Annalisa Annalisa NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 181 Deliperi Deliperi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 182 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 183 MD,‡ MD,‡ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 184 Michela Michela NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 185 Grazzini Grazzini NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 186 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 187 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 188 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 189 * * NFP work_jyzsgzx6ozemtdrfjlhthibtsm 18 190 * * NFP work_jyzsgzx6ozemtdrfjlhthibtsm 18 191 Florio Florio NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 192 Innocenti Innocenti NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 193 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 194 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 195 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 196 * * NFP work_jyzsgzx6ozemtdrfjlhthibtsm 18 197 * * NFP work_jyzsgzx6ozemtdrfjlhthibtsm 18 198 Cristina Cristina NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 199 Maddau Maddau NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 200 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 201 MD,¶ md,¶ CD work_jyzsgzx6ozemtdrfjlhthibtsm 18 202 Alessandra Alessandra NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 203 Vella Vella NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 204 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 205 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 206 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 207 PhD,†† PhD,†† NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 208 Luca Luca NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 209 Vaggelli Vaggelli NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 210 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 211 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 212 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 213 ║ ║ -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 18 214 ║ ║ -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 18 215 Eugenio Eugenio NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 216 Paci Paci NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 217 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 218 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 219 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 220 PhD,¶¶ PhD,¶¶ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 221 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 18 222 Mario Mario NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 223 Mascalchi Mascalchi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 224 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 225 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 226 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 227 PhD phd NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 228 ║ ║ CD work_jyzsgzx6ozemtdrfjlhthibtsm 18 229 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 230 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 18 231 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 232 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 233 Research Research NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 234 Group Group NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 235 * * NFP work_jyzsgzx6ozemtdrfjlhthibtsm 18 236 Pneumonology Pneumonology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 237 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 238 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 239 Careggi Careggi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 240 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 241 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 242 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 243 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 244 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 245 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 18 246 †Radiodiagnostic †Radiodiagnostic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 247 Unit Unit NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 248 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 249 Institute Institute NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 250 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 251 Oncological Oncological NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 252 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 253 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 18 254 Prevention Prevention NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 255 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 256 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 257 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 258 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 259 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 18 260 ‡2nd ‡2nd NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 261 Radiology Radiology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 262 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 263 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 264 University University NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 265 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 266 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 267 Pisa Pisa NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 268 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 269 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 270 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 18 271 § § ADD work_jyzsgzx6ozemtdrfjlhthibtsm 18 272 Cardiopulmonary Cardiopulmonary NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 273 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 274 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 275 University University NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 276 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 277 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 278 Pisa Pisa NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 279 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 280 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 281 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 18 282 ║ ║ -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 18 283 Radiodiagnostic Radiodiagnostic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 284 Section Section NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 285 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 286 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 287 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 288 Experimental Experimental NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 289 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 18 290 Clinical Clinical NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 291 Biomedical Biomedical NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 292 Sciences Sciences NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 18 293 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 294 University University NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 295 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 296 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 297 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 298 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 299 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 18 300 ¶Analytical ¶Analytical NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 301 Cytology Cytology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 302 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 18 303 Bio Bio NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 304 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 18 305 Molecular Molecular NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 306 Unit Unit NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 307 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 308 Institute Institute NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 309 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 310 Oncological Oncological NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 311 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 312 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 18 313 Prevention Prevention NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 314 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 315 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 316 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 317 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 318 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 18 319 # # NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 320 Pathology Pathology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 321 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 322 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 323 Careggi Careggi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 324 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 325 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 326 University University NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 327 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 328 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 329 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 330 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 331 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 18 332 * * NFP work_jyzsgzx6ozemtdrfjlhthibtsm 18 333 * * NFP work_jyzsgzx6ozemtdrfjlhthibtsm 18 334 Pneumonology pneumonology NN work_jyzsgzx6ozemtdrfjlhthibtsm 18 335 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 336 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 337 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 338 Pistoia Pistoia NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 339 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 340 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 341 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 18 342 ††Nuclear ††Nuclear NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 343 Medicine Medicine NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 344 Unit Unit NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 345 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 346 Le Le NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 347 Scotte Scotte NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 348 University University NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 349 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 350 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 351 Siena Siena NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 352 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 353 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 354 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 18 355 ║ ║ -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 18 356 ║ ║ : work_jyzsgzx6ozemtdrfjlhthibtsm 18 357 Nuclear Nuclear NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 358 Medicine Medicine NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 359 Unit Unit NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 360 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 361 Careggi Careggi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 362 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 363 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 364 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 365 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 366 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 367 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 18 368 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 18 369 ¶¶Department ¶¶Department JJS work_jyzsgzx6ozemtdrfjlhthibtsm 18 370 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 371 Epidemiology Epidemiology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 372 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 373 Institute Institute NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 374 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 18 375 Oncological Oncological NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 376 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 377 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 18 378 Prevention Prevention NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 379 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 380 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 381 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 18 382 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 18 383 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 19 1 Disclosure disclosure NN work_jyzsgzx6ozemtdrfjlhthibtsm 19 2 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 19 3 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 19 4 authors author NNS work_jyzsgzx6ozemtdrfjlhthibtsm 19 5 declare declare VBP work_jyzsgzx6ozemtdrfjlhthibtsm 19 6 no no DT work_jyzsgzx6ozemtdrfjlhthibtsm 19 7 conflict conflict NN work_jyzsgzx6ozemtdrfjlhthibtsm 19 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 19 9 interest interest NN work_jyzsgzx6ozemtdrfjlhthibtsm 19 10 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 20 1 Members member NNS work_jyzsgzx6ozemtdrfjlhthibtsm 20 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 20 3 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 20 4 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 5 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 6 Research Research NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 7 Group Group NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 8 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 20 9 Andrea Andrea NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 10 Lopes Lopes NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 11 Pegna Pegna NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 20 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 20 13 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 20 15 Roberto Roberto NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 16 Bianchi Bianchi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 17 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 20 18 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 19 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 20 20 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 20 21 Cristina Cristina NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 22 Ronchi Ronchi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 23 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 20 24 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 25 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 20 26 Pneumonology Pneumonology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 27 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 28 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 20 29 Careggi Careggi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 30 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 31 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 20 32 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 33 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 20 34 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 21 1 Laura Laura NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 2 Carrozzi Carrozzi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 4 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 5 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 6 Ferruccio Ferruccio NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 7 Aquilini Aquilini NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 9 BSc BSc NNS work_jyzsgzx6ozemtdrfjlhthibtsm 21 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 11 Stella Stella NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 12 Cini Cini NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 13 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 14 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 16 Mariella Mariella NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 17 De De NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 18 Santis Santis NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 19 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 20 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 21 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 22 Francesco Francesco NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 23 Pistelli Pistelli NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 24 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 25 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 26 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 27 Filomena Filomena NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 28 Baliva Baliva NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 29 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 30 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 31 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 32 Antonio Antonio NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 33 Chella Chella NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 34 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 35 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 36 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 37 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 21 38 Laura Laura NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 39 Tavanti Tavanti NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 40 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 41 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 42 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 21 43 Cardiopulmonary Cardiopulmonary NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 44 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 45 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 46 University University NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 47 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 48 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 21 49 Pisa Pisa NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 50 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 21 51 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 21 52 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 22 1 Michela Michela NNP work_jyzsgzx6ozemtdrfjlhthibtsm 22 2 Grazzini Grazzini NNP work_jyzsgzx6ozemtdrfjlhthibtsm 22 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 22 4 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 22 5 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 22 6 Florio Florio NNP work_jyzsgzx6ozemtdrfjlhthibtsm 22 7 Innocenti Innocenti NNP work_jyzsgzx6ozemtdrfjlhthibtsm 22 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 22 9 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 22 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 22 11 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 22 12 Ilaria Ilaria NNP work_jyzsgzx6ozemtdrfjlhthibtsm 22 13 Natali Natali NNP work_jyzsgzx6ozemtdrfjlhthibtsm 22 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 22 15 BSc BSc NNS work_jyzsgzx6ozemtdrfjlhthibtsm 22 16 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 22 17 Pneumonology Pneumonology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 22 18 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 22 19 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 22 20 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 22 21 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 22 22 Pistoia Pistoia NNP work_jyzsgzx6ozemtdrfjlhthibtsm 22 23 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 22 24 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 22 25 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 23 1 Mario Mario NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 2 Mascalchi Mascalchi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 4 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 5 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 6 PhD phd NN work_jyzsgzx6ozemtdrfjlhthibtsm 23 7 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 8 Maurizio Maurizio NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 9 Bartolucci Bartolucci NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 11 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 13 Elena Elena NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 14 Crisci Crisci NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 16 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 17 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 18 Agostino Agostino NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 19 De De NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 20 Francisci Francisci NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 21 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 22 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 23 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 24 Massimo Massimo NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 25 Falchini Falchini NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 26 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 27 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 28 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 29 Silvia Silvia NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 30 Gabbrielli Gabbrielli NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 31 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 32 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 33 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 34 Giulia Giulia NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 35 Picozzi Picozzi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 36 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 37 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 38 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 39 Giuliana Giuliana NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 40 Roselli Roselli NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 41 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 42 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 43 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 44 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 23 45 Andrea Andrea NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 46 Masi Masi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 47 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 48 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 49 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 23 50 Radiology Radiology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 51 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 52 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 53 Careggi Careggi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 54 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 55 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 56 University University NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 57 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 23 58 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 59 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 23 60 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 23 61 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 24 1 Fabio Fabio NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 2 Falaschi Falaschi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 24 4 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 5 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 24 6 Luigi Luigi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 7 Battola Battola NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 24 9 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 24 11 Anna Anna NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 12 Lisa Lisa NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 13 De De NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 14 Liperi Liperi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 24 16 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 17 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 24 18 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 24 19 Cheti Cheti NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 20 Spinelli Spinelli NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 21 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 24 22 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 23 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 24 24 Radiology Radiology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 25 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 26 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 24 27 University University NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 28 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 29 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 24 30 Pisa Pisa NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 31 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 24 32 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 24 33 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 25 1 Letizia Letizia NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 2 Vannucchi Vannucchi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 25 4 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 5 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 25 6 Alessia Alessia NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 7 Petruzzelli Petruzzelli NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 25 9 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 25 11 Davide Davide NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 12 Gadda Gadda NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 13 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 25 14 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 25 16 Anna Anna NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 17 Talina Talina NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 18 Neri Neri NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 19 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 25 20 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 21 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 25 22 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 25 23 Franco Franco NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 24 Niccolai Niccolai NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 25 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 25 26 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 27 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 25 28 Radiology Radiology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 29 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 30 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 25 31 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 32 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 25 33 Pistoia Pistoia NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 34 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 25 35 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 25 36 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 26 1 Luca Luca NNP work_jyzsgzx6ozemtdrfjlhthibtsm 26 2 Vaggelli Vaggelli NNP work_jyzsgzx6ozemtdrfjlhthibtsm 26 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 26 4 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 26 5 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 26 6 Nuclear Nuclear NNP work_jyzsgzx6ozemtdrfjlhthibtsm 26 7 Medicine Medicine NNP work_jyzsgzx6ozemtdrfjlhthibtsm 26 8 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 26 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 26 10 Careggi Careggi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 26 11 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 26 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 26 13 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 26 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 26 15 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 26 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 27 1 Alessandra Alessandra NNP work_jyzsgzx6ozemtdrfjlhthibtsm 27 2 Vella Vella NNP work_jyzsgzx6ozemtdrfjlhthibtsm 27 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 27 4 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 27 5 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 27 6 PhD phd NN work_jyzsgzx6ozemtdrfjlhthibtsm 27 7 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 27 8 Nuclear Nuclear NNP work_jyzsgzx6ozemtdrfjlhthibtsm 27 9 Medicine Medicine NNP work_jyzsgzx6ozemtdrfjlhthibtsm 27 10 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 27 11 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 27 12 Le Le NNP work_jyzsgzx6ozemtdrfjlhthibtsm 27 13 Scotte Scotte NNP work_jyzsgzx6ozemtdrfjlhthibtsm 27 14 University University NNP work_jyzsgzx6ozemtdrfjlhthibtsm 27 15 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 27 16 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 27 17 Siena Siena NNP work_jyzsgzx6ozemtdrfjlhthibtsm 27 18 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 27 19 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 27 20 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 28 1 Francesca Francesca NNP work_jyzsgzx6ozemtdrfjlhthibtsm 28 2 Maria Maria NNP work_jyzsgzx6ozemtdrfjlhthibtsm 28 3 Carozzi Carozzi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 28 4 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 28 5 BSc BSc NNS work_jyzsgzx6ozemtdrfjlhthibtsm 28 6 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 28 7 Cristina Cristina NNP work_jyzsgzx6ozemtdrfjlhthibtsm 28 8 Maddau Maddau NNP work_jyzsgzx6ozemtdrfjlhthibtsm 28 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 28 10 BSc BSc NNS work_jyzsgzx6ozemtdrfjlhthibtsm 28 11 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 28 12 Laboratory Laboratory NNP work_jyzsgzx6ozemtdrfjlhthibtsm 28 13 Unit Unit NNP work_jyzsgzx6ozemtdrfjlhthibtsm 28 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 28 15 Institute Institute NNP work_jyzsgzx6ozemtdrfjlhthibtsm 28 16 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 28 17 Oncological Oncological NNP work_jyzsgzx6ozemtdrfjlhthibtsm 28 18 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 28 19 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 28 20 Prevention Prevention NNP work_jyzsgzx6ozemtdrfjlhthibtsm 28 21 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 28 22 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 28 23 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 28 24 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 28 25 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 29 1 Alberto Alberto NNP work_jyzsgzx6ozemtdrfjlhthibtsm 29 2 Janni Janni NNP work_jyzsgzx6ozemtdrfjlhthibtsm 29 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 29 4 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 29 5 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 29 6 Thoracic Thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 29 7 Surgery Surgery NNP work_jyzsgzx6ozemtdrfjlhthibtsm 29 8 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 29 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 29 10 Careggi Careggi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 29 11 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 29 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 29 13 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 29 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 29 15 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 29 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 30 1 Alfredo Alfredo NNP work_jyzsgzx6ozemtdrfjlhthibtsm 30 2 Mussi Mussi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 30 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 30 4 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 30 5 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 30 6 Marco Marco NNP work_jyzsgzx6ozemtdrfjlhthibtsm 30 7 Lucchi Lucchi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 30 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 30 9 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 30 10 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 30 11 Thoracic Thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 30 12 Surgery Surgery NNP work_jyzsgzx6ozemtdrfjlhthibtsm 30 13 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 30 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 30 15 University University NNP work_jyzsgzx6ozemtdrfjlhthibtsm 30 16 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 30 17 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 30 18 Pisa Pisa NNP work_jyzsgzx6ozemtdrfjlhthibtsm 30 19 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 30 20 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 30 21 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 31 1 Camilla Camilla NNP work_jyzsgzx6ozemtdrfjlhthibtsm 31 2 Comin Comin NNP work_jyzsgzx6ozemtdrfjlhthibtsm 31 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 31 4 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 31 5 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 31 6 Pathology Pathology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 31 7 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 31 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 31 9 Careggi Careggi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 31 10 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 31 11 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 31 12 University University NNP work_jyzsgzx6ozemtdrfjlhthibtsm 31 13 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 31 14 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 31 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 31 16 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 31 17 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 32 1 Gabriella Gabriella NNP work_jyzsgzx6ozemtdrfjlhthibtsm 32 2 Fontanini Fontanini NNP work_jyzsgzx6ozemtdrfjlhthibtsm 32 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 32 4 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 32 5 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 32 6 Adele Adele NNP work_jyzsgzx6ozemtdrfjlhthibtsm 32 7 Renza Renza NNP work_jyzsgzx6ozemtdrfjlhthibtsm 32 8 Tognetti Tognetti NNP work_jyzsgzx6ozemtdrfjlhthibtsm 32 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 32 10 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 32 11 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 32 12 Pathology Pathology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 32 13 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 32 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 32 15 University University NNP work_jyzsgzx6ozemtdrfjlhthibtsm 32 16 Hospital Hospital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 32 17 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 32 18 Pisa Pisa NNP work_jyzsgzx6ozemtdrfjlhthibtsm 32 19 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 32 20 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 32 21 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 33 1 Eugenio Eugenio NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 2 Paci Paci NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 33 4 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 5 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 33 6 PhD phd NN work_jyzsgzx6ozemtdrfjlhthibtsm 33 7 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 33 8 Giovanna Giovanna NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 9 Cordopatri Cordopatri NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 33 11 BSc BSc NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 33 13 Francesco Francesco NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 14 Giusti Giusti NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 33 16 BSc BSc NNS work_jyzsgzx6ozemtdrfjlhthibtsm 33 17 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 33 18 PhD phd NN work_jyzsgzx6ozemtdrfjlhthibtsm 33 19 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 33 20 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 33 21 Ida Ida NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 22 Esposito Esposito NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 23 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 33 24 BSc BSc NNS work_jyzsgzx6ozemtdrfjlhthibtsm 33 25 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 33 26 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 27 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 33 28 Epidemiology Epidemiology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 29 Institute Institute NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 30 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 33 31 Oncological Oncological NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 32 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 33 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 33 34 Prevention Prevention NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 35 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 33 36 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 37 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 33 38 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 33 39 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 34 1 Address address NN work_jyzsgzx6ozemtdrfjlhthibtsm 34 2 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 34 3 correspondence correspondence NN work_jyzsgzx6ozemtdrfjlhthibtsm 34 4 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 34 5 Mario Mario NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 6 Mascalchi Mascalchi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 7 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 34 8 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 34 10 PhD phd NN work_jyzsgzx6ozemtdrfjlhthibtsm 34 11 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 34 12 Radiodiagnostic Radiodiagnostic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 13 Section Section NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 34 15 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 16 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 34 17 Experimental Experimental NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 18 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 34 19 Clinical Clinical NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 20 Biomedical Biomedical NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 21 Sciences Sciences NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 34 22 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 34 23 University University NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 24 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 34 25 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 26 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 34 27 Viale Viale NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 28 Pieraccini Pieraccini NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 29 6 6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 34 30 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 34 31 50139 50139 CD work_jyzsgzx6ozemtdrfjlhthibtsm 34 32 Florence Florence NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 33 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 34 34 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 34 35 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 35 1 E e NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 2 - - NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 3 mail mail NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 4 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 35 5 m.mascalchi@dfc.unifi.it m.mascalchi@dfc.unifi.it NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 6 ORIGINAL original JJ work_jyzsgzx6ozemtdrfjlhthibtsm 35 7 ARTICLE article NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 8 mailto:m.mascalchi@dfc.unifi.it mailto:m.mascalchi@dfc.unifi.it NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 9 867Copyright 867copyright CD work_jyzsgzx6ozemtdrfjlhthibtsm 35 10 © © CD work_jyzsgzx6ozemtdrfjlhthibtsm 35 11 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 35 12 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 35 13 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 35 14 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 15 Association Association NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 16 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 35 17 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 35 18 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 19 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 35 20 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 21 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 22 Journal Journal NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 23 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 35 24 Thoracic Thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 25 Oncology Oncology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 26 ® ® NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 27     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 35 28 • • NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 29     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 35 30 Volume volume NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 31     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 35 32 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 35 33 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 35 34     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 35 35 Number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 36     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 35 37 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 35 38 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 35 39     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 35 40 July July NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 41     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 35 42 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 35 43 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 44 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 35 45 Nodule Nodule NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 46 Management Management NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 47 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 35 48 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 49 Randomized randomized JJ work_jyzsgzx6ozemtdrfjlhthibtsm 35 50 clinical clinical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 35 51 trials trial NNS work_jyzsgzx6ozemtdrfjlhthibtsm 35 52 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 35 53 RCTs RCTs NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 35 54 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 35 55 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 35 56 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 57 radio- radio- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 58 graph graph NNP work_jyzsgzx6ozemtdrfjlhthibtsm 35 59 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 35 60 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 35 61 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 62 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 35 63 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 64 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 65 failed fail VBD work_jyzsgzx6ozemtdrfjlhthibtsm 35 66 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 35 67 show show VB work_jyzsgzx6ozemtdrfjlhthibtsm 35 68 any any DT work_jyzsgzx6ozemtdrfjlhthibtsm 35 69 ben- ben- NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 70 efit efit VB work_jyzsgzx6ozemtdrfjlhthibtsm 35 71 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 35 72 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 35 73 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 35 74 former former JJ work_jyzsgzx6ozemtdrfjlhthibtsm 35 75 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 35 76 because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 35 77 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 35 78 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 35 79 excess excess NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 80 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 35 81 deaths death NNS work_jyzsgzx6ozemtdrfjlhthibtsm 35 82 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 35 83 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 35 84 screened screened JJ work_jyzsgzx6ozemtdrfjlhthibtsm 35 85 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 35 86 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 36 1 This this DT work_jyzsgzx6ozemtdrfjlhthibtsm 36 2 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 36 3 presumably presumably RB work_jyzsgzx6ozemtdrfjlhthibtsm 36 4 because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 6 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 36 7 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 36 8 number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 9 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 10 surgically surgically RB work_jyzsgzx6ozemtdrfjlhthibtsm 36 11 resected resect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 36 12 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 36 13 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 14 associated associate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 36 15 side side NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 16 effects effect NNS work_jyzsgzx6ozemtdrfjlhthibtsm 36 17 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 36 18 unnecessary unnecessary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 36 19 surgical surgical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 36 20 procedures procedure NNS work_jyzsgzx6ozemtdrfjlhthibtsm 36 21 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 22 indolent indolent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 36 23 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 36 24 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 25 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 36 26 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 36 27 arm.7–10 arm.7–10 NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 28 After after IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 29 publication publication NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 30 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 31 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 36 32 Early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 36 33 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 36 34 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 36 35 Action Action NNP work_jyzsgzx6ozemtdrfjlhthibtsm 36 36 Project Project NNP work_jyzsgzx6ozemtdrfjlhthibtsm 36 37 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 36 38 ELCAP ELCAP NNP work_jyzsgzx6ozemtdrfjlhthibtsm 36 39 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 36 40 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 41 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 36 42 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 43 1999,11 1999,11 CD work_jyzsgzx6ozemtdrfjlhthibtsm 36 44 several several JJ work_jyzsgzx6ozemtdrfjlhthibtsm 36 45 observational observational NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 46 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 36 47 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 36 48 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 36 49 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 50 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 36 51 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 36 52 assessed assess VBD work_jyzsgzx6ozemtdrfjlhthibtsm 36 53 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 36 54 performance performance NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 55 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 56 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 36 57 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 36 58 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 59 com- com- NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 60 puted put VBN work_jyzsgzx6ozemtdrfjlhthibtsm 36 61 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 62 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 36 63 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 36 64 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 36 65 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 66 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 36 67 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 68 tool tool NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 69 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 70 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 71 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 72 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 73 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 74 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 36 75 risk risk NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 76 individuals.12 individuals.12 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 36 77 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 36 78 largest large JJS work_jyzsgzx6ozemtdrfjlhthibtsm 36 79 observational observational JJ work_jyzsgzx6ozemtdrfjlhthibtsm 36 80 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 81 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 36 82 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 36 83 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 36 84 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 36 85 ELCAP ELCAP NNP work_jyzsgzx6ozemtdrfjlhthibtsm 36 86 study,13 study,13 NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 87 confirmed confirm VBD work_jyzsgzx6ozemtdrfjlhthibtsm 36 88 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 36 89 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 36 90 sensitivity sensitivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 91 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 92 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 36 93 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 94 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 36 95 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 96 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 97 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 36 98 reported report VBD work_jyzsgzx6ozemtdrfjlhthibtsm 36 99 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 36 100 88 88 CD work_jyzsgzx6ozemtdrfjlhthibtsm 36 101 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 102 10-year 10-year CD work_jyzsgzx6ozemtdrfjlhthibtsm 36 103 sur- sur- NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 104 vival vival JJ work_jyzsgzx6ozemtdrfjlhthibtsm 36 105 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 106 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 107 surgical surgical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 36 108 resection resection NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 109 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 36 110 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 111 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 36 112 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 36 113 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 114 I -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 36 115 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 36 116 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 36 117 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 37 1 However however RB work_jyzsgzx6ozemtdrfjlhthibtsm 37 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 37 3 observational observational JJ work_jyzsgzx6ozemtdrfjlhthibtsm 37 4 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 37 5 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 37 6 insufficient insufficient JJ work_jyzsgzx6ozemtdrfjlhthibtsm 37 7 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 37 8 establish establish VB work_jyzsgzx6ozemtdrfjlhthibtsm 37 9 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 37 10 efficacy efficacy NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 11 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 12 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 37 13 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 14 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 15 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 16 reducing reduce VBG work_jyzsgzx6ozemtdrfjlhthibtsm 37 17 tumor- tumor- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 37 18 specific specific JJ work_jyzsgzx6ozemtdrfjlhthibtsm 37 19 mortality mortality NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 20 because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 21 they -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 37 22 suffer suffer VBP work_jyzsgzx6ozemtdrfjlhthibtsm 37 23 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 24 lead lead JJ work_jyzsgzx6ozemtdrfjlhthibtsm 37 25 time time NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 26 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 37 27 length length NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 28 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 37 29 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 37 30 overdiagnosis overdiagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 31 bias.14–16 bias.14–16 RB work_jyzsgzx6ozemtdrfjlhthibtsm 37 32 Accordingly accordingly RB work_jyzsgzx6ozemtdrfjlhthibtsm 37 33 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 37 34 several several JJ work_jyzsgzx6ozemtdrfjlhthibtsm 37 35 RCTs rct NNS work_jyzsgzx6ozemtdrfjlhthibtsm 37 36 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 37 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 38 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 39 screen- screen- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 40 ing ing NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 41 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 42 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 43 have have VBP work_jyzsgzx6ozemtdrfjlhthibtsm 37 44 been be VBN work_jyzsgzx6ozemtdrfjlhthibtsm 37 45 implemented implement VBN work_jyzsgzx6ozemtdrfjlhthibtsm 37 46 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 47 United United NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 48 States States NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 49 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 37 50 Europe.17–25 Europe.17–25 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 51 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 52 2011 2011 CD work_jyzsgzx6ozemtdrfjlhthibtsm 37 53 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 37 54 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 37 55 largest large JJS work_jyzsgzx6ozemtdrfjlhthibtsm 37 56 RCT rct NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 57 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 58 United United NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 59 States States NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 60 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 37 61 namely namely RB work_jyzsgzx6ozemtdrfjlhthibtsm 37 62 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 37 63 National National NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 64 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 65 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 66 Trial Trial NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 67 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 37 68 NLST),26 NLST),26 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 69 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 37 70 halted halt VBN work_jyzsgzx6ozemtdrfjlhthibtsm 37 71 because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 72 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 37 73 interim interim JJ work_jyzsgzx6ozemtdrfjlhthibtsm 37 74 analysis analysis NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 75 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 76 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 37 77 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 37 78 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 79 follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 80 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 37 81 up up NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 82 showed show VBD work_jyzsgzx6ozemtdrfjlhthibtsm 37 83 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 37 84 20 20 CD work_jyzsgzx6ozemtdrfjlhthibtsm 37 85 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 86 mortality mortality NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 87 reduction reduction NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 88 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 89 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 37 90 screened screened JJ work_jyzsgzx6ozemtdrfjlhthibtsm 37 91 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 92 receiv- receiv- VBD work_jyzsgzx6ozemtdrfjlhthibtsm 37 93 ing e VBG work_jyzsgzx6ozemtdrfjlhthibtsm 37 94 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 37 95 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 96 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 97 three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 37 98 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 37 99 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 100 compared compare VBN work_jyzsgzx6ozemtdrfjlhthibtsm 37 101 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 102 control control NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 103 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 104 receiving receive VBG work_jyzsgzx6ozemtdrfjlhthibtsm 37 105 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 37 106 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 107 radiograph radiograph NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 108 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 109 three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 37 110 rounds.27 rounds.27 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 111 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 37 112 result result NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 113 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 114 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 37 115 NLST NLST NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 116 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 37 117 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 37 118 first first JJ work_jyzsgzx6ozemtdrfjlhthibtsm 37 119 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 37 120 supporting support VBG work_jyzsgzx6ozemtdrfjlhthibtsm 37 121 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 37 122 efficacy efficacy NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 123 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 124 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 125 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 126 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 37 127 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 128 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 129 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 130 reducing reduce VBG work_jyzsgzx6ozemtdrfjlhthibtsm 37 131 mortality mortality NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 132 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 133 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 134 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 135 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 136 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 37 137 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 37 138 risk risk NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 139 individuals individual NNS work_jyzsgzx6ozemtdrfjlhthibtsm 37 140 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 37 141 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 37 142 has have VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 37 143 considerably considerably RB work_jyzsgzx6ozemtdrfjlhthibtsm 37 144 renewed renew VBN work_jyzsgzx6ozemtdrfjlhthibtsm 37 145 interest interest NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 146 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 37 147 enthusiasm enthusiasm NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 148 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 37 149 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 150 also also RB work_jyzsgzx6ozemtdrfjlhthibtsm 37 151 criticisms28–30 criticisms28–30 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 152 about about IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 153 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 37 154 pos- pos- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 37 155 sibility sibility NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 156 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 157 offering offer VBG work_jyzsgzx6ozemtdrfjlhthibtsm 37 158 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 159 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 160 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 37 161 large large JJ work_jyzsgzx6ozemtdrfjlhthibtsm 37 162 scale scale NN work_jyzsgzx6ozemtdrfjlhthibtsm 37 163 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 37 164 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 37 165 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 37 166 for- for- XX work_jyzsgzx6ozemtdrfjlhthibtsm 37 167 mer mer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 37 168 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 37 169 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 38 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 38 2 latter latter NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 3 has have VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 38 4 been be VBN work_jyzsgzx6ozemtdrfjlhthibtsm 38 5 recently recently RB work_jyzsgzx6ozemtdrfjlhthibtsm 38 6 recommended31,32 recommended31,32 RB work_jyzsgzx6ozemtdrfjlhthibtsm 38 7 despite despite IN work_jyzsgzx6ozemtdrfjlhthibtsm 38 8 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 38 9 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 38 10 short short JJ work_jyzsgzx6ozemtdrfjlhthibtsm 38 11 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 38 12 term term NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 13 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 38 14 concerning concern VBG work_jyzsgzx6ozemtdrfjlhthibtsm 38 15 decrease decrease NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 16 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 38 17 mortality mortality NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 18 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 38 19 three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 38 20 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 38 21 RCTs rct NNS work_jyzsgzx6ozemtdrfjlhthibtsm 38 22 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 38 23 Europe.18,33,34 europe.18,33,34 NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 24 Variable variable JJ work_jyzsgzx6ozemtdrfjlhthibtsm 38 25 approaches approach NNS work_jyzsgzx6ozemtdrfjlhthibtsm 38 26 concerning concern VBG work_jyzsgzx6ozemtdrfjlhthibtsm 38 27 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 38 28 recruit- recruit- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 38 29 ment ment NNP work_jyzsgzx6ozemtdrfjlhthibtsm 38 30 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 38 31 timing timing NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 32 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 38 33 reading reading NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 34 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 38 35 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 38 36 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 38 37 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 38 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 39 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 38 40 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 38 41 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 38 42 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 43 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 38 44 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 45 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 38 46 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 47 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 38 48 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 38 49 suspicious suspicious JJ work_jyzsgzx6ozemtdrfjlhthibtsm 38 50 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 38 51 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 38 52 proposed.18,21,25,27,35–37 proposed.18,21,25,27,35–37 CD work_jyzsgzx6ozemtdrfjlhthibtsm 38 53 Comparative comparative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 38 54 analyses analysis NNS work_jyzsgzx6ozemtdrfjlhthibtsm 38 55 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 38 56 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 38 57 different different JJ work_jyzsgzx6ozemtdrfjlhthibtsm 38 58 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 38 59 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 38 60 fundamental fundamental JJ work_jyzsgzx6ozemtdrfjlhthibtsm 38 61 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 38 62 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 38 63 thorough thorough JJ work_jyzsgzx6ozemtdrfjlhthibtsm 38 64 evalu- evalu- NNS work_jyzsgzx6ozemtdrfjlhthibtsm 38 65 ation ation NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 66 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 38 67 efficacy efficacy NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 68 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 38 69 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 38 70 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 71 procedure procedure NN work_jyzsgzx6ozemtdrfjlhthibtsm 38 72 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 39 1 To to IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 2 date date NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 39 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 5 complete complete JJ work_jyzsgzx6ozemtdrfjlhthibtsm 39 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 39 7 namely namely RB work_jyzsgzx6ozemtdrfjlhthibtsm 39 8 during during IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 9 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 10 entire entire JJ work_jyzsgzx6ozemtdrfjlhthibtsm 39 11 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 12 period period NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 13 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 39 14 per- per- CC work_jyzsgzx6ozemtdrfjlhthibtsm 39 15 formance formance NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 16 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 17 both both DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 18 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 19 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 20 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 21 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 22 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 23 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 39 24 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 25 manage- manage- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 39 26 ment ment JJ work_jyzsgzx6ozemtdrfjlhthibtsm 39 27 strategy strategy NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 28 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 29 suspicious suspicious JJ work_jyzsgzx6ozemtdrfjlhthibtsm 39 30 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 39 31 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 39 32 reported report VBN work_jyzsgzx6ozemtdrfjlhthibtsm 39 33 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 34 five five CD work_jyzsgzx6ozemtdrfjlhthibtsm 39 35 RCTs rct NNS work_jyzsgzx6ozemtdrfjlhthibtsm 39 36 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 39 37 namely namely RB work_jyzsgzx6ozemtdrfjlhthibtsm 39 38 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 39 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 40 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 41 Study,38 Study,38 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 42 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 43 NLST,27 NLST,27 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 44 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 45 DANTE DANTE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 46 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 39 47 MILD MILD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 48 trials trial NNS work_jyzsgzx6ozemtdrfjlhthibtsm 39 49 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 50 Italy,18,33 Italy,18,33 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 51 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 39 52 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 53 Danish Danish NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 54 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 55 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 56 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 57 trial.34,37 trial.34,37 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 58 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 59 Italian italian JJ work_jyzsgzx6ozemtdrfjlhthibtsm 39 60 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 61 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 39 62 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 63 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 39 64 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 65 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 39 66 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 67 RCT RCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 68 part part NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 69 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 70 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 71 international international JJ work_jyzsgzx6ozemtdrfjlhthibtsm 39 72 cooperation cooperation NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 73 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 39 74 aimed aim VBN work_jyzsgzx6ozemtdrfjlhthibtsm 39 75 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 76 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 77 pooled pool VBN work_jyzsgzx6ozemtdrfjlhthibtsm 39 78 evalu- evalu- NNS work_jyzsgzx6ozemtdrfjlhthibtsm 39 79 ation ation NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 80 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 81 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 82 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 39 83 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 84 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 85 RCTs rct NNS work_jyzsgzx6ozemtdrfjlhthibtsm 39 86 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 87 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 88 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 89 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 39 90 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 91 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 92 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 93 Europe Europe NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 94 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 39 95 possibly possibly RB work_jyzsgzx6ozemtdrfjlhthibtsm 39 96 United United NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 97 States.39 States.39 . work_jyzsgzx6ozemtdrfjlhthibtsm 39 98 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 99 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 100 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 101 design design NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 102 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 39 103 enrolment enrolment JJ work_jyzsgzx6ozemtdrfjlhthibtsm 39 104 procedure procedure NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 105 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 39 106 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 39 107 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 108 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 39 109 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 110 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 111 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 112 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 113 round round NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 114 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 39 115 previously previously RB work_jyzsgzx6ozemtdrfjlhthibtsm 39 116 reported.20 reported.20 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 117 Herein Herein NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 118 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 39 119 we -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 39 120 present present VBP work_jyzsgzx6ozemtdrfjlhthibtsm 39 121 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 122 final final JJ work_jyzsgzx6ozemtdrfjlhthibtsm 39 123 data datum NNS work_jyzsgzx6ozemtdrfjlhthibtsm 39 124 concerning concern VBG work_jyzsgzx6ozemtdrfjlhthibtsm 39 125 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 126 compliance compliance NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 127 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 128 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 129 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 39 130 recruited recruit VBN work_jyzsgzx6ozemtdrfjlhthibtsm 39 131 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 132 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 133 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 39 134 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 135 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 136 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 137 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 138 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 39 139 who who WP work_jyzsgzx6ozemtdrfjlhthibtsm 39 140 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 39 141 invited invite VBN work_jyzsgzx6ozemtdrfjlhthibtsm 39 142 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 39 143 undergo undergo VB work_jyzsgzx6ozemtdrfjlhthibtsm 39 144 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 39 145 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 39 146 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 147 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 39 148 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 149 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 39 150 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 151 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 152 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 153 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 154 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 155 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 156 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 157 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 39 158 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 159 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 39 160 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 39 161 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 39 162 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 39 163 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 39 164 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 165 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 166 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 39 167 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 39 168 screen- screen- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 39 169 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 39 170 suspicious suspicious JJ work_jyzsgzx6ozemtdrfjlhthibtsm 39 171 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 39 172 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 40 1 MATERIALS material NNS work_jyzsgzx6ozemtdrfjlhthibtsm 40 2 AND and CC work_jyzsgzx6ozemtdrfjlhthibtsm 40 3 METHODS methods JJ work_jyzsgzx6ozemtdrfjlhthibtsm 40 4 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 40 5 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 40 6 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 40 7 RCT RCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 40 8 aimed aim VBN work_jyzsgzx6ozemtdrfjlhthibtsm 40 9 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 40 10 evaluate evaluate VB work_jyzsgzx6ozemtdrfjlhthibtsm 40 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 40 12 efficacy efficacy NN work_jyzsgzx6ozemtdrfjlhthibtsm 40 13 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 40 14 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 40 15 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 40 16 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 40 17 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 40 18 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 40 19 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 40 20 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 40 21 reducing reduce VBG work_jyzsgzx6ozemtdrfjlhthibtsm 40 22 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 40 23 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 40 24 mor- mor- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 40 25 tality tality NN work_jyzsgzx6ozemtdrfjlhthibtsm 40 26 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 40 27 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 40 28 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 40 29 carried carry VBN work_jyzsgzx6ozemtdrfjlhthibtsm 40 30 out out RP work_jyzsgzx6ozemtdrfjlhthibtsm 40 31 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 40 32 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 40 33 Tuscany Tuscany NNP work_jyzsgzx6ozemtdrfjlhthibtsm 40 34 region region NN work_jyzsgzx6ozemtdrfjlhthibtsm 40 35 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 40 36 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 40 37 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 41 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 41 2 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 41 3 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 41 4 conducted conduct VBN work_jyzsgzx6ozemtdrfjlhthibtsm 41 5 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 41 6 accordance accordance NN work_jyzsgzx6ozemtdrfjlhthibtsm 41 7 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 41 8 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 41 9 amended amend VBN work_jyzsgzx6ozemtdrfjlhthibtsm 41 10 Declaration Declaration NNP work_jyzsgzx6ozemtdrfjlhthibtsm 41 11 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 41 12 Helsinki Helsinki NNP work_jyzsgzx6ozemtdrfjlhthibtsm 41 13 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 41 14 http://www.wma.net/ http://www.wma.net/ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 41 15 en/30publications/10policies en/30publications/10policies NNP work_jyzsgzx6ozemtdrfjlhthibtsm 41 16 / / SYM work_jyzsgzx6ozemtdrfjlhthibtsm 41 17 b3/ b3/ NN work_jyzsgzx6ozemtdrfjlhthibtsm 41 18 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 41 19 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 41 20 approved approve VBN work_jyzsgzx6ozemtdrfjlhthibtsm 41 21 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 41 22 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 41 23 Local Local NNP work_jyzsgzx6ozemtdrfjlhthibtsm 41 24 Ethic Ethic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 41 25 Committees Committees NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 41 26 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 41 27 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 41 28 participating participate VBG work_jyzsgzx6ozemtdrfjlhthibtsm 41 29 institution institution NN work_jyzsgzx6ozemtdrfjlhthibtsm 41 30 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 41 31 approval approval NN work_jyzsgzx6ozemtdrfjlhthibtsm 41 32 number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 41 33 29–30 29–30 CD work_jyzsgzx6ozemtdrfjlhthibtsm 41 34 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 41 35 September September NNP work_jyzsgzx6ozemtdrfjlhthibtsm 41 36 30 30 CD work_jyzsgzx6ozemtdrfjlhthibtsm 41 37 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 41 38 2003 2003 CD work_jyzsgzx6ozemtdrfjlhthibtsm 41 39 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 41 40 number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 41 41 23 23 CD work_jyzsgzx6ozemtdrfjlhthibtsm 41 42 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 41 43 October October NNP work_jyzsgzx6ozemtdrfjlhthibtsm 41 44 27 27 CD work_jyzsgzx6ozemtdrfjlhthibtsm 41 45 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 41 46 2003 2003 CD work_jyzsgzx6ozemtdrfjlhthibtsm 41 47 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 41 48 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 41 49 number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 41 50 00028543 00028543 CD work_jyzsgzx6ozemtdrfjlhthibtsm 41 51 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 41 52 May May NNP work_jyzsgzx6ozemtdrfjlhthibtsm 41 53 13 13 CD work_jyzsgzx6ozemtdrfjlhthibtsm 41 54 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 41 55 2004 2004 CD work_jyzsgzx6ozemtdrfjlhthibtsm 41 56 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 41 57 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 42 1 Selection selection NN work_jyzsgzx6ozemtdrfjlhthibtsm 42 2 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 42 3 Randomization Randomization NNP work_jyzsgzx6ozemtdrfjlhthibtsm 42 4 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 42 5 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 42 6 Participants Participants NNP work_jyzsgzx6ozemtdrfjlhthibtsm 42 7 Strategy Strategy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 42 8 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 42 9 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 42 10 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 42 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 42 12 exclusive exclusive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 42 13 mail mail NN work_jyzsgzx6ozemtdrfjlhthibtsm 42 14 recruitment recruitment NN work_jyzsgzx6ozemtdrfjlhthibtsm 42 15 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 42 16 trail trail NN work_jyzsgzx6ozemtdrfjlhthibtsm 42 17 participants participant NNS work_jyzsgzx6ozemtdrfjlhthibtsm 42 18 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 42 19 previously previously RB work_jyzsgzx6ozemtdrfjlhthibtsm 42 20 reported.20 reported.20 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 42 21 Those those DT work_jyzsgzx6ozemtdrfjlhthibtsm 42 22 eligible eligible JJ work_jyzsgzx6ozemtdrfjlhthibtsm 42 23 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 42 24 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 42 25 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 42 26 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 42 27 asymptomatic asymptomatic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 42 28 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 42 29 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 42 30 formers former NNS work_jyzsgzx6ozemtdrfjlhthibtsm 42 31 smok- smok- NN work_jyzsgzx6ozemtdrfjlhthibtsm 42 32 ers ers NNP work_jyzsgzx6ozemtdrfjlhthibtsm 42 33 aged aged JJ work_jyzsgzx6ozemtdrfjlhthibtsm 42 34 55 55 CD work_jyzsgzx6ozemtdrfjlhthibtsm 42 35 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 42 36 69 69 CD work_jyzsgzx6ozemtdrfjlhthibtsm 42 37 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 42 38 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 42 39 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 42 40 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 42 41 smoking smoking NN work_jyzsgzx6ozemtdrfjlhthibtsm 42 42 history history NN work_jyzsgzx6ozemtdrfjlhthibtsm 42 43 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 42 44 at at RB work_jyzsgzx6ozemtdrfjlhthibtsm 42 45 least least RBS work_jyzsgzx6ozemtdrfjlhthibtsm 42 46 20 20 CD work_jyzsgzx6ozemtdrfjlhthibtsm 42 47 pack pack NN work_jyzsgzx6ozemtdrfjlhthibtsm 42 48 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 42 49 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 42 50 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 42 51 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 42 52 no no DT work_jyzsgzx6ozemtdrfjlhthibtsm 42 53 history history NN work_jyzsgzx6ozemtdrfjlhthibtsm 42 54 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 42 55 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 42 56 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 42 57 other other JJ work_jyzsgzx6ozemtdrfjlhthibtsm 42 58 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 42 59 nonmela- nonmela- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 42 60 noma noma NNP work_jyzsgzx6ozemtdrfjlhthibtsm 42 61 skin skin NN work_jyzsgzx6ozemtdrfjlhthibtsm 42 62 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 42 63 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 42 64 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 42 65 general general JJ work_jyzsgzx6ozemtdrfjlhthibtsm 42 66 conditions condition NNS work_jyzsgzx6ozemtdrfjlhthibtsm 42 67 precluding preclude VBG work_jyzsgzx6ozemtdrfjlhthibtsm 42 68 thoracic thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 42 69 surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 42 70 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 43 1 Subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 43 2 randomized randomize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 43 3 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 43 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 43 5 control control NN work_jyzsgzx6ozemtdrfjlhthibtsm 43 6 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 43 7 received receive VBD work_jyzsgzx6ozemtdrfjlhthibtsm 43 8 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 43 9 let- let- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 43 10 ter ter NN work_jyzsgzx6ozemtdrfjlhthibtsm 43 11 communicating communicate VBG work_jyzsgzx6ozemtdrfjlhthibtsm 43 12 their -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 43 13 allocation allocation NN work_jyzsgzx6ozemtdrfjlhthibtsm 43 14 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 43 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 43 16 usual usual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 43 17 care care NN work_jyzsgzx6ozemtdrfjlhthibtsm 43 18 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 43 19 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 43 20 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 43 21 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 43 22 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 43 23 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 43 24 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 43 25 no no DT work_jyzsgzx6ozemtdrfjlhthibtsm 43 26 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 43 27 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 43 28 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 43 29 radiograph radiograph NNP work_jyzsgzx6ozemtdrfjlhthibtsm 43 30 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 43 31 sched- sched- VBN work_jyzsgzx6ozemtdrfjlhthibtsm 43 32 uled uled JJ work_jyzsgzx6ozemtdrfjlhthibtsm 43 33 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 44 1 Subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 44 2 randomized randomize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 44 3 into into IN work_jyzsgzx6ozemtdrfjlhthibtsm 44 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 44 5 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 44 6 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 7 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 44 8 con- con- NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 9 tacted tacte VBN work_jyzsgzx6ozemtdrfjlhthibtsm 44 10 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 44 11 phone phone NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 12 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 44 13 fix fix VB work_jyzsgzx6ozemtdrfjlhthibtsm 44 14 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 44 15 appointment appointment NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 16 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 44 17 counseling counseling NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 18 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 44 19 during during IN work_jyzsgzx6ozemtdrfjlhthibtsm 44 20 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 44 21 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 44 22 pneumonologist pneumonologist NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 23 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 44 24 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 44 25 providing provide VBG work_jyzsgzx6ozemtdrfjlhthibtsm 44 26 further further JJ work_jyzsgzx6ozemtdrfjlhthibtsm 44 27 informa- informa- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 44 28 tion tion NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 29 about about IN work_jyzsgzx6ozemtdrfjlhthibtsm 44 30 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 44 31 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 32 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 44 33 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 34 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 44 35 manage- manage- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 44 36 ment ment NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 37 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 44 38 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 44 39 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 40 tests test NNS work_jyzsgzx6ozemtdrfjlhthibtsm 44 41 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 44 42 collected collect VBD work_jyzsgzx6ozemtdrfjlhthibtsm 44 43 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 44 44 consent consent NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 45 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 44 46 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 44 47 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 48 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 44 49 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 44 50 scheduled schedule VBD work_jyzsgzx6ozemtdrfjlhthibtsm 44 51 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 44 52 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 44 53 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 54 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 44 55 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 45 1 An an DT work_jyzsgzx6ozemtdrfjlhthibtsm 45 2 additional additional JJ work_jyzsgzx6ozemtdrfjlhthibtsm 45 3 written write VBN work_jyzsgzx6ozemtdrfjlhthibtsm 45 4 consent consent NN work_jyzsgzx6ozemtdrfjlhthibtsm 45 5 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 45 6 enrolment enrolment NN work_jyzsgzx6ozemtdrfjlhthibtsm 45 7 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 45 8 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 45 9 biomark- biomark- NN work_jyzsgzx6ozemtdrfjlhthibtsm 45 10 ers ers JJ work_jyzsgzx6ozemtdrfjlhthibtsm 45 11 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 45 12 collateral collateral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 45 13 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 45 14 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 45 15 requested request VBN work_jyzsgzx6ozemtdrfjlhthibtsm 45 16 during during IN work_jyzsgzx6ozemtdrfjlhthibtsm 45 17 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 45 18 interview.40 interview.40 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 45 19 A a DT work_jyzsgzx6ozemtdrfjlhthibtsm 45 20 free free JJ work_jyzsgzx6ozemtdrfjlhthibtsm 45 21 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 45 22 access access NN work_jyzsgzx6ozemtdrfjlhthibtsm 45 23 invitation invitation NN work_jyzsgzx6ozemtdrfjlhthibtsm 45 24 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 45 25 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 45 26 smoking smoking NN work_jyzsgzx6ozemtdrfjlhthibtsm 45 27 cessation cessation NN work_jyzsgzx6ozemtdrfjlhthibtsm 45 28 program program NN work_jyzsgzx6ozemtdrfjlhthibtsm 45 29 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 45 30 provided provide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 45 31 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 45 32 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 45 33 enrolled enrol VBD work_jyzsgzx6ozemtdrfjlhthibtsm 45 34 both both DT work_jyzsgzx6ozemtdrfjlhthibtsm 45 35 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 45 36 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 45 37 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 45 38 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 45 39 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 45 40 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 45 41 control control NN work_jyzsgzx6ozemtdrfjlhthibtsm 45 42 arms arm NNS work_jyzsgzx6ozemtdrfjlhthibtsm 45 43 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 46 1 All all DT work_jyzsgzx6ozemtdrfjlhthibtsm 46 2 randomized randomized JJ work_jyzsgzx6ozemtdrfjlhthibtsm 46 3 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 46 4 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 46 5 planned plan VBN work_jyzsgzx6ozemtdrfjlhthibtsm 46 6 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 46 7 follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 46 8 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 46 9 up up NN work_jyzsgzx6ozemtdrfjlhthibtsm 46 10 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 46 11 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 46 12 registry registry NN work_jyzsgzx6ozemtdrfjlhthibtsm 46 13 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 46 14 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 46 15 Tuscany Tuscany NNP work_jyzsgzx6ozemtdrfjlhthibtsm 46 16 region region NN work_jyzsgzx6ozemtdrfjlhthibtsm 46 17 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 46 18 http://www.ispo http://www.ispo NNP work_jyzsgzx6ozemtdrfjlhthibtsm 46 19 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 47 1 toscana.it toscana.it LS work_jyzsgzx6ozemtdrfjlhthibtsm 47 2 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 47 3 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 47 4 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 47 5 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 47 6 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 47 7 randomization randomization NN work_jyzsgzx6ozemtdrfjlhthibtsm 47 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 47 9 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 47 10 assess assess VB work_jyzsgzx6ozemtdrfjlhthibtsm 47 11 incidence incidence NN work_jyzsgzx6ozemtdrfjlhthibtsm 47 12 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 47 13 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 47 14 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 47 15 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 47 16 mortality mortality NN work_jyzsgzx6ozemtdrfjlhthibtsm 47 17 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 47 18 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 47 19 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 47 20 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 47 21 other other JJ work_jyzsgzx6ozemtdrfjlhthibtsm 47 22 causes cause NNS work_jyzsgzx6ozemtdrfjlhthibtsm 47 23 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 48 1 Although although IN work_jyzsgzx6ozemtdrfjlhthibtsm 48 2 no no DT work_jyzsgzx6ozemtdrfjlhthibtsm 48 3 specific specific JJ work_jyzsgzx6ozemtdrfjlhthibtsm 48 4 instruction instruction NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 5 about about IN work_jyzsgzx6ozemtdrfjlhthibtsm 48 6 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 48 7 workup workup NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 48 9 cases case NNS work_jyzsgzx6ozemtdrfjlhthibtsm 48 10 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 48 11 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 12 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 13 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 48 14 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 48 15 control control NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 16 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 17 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 48 18 provided provide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 48 19 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 48 20 general general JJ work_jyzsgzx6ozemtdrfjlhthibtsm 48 21 practitioner practitioner NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 22 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 48 23 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 48 24 enrolled enrolled JJ work_jyzsgzx6ozemtdrfjlhthibtsm 48 25 subject subject NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 26 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 48 27 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 48 28 low low JJ work_jyzsgzx6ozemtdrfjlhthibtsm 48 29 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 30 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 48 31 migration migration NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 32 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 48 33 patients patient NNS work_jyzsgzx6ozemtdrfjlhthibtsm 48 34 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 48 35 who who WP work_jyzsgzx6ozemtdrfjlhthibtsm 48 36 receive receive VBP work_jyzsgzx6ozemtdrfjlhthibtsm 48 37 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 48 38 diagnosis diagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 39 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 48 40 primary primary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 48 41 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 42 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 43 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 48 44 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 48 45 Tuscany Tuscany NNP work_jyzsgzx6ozemtdrfjlhthibtsm 48 46 region region NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 47 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 48 48 < < XX work_jyzsgzx6ozemtdrfjlhthibtsm 48 49 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 48 50 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 51 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 48 52 personal personal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 48 53 unpublished unpublished JJ work_jyzsgzx6ozemtdrfjlhthibtsm 48 54 observation observation NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 55 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 48 56 2011 2011 CD work_jyzsgzx6ozemtdrfjlhthibtsm 48 57 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 48 58 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 48 59 makes make VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 48 60 it -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 48 61 probable probable JJ work_jyzsgzx6ozemtdrfjlhthibtsm 48 62 that that IN work_jyzsgzx6ozemtdrfjlhthibtsm 48 63 they -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 48 64 will will MD work_jyzsgzx6ozemtdrfjlhthibtsm 48 65 be be VB work_jyzsgzx6ozemtdrfjlhthibtsm 48 66 referred refer VBN work_jyzsgzx6ozemtdrfjlhthibtsm 48 67 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 48 68 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 48 69 same same JJ work_jyzsgzx6ozemtdrfjlhthibtsm 48 70 structures structure NNS work_jyzsgzx6ozemtdrfjlhthibtsm 48 71 participating participate VBG work_jyzsgzx6ozemtdrfjlhthibtsm 48 72 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 48 73 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 48 74 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 48 75 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 48 76 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 49 1 Because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 49 2 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 49 3 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 49 4 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 49 5 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 49 6 suspicious suspicious JJ work_jyzsgzx6ozemtdrfjlhthibtsm 49 7 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 49 8 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 49 9 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 49 10 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 49 11 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 49 12 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 49 13 derived derive VBN work_jyzsgzx6ozemtdrfjlhthibtsm 49 14 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 49 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 49 16 clinical clinical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 49 17 practice practice NN work_jyzsgzx6ozemtdrfjlhthibtsm 49 18 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 49 19 see see VB work_jyzsgzx6ozemtdrfjlhthibtsm 49 20 below below RB work_jyzsgzx6ozemtdrfjlhthibtsm 49 21 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 49 22 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 49 23 it -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 49 24 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 49 25 expected expect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 49 26 that that IN work_jyzsgzx6ozemtdrfjlhthibtsm 49 27 no no DT work_jyzsgzx6ozemtdrfjlhthibtsm 49 28 major major JJ work_jyzsgzx6ozemtdrfjlhthibtsm 49 29 discrepancies discrepancy NNS work_jyzsgzx6ozemtdrfjlhthibtsm 49 30 will will MD work_jyzsgzx6ozemtdrfjlhthibtsm 49 31 be be VB work_jyzsgzx6ozemtdrfjlhthibtsm 49 32 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 49 33 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 49 34 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 49 35 workup workup NN work_jyzsgzx6ozemtdrfjlhthibtsm 49 36 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 49 37 diagnosis diagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 49 38 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 49 39 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 49 40 staging staging NN work_jyzsgzx6ozemtdrfjlhthibtsm 49 41 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 49 42 such such JJ work_jyzsgzx6ozemtdrfjlhthibtsm 49 43 cases case NNS work_jyzsgzx6ozemtdrfjlhthibtsm 49 44 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 49 45 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 49 46 that that IN work_jyzsgzx6ozemtdrfjlhthibtsm 49 47 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 49 48 related related JJ work_jyzsgzx6ozemtdrfjlhthibtsm 49 49 information information NN work_jyzsgzx6ozemtdrfjlhthibtsm 49 50 will will MD work_jyzsgzx6ozemtdrfjlhthibtsm 49 51 be be VB work_jyzsgzx6ozemtdrfjlhthibtsm 49 52 available available JJ work_jyzsgzx6ozemtdrfjlhthibtsm 49 53 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 49 54 gathered gather VBN work_jyzsgzx6ozemtdrfjlhthibtsm 49 55 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 49 56 hospital hospital NN work_jyzsgzx6ozemtdrfjlhthibtsm 49 57 chart chart NN work_jyzsgzx6ozemtdrfjlhthibtsm 49 58 recordings recording NNS work_jyzsgzx6ozemtdrfjlhthibtsm 49 59 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 49 60 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 49 61 end end NN work_jyzsgzx6ozemtdrfjlhthibtsm 49 62 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 49 63 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 49 64 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 49 65 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 50 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 50 2 first first JJ work_jyzsgzx6ozemtdrfjlhthibtsm 50 3 mortality mortality NN work_jyzsgzx6ozemtdrfjlhthibtsm 50 4 data datum NNS work_jyzsgzx6ozemtdrfjlhthibtsm 50 5 concerning concern VBG work_jyzsgzx6ozemtdrfjlhthibtsm 50 6 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 50 7 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 50 8 enrolled enrol VBN work_jyzsgzx6ozemtdrfjlhthibtsm 50 9 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 50 10 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 50 11 ITALUNG ITALUNG NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 50 12 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 50 13 expected expect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 50 14 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 50 15 2014 2014 CD work_jyzsgzx6ozemtdrfjlhthibtsm 50 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 51 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 51 2 present present JJ work_jyzsgzx6ozemtdrfjlhthibtsm 51 3 report report NN work_jyzsgzx6ozemtdrfjlhthibtsm 51 4 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 51 5 based base VBN work_jyzsgzx6ozemtdrfjlhthibtsm 51 6 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 51 7 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 51 8 data datum NNS work_jyzsgzx6ozemtdrfjlhthibtsm 51 9 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 51 10 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 51 11 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 51 12 randomized randomize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 51 13 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 51 14 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 51 15 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 51 16 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 51 17 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 51 18 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 51 19 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 51 20 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 51 21 who who WP work_jyzsgzx6ozemtdrfjlhthibtsm 51 22 underwent undergo VBD work_jyzsgzx6ozemtdrfjlhthibtsm 51 23 baseline baseline JJ work_jyzsgzx6ozemtdrfjlhthibtsm 51 24 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 51 25 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 51 26 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 51 27 invited invite VBN work_jyzsgzx6ozemtdrfjlhthibtsm 51 28 again again RB work_jyzsgzx6ozemtdrfjlhthibtsm 51 29 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 51 30 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 51 31 next next JJ work_jyzsgzx6ozemtdrfjlhthibtsm 51 32 three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 51 33 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 51 34 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 51 35 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 51 36 examinations examination NNS work_jyzsgzx6ozemtdrfjlhthibtsm 51 37 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 52 1 Individuals individual NNS work_jyzsgzx6ozemtdrfjlhthibtsm 52 2 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 52 3 whom whom WP work_jyzsgzx6ozemtdrfjlhthibtsm 52 4 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 52 5 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 52 6 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 52 7 diagnosed diagnose VBN work_jyzsgzx6ozemtdrfjlhthibtsm 52 8 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 52 9 not not RB work_jyzsgzx6ozemtdrfjlhthibtsm 52 10 offered offer VBN work_jyzsgzx6ozemtdrfjlhthibtsm 52 11 subsequent subsequent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 52 12 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 52 13 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 52 14 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 53 1 http://www.wma.net/en/30publications/10policies/b3/ http://www.wma.net/en/30publications/10policies/b3/ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 53 2 http://www.wma.net/en/30publications/10policies/b3/ http://www.wma.net/en/30publications/10policies/b3/ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 53 3 http://www.ispo.toscana.it http://www.ispo.toscana.it NNP work_jyzsgzx6ozemtdrfjlhthibtsm 53 4 http://www.ispo.toscana.it http://www.ispo.toscana.it NNP work_jyzsgzx6ozemtdrfjlhthibtsm 53 5 868 868 CD work_jyzsgzx6ozemtdrfjlhthibtsm 53 6 Copyright copyright NN work_jyzsgzx6ozemtdrfjlhthibtsm 53 7 © © NN work_jyzsgzx6ozemtdrfjlhthibtsm 53 8 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 53 9 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 53 10 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 53 11 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 53 12 Association Association NNP work_jyzsgzx6ozemtdrfjlhthibtsm 53 13 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 53 14 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 53 15 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 53 16 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 53 17 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 53 18 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 53 19 Pegna Pegna NNP work_jyzsgzx6ozemtdrfjlhthibtsm 53 20 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 53 21 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 53 22 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 54 1 Journal Journal NNP work_jyzsgzx6ozemtdrfjlhthibtsm 54 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 54 3 Thoracic Thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 54 4 Oncology Oncology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 54 5 ® ® NNP work_jyzsgzx6ozemtdrfjlhthibtsm 54 6     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 54 7 • • NN work_jyzsgzx6ozemtdrfjlhthibtsm 54 8     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 54 9 Volume volume NN work_jyzsgzx6ozemtdrfjlhthibtsm 54 10     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 54 11 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 54 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 54 13     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 54 14 Number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 54 15     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 54 16 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 54 17 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 54 18     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 54 19 July July NNP work_jyzsgzx6ozemtdrfjlhthibtsm 54 20     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 54 21 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 54 22 Procedure Procedure NNP work_jyzsgzx6ozemtdrfjlhthibtsm 54 23 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 54 24 Instrument Instrument NNP work_jyzsgzx6ozemtdrfjlhthibtsm 54 25 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 54 26 Screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 54 27 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 54 28 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 54 29 examinations examination NNS work_jyzsgzx6ozemtdrfjlhthibtsm 54 30 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 54 31 obtained obtain VBN work_jyzsgzx6ozemtdrfjlhthibtsm 54 32 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 54 33 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 54 34 three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 54 35 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 54 36 centers center NNS work_jyzsgzx6ozemtdrfjlhthibtsm 54 37 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 54 38 eight eight CD work_jyzsgzx6ozemtdrfjlhthibtsm 54 39 different different JJ work_jyzsgzx6ozemtdrfjlhthibtsm 54 40 spiral spiral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 54 41 scanners scanner NNS work_jyzsgzx6ozemtdrfjlhthibtsm 54 42 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 54 43 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 54 44 included include VBD work_jyzsgzx6ozemtdrfjlhthibtsm 54 45 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 54 46 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 54 47 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 54 48 single single JJ work_jyzsgzx6ozemtdrfjlhthibtsm 54 49 row row NN work_jyzsgzx6ozemtdrfjlhthibtsm 54 50 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 54 51 detectors detector NNS work_jyzsgzx6ozemtdrfjlhthibtsm 54 52 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 54 53 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 54 54 seven seven CD work_jyzsgzx6ozemtdrfjlhthibtsm 54 55 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 54 56 mul- mul- XX work_jyzsgzx6ozemtdrfjlhthibtsm 54 57 tiple tiple JJ work_jyzsgzx6ozemtdrfjlhthibtsm 54 58 rows row NNS work_jyzsgzx6ozemtdrfjlhthibtsm 54 59 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 54 60 detectors detector NNS work_jyzsgzx6ozemtdrfjlhthibtsm 54 61 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 54 62 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 54 63 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 54 64 4 4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 54 65 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 54 66 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 54 67 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 54 68 16 16 CD work_jyzsgzx6ozemtdrfjlhthibtsm 54 69 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 54 70 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 54 71 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 54 72 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 54 73 64 64 CD work_jyzsgzx6ozemtdrfjlhthibtsm 54 74 rows row NNS work_jyzsgzx6ozemtdrfjlhthibtsm 54 75 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 54 76 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 55 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 55 2 following follow VBG work_jyzsgzx6ozemtdrfjlhthibtsm 55 3 technical technical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 55 4 parameter parameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 55 5 ranges range NNS work_jyzsgzx6ozemtdrfjlhthibtsm 55 6 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 55 7 selected select VBN work_jyzsgzx6ozemtdrfjlhthibtsm 55 8 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 55 9 con- con- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 55 10 tain tain VB work_jyzsgzx6ozemtdrfjlhthibtsm 55 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 55 12 radiation radiation NN work_jyzsgzx6ozemtdrfjlhthibtsm 55 13 dose dose VBD work_jyzsgzx6ozemtdrfjlhthibtsm 55 14 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 55 15 120 120 CD work_jyzsgzx6ozemtdrfjlhthibtsm 55 16 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 55 17 140 140 CD work_jyzsgzx6ozemtdrfjlhthibtsm 55 18 kV kV NNP work_jyzsgzx6ozemtdrfjlhthibtsm 55 19 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 55 20 20 20 CD work_jyzsgzx6ozemtdrfjlhthibtsm 55 21 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 55 22 43 43 CD work_jyzsgzx6ozemtdrfjlhthibtsm 55 23 mAs ma NNS work_jyzsgzx6ozemtdrfjlhthibtsm 55 24 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 55 25 pitch pitch VB work_jyzsgzx6ozemtdrfjlhthibtsm 55 26 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 55 27 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 55 28 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 55 29 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 56 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 56 2 section section NN work_jyzsgzx6ozemtdrfjlhthibtsm 56 3 collimations collimation NNS work_jyzsgzx6ozemtdrfjlhthibtsm 56 4 ranged range VBD work_jyzsgzx6ozemtdrfjlhthibtsm 56 5 between between IN work_jyzsgzx6ozemtdrfjlhthibtsm 56 6 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 56 7 mm mm NNS work_jyzsgzx6ozemtdrfjlhthibtsm 56 8 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 56 9 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 56 10 single- single- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 56 11 detector detector NN work_jyzsgzx6ozemtdrfjlhthibtsm 56 12 scanner scanner NN work_jyzsgzx6ozemtdrfjlhthibtsm 56 13 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 56 14 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 56 15 0.75 0.75 CD work_jyzsgzx6ozemtdrfjlhthibtsm 56 16 mm mm NNS work_jyzsgzx6ozemtdrfjlhthibtsm 56 17 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 56 18 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 56 19 64-row 64-row CD work_jyzsgzx6ozemtdrfjlhthibtsm 56 20 detector detector NN work_jyzsgzx6ozemtdrfjlhthibtsm 56 21 scanner scanner NN work_jyzsgzx6ozemtdrfjlhthibtsm 56 22 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 57 1 Because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 57 2 double double JJ work_jyzsgzx6ozemtdrfjlhthibtsm 57 3 reading reading NN work_jyzsgzx6ozemtdrfjlhthibtsm 57 4 increases increase VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 57 5 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 57 6 sensitivity sensitivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 57 7 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 57 8 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 57 9 screening,41 screening,41 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 57 10 each each DT work_jyzsgzx6ozemtdrfjlhthibtsm 57 11 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 57 12 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 57 13 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 57 14 assessed assess VBN work_jyzsgzx6ozemtdrfjlhthibtsm 57 15 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 57 16 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 57 17 workstation workstation NN work_jyzsgzx6ozemtdrfjlhthibtsm 57 18 independently independently RB work_jyzsgzx6ozemtdrfjlhthibtsm 57 19 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 57 20 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 57 21 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 57 22 17 17 CD work_jyzsgzx6ozemtdrfjlhthibtsm 57 23 certified certify VBN work_jyzsgzx6ozemtdrfjlhthibtsm 57 24 radiolo- radiolo- NN work_jyzsgzx6ozemtdrfjlhthibtsm 57 25 gists gist NNS work_jyzsgzx6ozemtdrfjlhthibtsm 57 26 having have VBG work_jyzsgzx6ozemtdrfjlhthibtsm 57 27 at at RB work_jyzsgzx6ozemtdrfjlhthibtsm 57 28 least least RBS work_jyzsgzx6ozemtdrfjlhthibtsm 57 29 5 5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 57 30 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 57 31 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 57 32 experience experience NN work_jyzsgzx6ozemtdrfjlhthibtsm 57 33 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 57 34 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 57 35 computed compute VBD work_jyzsgzx6ozemtdrfjlhthibtsm 57 36 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 57 37 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 57 38 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 57 39 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 57 40 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 58 1 A a DT work_jyzsgzx6ozemtdrfjlhthibtsm 58 2 consensus consensus NN work_jyzsgzx6ozemtdrfjlhthibtsm 58 3 between between IN work_jyzsgzx6ozemtdrfjlhthibtsm 58 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 58 5 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 58 6 radiologists radiologist NNS work_jyzsgzx6ozemtdrfjlhthibtsm 58 7 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 58 8 reached reach VBN work_jyzsgzx6ozemtdrfjlhthibtsm 58 9 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 58 10 case case NN work_jyzsgzx6ozemtdrfjlhthibtsm 58 11 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 58 12 disagreement disagreement NN work_jyzsgzx6ozemtdrfjlhthibtsm 58 13 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 59 1 All all DT work_jyzsgzx6ozemtdrfjlhthibtsm 59 2 previous previous JJ work_jyzsgzx6ozemtdrfjlhthibtsm 59 3 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 59 4 examinations examination NNS work_jyzsgzx6ozemtdrfjlhthibtsm 59 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 59 6 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 59 7 subject subject NN work_jyzsgzx6ozemtdrfjlhthibtsm 59 8 obtained obtain VBN work_jyzsgzx6ozemtdrfjlhthibtsm 59 9 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 59 10 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 59 11 context context NN work_jyzsgzx6ozemtdrfjlhthibtsm 59 12 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 59 13 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 59 14 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 59 15 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 59 16 available available JJ work_jyzsgzx6ozemtdrfjlhthibtsm 59 17 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 59 18 comparison comparison NN work_jyzsgzx6ozemtdrfjlhthibtsm 59 19 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 60 1 Management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 60 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 60 3 posi- posi- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 60 4 tive tive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 60 5 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 60 6 tests test NNS work_jyzsgzx6ozemtdrfjlhthibtsm 60 7 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 60 8 carried carry VBN work_jyzsgzx6ozemtdrfjlhthibtsm 60 9 out out RP work_jyzsgzx6ozemtdrfjlhthibtsm 60 10 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 60 11 each each DT work_jyzsgzx6ozemtdrfjlhthibtsm 60 12 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 60 13 cen- cen- NN work_jyzsgzx6ozemtdrfjlhthibtsm 60 14 ter ter NN work_jyzsgzx6ozemtdrfjlhthibtsm 60 15 according accord VBG work_jyzsgzx6ozemtdrfjlhthibtsm 60 16 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 60 17 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 60 18 shared shared JJ work_jyzsgzx6ozemtdrfjlhthibtsm 60 19 protocol,20 protocol,20 NN work_jyzsgzx6ozemtdrfjlhthibtsm 60 20 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 60 21 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 60 22 fundamentally fundamentally RB work_jyzsgzx6ozemtdrfjlhthibtsm 60 23 derived derive VBN work_jyzsgzx6ozemtdrfjlhthibtsm 60 24 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 60 25 that that DT work_jyzsgzx6ozemtdrfjlhthibtsm 60 26 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 60 27 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 60 28 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 60 29 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 60 30 ELCAP ELCAP NNP work_jyzsgzx6ozemtdrfjlhthibtsm 60 31 Study.35 Study.35 . work_jyzsgzx6ozemtdrfjlhthibtsm 60 32 This this DT work_jyzsgzx6ozemtdrfjlhthibtsm 60 33 includes include VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 60 34 follow follow VB work_jyzsgzx6ozemtdrfjlhthibtsm 60 35 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 60 36 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 60 37 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 60 38 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 60 39 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 60 40 without without IN work_jyzsgzx6ozemtdrfjlhthibtsm 60 41 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 60 42 month month NN work_jyzsgzx6ozemtdrfjlhthibtsm 60 43 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 60 44 antibi- antibi- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 60 45 otic otic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 60 46 therapy therapy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 60 47 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 60 48 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 60 49 2-[18F]fluoro-2-deoxy 2-[18f]fluoro-2-deoxy CD work_jyzsgzx6ozemtdrfjlhthibtsm 60 50 - - SYM work_jyzsgzx6ozemtdrfjlhthibtsm 60 51 D D NNP work_jyzsgzx6ozemtdrfjlhthibtsm 60 52 glucose glucose NNP work_jyzsgzx6ozemtdrfjlhthibtsm 60 53 positron positron NNP work_jyzsgzx6ozemtdrfjlhthibtsm 60 54 emission emission NN work_jyzsgzx6ozemtdrfjlhthibtsm 60 55 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 60 56 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 60 57 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 60 58 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 60 59 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 60 60 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 60 61 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 60 62 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 60 63 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 60 64 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 60 65 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 60 66 fine fine JJ work_jyzsgzx6ozemtdrfjlhthibtsm 60 67 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 60 68 needle needle NN work_jyzsgzx6ozemtdrfjlhthibtsm 60 69 aspiration aspiration NN work_jyzsgzx6ozemtdrfjlhthibtsm 60 70 biopsy biopsy NN work_jyzsgzx6ozemtdrfjlhthibtsm 60 71 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 60 72 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 60 73 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 60 74 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 61 1 Optical optical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 61 2 fibrobronchoscopy fibrobronchoscopy NN work_jyzsgzx6ozemtdrfjlhthibtsm 61 3 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 61 4 FBS FBS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 61 5 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 61 6 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 61 7 also also RB work_jyzsgzx6ozemtdrfjlhthibtsm 61 8 performed perform VBN work_jyzsgzx6ozemtdrfjlhthibtsm 61 9 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 61 10 selected select VBN work_jyzsgzx6ozemtdrfjlhthibtsm 61 11 cases case NNS work_jyzsgzx6ozemtdrfjlhthibtsm 61 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 62 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 62 2 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 3 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 62 4 PET pet JJ work_jyzsgzx6ozemtdrfjlhthibtsm 62 5 examinations examination NNS work_jyzsgzx6ozemtdrfjlhthibtsm 62 6 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 62 7 performed perform VBN work_jyzsgzx6ozemtdrfjlhthibtsm 62 8 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 62 9 three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 62 10 centers center NNS work_jyzsgzx6ozemtdrfjlhthibtsm 62 11 using use VBG work_jyzsgzx6ozemtdrfjlhthibtsm 62 12 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 62 13 scanners scanner NNS work_jyzsgzx6ozemtdrfjlhthibtsm 62 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 62 15 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 62 16 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 62 17 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 62 18 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 62 19 dedicated dedicated JJ work_jyzsgzx6ozemtdrfjlhthibtsm 62 20 positron positron NN work_jyzsgzx6ozemtdrfjlhthibtsm 62 21 emission emission NN work_jyzsgzx6ozemtdrfjlhthibtsm 62 22 tomographs tomographs NN work_jyzsgzx6ozemtdrfjlhthibtsm 62 23 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 62 24 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 62 25 GE GE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 26 Advance Advance NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 27 positron positron NN work_jyzsgzx6ozemtdrfjlhthibtsm 62 28 emission emission NN work_jyzsgzx6ozemtdrfjlhthibtsm 62 29 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 62 30 [ [ -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 62 31 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 32 ] ] -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 62 33 scanner scanner NN work_jyzsgzx6ozemtdrfjlhthibtsm 62 34 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 62 35 General General NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 36 Electric Electric NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 37 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 62 38 Milwaukee Milwaukee NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 39 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 62 40 WI WI NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 41 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 62 42 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 62 43 ECAT ECAT VBN work_jyzsgzx6ozemtdrfjlhthibtsm 62 44 Exact exact JJ work_jyzsgzx6ozemtdrfjlhthibtsm 62 45 HR+ hr+ NN work_jyzsgzx6ozemtdrfjlhthibtsm 62 46 scanner scanner NN work_jyzsgzx6ozemtdrfjlhthibtsm 62 47 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 62 48 Siemens Siemens NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 49 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 62 50 Erlangen Erlangen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 51 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 62 52 Germany Germany NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 53 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 62 54 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 62 55 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 62 56 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 62 57 dual dual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 62 58 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 62 59 modality modality NN work_jyzsgzx6ozemtdrfjlhthibtsm 62 60 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 61 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 62 62 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 63 scanners scanner NNS work_jyzsgzx6ozemtdrfjlhthibtsm 62 64 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 62 65 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 62 66 Discovery Discovery NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 67 LS LS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 68 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 62 69 General General NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 70 Electric Electric NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 71 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 62 72 Milwaukee Milwaukee NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 73 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 62 74 WI WI NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 75 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 62 76 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 62 77 Gemini Gemini NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 78 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 62 79 Philips Philips NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 80 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 62 81 Eindhoven Eindhoven NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 82 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 62 83 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 62 84 Netherlands Netherlands NNP work_jyzsgzx6ozemtdrfjlhthibtsm 62 85 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 62 86 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 63 1 Three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 63 2 trained train VBN work_jyzsgzx6ozemtdrfjlhthibtsm 63 3 nuclear nuclear JJ work_jyzsgzx6ozemtdrfjlhthibtsm 63 4 medicine medicine NN work_jyzsgzx6ozemtdrfjlhthibtsm 63 5 physicians physician NNS work_jyzsgzx6ozemtdrfjlhthibtsm 63 6 visually visually RB work_jyzsgzx6ozemtdrfjlhthibtsm 63 7 evaluated evaluate VBD work_jyzsgzx6ozemtdrfjlhthibtsm 63 8 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 63 9 tracer tracer NN work_jyzsgzx6ozemtdrfjlhthibtsm 63 10 uptake uptake NN work_jyzsgzx6ozemtdrfjlhthibtsm 63 11 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 63 12 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 63 13 suspicious suspicious JJ work_jyzsgzx6ozemtdrfjlhthibtsm 63 14 lesion lesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 63 15 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 63 16 classified classify VBD work_jyzsgzx6ozemtdrfjlhthibtsm 63 17 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 63 18 result result NN work_jyzsgzx6ozemtdrfjlhthibtsm 63 19 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 63 20 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 63 21 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 63 22 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 63 23 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 63 24 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 63 25 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 63 26 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 63 27 indeterminate indeterminate JJ work_jyzsgzx6ozemtdrfjlhthibtsm 63 28 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 63 29 mild mild JJ work_jyzsgzx6ozemtdrfjlhthibtsm 63 30 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 63 31 faint faint JJ work_jyzsgzx6ozemtdrfjlhthibtsm 63 32 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 63 33 uptake uptake NN work_jyzsgzx6ozemtdrfjlhthibtsm 63 34 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 63 35 typically typically RB work_jyzsgzx6ozemtdrfjlhthibtsm 63 36 similar similar JJ work_jyzsgzx6ozemtdrfjlhthibtsm 63 37 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 63 38 that that DT work_jyzsgzx6ozemtdrfjlhthibtsm 63 39 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 63 40 mediastinum mediastinum NN work_jyzsgzx6ozemtdrfjlhthibtsm 63 41 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 63 42 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 63 43 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 63 44 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 63 45 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 64 1 Because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 64 2 most most JJS work_jyzsgzx6ozemtdrfjlhthibtsm 64 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 64 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 64 5 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 64 6 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 64 7 be be VB work_jyzsgzx6ozemtdrfjlhthibtsm 64 8 investigated investigate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 64 9 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 64 10 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 64 11 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 64 12 size size NN work_jyzsgzx6ozemtdrfjlhthibtsm 64 13 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 64 14 we -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 64 15 did do VBD work_jyzsgzx6ozemtdrfjlhthibtsm 64 16 not not RB work_jyzsgzx6ozemtdrfjlhthibtsm 64 17 use use VB work_jyzsgzx6ozemtdrfjlhthibtsm 64 18 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 64 19 standardized standardized JJ work_jyzsgzx6ozemtdrfjlhthibtsm 64 20 uptake uptake JJ work_jyzsgzx6ozemtdrfjlhthibtsm 64 21 value value NN work_jyzsgzx6ozemtdrfjlhthibtsm 64 22 because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 64 23 it -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 64 24 can can MD work_jyzsgzx6ozemtdrfjlhthibtsm 64 25 be be VB work_jyzsgzx6ozemtdrfjlhthibtsm 64 26 unreliable unreliable JJ work_jyzsgzx6ozemtdrfjlhthibtsm 64 27 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 64 28 characterizing characterizing NN work_jyzsgzx6ozemtdrfjlhthibtsm 64 29 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 64 30 uptake.37.42 uptake.37.42 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 64 31 Moreover moreover RB work_jyzsgzx6ozemtdrfjlhthibtsm 64 32 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 64 33 taking take VBG work_jyzsgzx6ozemtdrfjlhthibtsm 64 34 into into IN work_jyzsgzx6ozemtdrfjlhthibtsm 64 35 con- con- NN work_jyzsgzx6ozemtdrfjlhthibtsm 64 36 sideration sideration NN work_jyzsgzx6ozemtdrfjlhthibtsm 64 37 that that WDT work_jyzsgzx6ozemtdrfjlhthibtsm 64 38 tumors tumor NNS work_jyzsgzx6ozemtdrfjlhthibtsm 64 39 identified identify VBN work_jyzsgzx6ozemtdrfjlhthibtsm 64 40 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 64 41 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 64 42 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 64 43 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 64 44 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 64 45 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 64 46 can can MD work_jyzsgzx6ozemtdrfjlhthibtsm 64 47 show show VB work_jyzsgzx6ozemtdrfjlhthibtsm 64 48 low low JJ work_jyzsgzx6ozemtdrfjlhthibtsm 64 49 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 64 50 uptake,42,43 uptake,42,43 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 64 51 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 64 52 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 64 53 purpose purpose NN work_jyzsgzx6ozemtdrfjlhthibtsm 64 54 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 64 55 compu- compu- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 64 56 tation tation NN work_jyzsgzx6ozemtdrfjlhthibtsm 64 57 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 64 58 performance performance NN work_jyzsgzx6ozemtdrfjlhthibtsm 64 59 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 64 60 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 64 61 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 64 62 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 64 63 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 64 64 we -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 64 65 assimilated assimilate VBD work_jyzsgzx6ozemtdrfjlhthibtsm 64 66 indetermi- indetermi- XX work_jyzsgzx6ozemtdrfjlhthibtsm 64 67 nate nate VBP work_jyzsgzx6ozemtdrfjlhthibtsm 64 68 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 64 69 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 64 70 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 64 71 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 64 72 PET pet JJ work_jyzsgzx6ozemtdrfjlhthibtsm 64 73 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 64 74 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 65 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 65 2 majority majority NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 3 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 65 4 35 35 CD work_jyzsgzx6ozemtdrfjlhthibtsm 65 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 65 6 38 38 CD work_jyzsgzx6ozemtdrfjlhthibtsm 65 7 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 65 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 65 9 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 65 10 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 11 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 65 12 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 65 13 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 14 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 65 15 performed perform VBN work_jyzsgzx6ozemtdrfjlhthibtsm 65 16 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 65 17 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 65 18 experienced experienced JJ work_jyzsgzx6ozemtdrfjlhthibtsm 65 19 interventional interventional JJ work_jyzsgzx6ozemtdrfjlhthibtsm 65 20 radiologists radiologist NNS work_jyzsgzx6ozemtdrfjlhthibtsm 65 21 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 65 22 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 65 23 single single JJ work_jyzsgzx6ozemtdrfjlhthibtsm 65 24 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 65 25 detector detector NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 26 spiral spiral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 65 27 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 28 scanner scanner NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 29 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 65 30 Somatom Somatom NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 31 plus plus CC work_jyzsgzx6ozemtdrfjlhthibtsm 65 32 4 4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 65 33 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 65 34 Siemens Siemens NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 35 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 65 36 Erlangen Erlangen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 37 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 65 38 Germany Germany NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 39 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 65 40 used use VBD work_jyzsgzx6ozemtdrfjlhthibtsm 65 41 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 65 42 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 65 43 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 44 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 45 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 65 46 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 65 47 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 48 center center NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 49 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 65 50 where where WRB work_jyzsgzx6ozemtdrfjlhthibtsm 65 51 aspiration aspiration NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 52 material material NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 53 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 65 54 evaluated evaluate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 65 55 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 65 56 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 65 57 trained train VBN work_jyzsgzx6ozemtdrfjlhthibtsm 65 58 cytopathologist cytopathologist NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 59 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 65 60 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 65 61 rapid rapid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 65 62 onsite onsite JJ work_jyzsgzx6ozemtdrfjlhthibtsm 65 63 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 64 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 65 65 ROSE ROSE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 66 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 65 67 technique.44,45 technique.44,45 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 68 Three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 65 69 CT ct NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 70 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 65 71 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 65 72 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 73 without without IN work_jyzsgzx6ozemtdrfjlhthibtsm 65 74 ROSE ROSE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 75 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 65 76 performed perform VBN work_jyzsgzx6ozemtdrfjlhthibtsm 65 77 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 65 78 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 65 79 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 80 radiologist radiologist NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 81 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 65 82 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 65 83 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 65 84 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 65 85 detector detector NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 86 spi- spi- CC work_jyzsgzx6ozemtdrfjlhthibtsm 65 87 ral ral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 65 88 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 89 scanner scanner NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 90 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 65 91 Somatom Somatom NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 92 Volume Volume NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 93 Zoom Zoom NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 94 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 65 95 Siemens Siemens NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 96 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 65 97 Erlangen Erlangen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 98 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 65 99 Germany Germany NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 100 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 65 101 used use VBD work_jyzsgzx6ozemtdrfjlhthibtsm 65 102 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 65 103 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 65 104 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 105 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 65 106 another another DT work_jyzsgzx6ozemtdrfjlhthibtsm 65 107 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 108 center center NN work_jyzsgzx6ozemtdrfjlhthibtsm 65 109 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 66 1 For for IN work_jyzsgzx6ozemtdrfjlhthibtsm 66 2 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 66 3 purpose purpose NN work_jyzsgzx6ozemtdrfjlhthibtsm 66 4 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 66 5 computation computation NN work_jyzsgzx6ozemtdrfjlhthibtsm 66 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 66 7 performance performance NN work_jyzsgzx6ozemtdrfjlhthibtsm 66 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 66 9 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 66 10 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 66 11 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 66 12 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 66 13 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 66 14 we -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 66 15 assimilated assimilate VBD work_jyzsgzx6ozemtdrfjlhthibtsm 66 16 inconclusive inconclusive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 66 17 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 66 18 because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 66 19 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 66 20 inadequate inadequate JJ work_jyzsgzx6ozemtdrfjlhthibtsm 66 21 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 66 22 insufficient insufficient JJ work_jyzsgzx6ozemtdrfjlhthibtsm 66 23 material material NN work_jyzsgzx6ozemtdrfjlhthibtsm 66 24 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 66 25 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 66 26 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 66 27 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 67 1 Criteria criterion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 67 2 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 3 Positive Positive NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 4 Test Test NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 5 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 67 6 Further Further NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 7 Diagnostic Diagnostic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 8 Investigations Investigations NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 67 9 Positivity positivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 10 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 67 12 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 13 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 14 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 15 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 67 16 fundamen- fundamen- IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 17 tally tally NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 18 based base VBN work_jyzsgzx6ozemtdrfjlhthibtsm 67 19 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 20 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 67 21 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 22 size size NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 23 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 67 24 growth growth NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 25 measured measure VBN work_jyzsgzx6ozemtdrfjlhthibtsm 67 26 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 27 terms term NNS work_jyzsgzx6ozemtdrfjlhthibtsm 67 28 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 29 mean mean JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 30 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 31 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 67 32 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 67 33 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 67 34 manually manually RB work_jyzsgzx6ozemtdrfjlhthibtsm 67 35 computed compute VBN work_jyzsgzx6ozemtdrfjlhthibtsm 67 36 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 37 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 67 38 radi- radi- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 39 ologist ologist NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 40 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 41 electronic electronic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 42 callipers calliper NNS work_jyzsgzx6ozemtdrfjlhthibtsm 67 43 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 44 workstations.20 workstations.20 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 45 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 46 particu- particu- NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 47 lar lar NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 48 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 67 49 significant significant JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 50 growth growth NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 51 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 67 52 defined define VBN work_jyzsgzx6ozemtdrfjlhthibtsm 67 53 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 54 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 67 55 increase increase NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 56 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 57 at at RB work_jyzsgzx6ozemtdrfjlhthibtsm 67 58 least least JJS work_jyzsgzx6ozemtdrfjlhthibtsm 67 59 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 67 60 mm mm CD work_jyzsgzx6ozemtdrfjlhthibtsm 67 61 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 62 mean mean NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 63 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 64 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 65 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 67 66 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 67 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 67 68 nonsolid nonsolid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 69 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 70 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 67 71 taking take VBG work_jyzsgzx6ozemtdrfjlhthibtsm 67 72 into into IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 73 account account NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 74 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 67 75 intra- intra- NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 76 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 67 77 interoperator interoperator NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 78 variability variability NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 79 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 80 measur- measur- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 81 ing ing NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 82 mean mean JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 83 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 84 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 85 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 86 nodules,46 nodules,46 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 87 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 67 88 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 67 89 appearance appearance NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 90 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 67 91 increase increase NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 92 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 93 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 67 94 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 95 component component NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 96 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 97 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 67 98 nonsolid nonsolid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 99 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 67 100 part part NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 101 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 67 102 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 103 nod- nod- NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 104 ule ule NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 105 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 106 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 67 107 successive successive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 108 LDCT ldct NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 109 examinations.35 examinations.35 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 110 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 67 111 criteria criterion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 67 112 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 113 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 114 tests test NNS work_jyzsgzx6ozemtdrfjlhthibtsm 67 115 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 67 116 further further JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 117 diagnostic diagnostic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 118 investigations investigation NNS work_jyzsgzx6ozemtdrfjlhthibtsm 67 119 concern- concern- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 120 ing ing NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 121 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 122 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 123 round round NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 124 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 67 125 previously previously RB work_jyzsgzx6ozemtdrfjlhthibtsm 67 126 detailed.20 detailed.20 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 127 At at IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 128 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 129 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 130 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 131 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 67 132 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 67 133 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 67 134 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 67 135 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 136 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 67 137 considered consider VBN work_jyzsgzx6ozemtdrfjlhthibtsm 67 138 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 139 if if IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 140 either either CC work_jyzsgzx6ozemtdrfjlhthibtsm 67 141 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 67 142 new new JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 143 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 144 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 67 145 part part NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 146 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 67 147 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 148 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 67 149 nonsolid nonsolid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 150 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 151 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 67 152 identified identify VBN work_jyzsgzx6ozemtdrfjlhthibtsm 67 153 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 67 154 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 67 155 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 156 least least RBS work_jyzsgzx6ozemtdrfjlhthibtsm 67 157 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 67 158 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 159 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 67 160 part part NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 161 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 67 162 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 163 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 67 164 non- non- RB work_jyzsgzx6ozemtdrfjlhthibtsm 67 165 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 166 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 167 already already RB work_jyzsgzx6ozemtdrfjlhthibtsm 67 168 present present JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 169 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 67 170 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 67 171 last last JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 172 LDCT ldct NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 173 showed show VBD work_jyzsgzx6ozemtdrfjlhthibtsm 67 174 interim interim JJ work_jyzsgzx6ozemtdrfjlhthibtsm 67 175 growth growth NN work_jyzsgzx6ozemtdrfjlhthibtsm 67 176 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 68 1 If if IN work_jyzsgzx6ozemtdrfjlhthibtsm 68 2 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 68 3 new new JJ work_jyzsgzx6ozemtdrfjlhthibtsm 68 4 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 68 5 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 68 6 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 68 7 mean mean JJ work_jyzsgzx6ozemtdrfjlhthibtsm 68 8 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 68 9 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 68 10 mm mm NNS work_jyzsgzx6ozemtdrfjlhthibtsm 68 11 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 68 12 less less JJR work_jyzsgzx6ozemtdrfjlhthibtsm 68 13 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 68 14 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 68 15 subject subject NN work_jyzsgzx6ozemtdrfjlhthibtsm 68 16 received receive VBD work_jyzsgzx6ozemtdrfjlhthibtsm 68 17 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 68 18 6-month 6-month CD work_jyzsgzx6ozemtdrfjlhthibtsm 68 19 follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 68 20 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 68 21 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 68 22 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 68 23 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 68 24 whereas whereas IN work_jyzsgzx6ozemtdrfjlhthibtsm 68 25 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 68 26 3-month 3-month CD work_jyzsgzx6ozemtdrfjlhthibtsm 68 27 follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 68 28 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 68 29 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 68 30 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 68 31 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 68 32 obtained obtain VBN work_jyzsgzx6ozemtdrfjlhthibtsm 68 33 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 68 34 case case NN work_jyzsgzx6ozemtdrfjlhthibtsm 68 35 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 68 36 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 68 37 new new JJ work_jyzsgzx6ozemtdrfjlhthibtsm 68 38 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 68 39 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 68 40 mean mean JJ work_jyzsgzx6ozemtdrfjlhthibtsm 68 41 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 68 42 between between IN work_jyzsgzx6ozemtdrfjlhthibtsm 68 43 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 68 44 mm mm NNP work_jyzsgzx6ozemtdrfjlhthibtsm 68 45 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 68 46 5 5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 68 47 mm mm CD work_jyzsgzx6ozemtdrfjlhthibtsm 68 48 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 69 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 69 2 case case NN work_jyzsgzx6ozemtdrfjlhthibtsm 69 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 69 4 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 69 5 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 69 6 that that WDT work_jyzsgzx6ozemtdrfjlhthibtsm 69 7 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 69 8 5 5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 69 9 mm mm CD work_jyzsgzx6ozemtdrfjlhthibtsm 69 10 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 69 11 more more JJR work_jyzsgzx6ozemtdrfjlhthibtsm 69 12 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 69 13 size size NN work_jyzsgzx6ozemtdrfjlhthibtsm 69 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 69 15 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 69 16 if if IN work_jyzsgzx6ozemtdrfjlhthibtsm 69 17 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 69 18 screen- screen- NN work_jyzsgzx6ozemtdrfjlhthibtsm 69 19 ing ing NNP work_jyzsgzx6ozemtdrfjlhthibtsm 69 20 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 69 21 revealed reveal VBD work_jyzsgzx6ozemtdrfjlhthibtsm 69 22 multiple multiple JJ work_jyzsgzx6ozemtdrfjlhthibtsm 69 23 focal focal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 69 24 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 69 25 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 69 26 nonsolid nonsolid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 69 27 abnormali- abnormali- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 69 28 ties tie NNS work_jyzsgzx6ozemtdrfjlhthibtsm 69 29 consistent consistent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 69 30 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 69 31 inflammatory inflammatory JJ work_jyzsgzx6ozemtdrfjlhthibtsm 69 32 disease disease NN work_jyzsgzx6ozemtdrfjlhthibtsm 69 33 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 69 34 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 69 35 follow follow VB work_jyzsgzx6ozemtdrfjlhthibtsm 69 36 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 69 37 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 69 38 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 69 39 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 69 40 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 69 41 month month NN work_jyzsgzx6ozemtdrfjlhthibtsm 69 42 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 69 43 antibiotic antibiotic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 69 44 therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 69 45 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 69 46 recommended recommend VBN work_jyzsgzx6ozemtdrfjlhthibtsm 69 47 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 70 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 70 2 case case NN work_jyzsgzx6ozemtdrfjlhthibtsm 70 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 70 4 complete complete JJ work_jyzsgzx6ozemtdrfjlhthibtsm 70 5 resolution resolution NN work_jyzsgzx6ozemtdrfjlhthibtsm 70 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 70 7 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 70 8 abnormalities abnormality NNS work_jyzsgzx6ozemtdrfjlhthibtsm 70 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 70 10 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 70 11 subject subject NN work_jyzsgzx6ozemtdrfjlhthibtsm 70 12 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 70 13 sent send VBN work_jyzsgzx6ozemtdrfjlhthibtsm 70 14 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 70 15 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 70 16 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 70 17 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 70 18 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 70 19 whereas whereas IN work_jyzsgzx6ozemtdrfjlhthibtsm 70 20 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 70 21 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 70 22 further further JJ work_jyzsgzx6ozemtdrfjlhthibtsm 70 23 follow follow VB work_jyzsgzx6ozemtdrfjlhthibtsm 70 24 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 70 25 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 70 26 LDCT ldct NN work_jyzsgzx6ozemtdrfjlhthibtsm 70 27 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 70 28 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 70 29 months month NNS work_jyzsgzx6ozemtdrfjlhthibtsm 70 30 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 70 31 performed perform VBN work_jyzsgzx6ozemtdrfjlhthibtsm 70 32 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 70 33 case case NN work_jyzsgzx6ozemtdrfjlhthibtsm 70 34 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 70 35 partial partial JJ work_jyzsgzx6ozemtdrfjlhthibtsm 70 36 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 70 37 lack lack NN work_jyzsgzx6ozemtdrfjlhthibtsm 70 38 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 70 39 resolution resolution NN work_jyzsgzx6ozemtdrfjlhthibtsm 70 40 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 70 41 antibiotic antibiotic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 70 42 therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 70 43 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 71 1 When when WRB work_jyzsgzx6ozemtdrfjlhthibtsm 71 2 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 71 3 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 71 4 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 71 5 observed observe VBN work_jyzsgzx6ozemtdrfjlhthibtsm 71 6 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 71 7 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 71 8 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 71 9 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 71 10 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 71 11 round round NN work_jyzsgzx6ozemtdrfjlhthibtsm 71 12 attained attain VBD work_jyzsgzx6ozemtdrfjlhthibtsm 71 13 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 71 14 mean mean JJ work_jyzsgzx6ozemtdrfjlhthibtsm 71 15 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 71 16 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 71 17 mm mm NNS work_jyzsgzx6ozemtdrfjlhthibtsm 71 18 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 71 19 more more JJR work_jyzsgzx6ozemtdrfjlhthibtsm 71 20 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 71 21 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 71 22 persisted persist VBN work_jyzsgzx6ozemtdrfjlhthibtsm 71 23 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 71 24 antibiotic antibiotic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 71 25 therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 71 26 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 71 27 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 71 28 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 71 29 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 71 30 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 71 31 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 71 32 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 71 33 recommended recommend VBN work_jyzsgzx6ozemtdrfjlhthibtsm 71 34 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 72 1 However however RB work_jyzsgzx6ozemtdrfjlhthibtsm 72 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 72 3 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 72 4 some some DT work_jyzsgzx6ozemtdrfjlhthibtsm 72 5 cases case NNS work_jyzsgzx6ozemtdrfjlhthibtsm 72 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 72 7 large large JJ work_jyzsgzx6ozemtdrfjlhthibtsm 72 8 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 72 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 72 10 strongly strongly RB work_jyzsgzx6ozemtdrfjlhthibtsm 72 11 suggestive suggestive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 72 12 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 72 13 malignancy malignancy NN work_jyzsgzx6ozemtdrfjlhthibtsm 72 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 72 15 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 72 16 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 72 17 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 72 18 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 72 19 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 72 20 FBS FBS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 72 21 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 72 22 directly directly RB work_jyzsgzx6ozemtdrfjlhthibtsm 72 23 performed perform VBN work_jyzsgzx6ozemtdrfjlhthibtsm 72 24 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 73 1 For for IN work_jyzsgzx6ozemtdrfjlhthibtsm 73 2 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 73 3 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 73 4 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 73 5 – – : work_jyzsgzx6ozemtdrfjlhthibtsm 73 6 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 73 7 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 73 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 73 9 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 73 10 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 73 11 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 73 12 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 73 13 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 73 14 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 73 15 ROSE ROSE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 73 16 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 73 17 recommended recommend VBN work_jyzsgzx6ozemtdrfjlhthibtsm 73 18 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 73 19 whereas whereas RB work_jyzsgzx6ozemtdrfjlhthibtsm 73 20 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 73 21 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 73 22 further further JJ work_jyzsgzx6ozemtdrfjlhthibtsm 73 23 3-month 3-month CD work_jyzsgzx6ozemtdrfjlhthibtsm 73 24 follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 73 25 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 73 26 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 73 27 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 73 28 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 73 29 obtained obtain VBN work_jyzsgzx6ozemtdrfjlhthibtsm 73 30 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 73 31 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 73 32 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 73 33 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 73 34 – – : work_jyzsgzx6ozemtdrfjlhthibtsm 73 35 indeterminate indeterminate JJ work_jyzsgzx6ozemtdrfjlhthibtsm 73 36 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 73 37 – – : work_jyzsgzx6ozemtdrfjlhthibtsm 73 38 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 73 39 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 73 40 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 74 1 A a DT work_jyzsgzx6ozemtdrfjlhthibtsm 74 2 3-month 3-month CD work_jyzsgzx6ozemtdrfjlhthibtsm 74 3 follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 74 4 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 74 5 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 74 6 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 74 7 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 74 8 also also RB work_jyzsgzx6ozemtdrfjlhthibtsm 74 9 scheduled schedule VBN work_jyzsgzx6ozemtdrfjlhthibtsm 74 10 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 74 11 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 74 12 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 74 13 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 74 14 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 74 15 indeterminate indeterminate JJ work_jyzsgzx6ozemtdrfjlhthibtsm 74 16 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 74 17 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 74 18 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 74 19 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 74 20 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 74 21 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 74 22 inconclusive inconclusive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 74 23 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 74 24 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 74 25 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 74 26 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 74 27 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 75 1 All all DT work_jyzsgzx6ozemtdrfjlhthibtsm 75 2 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 75 3 showing show VBG work_jyzsgzx6ozemtdrfjlhthibtsm 75 4 no no DT work_jyzsgzx6ozemtdrfjlhthibtsm 75 5 nodule nodule JJ work_jyzsgzx6ozemtdrfjlhthibtsm 75 6 growth growth NN work_jyzsgzx6ozemtdrfjlhthibtsm 75 7 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 75 8 this this DT work_jyzsgzx6ozemtdrfjlhthibtsm 75 9 latter latter JJ work_jyzsgzx6ozemtdrfjlhthibtsm 75 10 follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 75 11 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 75 12 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 75 13 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 75 14 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 75 15 invited invite VBN work_jyzsgzx6ozemtdrfjlhthibtsm 75 16 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 75 17 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 75 18 subsequent subsequent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 75 19 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 75 20 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 75 21 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 75 22 scan scan NNP work_jyzsgzx6ozemtdrfjlhthibtsm 75 23 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 76 1 For for IN work_jyzsgzx6ozemtdrfjlhthibtsm 76 2 pure pure JJ work_jyzsgzx6ozemtdrfjlhthibtsm 76 3 nonsolid nonsolid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 76 4 noncalcified noncalcified JJ work_jyzsgzx6ozemtdrfjlhthibtsm 76 5 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 76 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 76 7 at at RB work_jyzsgzx6ozemtdrfjlhthibtsm 76 8 least least RBS work_jyzsgzx6ozemtdrfjlhthibtsm 76 9 10 10 CD work_jyzsgzx6ozemtdrfjlhthibtsm 76 10 mm mm NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 11 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 12 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 76 13 baseline baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 76 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 76 15 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 76 16 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 76 17 new new JJ work_jyzsgzx6ozemtdrfjlhthibtsm 76 18 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 76 19 growing grow VBG work_jyzsgzx6ozemtdrfjlhthibtsm 76 20 nonsolid nonsolid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 76 21 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 76 22 part part JJ work_jyzsgzx6ozemtdrfjlhthibtsm 76 23 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 76 24 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 76 25 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 26 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 76 27 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 76 28 least least RBS work_jyzsgzx6ozemtdrfjlhthibtsm 76 29 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 76 30 mm mm NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 31 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 32 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 76 33 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 76 34 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 35 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 36 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 76 37 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 76 38 persisted persist VBD work_jyzsgzx6ozemtdrfjlhthibtsm 76 39 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 76 40 antibiotic antibiotic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 76 41 therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 42 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 76 43 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 76 44 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 76 45 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 76 46 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 76 47 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 76 48 scheduled schedule VBN work_jyzsgzx6ozemtdrfjlhthibtsm 76 49 because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 76 50 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 76 51 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 76 52 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 76 53 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 76 54 not not RB work_jyzsgzx6ozemtdrfjlhthibtsm 76 55 indicated.47 indicated.47 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 76 56 All all DT work_jyzsgzx6ozemtdrfjlhthibtsm 76 57 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 76 58 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 76 59 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 60 evidence evidence NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 61 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 76 62 malignancy malignancy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 76 63 under- under- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 76 64 went go VBD work_jyzsgzx6ozemtdrfjlhthibtsm 76 65 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 76 66 staging staging JJ work_jyzsgzx6ozemtdrfjlhthibtsm 76 67 full full RB work_jyzsgzx6ozemtdrfjlhthibtsm 76 68 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 76 69 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 70 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 71 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 76 72 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 73 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 76 74 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 76 75 intra- intra- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 76 76 venous venous NNP work_jyzsgzx6ozemtdrfjlhthibtsm 76 77 iodinated iodinate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 76 78 contrast contrast NNP work_jyzsgzx6ozemtdrfjlhthibtsm 76 79 administration administration NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 80 extended extend VBD work_jyzsgzx6ozemtdrfjlhthibtsm 76 81 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 76 82 upper upper JJ work_jyzsgzx6ozemtdrfjlhthibtsm 76 83 abdomen abdomen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 76 84 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 76 85 head head NN work_jyzsgzx6ozemtdrfjlhthibtsm 76 86 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 77 1 Surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 77 2 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 77 3 recommended recommend VBN work_jyzsgzx6ozemtdrfjlhthibtsm 77 4 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 77 5 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 77 6 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 77 7 findings finding NNS work_jyzsgzx6ozemtdrfjlhthibtsm 77 8 consistent consistent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 77 9 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 77 10 malignancy malignancy NN work_jyzsgzx6ozemtdrfjlhthibtsm 77 11 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 77 12 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 77 13 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 77 14 also also RB work_jyzsgzx6ozemtdrfjlhthibtsm 77 15 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 77 16 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 77 17 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 77 18 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 77 19 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 77 20 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 77 21 PET pet NN work_jyzsgzx6ozemtdrfjlhthibtsm 77 22 – – : work_jyzsgzx6ozemtdrfjlhthibtsm 77 23 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 77 24 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 77 25 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 77 26 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 77 27 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 77 28 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 77 29 inconclusively inconclusively RB work_jyzsgzx6ozemtdrfjlhthibtsm 77 30 evaluated evaluate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 77 31 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 77 32 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 77 33 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 78 1 All all PDT work_jyzsgzx6ozemtdrfjlhthibtsm 78 2 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 78 3 surgically surgically RB work_jyzsgzx6ozemtdrfjlhthibtsm 78 4 removed remove VBN work_jyzsgzx6ozemtdrfjlhthibtsm 78 5 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 78 6 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 78 7 evaluated evaluate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 78 8 according accord VBG work_jyzsgzx6ozemtdrfjlhthibtsm 78 9 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 78 10 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 78 11 World World NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 12 Health Health NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 13 Organization Organization NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 14 criteria.48 criteria.48 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 15 Staging Staging NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 16 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 78 17 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 78 18 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 78 19 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 78 20 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 78 21 can- can- NN work_jyzsgzx6ozemtdrfjlhthibtsm 78 22 cer cer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 23 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 78 24 based base VBN work_jyzsgzx6ozemtdrfjlhthibtsm 78 25 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 78 26 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 78 27 pathology pathology NN work_jyzsgzx6ozemtdrfjlhthibtsm 78 28 report report NN work_jyzsgzx6ozemtdrfjlhthibtsm 78 29 when when WRB work_jyzsgzx6ozemtdrfjlhthibtsm 78 30 available available JJ work_jyzsgzx6ozemtdrfjlhthibtsm 78 31 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 78 32 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 78 33 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 78 34 869Copyright 869copyright CD work_jyzsgzx6ozemtdrfjlhthibtsm 78 35 © © CD work_jyzsgzx6ozemtdrfjlhthibtsm 78 36 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 78 37 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 78 38 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 78 39 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 40 Association Association NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 41 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 78 42 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 78 43 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 44 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 78 45 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 46 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 47 Journal Journal NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 48 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 78 49 Thoracic Thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 50 Oncology Oncology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 51 ® ® NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 52     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 78 53 • • NN work_jyzsgzx6ozemtdrfjlhthibtsm 78 54     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 78 55 Volume volume NN work_jyzsgzx6ozemtdrfjlhthibtsm 78 56     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 78 57 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 78 58 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 78 59     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 78 60 Number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 78 61     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 78 62 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 78 63 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 78 64     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 78 65 July July NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 66     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 78 67 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 78 68 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 69 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 78 70 Nodule Nodule NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 71 Management Management NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 72 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 78 73 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 74 clinical clinical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 78 75 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 78 76 contrast contrast NN work_jyzsgzx6ozemtdrfjlhthibtsm 78 77 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 78 78 enhanced enhance VBN work_jyzsgzx6ozemtdrfjlhthibtsm 78 79 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 78 80 findings finding NNS work_jyzsgzx6ozemtdrfjlhthibtsm 78 81 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 78 82 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 78 83 cases case NNS work_jyzsgzx6ozemtdrfjlhthibtsm 78 84 not not RB work_jyzsgzx6ozemtdrfjlhthibtsm 78 85 amenable amenable JJ work_jyzsgzx6ozemtdrfjlhthibtsm 78 86 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 78 87 surgical surgical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 78 88 resection resection NN work_jyzsgzx6ozemtdrfjlhthibtsm 78 89 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 79 1 Sputum sputum NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 2 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 79 3 blood blood NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 4 samples sample NNS work_jyzsgzx6ozemtdrfjlhthibtsm 79 5 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 79 6 obtained obtain VBN work_jyzsgzx6ozemtdrfjlhthibtsm 79 7 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 79 8 each each DT work_jyzsgzx6ozemtdrfjlhthibtsm 79 9 participant participant NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 10 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 79 11 baseline baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 79 12 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 79 13 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 14 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 15 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 79 16 again again RB work_jyzsgzx6ozemtdrfjlhthibtsm 79 17 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 79 18 case case NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 19 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 79 20 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 79 21 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 79 22 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 23 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 79 24 all all PDT work_jyzsgzx6ozemtdrfjlhthibtsm 79 25 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 79 26 samples sample NNS work_jyzsgzx6ozemtdrfjlhthibtsm 79 27 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 79 28 stored store VBN work_jyzsgzx6ozemtdrfjlhthibtsm 79 29 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 79 30 subsequent subsequent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 79 31 biomarker biomarker NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 32 evaluation.40 evaluation.40 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 79 33 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 79 34 global global JJ work_jyzsgzx6ozemtdrfjlhthibtsm 79 35 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 79 36 individual individual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 79 37 radiation radiation NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 38 dose dose VBD work_jyzsgzx6ozemtdrfjlhthibtsm 79 39 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 79 40 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 79 41 recruited recruit VBN work_jyzsgzx6ozemtdrfjlhthibtsm 79 42 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 79 43 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 79 44 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 79 45 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 46 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 79 47 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 79 48 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 79 49 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 50 has have VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 79 51 been be VBN work_jyzsgzx6ozemtdrfjlhthibtsm 79 52 previously previously RB work_jyzsgzx6ozemtdrfjlhthibtsm 79 53 reported.49 reported.49 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 79 54 RESULTS RESULTS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 79 55 One one CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 56 thousand thousand CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 57 six six CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 58 hundred hundred CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 59 thirteen thirteen CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 60 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 79 61 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 79 62 1035 1035 CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 63 men man NNS work_jyzsgzx6ozemtdrfjlhthibtsm 79 64 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 79 65 578 578 CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 66 women woman NNS work_jyzsgzx6ozemtdrfjlhthibtsm 79 67 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 79 68 mean mean VB work_jyzsgzx6ozemtdrfjlhthibtsm 79 69 age age NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 70 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 79 71 60.7 60.7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 72 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 79 73 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 79 74 mean mean VB work_jyzsgzx6ozemtdrfjlhthibtsm 79 75 pack pack NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 76 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 79 77 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 79 78 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 79 79 42.9 42.9 CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 80 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 79 81 553 553 CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 82 former former JJ work_jyzsgzx6ozemtdrfjlhthibtsm 79 83 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 79 84 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 79 85 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 79 86 randomized randomize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 79 87 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 79 88 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 79 89 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 79 90 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 91 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 79 92 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 79 93 1593 1593 CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 94 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 79 95 1039 1039 CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 96 men man NNS work_jyzsgzx6ozemtdrfjlhthibtsm 79 97 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 79 98 554 554 CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 99 women woman NNS work_jyzsgzx6ozemtdrfjlhthibtsm 79 100 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 79 101 mean mean VB work_jyzsgzx6ozemtdrfjlhthibtsm 79 102 age age NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 103 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 79 104 61.0 61.0 CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 105 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 79 106 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 79 107 mean mean VB work_jyzsgzx6ozemtdrfjlhthibtsm 79 108 pack pack NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 109 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 79 110 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 79 111 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 79 112 41.6 41.6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 113 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 79 114 575 575 CD work_jyzsgzx6ozemtdrfjlhthibtsm 79 115 former former JJ work_jyzsgzx6ozemtdrfjlhthibtsm 79 116 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 79 117 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 79 118 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 79 119 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 79 120 control control NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 121 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 79 122 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 80 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 80 2 first first JJ work_jyzsgzx6ozemtdrfjlhthibtsm 80 3 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 80 4 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 80 5 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 80 6 obtained obtain VBN work_jyzsgzx6ozemtdrfjlhthibtsm 80 7 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 80 8 March March NNP work_jyzsgzx6ozemtdrfjlhthibtsm 80 9 2004 2004 CD work_jyzsgzx6ozemtdrfjlhthibtsm 80 10 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 80 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 80 12 last last JJ work_jyzsgzx6ozemtdrfjlhthibtsm 80 13 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 80 14 LDCT ldct NN work_jyzsgzx6ozemtdrfjlhthibtsm 80 15 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 80 16 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 80 17 February February NNP work_jyzsgzx6ozemtdrfjlhthibtsm 80 18 2010 2010 CD work_jyzsgzx6ozemtdrfjlhthibtsm 80 19 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 81 1 Table table NN work_jyzsgzx6ozemtdrfjlhthibtsm 81 2 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 81 3 summarizes summarize VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 81 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 81 5 compliance compliance NN work_jyzsgzx6ozemtdrfjlhthibtsm 81 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 81 7 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 81 8 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 81 9 randomized randomize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 81 10 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 81 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 81 12 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 81 13 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 81 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 81 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 81 16 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 81 17 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 81 18 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 81 19 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 81 20 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 81 21 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 81 22 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 81 23 nod- nod- NN work_jyzsgzx6ozemtdrfjlhthibtsm 81 24 ule ule NNP work_jyzsgzx6ozemtdrfjlhthibtsm 81 25 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 81 26 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 81 27 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 81 28 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 81 29 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 81 30 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 81 31 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 81 32 NSCLC NSCLC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 81 33 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 81 34 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 81 35 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 81 36 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 81 37 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 81 38 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 81 39 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 81 40 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 81 41 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 81 42 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 82 1 One one CD work_jyzsgzx6ozemtdrfjlhthibtsm 82 2 thousand thousand CD work_jyzsgzx6ozemtdrfjlhthibtsm 82 3 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 82 4 hundred hundred CD work_jyzsgzx6ozemtdrfjlhthibtsm 82 5 six six CD work_jyzsgzx6ozemtdrfjlhthibtsm 82 6 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 82 7 910 910 CD work_jyzsgzx6ozemtdrfjlhthibtsm 82 8 men man NNS work_jyzsgzx6ozemtdrfjlhthibtsm 82 9 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 82 10 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 82 11 mean mean JJ work_jyzsgzx6ozemtdrfjlhthibtsm 82 12 age age NN work_jyzsgzx6ozemtdrfjlhthibtsm 82 13 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 82 14 61.1 61.1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 82 15 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 82 16 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 82 17 496 496 CD work_jyzsgzx6ozemtdrfjlhthibtsm 82 18 women woman NNS work_jyzsgzx6ozemtdrfjlhthibtsm 82 19 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 82 20 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 82 21 mean mean JJ work_jyzsgzx6ozemtdrfjlhthibtsm 82 22 age age NN work_jyzsgzx6ozemtdrfjlhthibtsm 82 23 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 82 24 60.6 60.6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 82 25 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 82 26 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 82 27 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 82 28 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 82 29 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 82 30 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 82 31 87.1 87.1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 82 32 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 82 33 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 82 34 randomized randomize VBD work_jyzsgzx6ozemtdrfjlhthibtsm 82 35 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 82 36 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 82 37 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 82 38 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 82 39 underwent undergo VBD work_jyzsgzx6ozemtdrfjlhthibtsm 82 40 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 82 41 baseline baseline JJ work_jyzsgzx6ozemtdrfjlhthibtsm 82 42 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 82 43 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 83 1 After after IN work_jyzsgzx6ozemtdrfjlhthibtsm 83 2 exclusion exclusion NN work_jyzsgzx6ozemtdrfjlhthibtsm 83 3 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 83 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 83 5 next next JJ work_jyzsgzx6ozemtdrfjlhthibtsm 83 6 round round NN work_jyzsgzx6ozemtdrfjlhthibtsm 83 7 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 83 8 invitation invitation NN work_jyzsgzx6ozemtdrfjlhthibtsm 83 9 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 83 10 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 83 11 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 83 12 whom whom WP work_jyzsgzx6ozemtdrfjlhthibtsm 83 13 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 83 14 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 83 15 proce- proce- XX work_jyzsgzx6ozemtdrfjlhthibtsm 83 16 dure dure NN work_jyzsgzx6ozemtdrfjlhthibtsm 83 17 revealed reveal VBD work_jyzsgzx6ozemtdrfjlhthibtsm 83 18 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 83 19 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 83 20 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 83 21 1356 1356 CD work_jyzsgzx6ozemtdrfjlhthibtsm 83 22 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 83 23 85.1 85.1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 83 24 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 83 25 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 83 26 executed execute VBD work_jyzsgzx6ozemtdrfjlhthibtsm 83 27 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 83 28 second second JJ work_jyzsgzx6ozemtdrfjlhthibtsm 83 29 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 83 30 1308 1308 CD work_jyzsgzx6ozemtdrfjlhthibtsm 83 31 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 83 32 82.3 82.3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 83 33 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 83 34 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 83 35 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 83 36 third third JJ work_jyzsgzx6ozemtdrfjlhthibtsm 83 37 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 83 38 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 83 39 1263 1263 CD work_jyzsgzx6ozemtdrfjlhthibtsm 83 40 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 83 41 79.8 79.8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 83 42 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 83 43 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 83 44 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 83 45 fourth fourth JJ work_jyzsgzx6ozemtdrfjlhthibtsm 83 46 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 83 47 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 83 48 round round NN work_jyzsgzx6ozemtdrfjlhthibtsm 83 49 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 83 50 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 83 51 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 84 1 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 84 2 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 84 3 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 84 4 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 84 5 30.3 30.3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 84 6 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 84 7 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 84 8 baseline baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 84 9 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 84 10 15.7 15.7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 84 11 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 84 12 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 84 13 range range NN work_jyzsgzx6ozemtdrfjlhthibtsm 84 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 84 15 13.7–17.3 13.7–17.3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 84 16 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 84 17 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 84 18 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 84 19 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 84 20 three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 84 21 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 84 22 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 84 23 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 84 24 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 84 25 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 84 26 Table table NN work_jyzsgzx6ozemtdrfjlhthibtsm 84 27 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 84 28 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 84 29 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 85 1 Twenty twenty CD work_jyzsgzx6ozemtdrfjlhthibtsm 85 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 85 3 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 85 4 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 85 5 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 85 6 18 18 CD work_jyzsgzx6ozemtdrfjlhthibtsm 85 7 NSCLC NSCLC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 85 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 85 9 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 85 10 carcinoid carcinoid NN work_jyzsgzx6ozemtdrfjlhthibtsm 85 11 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 85 12 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 85 13 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 85 14 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 85 15 cell cell NN work_jyzsgzx6ozemtdrfjlhthibtsm 85 16 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 85 17 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 85 18 [ [ -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 85 19 SCLCs SCLCs NNP work_jyzsgzx6ozemtdrfjlhthibtsm 85 20 ] ] -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 85 21 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 85 22 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 85 23 found find VBN work_jyzsgzx6ozemtdrfjlhthibtsm 85 24 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 85 25 20 20 CD work_jyzsgzx6ozemtdrfjlhthibtsm 85 26 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 85 27 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 85 28 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 85 29 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 85 30 round round RB work_jyzsgzx6ozemtdrfjlhthibtsm 85 31 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 85 32 prevalent prevalent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 85 33 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 85 34 detection detection VBP work_jyzsgzx6ozemtdrfjlhthibtsm 85 35 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 85 36 1.5 1.5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 85 37 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 85 38 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 85 39 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 85 40 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 85 41 20 20 CD work_jyzsgzx6ozemtdrfjlhthibtsm 85 42 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 85 43 17 17 CD work_jyzsgzx6ozemtdrfjlhthibtsm 85 44 NSCLC NSCLC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 85 45 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 85 46 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 85 47 carcinoid carcinoid NN work_jyzsgzx6ozemtdrfjlhthibtsm 85 48 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 85 49 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 85 50 SCLC SCLC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 85 51 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 85 52 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 85 53 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 85 54 18 18 CD work_jyzsgzx6ozemtdrfjlhthibtsm 85 55 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 85 56 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 85 57 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 85 58 third third JJ work_jyzsgzx6ozemtdrfjlhthibtsm 85 59 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 85 60 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 85 61 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 85 62 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 85 63 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 85 64 mean mean NNP work_jyzsgzx6ozemtdrfjlhthibtsm 85 65 incident incident NN work_jyzsgzx6ozemtdrfjlhthibtsm 85 66 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 85 67 detection detection VBP work_jyzsgzx6ozemtdrfjlhthibtsm 85 68 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 85 69 0.5 0.5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 85 70 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 85 71 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 85 72 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 86 1 Adenocarcinoma Adenocarcinoma NNP work_jyzsgzx6ozemtdrfjlhthibtsm 86 2 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 86 3 AC AC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 86 4 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 86 5 accounted account VBD work_jyzsgzx6ozemtdrfjlhthibtsm 86 6 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 86 7 nine nine CD work_jyzsgzx6ozemtdrfjlhthibtsm 86 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 86 9 18 18 CD work_jyzsgzx6ozemtdrfjlhthibtsm 86 10 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 86 11 50 50 CD work_jyzsgzx6ozemtdrfjlhthibtsm 86 12 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 86 13 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 86 14 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 86 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 86 16 NSCLCs NSCLCs NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 86 17 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 86 18 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 86 19 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 86 20 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 86 21 15 15 CD work_jyzsgzx6ozemtdrfjlhthibtsm 86 22 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 86 23 17 17 CD work_jyzsgzx6ozemtdrfjlhthibtsm 86 24 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 86 25 88 88 CD work_jyzsgzx6ozemtdrfjlhthibtsm 86 26 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 86 27 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 86 28 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 86 29 subsequent subsequent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 86 30 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 86 31 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 86 32 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 86 33 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 86 34 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 87 1 Three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 87 2 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 87 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 87 4 38 38 CD work_jyzsgzx6ozemtdrfjlhthibtsm 87 5 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 87 6 7.8 7.8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 87 7 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 87 8 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 87 9 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 87 10 whom whom WP work_jyzsgzx6ozemtdrfjlhthibtsm 87 11 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 87 12 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 87 13 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 87 14 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 87 15 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 87 16 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 87 17 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 87 18 malignant malignant JJ work_jyzsgzx6ozemtdrfjlhthibtsm 87 19 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 87 20 tumors tumor NNS work_jyzsgzx6ozemtdrfjlhthibtsm 87 21 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 88 1 One one CD work_jyzsgzx6ozemtdrfjlhthibtsm 88 2 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 88 3 AC AC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 88 4 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 88 5 right right JJ work_jyzsgzx6ozemtdrfjlhthibtsm 88 6 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 88 7 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 88 8 SCLC SCLC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 88 9 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 88 10 limited limited JJ work_jyzsgzx6ozemtdrfjlhthibtsm 88 11 disease disease NN work_jyzsgzx6ozemtdrfjlhthibtsm 88 12 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 88 13 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 88 14 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 88 15 left left JJ work_jyzsgzx6ozemtdrfjlhthibtsm 88 16 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 88 17 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 88 18 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 88 19 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 88 20 AC AC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 88 21 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 88 22 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 88 23 right right JJ work_jyzsgzx6ozemtdrfjlhthibtsm 88 24 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 88 25 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 88 26 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 88 27 carcinoid carcinoid NN work_jyzsgzx6ozemtdrfjlhthibtsm 88 28 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 88 29 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 88 30 left left JJ work_jyzsgzx6ozemtdrfjlhthibtsm 88 31 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 88 32 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 88 33 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 88 34 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 88 35 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 88 36 AC AC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 88 37 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 88 38 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 88 39 right right JJ work_jyzsgzx6ozemtdrfjlhthibtsm 88 40 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 88 41 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 88 42 AC AC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 88 43 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 88 44 bronchiole- bronchiole- NN work_jyzsgzx6ozemtdrfjlhthibtsm 88 45 alveolar alveolar JJ work_jyzsgzx6ozemtdrfjlhthibtsm 88 46 features feature NNS work_jyzsgzx6ozemtdrfjlhthibtsm 88 47 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 88 48 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 88 49 left left JJ work_jyzsgzx6ozemtdrfjlhthibtsm 88 50 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 88 51 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 89 1 Isolated isolated JJ work_jyzsgzx6ozemtdrfjlhthibtsm 89 2 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 89 3 metastases metastasis NNS work_jyzsgzx6ozemtdrfjlhthibtsm 89 4 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 89 5 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 89 6 gastrointestinal gastrointestinal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 89 7 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 89 8 renal renal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 89 9 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 89 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 89 11 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 89 12 each each DT work_jyzsgzx6ozemtdrfjlhthibtsm 89 13 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 89 14 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 89 15 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 89 16 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 89 17 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 89 18 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 89 19 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 89 20 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 89 21 during during IN work_jyzsgzx6ozemtdrfjlhthibtsm 89 22 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 89 23 entire entire JJ work_jyzsgzx6ozemtdrfjlhthibtsm 89 24 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 89 25 cycle cycle NN work_jyzsgzx6ozemtdrfjlhthibtsm 89 26 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 90 1 Two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 90 2 interval interval JJ work_jyzsgzx6ozemtdrfjlhthibtsm 90 3 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 90 4 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 90 5 namely namely RB work_jyzsgzx6ozemtdrfjlhthibtsm 90 6 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 90 7 that that WDT work_jyzsgzx6ozemtdrfjlhthibtsm 90 8 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 90 9 diagnosed diagnose VBN work_jyzsgzx6ozemtdrfjlhthibtsm 90 10 outside outside IN work_jyzsgzx6ozemtdrfjlhthibtsm 90 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 90 12 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 90 13 frame frame NN work_jyzsgzx6ozemtdrfjlhthibtsm 90 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 90 15 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 90 16 observed observe VBN work_jyzsgzx6ozemtdrfjlhthibtsm 90 17 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 90 18 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 90 19 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 90 20 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 90 21 during during IN work_jyzsgzx6ozemtdrfjlhthibtsm 90 22 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 90 23 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 90 24 period period NN work_jyzsgzx6ozemtdrfjlhthibtsm 90 25 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 90 26 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 90 27 SCLC sclc NN work_jyzsgzx6ozemtdrfjlhthibtsm 90 28 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 90 29 extensive extensive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 90 30 disease disease NN work_jyzsgzx6ozemtdrfjlhthibtsm 90 31 diagnosed diagnose VBN work_jyzsgzx6ozemtdrfjlhthibtsm 90 32 between between IN work_jyzsgzx6ozemtdrfjlhthibtsm 90 33 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 90 34 second second JJ work_jyzsgzx6ozemtdrfjlhthibtsm 90 35 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 90 36 third third JJ work_jyzsgzx6ozemtdrfjlhthibtsm 90 37 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 90 38 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 90 39 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 90 40 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 90 41 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 90 42 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 90 43 IV IV NNP work_jyzsgzx6ozemtdrfjlhthibtsm 90 44 NSCLC NSCLC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 90 45 diagnosed diagnose VBN work_jyzsgzx6ozemtdrfjlhthibtsm 90 46 between between IN work_jyzsgzx6ozemtdrfjlhthibtsm 90 47 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 90 48 third third JJ work_jyzsgzx6ozemtdrfjlhthibtsm 90 49 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 90 50 fourth fourth JJ work_jyzsgzx6ozemtdrfjlhthibtsm 90 51 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 90 52 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 90 53 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 91 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 91 2 characteristics characteristic NNS work_jyzsgzx6ozemtdrfjlhthibtsm 91 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 91 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 91 5 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 91 6 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 91 7 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 91 8 primary primary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 91 9 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 91 10 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 91 11 found find VBD work_jyzsgzx6ozemtdrfjlhthibtsm 91 12 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 91 13 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 91 14 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 91 15 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 91 16 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 91 17 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 91 18 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 91 19 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 91 20 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 91 21 reported report VBN work_jyzsgzx6ozemtdrfjlhthibtsm 91 22 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 91 23 Supplemental Supplemental NNP work_jyzsgzx6ozemtdrfjlhthibtsm 91 24 Table Table NNP work_jyzsgzx6ozemtdrfjlhthibtsm 91 25 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 91 26 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 91 27 Supplemental Supplemental NNP work_jyzsgzx6ozemtdrfjlhthibtsm 91 28 Digital Digital NNP work_jyzsgzx6ozemtdrfjlhthibtsm 91 29 Content Content NNP work_jyzsgzx6ozemtdrfjlhthibtsm 91 30 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 91 31 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 91 32 http://links.lww.com/JTO/A409 http://links.lww.com/JTO/A409 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 91 33 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 91 34 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 92 1 Excluding exclude VBG work_jyzsgzx6ozemtdrfjlhthibtsm 92 2 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 92 3 SCLCs sclc NNS work_jyzsgzx6ozemtdrfjlhthibtsm 92 4 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 92 5 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 92 6 large large JJ work_jyzsgzx6ozemtdrfjlhthibtsm 92 7 hilar hilar JJ work_jyzsgzx6ozemtdrfjlhthibtsm 92 8 mass mass NN work_jyzsgzx6ozemtdrfjlhthibtsm 92 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 92 10 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 92 11 average average JJ work_jyzsgzx6ozemtdrfjlhthibtsm 92 12 mean mean VBP work_jyzsgzx6ozemtdrfjlhthibtsm 92 13 diam- diam- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 92 14 eter eter NN work_jyzsgzx6ozemtdrfjlhthibtsm 92 15 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 92 16 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 92 17 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 92 18 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 92 19 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 92 20 tumors tumor NNS work_jyzsgzx6ozemtdrfjlhthibtsm 92 21 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 92 22 24.2 24.2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 92 23 mm mm CD work_jyzsgzx6ozemtdrfjlhthibtsm 92 24 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 92 25 baseline baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 92 26 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 92 27 TABLE TABLE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 92 28 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 92 29 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 93 1 Compliance compliance NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 2     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 93 4     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 5 Subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 93 6     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 7 Randomized randomize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 93 8     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 9 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 93 10     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 93 12     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 13 Active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 93 14     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 15 Arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 16 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 93 17     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 18 Results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 93 19     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 20 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 93 21     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 22 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 93 23     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 24 Four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 25     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 26 Screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 27     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 28 Rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 93 29     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 30 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 93 31     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 32 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 33 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 93 34     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 35 Nodule Nodule NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 36     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 37 Management Management NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 38 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 93 39     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 40 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 93 41     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 42 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 43     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 44 Cancers Cancers NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 93 45     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 46 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 93 47     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 48 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 93 49     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 50 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 51     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 93 52 Trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 53 T0 t0 NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 54 T1 T1 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 55 T2 T2 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 56 T3 T3 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 57 T1–T3 t1–t3 NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 58 T0–T3 t0–t3 DT work_jyzsgzx6ozemtdrfjlhthibtsm 93 59 Subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 93 60 invited invite VBD work_jyzsgzx6ozemtdrfjlhthibtsm 93 61 1613 1613 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 62 1593 1593 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 63 1589 1589 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 64 1581 1581 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 65 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 66 executed execute VBD work_jyzsgzx6ozemtdrfjlhthibtsm 93 67 1406 1406 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 68 −87.10 −87.10 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 69 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 70 1356 1356 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 71 −85.10 −85.10 : work_jyzsgzx6ozemtdrfjlhthibtsm 93 72 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 73 1308 1308 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 74 −82.30 −82.30 SYM work_jyzsgzx6ozemtdrfjlhthibtsm 93 75 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 76 1263 1263 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 77 −79.80 −79.80 SYM work_jyzsgzx6ozemtdrfjlhthibtsm 93 78 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 79 3927 3927 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 80 5333 5333 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 81 Positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 93 82 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 83 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 84 426 426 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 85 −30.30 −30.30 : work_jyzsgzx6ozemtdrfjlhthibtsm 93 86 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 87 234 234 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 88 −17.30 −17.30 NNS work_jyzsgzx6ozemtdrfjlhthibtsm 93 89 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 90 211 211 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 91 −16.10 −16.10 SYM work_jyzsgzx6ozemtdrfjlhthibtsm 93 92 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 93 173 173 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 94 −13.70 −13.70 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 95 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 96 618 618 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 97 −15.80 −15.80 HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 93 98 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 99 Follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 100 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 93 101 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 93 102 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 103 366 366 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 104 225 225 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 105 202 202 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 106 173 173 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 107 600 600 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 108 966 966 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 109 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 110 month month NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 111 31 31 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 112 27 27 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 113 30 30 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 114 32 32 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 115 89 89 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 116 120 120 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 117 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 118 months month NNS work_jyzsgzx6ozemtdrfjlhthibtsm 93 119 335 335 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 120 163 163 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 121 132 132 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 122 115 115 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 123 410 410 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 124 745 745 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 125 6 6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 126 months month NNS work_jyzsgzx6ozemtdrfjlhthibtsm 93 127 0 0 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 128 35 35 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 129 40 40 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 130 26 26 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 131 101 101 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 132 101 101 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 133 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 134 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 93 135 PETa PETa NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 136 60 60 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 137 15 15 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 138 15 15 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 139 12 12 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 140 42 42 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 141 102 102 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 142 Positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 93 143 14 14 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 144 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 145 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 146 4 4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 147 18 18 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 148 32 32 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 149 Indeterminate indeterminate NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 150 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 151 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 152 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 153 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 154 5 5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 155 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 156 Negative Negative NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 157 44 44 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 158 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 159 6 6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 160 6 6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 161 19 19 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 162 63 63 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 163 CT ct NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 164 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 93 165 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 93 166 FNABb FNABb NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 167 18 18 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 168 6 6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 169 5 5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 170 9 9 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 171 20 20 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 172 38 38 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 173 Positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 93 174 12 12 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 175 5 5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 176 4 4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 177 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 178 16 16 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 179 28 28 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 180 Negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 93 181 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 182 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 183 0 0 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 184 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 185 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 186 6 6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 187 Inadequate Inadequate NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 188 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 189 0 0 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 190 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 191 0 0 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 192 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 193 4 4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 194 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 195 cancersc cancersc NNS work_jyzsgzx6ozemtdrfjlhthibtsm 93 196 18 18 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 197 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 198 9 9 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 199 6 6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 200 17 17 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 201 35 35 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 202 Stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 203 I -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 93 204 10 10 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 205 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 206 6 6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 207 5 5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 208 13 13 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 209 23 23 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 210 Stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 211 II II NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 212 – – : work_jyzsgzx6ozemtdrfjlhthibtsm 93 213 IV IV NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 214 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 215 0 0 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 216 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 217 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 218 4 4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 219 12 12 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 220 aNinety aNinety NNP work_jyzsgzx6ozemtdrfjlhthibtsm 93 221 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 93 222 seven seven CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 223 FDG fdg NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 224 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 93 225 PET pet JJ work_jyzsgzx6ozemtdrfjlhthibtsm 93 226 examinations examination NNS work_jyzsgzx6ozemtdrfjlhthibtsm 93 227 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 93 228 obtained obtain VBN work_jyzsgzx6ozemtdrfjlhthibtsm 93 229 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 93 230 92 92 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 231 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 93 232 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 93 233 102 102 CD work_jyzsgzx6ozemtdrfjlhthibtsm 93 234 target target NN work_jyzsgzx6ozemtdrfjlhthibtsm 93 235 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 93 236 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 94 1 bThirty bThirty NNP work_jyzsgzx6ozemtdrfjlhthibtsm 94 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 94 3 eight eight CD work_jyzsgzx6ozemtdrfjlhthibtsm 94 4 CT ct NN work_jyzsgzx6ozemtdrfjlhthibtsm 94 5 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 94 6 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 94 7 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 94 8 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 94 9 obtained obtain VBN work_jyzsgzx6ozemtdrfjlhthibtsm 94 10 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 94 11 34 34 CD work_jyzsgzx6ozemtdrfjlhthibtsm 94 12 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 94 13 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 94 14 38 38 CD work_jyzsgzx6ozemtdrfjlhthibtsm 94 15 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 94 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 95 1 cThree cthree NN work_jyzsgzx6ozemtdrfjlhthibtsm 95 2 carcinoids carcinoid NNS work_jyzsgzx6ozemtdrfjlhthibtsm 95 3 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 95 4 three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 95 5 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 95 6 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 95 7 cell cell NN work_jyzsgzx6ozemtdrfjlhthibtsm 95 8 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 95 9 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 95 10 excluded exclude VBD work_jyzsgzx6ozemtdrfjlhthibtsm 95 11 — — : work_jyzsgzx6ozemtdrfjlhthibtsm 95 12 pathological pathological JJ work_jyzsgzx6ozemtdrfjlhthibtsm 95 13 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 95 14 clinical clinical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 95 15 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 95 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 96 1 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 96 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 96 3 computed compute VBD work_jyzsgzx6ozemtdrfjlhthibtsm 96 4 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 96 5 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 96 6 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 96 7 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 96 8 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 96 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 96 10 2-[18F]fluoro-2-deoxy 2-[18f]fluoro-2-deoxy CD work_jyzsgzx6ozemtdrfjlhthibtsm 96 11 - - SYM work_jyzsgzx6ozemtdrfjlhthibtsm 96 12 D D NNP work_jyzsgzx6ozemtdrfjlhthibtsm 96 13 glucose glucose NNP work_jyzsgzx6ozemtdrfjlhthibtsm 96 14 positron positron NNP work_jyzsgzx6ozemtdrfjlhthibtsm 96 15 emission emission NN work_jyzsgzx6ozemtdrfjlhthibtsm 96 16 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 96 17 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 96 18 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 96 19 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 96 20 fine fine JJ work_jyzsgzx6ozemtdrfjlhthibtsm 96 21 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 96 22 needle needle NN work_jyzsgzx6ozemtdrfjlhthibtsm 96 23 aspiration aspiration NN work_jyzsgzx6ozemtdrfjlhthibtsm 96 24 biopsy biopsy NN work_jyzsgzx6ozemtdrfjlhthibtsm 96 25 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 96 26 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 96 27 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 96 28 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 96 29 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 96 30 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 96 31 computed computed JJ work_jyzsgzx6ozemtdrfjlhthibtsm 96 32 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 96 33 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 97 1 http://links.lww.com/JTO/A409 http://links.lww.com/JTO/A409 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 97 2 870 870 CD work_jyzsgzx6ozemtdrfjlhthibtsm 97 3 Copyright copyright NN work_jyzsgzx6ozemtdrfjlhthibtsm 97 4 © © NN work_jyzsgzx6ozemtdrfjlhthibtsm 97 5 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 97 6 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 97 7 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 97 8 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 97 9 Association Association NNP work_jyzsgzx6ozemtdrfjlhthibtsm 97 10 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 97 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 97 12 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 97 13 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 97 14 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 97 15 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 97 16 Pegna Pegna NNP work_jyzsgzx6ozemtdrfjlhthibtsm 97 17 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 97 18 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 97 19 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 98 1 Journal Journal NNP work_jyzsgzx6ozemtdrfjlhthibtsm 98 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 98 3 Thoracic Thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 98 4 Oncology Oncology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 98 5 ® ® NNP work_jyzsgzx6ozemtdrfjlhthibtsm 98 6     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 98 7 • • NN work_jyzsgzx6ozemtdrfjlhthibtsm 98 8     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 98 9 Volume volume NN work_jyzsgzx6ozemtdrfjlhthibtsm 98 10     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 98 11 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 98 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 98 13     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 98 14 Number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 98 15     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 98 16 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 98 17 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 98 18     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 98 19 July July NNP work_jyzsgzx6ozemtdrfjlhthibtsm 98 20     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 98 21 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 98 22 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 98 23 17.3 17.3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 98 24 mm mm CD work_jyzsgzx6ozemtdrfjlhthibtsm 98 25 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 98 26 subsequent subsequent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 98 27 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 98 28 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 98 29 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 98 30 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 98 31 p p NN work_jyzsgzx6ozemtdrfjlhthibtsm 98 32 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 98 33 not not RB work_jyzsgzx6ozemtdrfjlhthibtsm 98 34 significant significant JJ work_jyzsgzx6ozemtdrfjlhthibtsm 98 35 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 98 36 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 99 1 Ten ten CD work_jyzsgzx6ozemtdrfjlhthibtsm 99 2 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 99 3 56 56 CD work_jyzsgzx6ozemtdrfjlhthibtsm 99 4 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 99 5 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 99 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 99 7 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 99 8 18 18 CD work_jyzsgzx6ozemtdrfjlhthibtsm 99 9 prevalent prevalent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 99 10 NSCLCs NSCLCs NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 99 11 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 99 12 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 99 13 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 99 14 I -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 99 15 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 99 16 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 99 17 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 99 18 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 99 19 IA IA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 99 20 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 99 21 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 99 22 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 99 23 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 99 24 IB ib NN work_jyzsgzx6ozemtdrfjlhthibtsm 99 25 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 99 26 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 99 27 compared compare VBN work_jyzsgzx6ozemtdrfjlhthibtsm 99 28 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 99 29 13 13 CD work_jyzsgzx6ozemtdrfjlhthibtsm 99 30 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 99 31 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 99 32 17 17 CD work_jyzsgzx6ozemtdrfjlhthibtsm 99 33 incident incident NN work_jyzsgzx6ozemtdrfjlhthibtsm 99 34 NSCLCs nsclc NNS work_jyzsgzx6ozemtdrfjlhthibtsm 99 35 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 99 36 76 76 CD work_jyzsgzx6ozemtdrfjlhthibtsm 99 37 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 99 38 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 99 39 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 99 40 11 11 CD work_jyzsgzx6ozemtdrfjlhthibtsm 99 41 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 99 42 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 99 43 IA IA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 99 44 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 99 45 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 99 46 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 99 47 IB ib NN work_jyzsgzx6ozemtdrfjlhthibtsm 99 48 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 99 49 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 99 50 p p NN work_jyzsgzx6ozemtdrfjlhthibtsm 99 51 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 99 52 not not RB work_jyzsgzx6ozemtdrfjlhthibtsm 99 53 significant significant JJ work_jyzsgzx6ozemtdrfjlhthibtsm 99 54 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 99 55 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 99 56 Table table NN work_jyzsgzx6ozemtdrfjlhthibtsm 99 57 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 99 58 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 99 59 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 100 1 As as IN work_jyzsgzx6ozemtdrfjlhthibtsm 100 2 part part NN work_jyzsgzx6ozemtdrfjlhthibtsm 100 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 100 4 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 100 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 100 6 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 100 7 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 100 8 tests test NNS work_jyzsgzx6ozemtdrfjlhthibtsm 100 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 100 10 966 966 CD work_jyzsgzx6ozemtdrfjlhthibtsm 100 11 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 100 12 120 120 CD work_jyzsgzx6ozemtdrfjlhthibtsm 100 13 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 100 14 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 100 15 month month NN work_jyzsgzx6ozemtdrfjlhthibtsm 100 16 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 100 17 antibiotic antibiotic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 100 18 therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 100 19 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 100 20 745 745 CD work_jyzsgzx6ozemtdrfjlhthibtsm 100 21 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 100 22 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 100 23 months month NNS work_jyzsgzx6ozemtdrfjlhthibtsm 100 24 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 100 25 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 100 26 101 101 CD work_jyzsgzx6ozemtdrfjlhthibtsm 100 27 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 100 28 6 6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 100 29 months month NNS work_jyzsgzx6ozemtdrfjlhthibtsm 100 30 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 100 31 follow follow VB work_jyzsgzx6ozemtdrfjlhthibtsm 100 32 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 100 33 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 100 34 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 100 35 examinations examination NNS work_jyzsgzx6ozemtdrfjlhthibtsm 100 36 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 100 37 obtained obtain VBN work_jyzsgzx6ozemtdrfjlhthibtsm 100 38 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 101 1 They -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 101 2 accounted account VBD work_jyzsgzx6ozemtdrfjlhthibtsm 101 3 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 101 4 15 15 CD work_jyzsgzx6ozemtdrfjlhthibtsm 101 5 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 101 6 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 101 7 966 966 CD work_jyzsgzx6ozemtdrfjlhthibtsm 101 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 101 9 6299 6299 CD work_jyzsgzx6ozemtdrfjlhthibtsm 101 10 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 101 11 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 101 12 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 101 13 total total JJ work_jyzsgzx6ozemtdrfjlhthibtsm 101 14 number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 101 15 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 101 16 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 101 17 examinations examination NNS work_jyzsgzx6ozemtdrfjlhthibtsm 101 18 performed perform VBN work_jyzsgzx6ozemtdrfjlhthibtsm 101 19 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 101 20 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 101 21 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 101 22 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 101 23 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 101 24 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 101 25 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 101 26 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 101 27 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 102 1 Seven seven CD work_jyzsgzx6ozemtdrfjlhthibtsm 102 2 hundred hundred CD work_jyzsgzx6ozemtdrfjlhthibtsm 102 3 forty forty CD work_jyzsgzx6ozemtdrfjlhthibtsm 102 4 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 102 5 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 102 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 102 7 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 102 8 1406 1406 CD work_jyzsgzx6ozemtdrfjlhthibtsm 102 9 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 102 10 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 102 11 52.7 52.7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 102 12 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 102 13 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 102 14 who who WP work_jyzsgzx6ozemtdrfjlhthibtsm 102 15 underwent undergo VBD work_jyzsgzx6ozemtdrfjlhthibtsm 102 16 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 102 17 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 102 18 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 102 19 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 102 20 at at RB work_jyzsgzx6ozemtdrfjlhthibtsm 102 21 least least RBS work_jyzsgzx6ozemtdrfjlhthibtsm 102 22 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 102 23 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 102 24 LDCT ldct NN work_jyzsgzx6ozemtdrfjlhthibtsm 102 25 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 102 26 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 102 27 noncalcified noncalcified JJ work_jyzsgzx6ozemtdrfjlhthibtsm 102 28 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 102 29 over over IN work_jyzsgzx6ozemtdrfjlhthibtsm 102 30 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 102 31 entire entire JJ work_jyzsgzx6ozemtdrfjlhthibtsm 102 32 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 102 33 cycle cycle NN work_jyzsgzx6ozemtdrfjlhthibtsm 102 34 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 103 1 Lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 103 2 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 103 3 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 103 4 diagnosed diagnose VBN work_jyzsgzx6ozemtdrfjlhthibtsm 103 5 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 103 6 16 16 CD work_jyzsgzx6ozemtdrfjlhthibtsm 103 7 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 103 8 38 38 CD work_jyzsgzx6ozemtdrfjlhthibtsm 103 9 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 103 10 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 103 11 42 42 CD work_jyzsgzx6ozemtdrfjlhthibtsm 103 12 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 103 13 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 103 14 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 103 15 evidence evidence NN work_jyzsgzx6ozemtdrfjlhthibtsm 103 16 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 103 17 lesion lesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 103 18 growth growth NN work_jyzsgzx6ozemtdrfjlhthibtsm 103 19 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 103 20 follow follow VB work_jyzsgzx6ozemtdrfjlhthibtsm 103 21 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 103 22 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 103 23 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 103 24 examinations examination NNS work_jyzsgzx6ozemtdrfjlhthibtsm 103 25 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 104 1 Nodule nodule IN work_jyzsgzx6ozemtdrfjlhthibtsm 104 2 disappearance disappearance NN work_jyzsgzx6ozemtdrfjlhthibtsm 104 3 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 104 4 size size NN work_jyzsgzx6ozemtdrfjlhthibtsm 104 5 reduction reduction NN work_jyzsgzx6ozemtdrfjlhthibtsm 104 6 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 104 7 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 104 8 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 104 9 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 104 10 month month NN work_jyzsgzx6ozemtdrfjlhthibtsm 104 11 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 104 12 antibiotic antibiotic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 104 13 therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 104 14 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 104 15 observed observe VBN work_jyzsgzx6ozemtdrfjlhthibtsm 104 16 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 104 17 80 80 CD work_jyzsgzx6ozemtdrfjlhthibtsm 104 18 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 104 19 120 120 CD work_jyzsgzx6ozemtdrfjlhthibtsm 104 20 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 104 21 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 104 22 67 67 CD work_jyzsgzx6ozemtdrfjlhthibtsm 104 23 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 104 24 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 104 25 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 104 26 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 104 27 11 11 CD work_jyzsgzx6ozemtdrfjlhthibtsm 104 28 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 104 29 31 31 CD work_jyzsgzx6ozemtdrfjlhthibtsm 104 30 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 104 31 [ [ -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 104 32 35 35 CD work_jyzsgzx6ozemtdrfjlhthibtsm 104 33 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 104 34 ] ] -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 104 35 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 104 36 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 104 37 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 104 38 69 69 CD work_jyzsgzx6ozemtdrfjlhthibtsm 104 39 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 104 40 89 89 CD work_jyzsgzx6ozemtdrfjlhthibtsm 104 41 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 104 42 [ [ -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 104 43 77 77 CD work_jyzsgzx6ozemtdrfjlhthibtsm 104 44 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 104 45 ] ] -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 104 46 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 104 47 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 104 48 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 104 49 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 104 50 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 104 51 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 104 52 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 105 1 Ninety ninety CD work_jyzsgzx6ozemtdrfjlhthibtsm 105 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 105 3 seven seven CD work_jyzsgzx6ozemtdrfjlhthibtsm 105 4 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 105 5 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 105 6 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 105 7 PET pet JJ work_jyzsgzx6ozemtdrfjlhthibtsm 105 8 examinations examination NNS work_jyzsgzx6ozemtdrfjlhthibtsm 105 9 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 105 10 obtained obtain VBN work_jyzsgzx6ozemtdrfjlhthibtsm 105 11 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 105 12 92 92 CD work_jyzsgzx6ozemtdrfjlhthibtsm 105 13 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 105 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 105 15 namely namely RB work_jyzsgzx6ozemtdrfjlhthibtsm 105 16 6.5 6.5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 105 17 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 105 18 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 105 19 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 105 20 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 105 21 ran- ran- RB work_jyzsgzx6ozemtdrfjlhthibtsm 105 22 domized domize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 105 23 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 105 24 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 105 25 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 105 26 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 105 27 who who WP work_jyzsgzx6ozemtdrfjlhthibtsm 105 28 underwent undergo VBD work_jyzsgzx6ozemtdrfjlhthibtsm 105 29 baseline baseline JJ work_jyzsgzx6ozemtdrfjlhthibtsm 105 30 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 105 31 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 106 1 Five five CD work_jyzsgzx6ozemtdrfjlhthibtsm 106 2 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 106 3 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 106 4 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 106 5 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 106 6 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 106 7 PET pet NN work_jyzsgzx6ozemtdrfjlhthibtsm 106 8 each each DT work_jyzsgzx6ozemtdrfjlhthibtsm 106 9 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 107 1 Fifty fifty CD work_jyzsgzx6ozemtdrfjlhthibtsm 107 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 107 3 seven seven CD work_jyzsgzx6ozemtdrfjlhthibtsm 107 4 PET- pet- NN work_jyzsgzx6ozemtdrfjlhthibtsm 107 5 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 107 6 examinations examination NNS work_jyzsgzx6ozemtdrfjlhthibtsm 107 7 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 107 8 performed perform VBN work_jyzsgzx6ozemtdrfjlhthibtsm 107 9 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 107 10 baseline baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 107 11 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 107 12 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 107 13 40 40 CD work_jyzsgzx6ozemtdrfjlhthibtsm 107 14 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 107 15 subsequent subsequent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 107 16 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 107 17 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 107 18 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 107 19 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 108 1 Thirty thirty CD work_jyzsgzx6ozemtdrfjlhthibtsm 108 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 108 3 eight eight CD work_jyzsgzx6ozemtdrfjlhthibtsm 108 4 primary primary NN work_jyzsgzx6ozemtdrfjlhthibtsm 108 5 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 108 6 n n NN work_jyzsgzx6ozemtdrfjlhthibtsm 108 7 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 108 8 35 35 CD work_jyzsgzx6ozemtdrfjlhthibtsm 108 9 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 108 10 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 108 11 secondary secondary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 108 12 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 108 13 n n NNP work_jyzsgzx6ozemtdrfjlhthibtsm 108 14 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 108 15 3 3 LS work_jyzsgzx6ozemtdrfjlhthibtsm 108 16 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 108 17 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 108 18 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 108 19 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 108 20 ultimately ultimately RB work_jyzsgzx6ozemtdrfjlhthibtsm 108 21 diagnosed diagnose VBN work_jyzsgzx6ozemtdrfjlhthibtsm 108 22 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 108 23 35 35 CD work_jyzsgzx6ozemtdrfjlhthibtsm 108 24 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 108 25 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 108 26 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 108 27 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 108 28 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 108 29 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 108 30 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 108 31 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 108 32 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 108 33 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 108 34 mixed mixed JJ work_jyzsgzx6ozemtdrfjlhthibtsm 108 35 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 108 36 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 108 37 SCLC sclc NN work_jyzsgzx6ozemtdrfjlhthibtsm 108 38 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 108 39 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 108 40 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 108 41 carcinoid carcinoid NN work_jyzsgzx6ozemtdrfjlhthibtsm 108 42 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 108 43 AC AC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 108 44 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 108 45 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 108 46 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 108 47 subject subject NN work_jyzsgzx6ozemtdrfjlhthibtsm 108 48 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 108 49 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 108 50 AC AC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 108 51 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 108 52 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 108 53 controlateral controlateral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 108 54 early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 108 55 AC AC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 108 56 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 108 57 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 109 1 On on IN work_jyzsgzx6ozemtdrfjlhthibtsm 109 2 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 109 3 total total NN work_jyzsgzx6ozemtdrfjlhthibtsm 109 4 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 109 5 102 102 CD work_jyzsgzx6ozemtdrfjlhthibtsm 109 6 tar- tar- NN work_jyzsgzx6ozemtdrfjlhthibtsm 109 7 get get VBP work_jyzsgzx6ozemtdrfjlhthibtsm 109 8 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 109 9 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 109 10 92 92 CD work_jyzsgzx6ozemtdrfjlhthibtsm 109 11 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 109 12 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 109 13 84 84 CD work_jyzsgzx6ozemtdrfjlhthibtsm 109 14 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 109 15 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 109 16 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 109 17 single single JJ work_jyzsgzx6ozemtdrfjlhthibtsm 109 18 lesion lesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 109 19 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 109 20 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 109 21 examined examine VBN work_jyzsgzx6ozemtdrfjlhthibtsm 109 22 once once RB work_jyzsgzx6ozemtdrfjlhthibtsm 109 23 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 109 24 5 5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 109 25 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 109 26 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 109 27 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 109 28 single single JJ work_jyzsgzx6ozemtdrfjlhthibtsm 109 29 lesion lesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 109 30 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 109 31 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 109 32 examined examine VBN work_jyzsgzx6ozemtdrfjlhthibtsm 109 33 twice twice RB work_jyzsgzx6ozemtdrfjlhthibtsm 109 34 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 109 35 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 109 36 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 109 37 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 109 38 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 109 39 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 109 40 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 109 41 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 109 42 examined examine VBN work_jyzsgzx6ozemtdrfjlhthibtsm 109 43 once once RB work_jyzsgzx6ozemtdrfjlhthibtsm 109 44 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 109 45 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 109 46 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 109 47 subject subject NN work_jyzsgzx6ozemtdrfjlhthibtsm 109 48 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 109 49 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 109 50 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 109 51 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 109 52 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 109 53 examined examine VBN work_jyzsgzx6ozemtdrfjlhthibtsm 109 54 twice twice RB work_jyzsgzx6ozemtdrfjlhthibtsm 109 55 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 109 56 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 109 57 assimilating assimilate VBG work_jyzsgzx6ozemtdrfjlhthibtsm 109 58 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 109 59 positive positive VB work_jyzsgzx6ozemtdrfjlhthibtsm 109 60 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 109 61 seven seven CD work_jyzsgzx6ozemtdrfjlhthibtsm 109 62 indeterminate indeterminate NN work_jyzsgzx6ozemtdrfjlhthibtsm 109 63 FDG- FDG- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 109 64 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 109 65 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 109 66 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 109 67 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 109 68 corresponded correspond VBD work_jyzsgzx6ozemtdrfjlhthibtsm 109 69 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 109 70 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 109 71 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 109 72 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 109 73 six six CD work_jyzsgzx6ozemtdrfjlhthibtsm 109 74 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 109 75 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 109 76 overall overall JJ work_jyzsgzx6ozemtdrfjlhthibtsm 109 77 sensitivity sensitivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 109 78 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 109 79 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 109 80 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 109 81 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 109 82 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 109 83 84 84 CD work_jyzsgzx6ozemtdrfjlhthibtsm 109 84 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 109 85 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 109 86 specificity specificity NN work_jyzsgzx6ozemtdrfjlhthibtsm 109 87 89 89 CD work_jyzsgzx6ozemtdrfjlhthibtsm 109 88 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 109 89 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 109 90 Table table NN work_jyzsgzx6ozemtdrfjlhthibtsm 109 91 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 109 92 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 109 93 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 110 1 Overall overall JJ work_jyzsgzx6ozemtdrfjlhthibtsm 110 2 sensitivity sensitivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 110 3 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 110 4 specificity specificity NN work_jyzsgzx6ozemtdrfjlhthibtsm 110 5 assimilating assimilate VBG work_jyzsgzx6ozemtdrfjlhthibtsm 110 6 inde- inde- XX work_jyzsgzx6ozemtdrfjlhthibtsm 110 7 terminate terminate VB work_jyzsgzx6ozemtdrfjlhthibtsm 110 8 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 110 9 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 110 10 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 110 11 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 110 12 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 110 13 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 110 14 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 110 15 68 68 CD work_jyzsgzx6ozemtdrfjlhthibtsm 110 16 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 110 17 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 110 18 90 90 CD work_jyzsgzx6ozemtdrfjlhthibtsm 110 19 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 110 20 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 110 21 respectively respectively RB work_jyzsgzx6ozemtdrfjlhthibtsm 110 22 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 111 1 Thirty thirty CD work_jyzsgzx6ozemtdrfjlhthibtsm 111 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 111 3 eight eight CD work_jyzsgzx6ozemtdrfjlhthibtsm 111 4 CT ct NN work_jyzsgzx6ozemtdrfjlhthibtsm 111 5 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 111 6 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 111 7 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 111 8 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 111 9 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 111 10 ROSE ROSE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 111 11 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 111 12 34 34 CD work_jyzsgzx6ozemtdrfjlhthibtsm 111 13 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 111 14 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 111 15 obtained obtain VBN work_jyzsgzx6ozemtdrfjlhthibtsm 111 16 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 111 17 38 38 CD work_jyzsgzx6ozemtdrfjlhthibtsm 111 18 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 111 19 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 111 20 34 34 CD work_jyzsgzx6ozemtdrfjlhthibtsm 111 21 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 111 22 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 111 23 that that RB work_jyzsgzx6ozemtdrfjlhthibtsm 111 24 is is RB work_jyzsgzx6ozemtdrfjlhthibtsm 111 25 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 111 26 2.4 2.4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 111 27 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 111 28 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 111 29 sub- sub- DT work_jyzsgzx6ozemtdrfjlhthibtsm 111 30 jects ject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 111 31 randomized randomize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 111 32 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 111 33 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 111 34 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 111 35 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 111 36 who who WP work_jyzsgzx6ozemtdrfjlhthibtsm 111 37 underwent undergo VBD work_jyzsgzx6ozemtdrfjlhthibtsm 111 38 baseline baseline JJ work_jyzsgzx6ozemtdrfjlhthibtsm 111 39 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 111 40 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 112 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 112 2 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 112 3 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 112 4 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 112 5 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 112 6 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 112 7 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 112 8 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 112 9 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 112 10 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 112 11 performed perform VBN work_jyzsgzx6ozemtdrfjlhthibtsm 112 12 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 112 13 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 112 14 distinct distinct JJ work_jyzsgzx6ozemtdrfjlhthibtsm 112 15 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 112 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 113 1 Eighteen eighteen CD work_jyzsgzx6ozemtdrfjlhthibtsm 113 2 FNAB FNAB NNS work_jyzsgzx6ozemtdrfjlhthibtsm 113 3 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 113 4 performed perform VBN work_jyzsgzx6ozemtdrfjlhthibtsm 113 5 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 113 6 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 113 7 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 113 8 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 113 9 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 113 10 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 113 11 round round RB work_jyzsgzx6ozemtdrfjlhthibtsm 113 12 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 113 13 20 20 CD work_jyzsgzx6ozemtdrfjlhthibtsm 113 14 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 113 15 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 113 16 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 113 17 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 113 18 subsequent subsequent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 113 19 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 113 20 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 113 21 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 113 22 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 114 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 114 2 mean mean JJ work_jyzsgzx6ozemtdrfjlhthibtsm 114 3 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 114 4 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 114 5 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 114 6 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 114 7 referred refer VBN work_jyzsgzx6ozemtdrfjlhthibtsm 114 8 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 114 9 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 114 10 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 114 11 18.2 18.2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 114 12 mm mm NNP work_jyzsgzx6ozemtdrfjlhthibtsm 114 13 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 114 14 range range NN work_jyzsgzx6ozemtdrfjlhthibtsm 114 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 114 16 5–48 5–48 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 114 17 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 114 18 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 115 1 Overall overall RB work_jyzsgzx6ozemtdrfjlhthibtsm 115 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 115 3 34 34 CD work_jyzsgzx6ozemtdrfjlhthibtsm 115 4 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 115 5 38 38 CD work_jyzsgzx6ozemtdrfjlhthibtsm 115 6 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 115 7 89 89 CD work_jyzsgzx6ozemtdrfjlhthibtsm 115 8 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 115 9 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 115 10 procedures procedure NNS work_jyzsgzx6ozemtdrfjlhthibtsm 115 11 yielded yield VBD work_jyzsgzx6ozemtdrfjlhthibtsm 115 12 adequate adequate JJ work_jyzsgzx6ozemtdrfjlhthibtsm 115 13 material material NN work_jyzsgzx6ozemtdrfjlhthibtsm 115 14 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 115 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 115 16 cytological cytological JJ work_jyzsgzx6ozemtdrfjlhthibtsm 115 17 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 115 18 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 115 19 Table table NN work_jyzsgzx6ozemtdrfjlhthibtsm 115 20 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 115 21 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 115 22 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 116 1 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 116 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 116 3 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 116 4 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 116 5 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 116 6 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 116 7 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 116 8 histological histological JJ work_jyzsgzx6ozemtdrfjlhthibtsm 116 9 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 116 10 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 116 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 116 12 sur- sur- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 116 13 gical gical NNP work_jyzsgzx6ozemtdrfjlhthibtsm 116 14 specimen speciman NNS work_jyzsgzx6ozemtdrfjlhthibtsm 116 15 revealed reveal VBD work_jyzsgzx6ozemtdrfjlhthibtsm 116 16 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 116 17 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 116 18 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 116 19 n n NN work_jyzsgzx6ozemtdrfjlhthibtsm 116 20 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 116 21 25 25 CD work_jyzsgzx6ozemtdrfjlhthibtsm 116 22 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 116 23 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 116 24 metastasis metastasis NN work_jyzsgzx6ozemtdrfjlhthibtsm 116 25 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 116 26 n n NN work_jyzsgzx6ozemtdrfjlhthibtsm 116 27 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 116 28 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 116 29 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 116 30 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 116 31 27 27 CD work_jyzsgzx6ozemtdrfjlhthibtsm 116 32 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 116 33 38 38 CD work_jyzsgzx6ozemtdrfjlhthibtsm 116 34 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 116 35 71 71 CD work_jyzsgzx6ozemtdrfjlhthibtsm 116 36 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 116 37 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 116 38 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 116 39 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 116 40 atypical atypical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 116 41 adenomatous adenomatous JJ work_jyzsgzx6ozemtdrfjlhthibtsm 116 42 hyperplasia hyperplasia NNP work_jyzsgzx6ozemtdrfjlhthibtsm 116 43 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 116 44 AAH AAH NNP work_jyzsgzx6ozemtdrfjlhthibtsm 116 45 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 116 46 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 116 47 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 116 48 lesion lesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 116 49 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 117 1 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 117 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 117 3 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 117 4 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 117 5 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 117 6 nega- nega- IN work_jyzsgzx6ozemtdrfjlhthibtsm 117 7 tive tive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 117 8 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 117 9 six six CD work_jyzsgzx6ozemtdrfjlhthibtsm 117 10 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 117 11 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 117 12 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 117 13 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 117 14 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 117 15 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 117 16 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 117 17 subject subject NN work_jyzsgzx6ozemtdrfjlhthibtsm 117 18 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 117 19 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 117 20 inconclu- inconclu- VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 117 21 sive sive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 117 22 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 117 23 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 117 24 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 117 25 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 117 26 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 117 27 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 117 28 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 117 29 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 117 30 renal renal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 117 31 metastasis metastasis NN work_jyzsgzx6ozemtdrfjlhthibtsm 117 32 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 117 33 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 117 34 subject subject NN work_jyzsgzx6ozemtdrfjlhthibtsm 117 35 each each DT work_jyzsgzx6ozemtdrfjlhthibtsm 117 36 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 117 37 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 118 1 By by IN work_jyzsgzx6ozemtdrfjlhthibtsm 118 2 assimilating assimilate VBG work_jyzsgzx6ozemtdrfjlhthibtsm 118 3 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 118 4 inconclusive inconclusive NN work_jyzsgzx6ozemtdrfjlhthibtsm 118 5 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 118 6 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 118 7 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 118 8 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 118 9 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 118 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 118 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 118 12 overall overall JJ work_jyzsgzx6ozemtdrfjlhthibtsm 118 13 sensitivity sensitivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 118 14 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 118 15 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 118 16 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 118 17 90 90 CD work_jyzsgzx6ozemtdrfjlhthibtsm 118 18 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 118 19 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 118 20 specificity specificity NN work_jyzsgzx6ozemtdrfjlhthibtsm 118 21 88 88 CD work_jyzsgzx6ozemtdrfjlhthibtsm 118 22 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 118 23 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 119 1 Sensitivity sensitivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 119 2 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 119 3 96 96 CD work_jyzsgzx6ozemtdrfjlhthibtsm 119 4 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 119 5 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 119 6 specificity specificity NN work_jyzsgzx6ozemtdrfjlhthibtsm 119 7 83 83 CD work_jyzsgzx6ozemtdrfjlhthibtsm 119 8 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 119 9 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 119 10 exclusion exclusion NN work_jyzsgzx6ozemtdrfjlhthibtsm 119 11 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 119 12 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 119 13 inconclusive inconclusive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 119 14 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 119 15 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 119 16 insufficient insufficient JJ work_jyzsgzx6ozemtdrfjlhthibtsm 119 17 material material NN work_jyzsgzx6ozemtdrfjlhthibtsm 119 18 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 120 1 Pneumothorax Pneumothorax NNP work_jyzsgzx6ozemtdrfjlhthibtsm 120 2 occurred occur VBD work_jyzsgzx6ozemtdrfjlhthibtsm 120 3 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 120 4 11 11 CD work_jyzsgzx6ozemtdrfjlhthibtsm 120 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 120 6 38 38 CD work_jyzsgzx6ozemtdrfjlhthibtsm 120 7 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 120 8 29 29 CD work_jyzsgzx6ozemtdrfjlhthibtsm 120 9 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 120 10 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 120 11 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 120 12 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 120 13 procedures procedure NNS work_jyzsgzx6ozemtdrfjlhthibtsm 120 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 120 15 but but CC work_jyzsgzx6ozemtdrfjlhthibtsm 120 16 only only RB work_jyzsgzx6ozemtdrfjlhthibtsm 120 17 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 120 18 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 120 19 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 120 20 5 5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 120 21 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 120 22 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 120 23 needed need VBD work_jyzsgzx6ozemtdrfjlhthibtsm 120 24 thoracic thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 120 25 drainage drainage NN work_jyzsgzx6ozemtdrfjlhthibtsm 120 26 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 121 1 FBS FBS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 121 2 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 121 3 obtained obtain VBN work_jyzsgzx6ozemtdrfjlhthibtsm 121 4 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 121 5 30 30 CD work_jyzsgzx6ozemtdrfjlhthibtsm 121 6 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 121 7 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 121 8 that that RB work_jyzsgzx6ozemtdrfjlhthibtsm 121 9 is is RB work_jyzsgzx6ozemtdrfjlhthibtsm 121 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 121 11 2.1 2.1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 121 12 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 121 13 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 121 14 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 121 15 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 121 16 who who WP work_jyzsgzx6ozemtdrfjlhthibtsm 121 17 underwent undergo VBD work_jyzsgzx6ozemtdrfjlhthibtsm 121 18 baseline baseline JJ work_jyzsgzx6ozemtdrfjlhthibtsm 121 19 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 121 20 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 121 21 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 122 1 Twenty twenty CD work_jyzsgzx6ozemtdrfjlhthibtsm 122 2 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 122 3 performed perform VBN work_jyzsgzx6ozemtdrfjlhthibtsm 122 4 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 122 5 baseline baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 122 6 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 122 7 10 10 CD work_jyzsgzx6ozemtdrfjlhthibtsm 122 8 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 122 9 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 122 10 subsequent subsequent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 122 11 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 122 12 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 122 13 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 123 1 FBS FBS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 123 2 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 123 3 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 123 4 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 123 5 eight eight CD work_jyzsgzx6ozemtdrfjlhthibtsm 123 6 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 123 7 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 123 8 all all DT work_jyzsgzx6ozemtdrfjlhthibtsm 123 9 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 123 10 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 123 11 can- can- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 123 12 cer cer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 123 13 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 123 14 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 123 15 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 123 16 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 123 17 22 22 CD work_jyzsgzx6ozemtdrfjlhthibtsm 123 18 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 123 19 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 124 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 124 2 six six CD work_jyzsgzx6ozemtdrfjlhthibtsm 124 3 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 124 4 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 124 5 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 124 6 FBS FBS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 124 7 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 124 8 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 124 9 diagnosis diagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 124 10 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 124 11 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 124 12 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 124 13 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 124 14 finally finally RB work_jyzsgzx6ozemtdrfjlhthibtsm 124 15 reached reach VBN work_jyzsgzx6ozemtdrfjlhthibtsm 124 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 125 1 Overall overall JJ work_jyzsgzx6ozemtdrfjlhthibtsm 125 2 sensitivity sensitivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 125 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 125 4 FBS FBS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 125 5 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 125 6 57 57 CD work_jyzsgzx6ozemtdrfjlhthibtsm 125 7 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 125 8 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 125 9 specificity specificity NN work_jyzsgzx6ozemtdrfjlhthibtsm 125 10 100 100 CD work_jyzsgzx6ozemtdrfjlhthibtsm 125 11 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 125 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 126 1 Twenty twenty CD work_jyzsgzx6ozemtdrfjlhthibtsm 126 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 126 3 eight eight CD work_jyzsgzx6ozemtdrfjlhthibtsm 126 4 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 126 5 received receive VBD work_jyzsgzx6ozemtdrfjlhthibtsm 126 6 both both CC work_jyzsgzx6ozemtdrfjlhthibtsm 126 7 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 126 8 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 126 9 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 126 10 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 126 11 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 126 12 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 126 13 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 126 14 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 126 15 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 126 16 part part NN work_jyzsgzx6ozemtdrfjlhthibtsm 126 17 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 126 18 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 126 19 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 126 20 suspicious suspicious JJ work_jyzsgzx6ozemtdrfjlhthibtsm 126 21 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 126 22 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 127 1 Positivity positivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 127 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 127 3 both both CC work_jyzsgzx6ozemtdrfjlhthibtsm 127 4 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 127 5 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 127 6 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 127 7 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 127 8 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 127 9 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 127 10 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 127 11 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 127 12 enabled enable VBD work_jyzsgzx6ozemtdrfjlhthibtsm 127 13 pre- pre- NN work_jyzsgzx6ozemtdrfjlhthibtsm 127 14 diction diction NN work_jyzsgzx6ozemtdrfjlhthibtsm 127 15 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 127 16 lung lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 127 17 malignancy malignancy NN work_jyzsgzx6ozemtdrfjlhthibtsm 127 18 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 127 19 all all DT work_jyzsgzx6ozemtdrfjlhthibtsm 127 20 18 18 CD work_jyzsgzx6ozemtdrfjlhthibtsm 127 21 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 127 22 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 127 23 such such PDT work_jyzsgzx6ozemtdrfjlhthibtsm 127 24 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 127 25 com- com- NN work_jyzsgzx6ozemtdrfjlhthibtsm 127 26 bination bination NN work_jyzsgzx6ozemtdrfjlhthibtsm 127 27 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 127 28 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 127 29 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 128 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 128 2 particular particular JJ work_jyzsgzx6ozemtdrfjlhthibtsm 128 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 128 4 primary primary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 128 5 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 128 6 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 128 7 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 128 8 found find VBN work_jyzsgzx6ozemtdrfjlhthibtsm 128 9 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 128 10 16 16 CD work_jyzsgzx6ozemtdrfjlhthibtsm 128 11 cases case NNS work_jyzsgzx6ozemtdrfjlhthibtsm 128 12 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 128 13 solitary solitary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 128 14 metastases metastasis NNS work_jyzsgzx6ozemtdrfjlhthibtsm 128 15 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 128 16 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 128 17 gastrointestinal gastrointestinal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 128 18 can- can- NN work_jyzsgzx6ozemtdrfjlhthibtsm 128 19 cers cer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 128 20 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 128 21 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 128 22 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 128 23 cases case NNS work_jyzsgzx6ozemtdrfjlhthibtsm 128 24 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 129 1 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 129 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 129 3 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 129 4 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 129 5 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 129 6 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 129 7 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 129 8 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 129 9 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 129 10 both both DT work_jyzsgzx6ozemtdrfjlhthibtsm 129 11 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 129 12 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 129 13 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 129 14 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 129 15 without without IN work_jyzsgzx6ozemtdrfjlhthibtsm 129 16 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 129 17 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 129 18 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 130 1 Discrepancies discrepancy NNS work_jyzsgzx6ozemtdrfjlhthibtsm 130 2 between between IN work_jyzsgzx6ozemtdrfjlhthibtsm 130 3 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 130 4 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 130 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 130 6 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 130 7 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 130 8 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 130 9 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 130 10 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 130 11 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 130 12 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 130 13 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 130 14 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 130 15 observed observe VBN work_jyzsgzx6ozemtdrfjlhthibtsm 130 16 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 130 17 six six CD work_jyzsgzx6ozemtdrfjlhthibtsm 130 18 cases case NNS work_jyzsgzx6ozemtdrfjlhthibtsm 130 19 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 131 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 131 2 three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 131 3 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 131 4 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 131 5 final final JJ work_jyzsgzx6ozemtdrfjlhthibtsm 131 6 diagnosis diagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 131 7 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 131 8 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 131 9 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 131 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 131 11 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 131 12 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 131 13 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 131 14 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 131 15 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 131 16 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 131 17 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 131 18 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 131 19 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 131 20 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 131 21 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 131 22 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 131 23 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 132 1 However however RB work_jyzsgzx6ozemtdrfjlhthibtsm 132 2 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 132 3 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 132 4 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 132 5 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 132 6 three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 132 7 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 132 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 132 9 because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 132 10 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 132 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 132 12 deep deep JJ work_jyzsgzx6ozemtdrfjlhthibtsm 132 13 location location NN work_jyzsgzx6ozemtdrfjlhthibtsm 132 14 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 132 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 132 16 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 132 17 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 132 18 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 132 19 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 132 20 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 132 21 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 132 22 performed perform VBN work_jyzsgzx6ozemtdrfjlhthibtsm 132 23 under under IN work_jyzsgzx6ozemtdrfjlhthibtsm 132 24 transoesophegeal transoesophegeal NN work_jyzsgzx6ozemtdrfjlhthibtsm 132 25 ultrasound ultrasound NN work_jyzsgzx6ozemtdrfjlhthibtsm 132 26 guidance guidance NN work_jyzsgzx6ozemtdrfjlhthibtsm 132 27 rather rather RB work_jyzsgzx6ozemtdrfjlhthibtsm 132 28 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 132 29 under under IN work_jyzsgzx6ozemtdrfjlhthibtsm 132 30 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 132 31 guidance guidance NN work_jyzsgzx6ozemtdrfjlhthibtsm 132 32 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 133 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 133 2 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 133 3 additional additional JJ work_jyzsgzx6ozemtdrfjlhthibtsm 133 4 subject subject NN work_jyzsgzx6ozemtdrfjlhthibtsm 133 5 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 133 6 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 133 7 final final JJ work_jyzsgzx6ozemtdrfjlhthibtsm 133 8 diagnosis diagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 133 9 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 133 10 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 133 11 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 133 12 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 133 13 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 133 14 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 133 15 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 133 16 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 133 17 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 133 18 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 133 19 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 133 20 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 133 21 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 133 22 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 133 23 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 133 24 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 134 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 134 2 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 134 3 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 134 4 final final JJ work_jyzsgzx6ozemtdrfjlhthibtsm 134 5 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 134 6 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 134 7 whom whom WP work_jyzsgzx6ozemtdrfjlhthibtsm 134 8 no no DT work_jyzsgzx6ozemtdrfjlhthibtsm 134 9 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 134 10 can- can- NN work_jyzsgzx6ozemtdrfjlhthibtsm 134 11 cer cer NN work_jyzsgzx6ozemtdrfjlhthibtsm 134 12 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 134 13 ultimately ultimately RB work_jyzsgzx6ozemtdrfjlhthibtsm 134 14 diagnosed diagnose VBN work_jyzsgzx6ozemtdrfjlhthibtsm 134 15 during during IN work_jyzsgzx6ozemtdrfjlhthibtsm 134 16 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 134 17 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 134 18 period period NN work_jyzsgzx6ozemtdrfjlhthibtsm 134 19 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 134 20 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 134 21 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 134 22 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 134 23 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 134 24 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 134 25 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 134 26 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 134 27 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 134 28 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 134 29 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 134 30 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 134 31 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 134 32 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 134 33 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 134 34 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 134 35 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 134 36 case case NN work_jyzsgzx6ozemtdrfjlhthibtsm 134 37 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 134 38 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 134 39 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 134 40 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 134 41 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 134 42 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 134 43 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 134 44 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 134 45 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 134 46 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 134 47 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 134 48 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 134 49 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 134 50 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 134 51 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 134 52 inconclusive inconclusive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 134 53 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 134 54 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 134 55 other other JJ work_jyzsgzx6ozemtdrfjlhthibtsm 134 56 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 135 1 Six six CD work_jyzsgzx6ozemtdrfjlhthibtsm 135 2 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 135 3 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 135 4 final final JJ work_jyzsgzx6ozemtdrfjlhthibtsm 135 5 diagnosis diagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 135 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 135 7 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 135 8 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 135 9 did do VBD work_jyzsgzx6ozemtdrfjlhthibtsm 135 10 not not RB work_jyzsgzx6ozemtdrfjlhthibtsm 135 11 undergo undergo VB work_jyzsgzx6ozemtdrfjlhthibtsm 135 12 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 135 13 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 135 14 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 135 15 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 136 1 Three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 136 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 136 3 them -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 136 4 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 136 5 large large JJ work_jyzsgzx6ozemtdrfjlhthibtsm 136 6 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 136 7 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 136 8 diam- diam- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 136 9 eter eter NNP work_jyzsgzx6ozemtdrfjlhthibtsm 136 10 range range NNP work_jyzsgzx6ozemtdrfjlhthibtsm 136 11 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 136 12 35–48 35–48 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 136 13 mm mm NNP work_jyzsgzx6ozemtdrfjlhthibtsm 136 14 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 136 15 detected detect VBD work_jyzsgzx6ozemtdrfjlhthibtsm 136 16 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 136 17 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 136 18 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 136 19 round round RB work_jyzsgzx6ozemtdrfjlhthibtsm 136 20 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 136 21 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 136 22 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 136 23 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 136 24 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 136 25 enabled enable VBD work_jyzsgzx6ozemtdrfjlhthibtsm 136 26 direct direct JJ work_jyzsgzx6ozemtdrfjlhthibtsm 136 27 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 136 28 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 136 29 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 136 30 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 136 31 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 137 1 Two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 137 2 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 137 3 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 137 4 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 137 5 appearing appear VBG work_jyzsgzx6ozemtdrfjlhthibtsm 137 6 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 137 7 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 137 8 part part NN work_jyzsgzx6ozemtdrfjlhthibtsm 137 9 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 137 10 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 137 11 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 137 12 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 137 13 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 137 14 very very RB work_jyzsgzx6ozemtdrfjlhthibtsm 137 15 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 137 16 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 137 17 component component NN work_jyzsgzx6ozemtdrfjlhthibtsm 137 18 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 137 19 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 137 20 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 137 21 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 137 22 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 137 23 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 137 24 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 137 25 directly directly RB work_jyzsgzx6ozemtdrfjlhthibtsm 137 26 underwent undergo VBD work_jyzsgzx6ozemtdrfjlhthibtsm 137 27 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 137 28 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 137 29 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 137 30 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 137 31 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 138 1 One one CD work_jyzsgzx6ozemtdrfjlhthibtsm 138 2 final final JJ work_jyzsgzx6ozemtdrfjlhthibtsm 138 3 sub- sub- NN work_jyzsgzx6ozemtdrfjlhthibtsm 138 4 ject ject NN work_jyzsgzx6ozemtdrfjlhthibtsm 138 5 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 138 6 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 138 7 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 138 8 peripheral peripheral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 138 9 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 138 10 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 138 11 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 138 12 baseline baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 138 13 screen- screen- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 138 14 ing ing NNP work_jyzsgzx6ozemtdrfjlhthibtsm 138 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 138 16 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 138 17 exhibited exhibit VBD work_jyzsgzx6ozemtdrfjlhthibtsm 138 18 significant significant JJ work_jyzsgzx6ozemtdrfjlhthibtsm 138 19 growth growth NN work_jyzsgzx6ozemtdrfjlhthibtsm 138 20 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 138 21 follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 138 22 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 138 23 up up NN work_jyzsgzx6ozemtdrfjlhthibtsm 138 24 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 138 25 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 138 26 also also RB work_jyzsgzx6ozemtdrfjlhthibtsm 138 27 directly directly RB work_jyzsgzx6ozemtdrfjlhthibtsm 138 28 underwent undergo VBD work_jyzsgzx6ozemtdrfjlhthibtsm 138 29 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 138 30 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 138 31 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 138 32 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 138 33 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 139 1 Eight eight CD work_jyzsgzx6ozemtdrfjlhthibtsm 139 2 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 139 3 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 139 4 final final JJ work_jyzsgzx6ozemtdrfjlhthibtsm 139 5 diagnosis diagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 139 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 139 7 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 139 8 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 139 9 did do VBD work_jyzsgzx6ozemtdrfjlhthibtsm 139 10 not not RB work_jyzsgzx6ozemtdrfjlhthibtsm 139 11 undergo undergo VB work_jyzsgzx6ozemtdrfjlhthibtsm 139 12 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 139 13 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 139 14 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 139 15 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 139 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 140 1 Five five CD work_jyzsgzx6ozemtdrfjlhthibtsm 140 2 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 140 3 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 140 4 histological histological JJ work_jyzsgzx6ozemtdrfjlhthibtsm 140 5 lung lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 140 6 malignancy malignancy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 140 7 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 140 8 4 4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 140 9 NSCLC NSCLC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 140 10 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 140 11 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 140 12 metastasis metastasis NN work_jyzsgzx6ozemtdrfjlhthibtsm 140 13 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 140 14 renal renal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 140 15 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 140 16 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 140 17 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 140 18 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 140 19 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 140 20 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 140 21 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 140 22 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 140 23 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 140 24 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 140 25 directly directly RB work_jyzsgzx6ozemtdrfjlhthibtsm 140 26 sent send VBN work_jyzsgzx6ozemtdrfjlhthibtsm 140 27 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 140 28 surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 140 29 as as RB work_jyzsgzx6ozemtdrfjlhthibtsm 140 30 well well RB work_jyzsgzx6ozemtdrfjlhthibtsm 140 31 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 140 32 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 140 33 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 140 34 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 140 35 carcinoid carcinoid NNP work_jyzsgzx6ozemtdrfjlhthibtsm 140 36 who who WP work_jyzsgzx6ozemtdrfjlhthibtsm 140 37 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 140 38 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 140 39 indeterminate indeterminate JJ work_jyzsgzx6ozemtdrfjlhthibtsm 140 40 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 140 41 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 140 42 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 140 43 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 140 44 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 140 45 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 140 46 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 140 47 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 140 48 final final JJ work_jyzsgzx6ozemtdrfjlhthibtsm 140 49 subject subject NN work_jyzsgzx6ozemtdrfjlhthibtsm 140 50 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 140 51 metastasis metastasis NN work_jyzsgzx6ozemtdrfjlhthibtsm 140 52 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 140 53 renal renal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 140 54 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 140 55 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 140 56 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 140 57 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 140 58 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 140 59 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 140 60 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 141 1 Therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 141 3 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 4 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 141 5 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 141 6 primary primary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 141 7 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 8 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 141 9 included include VBD work_jyzsgzx6ozemtdrfjlhthibtsm 141 10 surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 11 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 141 12 lobectomy lobectomy NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 13 n n NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 14 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 141 15 29 29 CD work_jyzsgzx6ozemtdrfjlhthibtsm 141 16 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 141 17 sublobar sublobar NNP work_jyzsgzx6ozemtdrfjlhthibtsm 141 18 resection resection NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 19 n n NNP work_jyzsgzx6ozemtdrfjlhthibtsm 141 20 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 141 21 6 6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 141 22 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 141 23 pneumonectomy pneumonectomy NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 24 n n NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 25 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 141 26 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 141 27 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 141 28 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 141 29 34 34 CD work_jyzsgzx6ozemtdrfjlhthibtsm 141 30 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 141 31 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 141 32 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 33 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 34 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 141 35 30 30 CD work_jyzsgzx6ozemtdrfjlhthibtsm 141 36 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 141 37 NSCLC NSCLC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 141 38 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 141 39 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 141 40 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 141 41 carcinoids carcinoid NNS work_jyzsgzx6ozemtdrfjlhthibtsm 141 42 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 141 43 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 141 44 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 141 45 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 141 46 both both CC work_jyzsgzx6ozemtdrfjlhthibtsm 141 47 NSCLC NSCLC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 141 48 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 141 49 SCLC sclc NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 50 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 141 51 alone alone RB work_jyzsgzx6ozemtdrfjlhthibtsm 141 52 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 141 53 n n NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 54 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 141 55 29 29 CD work_jyzsgzx6ozemtdrfjlhthibtsm 141 56 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 141 57 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 141 58 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 141 59 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 141 60 combination combination NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 61 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 141 62 both both DT work_jyzsgzx6ozemtdrfjlhthibtsm 141 63 chemo chemo NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 64 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 141 65 radiation radiation NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 66 therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 67 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 141 68 n n NNP work_jyzsgzx6ozemtdrfjlhthibtsm 141 69 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 141 70 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 141 71 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 141 72 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 141 73 just just RB work_jyzsgzx6ozemtdrfjlhthibtsm 141 74 chemotherapy chemotherapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 75 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 141 76 n n NN work_jyzsgzx6ozemtdrfjlhthibtsm 141 77 = = SYM work_jyzsgzx6ozemtdrfjlhthibtsm 141 78 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 141 79 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 141 80 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 142 1 Six six CD work_jyzsgzx6ozemtdrfjlhthibtsm 142 2 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 142 3 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 142 4 primary primary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 142 5 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 142 6 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 142 7 did do VBD work_jyzsgzx6ozemtdrfjlhthibtsm 142 8 not not RB work_jyzsgzx6ozemtdrfjlhthibtsm 142 9 receive receive VB work_jyzsgzx6ozemtdrfjlhthibtsm 142 10 surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 142 11 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 143 1 Two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 143 2 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 143 3 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 143 4 treated treat VBN work_jyzsgzx6ozemtdrfjlhthibtsm 143 5 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 143 6 combined combine VBN work_jyzsgzx6ozemtdrfjlhthibtsm 143 7 chemo chemo NN work_jyzsgzx6ozemtdrfjlhthibtsm 143 8 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 143 9 radiation radiation NN work_jyzsgzx6ozemtdrfjlhthibtsm 143 10 therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 143 11 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 143 12 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 143 13 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 143 14 chemotherapy chemotherapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 143 15 alone alone RB work_jyzsgzx6ozemtdrfjlhthibtsm 143 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 144 1 Surgical surgical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 144 2 resection resection NN work_jyzsgzx6ozemtdrfjlhthibtsm 144 3 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 144 4 benign benign JJ work_jyzsgzx6ozemtdrfjlhthibtsm 144 5 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 144 6 pathology pathology NN work_jyzsgzx6ozemtdrfjlhthibtsm 144 7 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 144 8 car- car- RB work_jyzsgzx6ozemtdrfjlhthibtsm 144 9 ried rie VBN work_jyzsgzx6ozemtdrfjlhthibtsm 144 10 out out RP work_jyzsgzx6ozemtdrfjlhthibtsm 144 11 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 144 12 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 144 13 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 144 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 144 15 corresponding correspond VBG work_jyzsgzx6ozemtdrfjlhthibtsm 144 16 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 144 17 10 10 CD work_jyzsgzx6ozemtdrfjlhthibtsm 144 18 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 144 19 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 144 20 4 4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 144 21 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 144 22 38 38 CD work_jyzsgzx6ozemtdrfjlhthibtsm 144 23 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 144 24 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 144 25 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 144 26 871Copyright 871copyright JJ work_jyzsgzx6ozemtdrfjlhthibtsm 144 27 © © NN work_jyzsgzx6ozemtdrfjlhthibtsm 144 28 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 144 29 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 144 30 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 144 31 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 32 Association Association NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 33 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 144 34 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 144 35 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 36 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 144 37 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 38 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 39 Journal Journal NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 40 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 144 41 Thoracic Thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 42 Oncology Oncology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 43 ® ® NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 44     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 144 45 • • NN work_jyzsgzx6ozemtdrfjlhthibtsm 144 46     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 144 47 Volume volume NN work_jyzsgzx6ozemtdrfjlhthibtsm 144 48     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 144 49 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 144 50 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 144 51     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 144 52 Number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 144 53     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 144 54 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 144 55 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 144 56     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 144 57 July July NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 58     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 144 59 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 144 60 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 61 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 144 62 Nodule Nodule NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 63 Management Management NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 64 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 144 65 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 66 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 144 67 undergoing undergo VBG work_jyzsgzx6ozemtdrfjlhthibtsm 144 68 surgical surgical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 144 69 resections resection NNS work_jyzsgzx6ozemtdrfjlhthibtsm 144 70 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 144 71 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 144 72 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 144 73 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 144 74 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 144 75 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 144 76 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 144 77 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 145 1 Three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 145 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 145 3 them -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 145 4 followed follow VBD work_jyzsgzx6ozemtdrfjlhthibtsm 145 5 violations violation NNS work_jyzsgzx6ozemtdrfjlhthibtsm 145 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 145 7 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 145 8 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 145 9 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 145 10 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 146 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 146 2 particular particular JJ work_jyzsgzx6ozemtdrfjlhthibtsm 146 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 146 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 146 5 first first JJ work_jyzsgzx6ozemtdrfjlhthibtsm 146 6 subject subject NN work_jyzsgzx6ozemtdrfjlhthibtsm 146 7 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 146 8 referred refer VBN work_jyzsgzx6ozemtdrfjlhthibtsm 146 9 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 146 10 surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 146 11 without without IN work_jyzsgzx6ozemtdrfjlhthibtsm 146 12 undergoing undergo VBG work_jyzsgzx6ozemtdrfjlhthibtsm 146 13 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 146 14 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 146 15 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 146 16 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 146 17 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 146 18 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 146 19 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 146 20 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 146 21 because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 146 22 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 146 23 comparison comparison NN work_jyzsgzx6ozemtdrfjlhthibtsm 146 24 between between IN work_jyzsgzx6ozemtdrfjlhthibtsm 146 25 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 146 26 baseline baseline JJ work_jyzsgzx6ozemtdrfjlhthibtsm 146 27 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 146 28 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 146 29 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 146 30 prior prior JJ work_jyzsgzx6ozemtdrfjlhthibtsm 146 31 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 146 32 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 146 33 performed perform VBD work_jyzsgzx6ozemtdrfjlhthibtsm 146 34 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 146 35 other other JJ work_jyzsgzx6ozemtdrfjlhthibtsm 146 36 reasons reason NNS work_jyzsgzx6ozemtdrfjlhthibtsm 146 37 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 146 38 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 146 39 before before IN work_jyzsgzx6ozemtdrfjlhthibtsm 146 40 enrolment enrolment NN work_jyzsgzx6ozemtdrfjlhthibtsm 146 41 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 146 42 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 146 43 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 146 44 showed show VBD work_jyzsgzx6ozemtdrfjlhthibtsm 146 45 increase increase NN work_jyzsgzx6ozemtdrfjlhthibtsm 146 46 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 146 47 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 146 48 mean mean JJ work_jyzsgzx6ozemtdrfjlhthibtsm 146 49 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 146 50 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 146 51 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 146 52 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 146 53 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 146 54 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 146 55 5 5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 146 56 mm mm NNS work_jyzsgzx6ozemtdrfjlhthibtsm 146 57 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 146 58 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 146 59 mm mm CD work_jyzsgzx6ozemtdrfjlhthibtsm 146 60 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 147 1 Histological histological JJ work_jyzsgzx6ozemtdrfjlhthibtsm 147 2 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 147 3 revealed reveal VBD work_jyzsgzx6ozemtdrfjlhthibtsm 147 4 hamartocondroma hamartocondroma NNP work_jyzsgzx6ozemtdrfjlhthibtsm 147 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 148 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 148 2 second second JJ work_jyzsgzx6ozemtdrfjlhthibtsm 148 3 subject subject NN work_jyzsgzx6ozemtdrfjlhthibtsm 148 4 showed show VBD work_jyzsgzx6ozemtdrfjlhthibtsm 148 5 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 148 6 new new JJ work_jyzsgzx6ozemtdrfjlhthibtsm 148 7 part- part- NNS work_jyzsgzx6ozemtdrfjlhthibtsm 148 8 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 148 9 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 148 10 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 148 11 10-mm 10-mm NNP work_jyzsgzx6ozemtdrfjlhthibtsm 148 12 mean mean VB work_jyzsgzx6ozemtdrfjlhthibtsm 148 13 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 148 14 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 148 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 148 16 last last JJ work_jyzsgzx6ozemtdrfjlhthibtsm 148 17 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 148 18 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 148 19 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 148 20 round round NN work_jyzsgzx6ozemtdrfjlhthibtsm 148 21 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 148 22 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 148 23 doubled double VBD work_jyzsgzx6ozemtdrfjlhthibtsm 148 24 its -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 148 25 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 148 26 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 148 27 3-month 3-month CD work_jyzsgzx6ozemtdrfjlhthibtsm 148 28 follow- follow- NN work_jyzsgzx6ozemtdrfjlhthibtsm 148 29 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 148 30 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 148 31 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 149 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 149 2 lesion lesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 149 3 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 149 4 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 149 5 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 149 6 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 149 7 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 149 8 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 149 9 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 149 10 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 149 11 surgi- surgi- NN work_jyzsgzx6ozemtdrfjlhthibtsm 149 12 cally cally RB work_jyzsgzx6ozemtdrfjlhthibtsm 149 13 removed remove VBN work_jyzsgzx6ozemtdrfjlhthibtsm 149 14 without without IN work_jyzsgzx6ozemtdrfjlhthibtsm 149 15 preliminary preliminary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 149 16 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 149 17 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 149 18 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 149 19 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 149 20 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 150 1 Surgical surgical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 150 2 pathology pathology NN work_jyzsgzx6ozemtdrfjlhthibtsm 150 3 failed fail VBD work_jyzsgzx6ozemtdrfjlhthibtsm 150 4 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 150 5 identify identify VB work_jyzsgzx6ozemtdrfjlhthibtsm 150 6 malignant malignant JJ work_jyzsgzx6ozemtdrfjlhthibtsm 150 7 cells cell NNS work_jyzsgzx6ozemtdrfjlhthibtsm 150 8 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 151 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 151 2 third third JJ work_jyzsgzx6ozemtdrfjlhthibtsm 151 3 subject subject JJ work_jyzsgzx6ozemtdrfjlhthibtsm 151 4 underwent undergo VBD work_jyzsgzx6ozemtdrfjlhthibtsm 151 5 surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 151 6 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 151 7 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 151 8 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 151 9 lesion lesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 151 10 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 151 11 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 151 12 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 151 13 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 151 14 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 151 15 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 151 16 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 151 17 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 151 18 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 151 19 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 151 20 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 151 21 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 151 22 right right JJ work_jyzsgzx6ozemtdrfjlhthibtsm 151 23 upper upper JJ work_jyzsgzx6ozemtdrfjlhthibtsm 151 24 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 151 25 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 151 26 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 151 27 increased increase VBD work_jyzsgzx6ozemtdrfjlhthibtsm 151 28 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 151 29 mean mean JJ work_jyzsgzx6ozemtdrfjlhthibtsm 151 30 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 151 31 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 151 32 6 6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 151 33 mm mm NNS work_jyzsgzx6ozemtdrfjlhthibtsm 151 34 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 151 35 9 9 CD work_jyzsgzx6ozemtdrfjlhthibtsm 151 36 mm mm NNS work_jyzsgzx6ozemtdrfjlhthibtsm 151 37 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 151 38 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 151 39 last last JJ work_jyzsgzx6ozemtdrfjlhthibtsm 151 40 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 151 41 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 151 42 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 151 43 round round NN work_jyzsgzx6ozemtdrfjlhthibtsm 151 44 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 151 45 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 151 46 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 151 47 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 151 48 pathological pathological JJ work_jyzsgzx6ozemtdrfjlhthibtsm 151 49 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 151 50 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 151 51 found find VBN work_jyzsgzx6ozemtdrfjlhthibtsm 151 52 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 151 53 be be VB work_jyzsgzx6ozemtdrfjlhthibtsm 151 54 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 151 55 AC ac NN work_jyzsgzx6ozemtdrfjlhthibtsm 151 56 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 152 1 However however RB work_jyzsgzx6ozemtdrfjlhthibtsm 152 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 152 3 during during IN work_jyzsgzx6ozemtdrfjlhthibtsm 152 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 152 5 same same JJ work_jyzsgzx6ozemtdrfjlhthibtsm 152 6 surgical surgical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 152 7 session session NN work_jyzsgzx6ozemtdrfjlhthibtsm 152 8 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 152 9 thoracic thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 152 10 surgeon surgeon NNP work_jyzsgzx6ozemtdrfjlhthibtsm 152 11 also also RB work_jyzsgzx6ozemtdrfjlhthibtsm 152 12 decided decide VBD work_jyzsgzx6ozemtdrfjlhthibtsm 152 13 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 152 14 resect resect VB work_jyzsgzx6ozemtdrfjlhthibtsm 152 15 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 152 16 purely purely RB work_jyzsgzx6ozemtdrfjlhthibtsm 152 17 nonsolid nonsolid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 152 18 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 152 19 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 152 20 10 10 CD work_jyzsgzx6ozemtdrfjlhthibtsm 152 21 mm mm NNS work_jyzsgzx6ozemtdrfjlhthibtsm 152 22 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 152 23 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 152 24 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 152 25 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 152 26 right right JJ work_jyzsgzx6ozemtdrfjlhthibtsm 152 27 inferior inferior JJ work_jyzsgzx6ozemtdrfjlhthibtsm 152 28 lobe lobe NNP work_jyzsgzx6ozemtdrfjlhthibtsm 152 29 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 152 30 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 152 31 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 152 32 not not RB work_jyzsgzx6ozemtdrfjlhthibtsm 152 33 previously previously RB work_jyzsgzx6ozemtdrfjlhthibtsm 152 34 evaluated evaluate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 152 35 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 152 36 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 152 37 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 152 38 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 152 39 whose whose WP$ work_jyzsgzx6ozemtdrfjlhthibtsm 152 40 pathol- pathol- NN work_jyzsgzx6ozemtdrfjlhthibtsm 152 41 ogy ogy NN work_jyzsgzx6ozemtdrfjlhthibtsm 152 42 showed show VBD work_jyzsgzx6ozemtdrfjlhthibtsm 152 43 it -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 152 44 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 152 45 be be VB work_jyzsgzx6ozemtdrfjlhthibtsm 152 46 AAH AAH NNP work_jyzsgzx6ozemtdrfjlhthibtsm 152 47 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 153 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 153 2 fourth fourth JJ work_jyzsgzx6ozemtdrfjlhthibtsm 153 3 subject subject NN work_jyzsgzx6ozemtdrfjlhthibtsm 153 4 underwent undergo VBD work_jyzsgzx6ozemtdrfjlhthibtsm 153 5 sur- sur- NN work_jyzsgzx6ozemtdrfjlhthibtsm 153 6 gical gical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 153 7 removal removal NN work_jyzsgzx6ozemtdrfjlhthibtsm 153 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 153 9 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 153 10 nonsolid nonsolid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 153 11 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 153 12 that that WDT work_jyzsgzx6ozemtdrfjlhthibtsm 153 13 showed show VBD work_jyzsgzx6ozemtdrfjlhthibtsm 153 14 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 153 15 increased increase VBN work_jyzsgzx6ozemtdrfjlhthibtsm 153 16 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 153 17 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 153 18 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 153 19 mm mm NN work_jyzsgzx6ozemtdrfjlhthibtsm 153 20 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 153 21 12 12 CD work_jyzsgzx6ozemtdrfjlhthibtsm 153 22 mm mm CD work_jyzsgzx6ozemtdrfjlhthibtsm 153 23 mean mean VB work_jyzsgzx6ozemtdrfjlhthibtsm 153 24 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 153 25 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 153 26 baseline baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 153 27 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 153 28 second second JJ work_jyzsgzx6ozemtdrfjlhthibtsm 153 29 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 153 30 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 153 31 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 153 32 round round NN work_jyzsgzx6ozemtdrfjlhthibtsm 153 33 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 153 34 indeterminate indeterminate JJ work_jyzsgzx6ozemtdrfjlhthibtsm 153 35 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 153 36 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 153 37 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 153 38 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 153 39 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 153 40 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 153 41 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 153 42 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 153 43 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 153 44 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 153 45 but but CC work_jyzsgzx6ozemtdrfjlhthibtsm 153 46 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 153 47 histological histological JJ work_jyzsgzx6ozemtdrfjlhthibtsm 153 48 diagnosis diagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 153 49 also also RB work_jyzsgzx6ozemtdrfjlhthibtsm 153 50 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 153 51 this this DT work_jyzsgzx6ozemtdrfjlhthibtsm 153 52 case case NN work_jyzsgzx6ozemtdrfjlhthibtsm 153 53 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 153 54 AAH AAH NNP work_jyzsgzx6ozemtdrfjlhthibtsm 153 55 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 154 1 Five five CD work_jyzsgzx6ozemtdrfjlhthibtsm 154 2 extrapulmonary extrapulmonary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 154 3 malignancies malignancy NNS work_jyzsgzx6ozemtdrfjlhthibtsm 154 4 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 154 5 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 154 6 cases case NNS work_jyzsgzx6ozemtdrfjlhthibtsm 154 7 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 154 8 malig- malig- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 154 9 nant nant JJ work_jyzsgzx6ozemtdrfjlhthibtsm 154 10 mesothelioma mesothelioma NNP work_jyzsgzx6ozemtdrfjlhthibtsm 154 11 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 154 12 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 154 13 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 154 14 primary primary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 154 15 breast breast NN work_jyzsgzx6ozemtdrfjlhthibtsm 154 16 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 154 17 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 154 18 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 154 19 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 154 20 primary primary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 154 21 kidney kidney NN work_jyzsgzx6ozemtdrfjlhthibtsm 154 22 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 154 23 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 154 24 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 154 25 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 154 26 thymoma thymoma NN work_jyzsgzx6ozemtdrfjlhthibtsm 154 27 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 154 28 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 154 29 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 154 30 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 154 31 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 154 32 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 154 33 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 154 34 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 154 35 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 154 36 undergoing undergo VBG work_jyzsgzx6ozemtdrfjlhthibtsm 154 37 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 154 38 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 154 39 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 155 1 DISCUSSION DISCUSSION NNP work_jyzsgzx6ozemtdrfjlhthibtsm 155 2 Comparative Comparative NNP work_jyzsgzx6ozemtdrfjlhthibtsm 155 3 analyses analysis NNS work_jyzsgzx6ozemtdrfjlhthibtsm 155 4 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 155 5 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 155 6 recruitment recruitment NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 7 strategies strategy NNS work_jyzsgzx6ozemtdrfjlhthibtsm 155 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 155 9 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 155 10 ’ ’ POS work_jyzsgzx6ozemtdrfjlhthibtsm 155 11 compliance compliance NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 155 13 performance performance NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 14 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 155 15 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 155 16 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 155 17 screen- screen- NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 18 ing ing NNP work_jyzsgzx6ozemtdrfjlhthibtsm 155 19 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 20 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 155 21 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 155 22 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 23 protocols protocol NNS work_jyzsgzx6ozemtdrfjlhthibtsm 155 24 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 155 25 suspicious suspicious JJ work_jyzsgzx6ozemtdrfjlhthibtsm 155 26 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 155 27 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 155 28 fundamental fundamental JJ work_jyzsgzx6ozemtdrfjlhthibtsm 155 29 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 155 30 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 155 31 thorough thorough JJ work_jyzsgzx6ozemtdrfjlhthibtsm 155 32 evaluation evaluation NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 33 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 155 34 efficacy efficacy NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 35 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 155 36 cost cost VB work_jyzsgzx6ozemtdrfjlhthibtsm 155 37 effectiveness effectiveness NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 38 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 155 39 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 155 40 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 41 procedure procedure NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 42 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 155 43 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 44 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 45 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 155 46 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 155 47 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 155 48 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 155 49 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 155 50 risk risk NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 51 populations population NNS work_jyzsgzx6ozemtdrfjlhthibtsm 155 52 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 155 53 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 155 54 its -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 155 55 standardization standardization NN work_jyzsgzx6ozemtdrfjlhthibtsm 155 56 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 156 1 Moreover moreover RB work_jyzsgzx6ozemtdrfjlhthibtsm 156 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 156 3 they -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 156 4 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 156 5 mandatory mandatory JJ work_jyzsgzx6ozemtdrfjlhthibtsm 156 6 before before IN work_jyzsgzx6ozemtdrfjlhthibtsm 156 7 data datum NNS work_jyzsgzx6ozemtdrfjlhthibtsm 156 8 pooling pooling NN work_jyzsgzx6ozemtdrfjlhthibtsm 156 9 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 156 10 RCTs rct NNS work_jyzsgzx6ozemtdrfjlhthibtsm 156 11 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 157 1 Different different JJ work_jyzsgzx6ozemtdrfjlhthibtsm 157 2 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 3 all all DT work_jyzsgzx6ozemtdrfjlhthibtsm 157 4 other other JJ work_jyzsgzx6ozemtdrfjlhthibtsm 157 5 observational observational JJ work_jyzsgzx6ozemtdrfjlhthibtsm 157 6 studies12 studies12 FW work_jyzsgzx6ozemtdrfjlhthibtsm 157 7 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 157 8 several several JJ work_jyzsgzx6ozemtdrfjlhthibtsm 157 9 RCTs17,18,21,27 RCTs17,18,21,27 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 157 10 that that WDT work_jyzsgzx6ozemtdrfjlhthibtsm 157 11 recruited recruit VBD work_jyzsgzx6ozemtdrfjlhthibtsm 157 12 volunteers volunteer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 157 13 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 14 response response NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 15 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 16 advertisements advertisement NNS work_jyzsgzx6ozemtdrfjlhthibtsm 157 17 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 18 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 157 19 media medium NNS work_jyzsgzx6ozemtdrfjlhthibtsm 157 20 implying imply VBG work_jyzsgzx6ozemtdrfjlhthibtsm 157 21 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 157 22 selection selection NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 23 bias bias NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 24 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 157 25 we -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 157 26 recruited recruit VBD work_jyzsgzx6ozemtdrfjlhthibtsm 157 27 participants participant NNS work_jyzsgzx6ozemtdrfjlhthibtsm 157 28 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 29 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 157 30 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 157 31 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 32 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 33 direct direct JJ work_jyzsgzx6ozemtdrfjlhthibtsm 157 34 mailing mailing NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 35 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 36 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 157 37 potentially potentially RB work_jyzsgzx6ozemtdrfjlhthibtsm 157 38 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 39 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 157 40 risk risk NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 41 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 42 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 43 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 44 because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 45 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 46 age age NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 47 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 157 48 smoking smoke VBG work_jyzsgzx6ozemtdrfjlhthibtsm 157 49 history.20 history.20 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 157 50 A a DT work_jyzsgzx6ozemtdrfjlhthibtsm 157 51 similar similar JJ work_jyzsgzx6ozemtdrfjlhthibtsm 157 52 recruitment recruitment NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 53 procedure procedure NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 54 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 157 55 adopted adopt VBN work_jyzsgzx6ozemtdrfjlhthibtsm 157 56 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 57 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 157 58 Dutch Dutch NNP work_jyzsgzx6ozemtdrfjlhthibtsm 157 59 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 157 60 Belgian belgian JJ work_jyzsgzx6ozemtdrfjlhthibtsm 157 61 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 157 62 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 157 63 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 157 64 Trial Trial NNP work_jyzsgzx6ozemtdrfjlhthibtsm 157 65 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 157 66 NELSON NELSON NNP work_jyzsgzx6ozemtdrfjlhthibtsm 157 67 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 157 68 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 157 69 German German NNP work_jyzsgzx6ozemtdrfjlhthibtsm 157 70 trials.19,24 trials.19,24 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 157 71 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 72 general general JJ work_jyzsgzx6ozemtdrfjlhthibtsm 157 73 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 157 74 this this DT work_jyzsgzx6ozemtdrfjlhthibtsm 157 75 procedure procedure NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 76 follows follow VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 157 77 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 157 78 one one NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 79 used use VBN work_jyzsgzx6ozemtdrfjlhthibtsm 157 80 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 81 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 157 82 Tuscany Tuscany NNP work_jyzsgzx6ozemtdrfjlhthibtsm 157 83 region region NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 84 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 85 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 157 86 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 87 population population NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 88 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 89 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 90 breast breast NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 91 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 92 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 93 mammography mammography NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 94 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 157 95 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 157 96 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 97 colorectal colorectal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 157 98 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 99 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 100 fecal fecal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 157 101 occult occult NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 102 blood blood NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 103 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 104 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 157 105 both both DT work_jyzsgzx6ozemtdrfjlhthibtsm 157 106 involved involve VBD work_jyzsgzx6ozemtdrfjlhthibtsm 157 107 direct direct JJ work_jyzsgzx6ozemtdrfjlhthibtsm 157 108 mailing mailing NN work_jyzsgzx6ozemtdrfjlhthibtsm 157 109 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 157 110 registered register VBN work_jyzsgzx6ozemtdrfjlhthibtsm 157 111 residents resident NNS work_jyzsgzx6ozemtdrfjlhthibtsm 157 112 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 158 1 Admittedly admittedly RB work_jyzsgzx6ozemtdrfjlhthibtsm 158 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 158 3 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 158 4 overall overall JJ work_jyzsgzx6ozemtdrfjlhthibtsm 158 5 23.9 23.9 CD work_jyzsgzx6ozemtdrfjlhthibtsm 158 6 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 7 adhesion adhesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 8 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 9 terms term NNS work_jyzsgzx6ozemtdrfjlhthibtsm 158 10 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 11 replies reply NNS work_jyzsgzx6ozemtdrfjlhthibtsm 158 12 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 158 13 mail mail VB work_jyzsgzx6ozemtdrfjlhthibtsm 158 14 invitation invitation NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 15 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 16 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 158 17 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 158 18 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 19 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 158 20 lower low JJR work_jyzsgzx6ozemtdrfjlhthibtsm 158 21 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 22 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 158 23 32 32 CD work_jyzsgzx6ozemtdrfjlhthibtsm 158 24 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 25 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 158 26 33 33 CD work_jyzsgzx6ozemtdrfjlhthibtsm 158 27 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 28 reported report VBN work_jyzsgzx6ozemtdrfjlhthibtsm 158 29 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 30 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 158 31 NELSON NELSON NNP work_jyzsgzx6ozemtdrfjlhthibtsm 158 32 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 158 33 German german JJ work_jyzsgzx6ozemtdrfjlhthibtsm 158 34 trial,19,24 trial,19,24 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 158 35 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 158 36 much much RB work_jyzsgzx6ozemtdrfjlhthibtsm 158 37 lower low JJR work_jyzsgzx6ozemtdrfjlhthibtsm 158 38 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 39 that that DT work_jyzsgzx6ozemtdrfjlhthibtsm 158 40 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 41 breast breast NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 42 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 158 43 60–70%)50 60–70%)50 CD work_jyzsgzx6ozemtdrfjlhthibtsm 158 44 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 158 45 colorectal colorectal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 158 46 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 47 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 158 48 56 56 CD work_jyzsgzx6ozemtdrfjlhthibtsm 158 49 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 50 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 158 51 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 52 Tuscany.51 tuscany.51 NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 53 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 54 our -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 158 55 opinion opinion NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 56 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 158 57 besides besides IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 58 general general JJ work_jyzsgzx6ozemtdrfjlhthibtsm 158 59 reasons reason NNS work_jyzsgzx6ozemtdrfjlhthibtsm 158 60 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 61 nonattendance nonattendance NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 62 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 63 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 64 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 65 procedures procedure NNS work_jyzsgzx6ozemtdrfjlhthibtsm 158 66 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 158 67 including include VBG work_jyzsgzx6ozemtdrfjlhthibtsm 158 68 distrust distrust NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 69 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 70 medicine medicine NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 71 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 158 72 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 73 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 158 74 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 158 75 sense sense NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 76 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 77 fatality fatality NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 78 about about IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 79 diseases disease NNS work_jyzsgzx6ozemtdrfjlhthibtsm 158 80 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 158 81 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 158 82 additional additional JJ work_jyzsgzx6ozemtdrfjlhthibtsm 158 83 reasons reason NNS work_jyzsgzx6ozemtdrfjlhthibtsm 158 84 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 85 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 158 86 lower low JJR work_jyzsgzx6ozemtdrfjlhthibtsm 158 87 adhesion adhesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 88 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 89 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 158 90 mail mail NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 91 invitation invitation NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 92 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 93 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 158 94 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 158 95 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 96 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 158 97 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 158 98 unproven unproven JJ work_jyzsgzx6ozemtdrfjlhthibtsm 158 99 efficacy efficacy NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 100 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 101 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 158 102 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 158 103 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 104 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 105 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 158 106 time time NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 107 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 108 enrollment enrollment NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 109 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 158 110 2004–2006 2004–2006 CD work_jyzsgzx6ozemtdrfjlhthibtsm 158 111 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 158 112 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 158 113 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 158 114 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 158 115 possibility possibility NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 116 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 117 being be VBG work_jyzsgzx6ozemtdrfjlhthibtsm 158 118 randomized randomize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 158 119 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 158 120 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 158 121 control control NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 122 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 123 receiving receive VBG work_jyzsgzx6ozemtdrfjlhthibtsm 158 124 usual usual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 158 125 care care NN work_jyzsgzx6ozemtdrfjlhthibtsm 158 126 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 159 1 Further further JJ work_jyzsgzx6ozemtdrfjlhthibtsm 159 2 information information NN work_jyzsgzx6ozemtdrfjlhthibtsm 159 3 about about IN work_jyzsgzx6ozemtdrfjlhthibtsm 159 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 159 5 experience experience NN work_jyzsgzx6ozemtdrfjlhthibtsm 159 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 159 7 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 159 8 participants participant NNS work_jyzsgzx6ozemtdrfjlhthibtsm 159 9 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 159 10 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 159 11 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 159 12 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 159 13 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 159 14 being be VBG work_jyzsgzx6ozemtdrfjlhthibtsm 159 15 collected collect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 159 16 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 159 17 follow follow VB work_jyzsgzx6ozemtdrfjlhthibtsm 159 18 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 159 19 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 159 20 questionnaires questionnaire NNS work_jyzsgzx6ozemtdrfjlhthibtsm 159 21 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 160 1 We -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 160 2 observed observe VBD work_jyzsgzx6ozemtdrfjlhthibtsm 160 3 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 160 4 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 160 5 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 160 6 sustained sustained JJ work_jyzsgzx6ozemtdrfjlhthibtsm 160 7 compliance compliance NN work_jyzsgzx6ozemtdrfjlhthibtsm 160 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 160 9 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 160 10 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 160 11 randomized randomize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 160 12 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 160 13 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 160 14 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 160 15 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 160 16 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 160 17 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 160 18 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 160 19 79 79 CD work_jyzsgzx6ozemtdrfjlhthibtsm 160 20 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 160 21 propor- propor- NN work_jyzsgzx6ozemtdrfjlhthibtsm 160 22 tion tion NN work_jyzsgzx6ozemtdrfjlhthibtsm 160 23 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 160 24 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 160 25 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 160 26 that that WDT work_jyzsgzx6ozemtdrfjlhthibtsm 160 27 completed complete VBD work_jyzsgzx6ozemtdrfjlhthibtsm 160 28 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 160 29 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 160 30 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 160 31 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 160 32 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 161 1 Notably notably RB work_jyzsgzx6ozemtdrfjlhthibtsm 161 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 161 3 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 161 4 greatest great JJS work_jyzsgzx6ozemtdrfjlhthibtsm 161 5 drop drop NN work_jyzsgzx6ozemtdrfjlhthibtsm 161 6 out out RP work_jyzsgzx6ozemtdrfjlhthibtsm 161 7 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 161 8 12.8 12.8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 161 9 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 161 10 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 161 11 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 161 12 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 161 13 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 161 14 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 161 15 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 161 16 our -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 161 17 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 161 18 occurred occur VBD work_jyzsgzx6ozemtdrfjlhthibtsm 161 19 between between IN work_jyzsgzx6ozemtdrfjlhthibtsm 161 20 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 161 21 consensus consensus NN work_jyzsgzx6ozemtdrfjlhthibtsm 161 22 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 161 23 be be VB work_jyzsgzx6ozemtdrfjlhthibtsm 161 24 randomized randomize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 161 25 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 161 26 execution execution NN work_jyzsgzx6ozemtdrfjlhthibtsm 161 27 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 161 28 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 161 29 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 161 30 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 31 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 161 32 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 161 33 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 161 34 similar similar JJ work_jyzsgzx6ozemtdrfjlhthibtsm 161 35 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 161 36 what what WP work_jyzsgzx6ozemtdrfjlhthibtsm 161 37 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 161 38 observed observe VBN work_jyzsgzx6ozemtdrfjlhthibtsm 161 39 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 161 40 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 161 41 Depiscan Depiscan NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 42 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 161 43 12.7%)52 12.7%)52 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 44 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 161 45 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 161 46 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 161 47 Detection Detection NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 48 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 161 49 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 50 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 161 51 Early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 161 52 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 53 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 54 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 161 55 Novel Novel NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 56 Imaging Imaging NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 57 Technology Technology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 58 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 161 59 Molecular Molecular NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 60 Essays Essays NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 161 61 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 161 62 DANTE DANTE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 63 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 161 64 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 161 65 19%)33 19%)33 CD work_jyzsgzx6ozemtdrfjlhthibtsm 161 66 RCTs rct NNS work_jyzsgzx6ozemtdrfjlhthibtsm 161 67 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 161 68 but but CC work_jyzsgzx6ozemtdrfjlhthibtsm 161 69 remarkably remarkably RB work_jyzsgzx6ozemtdrfjlhthibtsm 161 70 higher high JJR work_jyzsgzx6ozemtdrfjlhthibtsm 161 71 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 161 72 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 161 73 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 161 74 NLST NLST NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 75 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 161 76 2.6%)27 2.6%)27 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 77 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 161 78 Danish Danish NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 79 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 161 80 0.2%)34 0.2%)34 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 161 81 RCTs rct NNS work_jyzsgzx6ozemtdrfjlhthibtsm 161 82 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 162 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 162 2 our -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 162 3 opinion opinion NN work_jyzsgzx6ozemtdrfjlhthibtsm 162 4 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 162 5 this this DT work_jyzsgzx6ozemtdrfjlhthibtsm 162 6 phenomenon phenomenon NN work_jyzsgzx6ozemtdrfjlhthibtsm 162 7 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 162 8 presum- presum- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 162 9 ably ably RB work_jyzsgzx6ozemtdrfjlhthibtsm 162 10 because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 162 11 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 162 12 our -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 162 13 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 162 14 design design NN work_jyzsgzx6ozemtdrfjlhthibtsm 162 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 162 16 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 162 17 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 162 18 we -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 162 19 first first RB work_jyzsgzx6ozemtdrfjlhthibtsm 162 20 obtained obtain VBD work_jyzsgzx6ozemtdrfjlhthibtsm 162 21 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 162 22 participant participant NN work_jyzsgzx6ozemtdrfjlhthibtsm 162 23 ’s ’s POS work_jyzsgzx6ozemtdrfjlhthibtsm 162 24 consent consent NN work_jyzsgzx6ozemtdrfjlhthibtsm 162 25 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 162 26 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 162 27 randomization randomization NN work_jyzsgzx6ozemtdrfjlhthibtsm 162 28 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 162 29 then then RB work_jyzsgzx6ozemtdrfjlhthibtsm 162 30 invited invite VBD work_jyzsgzx6ozemtdrfjlhthibtsm 162 31 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 162 32 eligible eligible JJ work_jyzsgzx6ozemtdrfjlhthibtsm 162 33 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 162 34 allocated allocate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 162 35 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 162 36 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 162 37 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 162 38 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 162 39 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 162 40 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 162 41 test- test- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 162 42 ing ing NNP work_jyzsgzx6ozemtdrfjlhthibtsm 162 43 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 163 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 2 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 163 3 period period NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 4 between between IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 5 compilation compilation NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 7 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 163 8 questionnaire questionnaire NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 9 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 10 eligibility eligibility NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 11 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 163 12 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 163 13 date date NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 14 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 163 16 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 163 17 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 163 18 these these DT work_jyzsgzx6ozemtdrfjlhthibtsm 163 19 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 163 20 might may MD work_jyzsgzx6ozemtdrfjlhthibtsm 163 21 have have VB work_jyzsgzx6ozemtdrfjlhthibtsm 163 22 elaborated elaborate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 163 23 their -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 163 24 fear fear NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 25 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 163 26 anxiety anxiety NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 27 about about IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 28 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 163 29 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 30 procedure procedure NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 31 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 163 32 especially especially RB work_jyzsgzx6ozemtdrfjlhthibtsm 163 33 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 34 explanation explanation NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 35 during during IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 36 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 163 37 preliminary preliminary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 163 38 counseling counseling NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 39 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 40 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 163 41 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 42 procedure procedure NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 43 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 44 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 163 45 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 163 46 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 47 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 163 48 probability probability NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 49 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 50 obtaining obtain VBG work_jyzsgzx6ozemtdrfjlhthibtsm 163 51 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 163 52 false false JJ work_jyzsgzx6ozemtdrfjlhthibtsm 163 53 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 163 54 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 163 55 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 56 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 163 57 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 163 58 would would MD work_jyzsgzx6ozemtdrfjlhthibtsm 163 59 require require VB work_jyzsgzx6ozemtdrfjlhthibtsm 163 60 further further RB work_jyzsgzx6ozemtdrfjlhthibtsm 163 61 possibly possibly RB work_jyzsgzx6ozemtdrfjlhthibtsm 163 62 invasive invasive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 163 63 investigations investigation NNS work_jyzsgzx6ozemtdrfjlhthibtsm 163 64 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 65 absence absence NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 66 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 67 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 163 68 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 69 cancer.12 cancer.12 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 163 70 This this DT work_jyzsgzx6ozemtdrfjlhthibtsm 163 71 detailed detailed JJ work_jyzsgzx6ozemtdrfjlhthibtsm 163 72 information information NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 73 could could MD work_jyzsgzx6ozemtdrfjlhthibtsm 163 74 have have VB work_jyzsgzx6ozemtdrfjlhthibtsm 163 75 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 163 76 effect effect NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 77 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 78 discouraging discouraging JJ work_jyzsgzx6ozemtdrfjlhthibtsm 163 79 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 163 80 passively passively RB work_jyzsgzx6ozemtdrfjlhthibtsm 163 81 recruited recruit VBN work_jyzsgzx6ozemtdrfjlhthibtsm 163 82 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 83 mail,23 mail,23 NNS work_jyzsgzx6ozemtdrfjlhthibtsm 163 84 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 163 85 ultimately ultimately RB work_jyzsgzx6ozemtdrfjlhthibtsm 163 86 determine determine VB work_jyzsgzx6ozemtdrfjlhthibtsm 163 87 decline decline NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 88 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 163 89 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 163 90 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 91 appointment appointment NN work_jyzsgzx6ozemtdrfjlhthibtsm 163 92 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 164 1 This this DT work_jyzsgzx6ozemtdrfjlhthibtsm 164 2 mechanism mechanism NN work_jyzsgzx6ozemtdrfjlhthibtsm 164 3 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 164 4 unlikely unlikely JJ work_jyzsgzx6ozemtdrfjlhthibtsm 164 5 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 164 6 occur occur VB work_jyzsgzx6ozemtdrfjlhthibtsm 164 7 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 164 8 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 164 9 recruiting recruit VBG work_jyzsgzx6ozemtdrfjlhthibtsm 164 10 volun- volun- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 164 11 teers teer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 164 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 164 13 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 164 14 indicates indicate VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 164 15 that that IN work_jyzsgzx6ozemtdrfjlhthibtsm 164 16 further further JJ work_jyzsgzx6ozemtdrfjlhthibtsm 164 17 investigation investigation NN work_jyzsgzx6ozemtdrfjlhthibtsm 164 18 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 164 19 worthwhile worthwhile JJ work_jyzsgzx6ozemtdrfjlhthibtsm 164 20 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 164 21 improve improve VB work_jyzsgzx6ozemtdrfjlhthibtsm 164 22 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 164 23 communication communication NN work_jyzsgzx6ozemtdrfjlhthibtsm 164 24 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 164 25 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 164 26 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 164 27 risk risk NN work_jyzsgzx6ozemtdrfjlhthibtsm 164 28 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 164 29 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 165 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 165 2 our -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 165 3 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 165 4 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 165 5 90 90 CD work_jyzsgzx6ozemtdrfjlhthibtsm 165 6 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 165 7 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 165 8 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 165 9 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 165 10 who who WP work_jyzsgzx6ozemtdrfjlhthibtsm 165 11 executed execute VBD work_jyzsgzx6ozemtdrfjlhthibtsm 165 12 base- base- NN work_jyzsgzx6ozemtdrfjlhthibtsm 165 13 line line NN work_jyzsgzx6ozemtdrfjlhthibtsm 165 14 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 165 15 completed complete VBD work_jyzsgzx6ozemtdrfjlhthibtsm 165 16 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 165 17 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 165 18 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 165 19 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 165 20 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 166 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 166 2 final final JJ work_jyzsgzx6ozemtdrfjlhthibtsm 166 3 TABLE TABLE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 166 4 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 166 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 167 1 Results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 167 2     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 167 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 167 4     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 167 5 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 6 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 167 7 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 8     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 167 9 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 167 10     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 167 11 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 12 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 167 13 Guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 167 14     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 167 15 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 167 16     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 167 17 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 167 18     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 167 19 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 167 20     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 167 21 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 22     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 167 23 Triala Triala NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 24 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 25 True- True- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 26 Positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 167 27 True- True- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 28 Negative Negative NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 29 False- False- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 30 Positive Positive NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 31 False- False- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 32 Negative Negative NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 33 TotalRound TotalRound NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 34 FDG- FDG- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 35 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 36 Baseline Baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 37 16 16 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 38 40 40 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 39 0 0 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 40 4 4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 41 60 60 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 42 Repeat Repeat NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 43 16 16 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 44 17 17 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 45 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 46 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 47 42 42 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 48 Total total JJ work_jyzsgzx6ozemtdrfjlhthibtsm 167 49 32 32 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 50 57 57 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 51 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 52 6 6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 53 102 102 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 54 CT- CT- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 55 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 167 56 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 57 Baseline Baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 58 10 10 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 59 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 60 0 0 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 61 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 62 14 14 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 63 Repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 167 64 17 17 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 65 4 4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 66 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 67 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 68 24 24 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 69 Total total JJ work_jyzsgzx6ozemtdrfjlhthibtsm 167 70 27 27 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 71 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 72 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 73 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 74 38 38 CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 75 aThe aThe NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 76 seven seven CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 77 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 167 78 showing show VBG work_jyzsgzx6ozemtdrfjlhthibtsm 167 79 faint faint JJ work_jyzsgzx6ozemtdrfjlhthibtsm 167 80 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 81 uptake uptake JJ work_jyzsgzx6ozemtdrfjlhthibtsm 167 82 qualifying qualify VBG work_jyzsgzx6ozemtdrfjlhthibtsm 167 83 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 167 84 indeterminate indeterminate JJ work_jyzsgzx6ozemtdrfjlhthibtsm 167 85 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 167 86 result result NN work_jyzsgzx6ozemtdrfjlhthibtsm 167 87 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 167 88 considered consider VBN work_jyzsgzx6ozemtdrfjlhthibtsm 167 89 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 167 90 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 167 91 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 167 92 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 167 93 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 167 94 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 167 95 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 167 96 whose whose WP$ work_jyzsgzx6ozemtdrfjlhthibtsm 167 97 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 167 98 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 167 99 not not RB work_jyzsgzx6ozemtdrfjlhthibtsm 167 100 diagnostic diagnostic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 167 101 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 167 102 considered consider VBN work_jyzsgzx6ozemtdrfjlhthibtsm 167 103 as as RB work_jyzsgzx6ozemtdrfjlhthibtsm 167 104 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 167 105 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 168 1 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 168 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 168 3 computed compute VBD work_jyzsgzx6ozemtdrfjlhthibtsm 168 4 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 168 5 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 168 6 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 168 7 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 168 8 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 168 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 168 10 2-[18F]fluoro-2-deoxy 2-[18f]fluoro-2-deoxy CD work_jyzsgzx6ozemtdrfjlhthibtsm 168 11 - - SYM work_jyzsgzx6ozemtdrfjlhthibtsm 168 12 D D NNP work_jyzsgzx6ozemtdrfjlhthibtsm 168 13 glucose glucose NNP work_jyzsgzx6ozemtdrfjlhthibtsm 168 14 positron positron NNP work_jyzsgzx6ozemtdrfjlhthibtsm 168 15 emission emission NN work_jyzsgzx6ozemtdrfjlhthibtsm 168 16 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 168 17 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 168 18 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 168 19 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 168 20 fine fine JJ work_jyzsgzx6ozemtdrfjlhthibtsm 168 21 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 168 22 needle needle NN work_jyzsgzx6ozemtdrfjlhthibtsm 168 23 aspiration aspiration NN work_jyzsgzx6ozemtdrfjlhthibtsm 168 24 biopsy biopsy NN work_jyzsgzx6ozemtdrfjlhthibtsm 168 25 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 169 1 872 872 CD work_jyzsgzx6ozemtdrfjlhthibtsm 169 2 Copyright copyright NN work_jyzsgzx6ozemtdrfjlhthibtsm 169 3 © © NN work_jyzsgzx6ozemtdrfjlhthibtsm 169 4 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 169 5 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 169 6 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 169 7 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 169 8 Association Association NNP work_jyzsgzx6ozemtdrfjlhthibtsm 169 9 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 169 10 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 169 11 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 169 12 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 169 13 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 169 14 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 169 15 Pegna Pegna NNP work_jyzsgzx6ozemtdrfjlhthibtsm 169 16 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 169 17 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 169 18 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 170 1 Journal Journal NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 170 3 Thoracic Thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 4 Oncology Oncology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 5 ® ® NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 6     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 170 7 • • NN work_jyzsgzx6ozemtdrfjlhthibtsm 170 8     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 170 9 Volume volume NN work_jyzsgzx6ozemtdrfjlhthibtsm 170 10     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 170 11 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 170 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 170 13     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 170 14 Number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 170 15     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 170 16 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 170 17 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 170 18     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 170 19 July July NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 20     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 170 21 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 170 22 79 79 CD work_jyzsgzx6ozemtdrfjlhthibtsm 170 23 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 170 24 compliance compliance NN work_jyzsgzx6ozemtdrfjlhthibtsm 170 25 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 170 26 higher high JJR work_jyzsgzx6ozemtdrfjlhthibtsm 170 27 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 170 28 those those DT work_jyzsgzx6ozemtdrfjlhthibtsm 170 29 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 170 30 several several JJ work_jyzsgzx6ozemtdrfjlhthibtsm 170 31 observa- observa- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 170 32 tional tional JJ work_jyzsgzx6ozemtdrfjlhthibtsm 170 33 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 170 34 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 170 35 RCTs,12 RCTs,12 NNS work_jyzsgzx6ozemtdrfjlhthibtsm 170 36 but but CC work_jyzsgzx6ozemtdrfjlhthibtsm 170 37 lower low JJR work_jyzsgzx6ozemtdrfjlhthibtsm 170 38 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 170 39 those those DT work_jyzsgzx6ozemtdrfjlhthibtsm 170 40 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 170 41 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 170 42 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 43 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 44 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 45 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 170 46 LSS LSS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 47 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 170 48 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 170 49 84 84 CD work_jyzsgzx6ozemtdrfjlhthibtsm 170 50 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 170 51 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 170 52 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 170 53 second second JJ work_jyzsgzx6ozemtdrfjlhthibtsm 170 54 year),38 year),38 NN work_jyzsgzx6ozemtdrfjlhthibtsm 170 55 NLST NLST NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 56 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 170 57 90 90 CD work_jyzsgzx6ozemtdrfjlhthibtsm 170 58 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 170 59 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 170 60 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 170 61 third third JJ work_jyzsgzx6ozemtdrfjlhthibtsm 170 62 year),27 year),27 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 63 Multicentric Multicentric NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 64 Italian italian JJ work_jyzsgzx6ozemtdrfjlhthibtsm 170 65 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 66 Detection Detection NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 67 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 170 68 MILD MILD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 170 69 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 170 70 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 170 71 95 95 CD work_jyzsgzx6ozemtdrfjlhthibtsm 170 72 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 170 73 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 170 74 96%),18 96%),18 CD work_jyzsgzx6ozemtdrfjlhthibtsm 170 75 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 170 76 Danish danish JJ work_jyzsgzx6ozemtdrfjlhthibtsm 170 77 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 170 78 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 170 79 90 90 CD work_jyzsgzx6ozemtdrfjlhthibtsm 170 80 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 170 81 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 170 82 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 170 83 fifth fifth JJ work_jyzsgzx6ozemtdrfjlhthibtsm 170 84 year),34 year),34 NN work_jyzsgzx6ozemtdrfjlhthibtsm 170 85 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 170 86 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 170 87 however however RB work_jyzsgzx6ozemtdrfjlhthibtsm 170 88 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 170 89 recruited recruit VBN work_jyzsgzx6ozemtdrfjlhthibtsm 170 90 volunteers volunteer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 170 91 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 171 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 171 2 adhesion adhesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 171 3 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 171 4 compliance compliance NN work_jyzsgzx6ozemtdrfjlhthibtsm 171 5 rates rate NNS work_jyzsgzx6ozemtdrfjlhthibtsm 171 6 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 171 7 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 171 8 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 171 9 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 171 10 might may MD work_jyzsgzx6ozemtdrfjlhthibtsm 171 11 constitute constitute VB work_jyzsgzx6ozemtdrfjlhthibtsm 171 12 valuable valuable JJ work_jyzsgzx6ozemtdrfjlhthibtsm 171 13 reference reference NN work_jyzsgzx6ozemtdrfjlhthibtsm 171 14 terms term NNS work_jyzsgzx6ozemtdrfjlhthibtsm 171 15 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 171 16 future future JJ work_jyzsgzx6ozemtdrfjlhthibtsm 171 17 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 171 18 programs program NNS work_jyzsgzx6ozemtdrfjlhthibtsm 171 19 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 171 20 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 171 21 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 171 22 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 171 23 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 171 24 involving involve VBG work_jyzsgzx6ozemtdrfjlhthibtsm 171 25 population population NN work_jyzsgzx6ozemtdrfjlhthibtsm 171 26 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 171 27 based base VBN work_jyzsgzx6ozemtdrfjlhthibtsm 171 28 invita- invita- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 171 29 tion tion NN work_jyzsgzx6ozemtdrfjlhthibtsm 171 30 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 171 31 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 171 32 mail mail NN work_jyzsgzx6ozemtdrfjlhthibtsm 171 33 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 171 34 counseling counseling NN work_jyzsgzx6ozemtdrfjlhthibtsm 171 35 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 171 36 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 171 37 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 171 38 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 171 39 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 171 40 risk risk NN work_jyzsgzx6ozemtdrfjlhthibtsm 171 41 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 171 42 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 171 43 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 171 44 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 172 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 172 2 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 172 3 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 172 4 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 172 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 172 6 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 172 7 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 172 8 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 172 9 we -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 172 10 observed observe VBD work_jyzsgzx6ozemtdrfjlhthibtsm 172 11 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 172 12 low low JJ work_jyzsgzx6ozemtdrfjlhthibtsm 172 13 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 172 14 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 172 15 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 172 16 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 172 17 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 172 18 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 172 19 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 172 20 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 172 21 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 172 22 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 172 23 mostly mostly RB work_jyzsgzx6ozemtdrfjlhthibtsm 172 24 represented represent VBN work_jyzsgzx6ozemtdrfjlhthibtsm 172 25 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 172 26 ACs ac NNS work_jyzsgzx6ozemtdrfjlhthibtsm 172 27 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 172 28 early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 172 29 stages stage NNS work_jyzsgzx6ozemtdrfjlhthibtsm 172 30 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 172 31 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 172 32 surgically surgically RB work_jyzsgzx6ozemtdrfjlhthibtsm 172 33 resect- resect- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 172 34 able able JJ work_jyzsgzx6ozemtdrfjlhthibtsm 172 35 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 173 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 173 2 1.5 1.5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 173 3 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 173 4 prevalence prevalence NN work_jyzsgzx6ozemtdrfjlhthibtsm 173 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 173 6 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 173 7 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 173 8 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 173 9 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 173 10 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 173 11 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 173 12 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 173 13 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 173 14 substantially substantially RB work_jyzsgzx6ozemtdrfjlhthibtsm 173 15 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 173 16 line line NN work_jyzsgzx6ozemtdrfjlhthibtsm 173 17 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 173 18 those those DT work_jyzsgzx6ozemtdrfjlhthibtsm 173 19 reported report VBN work_jyzsgzx6ozemtdrfjlhthibtsm 173 20 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 173 21 observational observational JJ work_jyzsgzx6ozemtdrfjlhthibtsm 173 22 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 173 23 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 173 24 range range NN work_jyzsgzx6ozemtdrfjlhthibtsm 173 25 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 173 26 0.2%–2.7%)12 0.2%–2.7%)12 CD work_jyzsgzx6ozemtdrfjlhthibtsm 173 27 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 173 28 RCTs RCTs NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 173 29 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 173 30 range range NN work_jyzsgzx6ozemtdrfjlhthibtsm 173 31 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 173 32 0.8%–2.4%)17,18,21,22,24,27,52,53 0.8%–2.4%)17,18,21,22,24,27,52,53 '' work_jyzsgzx6ozemtdrfjlhthibtsm 173 33 that that WDT work_jyzsgzx6ozemtdrfjlhthibtsm 173 34 recruited recruit VBD work_jyzsgzx6ozemtdrfjlhthibtsm 173 35 elderly elderly JJ work_jyzsgzx6ozemtdrfjlhthibtsm 173 36 heavy heavy JJ work_jyzsgzx6ozemtdrfjlhthibtsm 173 37 smok- smok- NN work_jyzsgzx6ozemtdrfjlhthibtsm 173 38 ers ers NNP work_jyzsgzx6ozemtdrfjlhthibtsm 173 39 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 173 40 former former JJ work_jyzsgzx6ozemtdrfjlhthibtsm 173 41 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 173 42 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 174 1 Also also RB work_jyzsgzx6ozemtdrfjlhthibtsm 174 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 174 3 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 174 4 0.5 0.5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 174 5 mean mean JJ work_jyzsgzx6ozemtdrfjlhthibtsm 174 6 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 174 7 incidence incidence NN work_jyzsgzx6ozemtdrfjlhthibtsm 174 8 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 174 9 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 174 10 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 174 11 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 174 12 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 174 13 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 174 14 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 174 15 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 174 16 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 174 17 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 174 18 comprised comprise VBN work_jyzsgzx6ozemtdrfjlhthibtsm 174 19 within within IN work_jyzsgzx6ozemtdrfjlhthibtsm 174 20 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 174 21 range range NN work_jyzsgzx6ozemtdrfjlhthibtsm 174 22 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 174 23 previous previous JJ work_jyzsgzx6ozemtdrfjlhthibtsm 174 24 observational observational JJ work_jyzsgzx6ozemtdrfjlhthibtsm 174 25 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 174 26 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 174 27 RCTs rct NNS work_jyzsgzx6ozemtdrfjlhthibtsm 174 28 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 174 29 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 174 30 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 174 31 it -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 174 32 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 174 33 consistently consistently RB work_jyzsgzx6ozemtdrfjlhthibtsm 174 34 lower low JJR work_jyzsgzx6ozemtdrfjlhthibtsm 174 35 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 174 36 1%.12,13,18,27,33,34,38,53 1%.12,13,18,27,33,34,38,53 CD work_jyzsgzx6ozemtdrfjlhthibtsm 174 37 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 174 38 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 174 39 AC AC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 174 40 accounted account VBD work_jyzsgzx6ozemtdrfjlhthibtsm 174 41 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 174 42 56 56 CD work_jyzsgzx6ozemtdrfjlhthibtsm 174 43 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 174 44 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 174 45 NSCLC NSCLC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 174 46 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 174 47 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 174 48 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 174 49 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 174 50 88 88 CD work_jyzsgzx6ozemtdrfjlhthibtsm 174 51 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 174 52 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 174 53 NSCLC NSCLC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 174 54 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 174 55 subsequent subsequent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 174 56 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 174 57 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 174 58 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 174 59 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 174 60 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 175 1 This this DT work_jyzsgzx6ozemtdrfjlhthibtsm 175 2 predominance predominance NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 4 AC AC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 175 5 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 6 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 7 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 175 8 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 175 9 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 10 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 175 11 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 175 12 well well RB work_jyzsgzx6ozemtdrfjlhthibtsm 175 13 established13,18,24,27,34 established13,18,24,27,34 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 175 14 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 175 15 presumably presumably RB work_jyzsgzx6ozemtdrfjlhthibtsm 175 16 reflects reflect VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 175 17 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 175 18 capability capability NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 19 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 20 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 175 21 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 175 22 show show VB work_jyzsgzx6ozemtdrfjlhthibtsm 175 23 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 175 24 ACs ac NNS work_jyzsgzx6ozemtdrfjlhthibtsm 175 25 appearing appear VBG work_jyzsgzx6ozemtdrfjlhthibtsm 175 26 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 27 peripheral peripheral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 175 28 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 175 29 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 175 30 whereas whereas IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 31 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 175 32 detection detection NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 33 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 34 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 175 35 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 36 cen- cen- NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 37 tral tral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 175 38 tumors tumor NNS work_jyzsgzx6ozemtdrfjlhthibtsm 175 39 developing develop VBG work_jyzsgzx6ozemtdrfjlhthibtsm 175 40 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 41 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 175 42 large large JJ work_jyzsgzx6ozemtdrfjlhthibtsm 175 43 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 175 44 medium medium NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 45 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 175 46 size size NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 47 airways airway NNS work_jyzsgzx6ozemtdrfjlhthibtsm 175 48 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 175 49 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 175 50 more more RBR work_jyzsgzx6ozemtdrfjlhthibtsm 175 51 frequently frequently RB work_jyzsgzx6ozemtdrfjlhthibtsm 175 52 correspond correspond VBP work_jyzsgzx6ozemtdrfjlhthibtsm 175 53 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 54 squamous squamous JJ work_jyzsgzx6ozemtdrfjlhthibtsm 175 55 carcinomas carcinoma NNS work_jyzsgzx6ozemtdrfjlhthibtsm 175 56 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 175 57 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 175 58 suboptimal.54 suboptimal.54 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 175 59 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 175 60 majority majority NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 61 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 62 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 175 63 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 64 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 175 65 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 175 66 NSCLC NSCLC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 175 67 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 175 68 23 23 CD work_jyzsgzx6ozemtdrfjlhthibtsm 175 69 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 70 35 35 CD work_jyzsgzx6ozemtdrfjlhthibtsm 175 71 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 175 72 66 66 CD work_jyzsgzx6ozemtdrfjlhthibtsm 175 73 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 74 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 175 75 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 76 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 175 77 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 175 78 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 175 79 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 80 stages stage NNS work_jyzsgzx6ozemtdrfjlhthibtsm 175 81 IA IA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 175 82 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 175 83 IB IB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 175 84 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 175 85 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 86 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 175 87 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 175 88 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 175 89 not not RB work_jyzsgzx6ozemtdrfjlhthibtsm 175 90 statistically statistically RB work_jyzsgzx6ozemtdrfjlhthibtsm 175 91 significant significant JJ work_jyzsgzx6ozemtdrfjlhthibtsm 175 92 increase increase NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 93 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 94 such such JJ work_jyzsgzx6ozemtdrfjlhthibtsm 175 95 low low JJ work_jyzsgzx6ozemtdrfjlhthibtsm 175 96 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 175 97 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 98 can- can- NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 99 cers cer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 175 100 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 101 baseline baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 175 102 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 175 103 56 56 CD work_jyzsgzx6ozemtdrfjlhthibtsm 175 104 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 105 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 175 106 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 175 107 subsequent subsequent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 175 108 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 175 109 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 110 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 175 111 76 76 CD work_jyzsgzx6ozemtdrfjlhthibtsm 175 112 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 113 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 175 114 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 175 115 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 175 116 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 176 1 Increase increase NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 3 low low JJ work_jyzsgzx6ozemtdrfjlhthibtsm 176 4 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 176 5 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 6 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 176 7 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 8 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 176 9 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 10 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 176 11 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 12 baseline baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 176 13 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 176 14 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 15 shift shift NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 16 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 176 17 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 176 18 considered consider VBN work_jyzsgzx6ozemtdrfjlhthibtsm 176 19 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 176 20 indirect indirect JJ work_jyzsgzx6ozemtdrfjlhthibtsm 176 21 element element NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 22 militating militating NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 23 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 24 favor favor NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 25 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 26 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 176 27 capability capability NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 28 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 29 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 176 30 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 31 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 176 32 efficiently efficiently RB work_jyzsgzx6ozemtdrfjlhthibtsm 176 33 impact impact VB work_jyzsgzx6ozemtdrfjlhthibtsm 176 34 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 35 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 36 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 37 mortal- mortal- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 176 38 ity ity NNP work_jyzsgzx6ozemtdrfjlhthibtsm 176 39 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 176 40 but but CC work_jyzsgzx6ozemtdrfjlhthibtsm 176 41 available available JJ work_jyzsgzx6ozemtdrfjlhthibtsm 176 42 data datum NNS work_jyzsgzx6ozemtdrfjlhthibtsm 176 43 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 44 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 45 shift shift NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 46 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 47 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 48 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 49 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 50 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 51 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 176 52 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 176 53 inconsistent.55,56 inconsistent.55,56 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 176 54 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 176 55 predominance predominance NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 56 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 57 low- low- NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 58 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 59 NSLCL NSLCL NNP work_jyzsgzx6ozemtdrfjlhthibtsm 176 60 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 176 61 observed observe VBN work_jyzsgzx6ozemtdrfjlhthibtsm 176 62 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 63 all all DT work_jyzsgzx6ozemtdrfjlhthibtsm 176 64 prior prior JJ work_jyzsgzx6ozemtdrfjlhthibtsm 176 65 observational observational JJ work_jyzsgzx6ozemtdrfjlhthibtsm 176 66 stud- stud- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 176 67 ies12 ies12 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 176 68 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 176 69 RCTs.18,21,24,38,53 RCTs.18,21,24,38,53 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 176 70 As as IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 71 expected expect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 176 72 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 176 73 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 74 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 176 75 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 176 76 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 77 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 176 78 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 79 low low JJ work_jyzsgzx6ozemtdrfjlhthibtsm 176 80 stages stage NNS work_jyzsgzx6ozemtdrfjlhthibtsm 176 81 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 176 82 amenable amenable JJ work_jyzsgzx6ozemtdrfjlhthibtsm 176 83 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 84 surgical surgical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 176 85 resection resection NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 86 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 176 87 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 176 88 this this DT work_jyzsgzx6ozemtdrfjlhthibtsm 176 89 occurred occur VBD work_jyzsgzx6ozemtdrfjlhthibtsm 176 90 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 91 35 35 CD work_jyzsgzx6ozemtdrfjlhthibtsm 176 92 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 93 41 41 CD work_jyzsgzx6ozemtdrfjlhthibtsm 176 94 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 95 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 176 96 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 176 97 85 85 CD work_jyzsgzx6ozemtdrfjlhthibtsm 176 98 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 99 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 176 100 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 101 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 176 102 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 176 103 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 104 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 176 105 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 176 106 again again RB work_jyzsgzx6ozemtdrfjlhthibtsm 176 107 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 176 108 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 109 line line NN work_jyzsgzx6ozemtdrfjlhthibtsm 176 110 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 176 111 other other JJ work_jyzsgzx6ozemtdrfjlhthibtsm 176 112 observational observational JJ work_jyzsgzx6ozemtdrfjlhthibtsm 176 113 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 176 114 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 176 115 RCTs rct NNS work_jyzsgzx6ozemtdrfjlhthibtsm 176 116 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 177 1 It -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 177 2 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 177 3 noteworthy noteworthy JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 4 that that IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 5 despite despite IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 6 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 177 7 different different JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 8 recruitment recruitment NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 9 strategies strategy NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 10 mentioned mention VBN work_jyzsgzx6ozemtdrfjlhthibtsm 177 11 above above RB work_jyzsgzx6ozemtdrfjlhthibtsm 177 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 177 13 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 177 14 variable variable JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 15 schedule schedule NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 16 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 17 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 177 18 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 19 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 177 20 rounds round VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 177 21 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 22 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 177 23 couple couple NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 24 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 25 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 26 offering offer VBG work_jyzsgzx6ozemtdrfjlhthibtsm 177 27 biennial biennial NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 28 rather rather RB work_jyzsgzx6ozemtdrfjlhthibtsm 177 29 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 30 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 31 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 177 32 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 177 33 rounds,18,53 rounds,18,53 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 177 34 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 177 35 some some DT work_jyzsgzx6ozemtdrfjlhthibtsm 177 36 additional additional JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 37 minor minor JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 38 differences difference NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 39 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 40 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 177 41 target target NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 42 population population NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 43 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 177 44 sex sex NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 45 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 177 46 age age NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 47 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 177 48 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 177 49 pack pack NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 50 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 177 51 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 52 distribution distribution NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 53 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 177 54 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 177 55 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 56 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 177 57 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 177 58 acquisition acquisition NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 59 technique technique NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 60 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 177 61 slice slice NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 62 collimation collimation NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 63 ranging range VBG work_jyzsgzx6ozemtdrfjlhthibtsm 177 64 between between IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 65 5 5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 177 66 mm17,21 mm17,21 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 177 67 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 177 68 0.75 0.75 CD work_jyzsgzx6ozemtdrfjlhthibtsm 177 69 mm18 mm18 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 177 70 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 177 71 implying imply VBG work_jyzsgzx6ozemtdrfjlhthibtsm 177 72 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 177 73 possible possible JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 74 lower low JJR work_jyzsgzx6ozemtdrfjlhthibtsm 177 75 sensitivity sensitivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 76 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 77 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 78 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 79 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 177 80 nonsolid nonsolid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 81 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 82 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 83 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 177 84 examinations examination NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 85 adopting adopt VBG work_jyzsgzx6ozemtdrfjlhthibtsm 177 86 thicker thick JJR work_jyzsgzx6ozemtdrfjlhthibtsm 177 87 collimation collimation NNP work_jyzsgzx6ozemtdrfjlhthibtsm 177 88 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 177 89 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 177 90 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 91 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 177 92 criteria criterion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 93 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 94 positivity positivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 95 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 96 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 177 97 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 98 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 99 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 177 100 mean mean NNP work_jyzsgzx6ozemtdrfjlhthibtsm 177 101 diameter diameter NNP work_jyzsgzx6ozemtdrfjlhthibtsm 177 102 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 103 > > NNP work_jyzsgzx6ozemtdrfjlhthibtsm 177 104 4 4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 177 105 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 177 106 > > XX work_jyzsgzx6ozemtdrfjlhthibtsm 177 107 5 5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 177 108 mm mm NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 109 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 177 110 volume volume NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 111 > > NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 112 50 50 CD work_jyzsgzx6ozemtdrfjlhthibtsm 177 113 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 177 114 > > XX work_jyzsgzx6ozemtdrfjlhthibtsm 177 115 60 60 CD work_jyzsgzx6ozemtdrfjlhthibtsm 177 116 mm3 mm3 NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 117 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 118 prevalent prevalent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 119 solid solid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 120 nodules)17,18,22,36 nodules)17,18,22,36 NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 121 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 177 122 nodule nodule VBP work_jyzsgzx6ozemtdrfjlhthibtsm 177 123 man- man- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 177 124 agement agement NNP work_jyzsgzx6ozemtdrfjlhthibtsm 177 125 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 177 126 see see VB work_jyzsgzx6ozemtdrfjlhthibtsm 177 127 below below RB work_jyzsgzx6ozemtdrfjlhthibtsm 177 128 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 177 129 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 177 130 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 177 131 yield yield NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 132 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 133 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 177 134 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 177 135 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 136 terms term NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 137 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 138 rates rate NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 139 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 177 140 types type NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 141 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 142 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 143 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 177 144 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 177 145 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 146 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 147 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 177 148 remarkably remarkably RB work_jyzsgzx6ozemtdrfjlhthibtsm 177 149 simi- simi- VBN work_jyzsgzx6ozemtdrfjlhthibtsm 177 150 lar lar NN work_jyzsgzx6ozemtdrfjlhthibtsm 177 151 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 177 152 observational observational JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 153 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 177 154 randomized randomized JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 155 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 156 involving involve VBG work_jyzsgzx6ozemtdrfjlhthibtsm 177 157 elderly elderly JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 158 heavy heavy JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 159 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 160 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 177 161 former former JJ work_jyzsgzx6ozemtdrfjlhthibtsm 177 162 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 177 163 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 178 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 178 2 low low JJ work_jyzsgzx6ozemtdrfjlhthibtsm 178 3 detection detection NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 4 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 5 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 178 6 prevalent prevalent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 178 7 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 178 8 especially especially RB work_jyzsgzx6ozemtdrfjlhthibtsm 178 9 incident incident NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 10 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 11 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 178 12 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 178 13 key key JJ work_jyzsgzx6ozemtdrfjlhthibtsm 178 14 ele- ele- NNS work_jyzsgzx6ozemtdrfjlhthibtsm 178 15 ments ment NNS work_jyzsgzx6ozemtdrfjlhthibtsm 178 16 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 178 17 explaining explain VBG work_jyzsgzx6ozemtdrfjlhthibtsm 178 18 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 178 19 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 178 20 cost cost NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 21 / / SYM work_jyzsgzx6ozemtdrfjlhthibtsm 178 22 effectiveness effectiveness NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 23 ratio ratio NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 24 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 178 25 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 26 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 27 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 28 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 178 29 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 178 30 alone.12,18 alone.12,18 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 178 31 This this DT work_jyzsgzx6ozemtdrfjlhthibtsm 178 32 clearly clearly RB work_jyzsgzx6ozemtdrfjlhthibtsm 178 33 indicates indicate VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 178 34 that that IN work_jyzsgzx6ozemtdrfjlhthibtsm 178 35 alternative alternative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 178 36 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 178 37 supplemental supplemental JJ work_jyzsgzx6ozemtdrfjlhthibtsm 178 38 strategies strategy NNS work_jyzsgzx6ozemtdrfjlhthibtsm 178 39 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 178 40 increasing increase VBG work_jyzsgzx6ozemtdrfjlhthibtsm 178 41 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 178 42 rates rate NNS work_jyzsgzx6ozemtdrfjlhthibtsm 178 43 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 178 44 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 45 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 178 46 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 178 47 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 48 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 178 49 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 178 50 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 178 51 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 178 52 improving improve VBG work_jyzsgzx6ozemtdrfjlhthibtsm 178 53 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 178 54 selection selection NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 55 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 178 56 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 178 57 target target NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 58 population population NN work_jyzsgzx6ozemtdrfjlhthibtsm 178 59 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 178 60 needed need VBN work_jyzsgzx6ozemtdrfjlhthibtsm 178 61 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 179 1 Inclusion inclusion NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 179 3 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 179 4 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 179 5 additional additional JJ work_jyzsgzx6ozemtdrfjlhthibtsm 179 6 risk risk NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 7 factors factor NNS work_jyzsgzx6ozemtdrfjlhthibtsm 179 8 besides besides IN work_jyzsgzx6ozemtdrfjlhthibtsm 179 9 smoking smoke VBG work_jyzsgzx6ozemtdrfjlhthibtsm 179 10 history history NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 11 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 179 12 age age NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 13 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 179 14 such such JJ work_jyzsgzx6ozemtdrfjlhthibtsm 179 15 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 179 16 occupational occupational JJ work_jyzsgzx6ozemtdrfjlhthibtsm 179 17 asbestos asbestos NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 18 exposure,57 exposure,57 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 179 19 chronic chronic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 179 20 obstructive obstructive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 179 21 pulmonary pulmonary NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 22 disease,58 disease,58 NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 23 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 179 24 especially especially RB work_jyzsgzx6ozemtdrfjlhthibtsm 179 25 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 179 26 inclusion inclusion NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 27 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 179 28 sputum sputum NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 29 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 179 30 blood blood NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 31 biomarkers40,59,60 biomarkers40,59,60 NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 32 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 179 33 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 179 34 multidimensional multidimensional JJ work_jyzsgzx6ozemtdrfjlhthibtsm 179 35 inte- inte- NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 36 grated grate VBD work_jyzsgzx6ozemtdrfjlhthibtsm 179 37 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 38 strategy strategy NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 39 should should MD work_jyzsgzx6ozemtdrfjlhthibtsm 179 40 be be VB work_jyzsgzx6ozemtdrfjlhthibtsm 179 41 explored explore VBN work_jyzsgzx6ozemtdrfjlhthibtsm 179 42 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 179 43 this this DT work_jyzsgzx6ozemtdrfjlhthibtsm 179 44 context context NN work_jyzsgzx6ozemtdrfjlhthibtsm 179 45 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 180 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 180 2 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 180 3 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 180 4 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 180 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 180 6 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 180 7 ITALUNG ITALUNG NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 180 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 180 9 we -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 180 10 observed observe VBD work_jyzsgzx6ozemtdrfjlhthibtsm 180 11 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 180 12 interval interval JJ work_jyzsgzx6ozemtdrfjlhthibtsm 180 13 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 180 14 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 180 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 180 16 both both CC work_jyzsgzx6ozemtdrfjlhthibtsm 180 17 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 180 18 advanced advanced JJ work_jyzsgzx6ozemtdrfjlhthibtsm 180 19 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 180 20 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 180 21 over over IN work_jyzsgzx6ozemtdrfjlhthibtsm 180 22 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 180 23 screen- screen- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 180 24 ing ing NN work_jyzsgzx6ozemtdrfjlhthibtsm 180 25 period period NN work_jyzsgzx6ozemtdrfjlhthibtsm 180 26 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 180 27 4 4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 180 28 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 180 29 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 180 30 1406 1406 CD work_jyzsgzx6ozemtdrfjlhthibtsm 180 31 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 180 32 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 180 33 confirming confirm VBG work_jyzsgzx6ozemtdrfjlhthibtsm 180 34 that that IN work_jyzsgzx6ozemtdrfjlhthibtsm 180 35 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 180 36 most most RBS work_jyzsgzx6ozemtdrfjlhthibtsm 180 37 virulent virulent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 180 38 forms form NNS work_jyzsgzx6ozemtdrfjlhthibtsm 180 39 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 180 40 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 180 41 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 180 42 can can MD work_jyzsgzx6ozemtdrfjlhthibtsm 180 43 rarely rarely RB work_jyzsgzx6ozemtdrfjlhthibtsm 180 44 elude elude VB work_jyzsgzx6ozemtdrfjlhthibtsm 180 45 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 180 46 screening.18,61 screening.18,61 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 180 47 Ascertainment Ascertainment NNP work_jyzsgzx6ozemtdrfjlhthibtsm 180 48 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 180 49 using use VBG work_jyzsgzx6ozemtdrfjlhthibtsm 180 50 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 180 51 registry registry NN work_jyzsgzx6ozemtdrfjlhthibtsm 180 52 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 180 53 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 180 54 interval interval JJ work_jyzsgzx6ozemtdrfjlhthibtsm 180 55 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 180 56 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 180 57 cases case NNS work_jyzsgzx6ozemtdrfjlhthibtsm 180 58 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 180 59 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 180 60 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 180 61 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 180 62 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 180 63 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 180 64 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 180 65 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 180 66 still still RB work_jyzsgzx6ozemtdrfjlhthibtsm 180 67 underway underway JJ work_jyzsgzx6ozemtdrfjlhthibtsm 180 68 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 181 1 However however RB work_jyzsgzx6ozemtdrfjlhthibtsm 181 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 181 3 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 181 4 above above RB work_jyzsgzx6ozemtdrfjlhthibtsm 181 5 mentioned mention VBN work_jyzsgzx6ozemtdrfjlhthibtsm 181 6 low low JJ work_jyzsgzx6ozemtdrfjlhthibtsm 181 7 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 181 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 181 9 interval interval JJ work_jyzsgzx6ozemtdrfjlhthibtsm 181 10 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 181 11 apparently apparently RB work_jyzsgzx6ozemtdrfjlhthibtsm 181 12 seems seem VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 181 13 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 181 14 support support VB work_jyzsgzx6ozemtdrfjlhthibtsm 181 15 efficacy efficacy NN work_jyzsgzx6ozemtdrfjlhthibtsm 181 16 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 181 17 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 181 18 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 181 19 procedure procedure NN work_jyzsgzx6ozemtdrfjlhthibtsm 181 20 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 181 21 identifying identify VBG work_jyzsgzx6ozemtdrfjlhthibtsm 181 22 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 181 23 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 181 24 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 182 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 182 2 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 182 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 182 4 we -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 182 5 observed observe VBD work_jyzsgzx6ozemtdrfjlhthibtsm 182 6 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 182 7 30.3 30.3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 182 8 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 182 9 recall recall NN work_jyzsgzx6ozemtdrfjlhthibtsm 182 10 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 182 11 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 182 12 baseline baseline JJ work_jyzsgzx6ozemtdrfjlhthibtsm 182 13 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 182 14 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 182 15 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 182 16 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 182 17 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 182 18 almost almost RB work_jyzsgzx6ozemtdrfjlhthibtsm 182 19 halved halve VBD work_jyzsgzx6ozemtdrfjlhthibtsm 182 20 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 182 21 15.7 15.7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 182 22 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 182 23 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 182 24 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 182 25 stabilized stabilize VBD work_jyzsgzx6ozemtdrfjlhthibtsm 182 26 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 182 27 subsequent subsequent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 182 28 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 182 29 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 182 30 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 182 31 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 183 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 183 2 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 183 3 figures figure NNS work_jyzsgzx6ozemtdrfjlhthibtsm 183 4 seem seem VBP work_jyzsgzx6ozemtdrfjlhthibtsm 183 5 higher high JJR work_jyzsgzx6ozemtdrfjlhthibtsm 183 6 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 183 7 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 183 8 average average JJ work_jyzsgzx6ozemtdrfjlhthibtsm 183 9 20 20 CD work_jyzsgzx6ozemtdrfjlhthibtsm 183 10 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 183 11 reported report VBN work_jyzsgzx6ozemtdrfjlhthibtsm 183 12 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 183 13 observational observational JJ work_jyzsgzx6ozemtdrfjlhthibtsm 183 14 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 183 15 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 183 16 RCTs12 RCTs12 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 183 17 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 183 18 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 183 19 exception exception NN work_jyzsgzx6ozemtdrfjlhthibtsm 183 20 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 183 21 three.62–64 three.62–64 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 183 22 This this DT work_jyzsgzx6ozemtdrfjlhthibtsm 183 23 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 183 24 recall recall NN work_jyzsgzx6ozemtdrfjlhthibtsm 183 25 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 183 26 might may MD work_jyzsgzx6ozemtdrfjlhthibtsm 183 27 be be VB work_jyzsgzx6ozemtdrfjlhthibtsm 183 28 because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 183 29 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 183 30 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 183 31 radiologist radiologist NN work_jyzsgzx6ozemtdrfjlhthibtsm 183 32 learning learn VBG work_jyzsgzx6ozemtdrfjlhthibtsm 183 33 curve curve NN work_jyzsgzx6ozemtdrfjlhthibtsm 183 34 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 183 35 reflect reflect VB work_jyzsgzx6ozemtdrfjlhthibtsm 183 36 characteristics characteristic NNS work_jyzsgzx6ozemtdrfjlhthibtsm 183 37 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 183 38 screened screened JJ work_jyzsgzx6ozemtdrfjlhthibtsm 183 39 population population NN work_jyzsgzx6ozemtdrfjlhthibtsm 183 40 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 184 1 As as IN work_jyzsgzx6ozemtdrfjlhthibtsm 184 2 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 184 3 matter matter NN work_jyzsgzx6ozemtdrfjlhthibtsm 184 4 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 184 5 fact fact NN work_jyzsgzx6ozemtdrfjlhthibtsm 184 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 184 7 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 184 8 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 184 9 end end NN work_jyzsgzx6ozemtdrfjlhthibtsm 184 10 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 184 11 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 184 12 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 184 13 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 184 14 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 184 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 184 16 52.7 52.7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 184 17 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 184 18 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 184 19 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 184 20 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 184 21 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 184 22 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 184 23 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 184 24 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 184 25 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 184 26 ITALUNG ITALUNG NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 184 27 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 184 28 recalled recall VBN work_jyzsgzx6ozemtdrfjlhthibtsm 184 29 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 184 30 least least JJS work_jyzsgzx6ozemtdrfjlhthibtsm 184 31 once once RB work_jyzsgzx6ozemtdrfjlhthibtsm 184 32 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 184 33 follow follow VB work_jyzsgzx6ozemtdrfjlhthibtsm 184 34 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 184 35 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 184 36 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 184 37 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 185 1 This this DT work_jyzsgzx6ozemtdrfjlhthibtsm 185 2 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 185 3 cumulative cumulative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 185 4 false false JJ work_jyzsgzx6ozemtdrfjlhthibtsm 185 5 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 185 6 positivity positivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 185 7 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 185 8 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 185 9 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 185 10 line line NN work_jyzsgzx6ozemtdrfjlhthibtsm 185 11 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 185 12 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 185 13 data datum NNS work_jyzsgzx6ozemtdrfjlhthibtsm 185 14 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 185 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 185 16 Mayo Mayo NNP work_jyzsgzx6ozemtdrfjlhthibtsm 185 17 Clinic Clinic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 185 18 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 185 19 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 185 20 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 185 21 69 69 CD work_jyzsgzx6ozemtdrfjlhthibtsm 185 22 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 185 23 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 185 24 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 185 25 participants participant NNS work_jyzsgzx6ozemtdrfjlhthibtsm 185 26 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 185 27 at at RB work_jyzsgzx6ozemtdrfjlhthibtsm 185 28 least least RBS work_jyzsgzx6ozemtdrfjlhthibtsm 185 29 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 185 30 false false JJ work_jyzsgzx6ozemtdrfjlhthibtsm 185 31 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 185 32 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 185 33 finding finding NN work_jyzsgzx6ozemtdrfjlhthibtsm 185 34 over over IN work_jyzsgzx6ozemtdrfjlhthibtsm 185 35 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 185 36 5-year 5-year CD work_jyzsgzx6ozemtdrfjlhthibtsm 185 37 program,56 program,56 NNS work_jyzsgzx6ozemtdrfjlhthibtsm 185 38 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 185 39 both both DT work_jyzsgzx6ozemtdrfjlhthibtsm 185 40 substantially substantially RB work_jyzsgzx6ozemtdrfjlhthibtsm 185 41 match match VBP work_jyzsgzx6ozemtdrfjlhthibtsm 185 42 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 185 43 21 21 CD work_jyzsgzx6ozemtdrfjlhthibtsm 185 44 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 185 45 cumulative cumulative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 185 46 probability probability NN work_jyzsgzx6ozemtdrfjlhthibtsm 185 47 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 185 48 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 185 49 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 185 50 more more RBR work_jyzsgzx6ozemtdrfjlhthibtsm 185 51 false false JJ work_jyzsgzx6ozemtdrfjlhthibtsm 185 52 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 185 53 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 185 54 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 185 55 examinations examination NNS work_jyzsgzx6ozemtdrfjlhthibtsm 185 56 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 185 57 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 185 58 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 185 59 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 185 60 33 33 CD work_jyzsgzx6ozemtdrfjlhthibtsm 185 61 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 185 62 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 185 63 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 185 64 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 185 65 calculated calculate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 185 66 using use VBG work_jyzsgzx6ozemtdrfjlhthibtsm 185 67 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 185 68 Kaplan Kaplan NNP work_jyzsgzx6ozemtdrfjlhthibtsm 185 69 – – : work_jyzsgzx6ozemtdrfjlhthibtsm 185 70 Meier Meier NNP work_jyzsgzx6ozemtdrfjlhthibtsm 185 71 analysis.23 analysis.23 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 185 72 Reduction Reduction NNP work_jyzsgzx6ozemtdrfjlhthibtsm 185 73 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 185 74 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 185 75 numbers number NNS work_jyzsgzx6ozemtdrfjlhthibtsm 185 76 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 185 77 follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 185 78 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 185 79 up up NN work_jyzsgzx6ozemtdrfjlhthibtsm 185 80 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 185 81 recall recall VB work_jyzsgzx6ozemtdrfjlhthibtsm 185 82 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 185 83 would would MD work_jyzsgzx6ozemtdrfjlhthibtsm 185 84 be be VB work_jyzsgzx6ozemtdrfjlhthibtsm 185 85 valuable valuable JJ work_jyzsgzx6ozemtdrfjlhthibtsm 185 86 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 185 87 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 185 88 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 185 89 our -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 185 90 opinion opinion NN work_jyzsgzx6ozemtdrfjlhthibtsm 185 91 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 185 92 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 185 93 basic basic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 185 94 strategies strategy NNS work_jyzsgzx6ozemtdrfjlhthibtsm 185 95 can can MD work_jyzsgzx6ozemtdrfjlhthibtsm 185 96 be be VB work_jyzsgzx6ozemtdrfjlhthibtsm 185 97 hypothesized hypothesize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 185 98 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 186 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 186 2 first first JJ work_jyzsgzx6ozemtdrfjlhthibtsm 186 3 concerns concern NNS work_jyzsgzx6ozemtdrfjlhthibtsm 186 4 recent recent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 186 5 developments development NNS work_jyzsgzx6ozemtdrfjlhthibtsm 186 6 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 186 7 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 186 8 efforts effort NNS work_jyzsgzx6ozemtdrfjlhthibtsm 186 9 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 186 10 radiologically radiologically RB work_jyzsgzx6ozemtdrfjlhthibtsm 186 11 characterize characterize VB work_jyzsgzx6ozemtdrfjlhthibtsm 186 12 solitary solitary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 186 13 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 14 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 186 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 186 16 possibly possibly RB work_jyzsgzx6ozemtdrfjlhthibtsm 186 17 using use VBG work_jyzsgzx6ozemtdrfjlhthibtsm 186 18 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 186 19 texture texture NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 20 analysis.65,66 analysis.65,66 CC work_jyzsgzx6ozemtdrfjlhthibtsm 186 21 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 186 22 second second JJ work_jyzsgzx6ozemtdrfjlhthibtsm 186 23 solution solution NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 24 entails entail VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 186 25 combination combination NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 26 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 186 27 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 186 28 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 186 29 blood blood NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 30 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 186 31 sputum sputum NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 32 biomarker biomarker NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 33 status status NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 34 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 186 35 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 186 36 could could MD work_jyzsgzx6ozemtdrfjlhthibtsm 186 37 independently independently RB work_jyzsgzx6ozemtdrfjlhthibtsm 186 38 contribute contribute VB work_jyzsgzx6ozemtdrfjlhthibtsm 186 39 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 186 40 identifying identify VBG work_jyzsgzx6ozemtdrfjlhthibtsm 186 41 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 186 42 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 186 43 lethal lethal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 186 44 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 45 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 186 46 appearing appear VBG work_jyzsgzx6ozemtdrfjlhthibtsm 186 47 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 186 48 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 186 49 nodules.40,59 nodules.40,59 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 186 50 At at IN work_jyzsgzx6ozemtdrfjlhthibtsm 186 51 variance variance NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 52 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 186 53 NLST NLST NNP work_jyzsgzx6ozemtdrfjlhthibtsm 186 54 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 186 55 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 186 56 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 186 57 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 58 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 186 59 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 60 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 186 61 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 186 62 suspicious suspicious JJ work_jyzsgzx6ozemtdrfjlhthibtsm 186 63 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 186 64 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 186 65 left leave VBN work_jyzsgzx6ozemtdrfjlhthibtsm 186 66 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 186 67 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 186 68 subject subject NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 69 ’s ’s POS work_jyzsgzx6ozemtdrfjlhthibtsm 186 70 personal personal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 186 71 health health NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 72 provider provider NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 73 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 186 74 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 186 75 members member NNS work_jyzsgzx6ozemtdrfjlhthibtsm 186 76 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 186 77 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 186 78 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 186 79 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 80 adopted adopt VBD work_jyzsgzx6ozemtdrfjlhthibtsm 186 81 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 186 82 shared shared JJ work_jyzsgzx6ozemtdrfjlhthibtsm 186 83 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 84 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 186 85 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 86 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 186 87 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 186 88 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 186 89 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 90 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 186 91 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 186 92 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 186 93 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 186 94 simple simple JJ work_jyzsgzx6ozemtdrfjlhthibtsm 186 95 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 186 96 cheap cheap JJ work_jyzsgzx6ozemtdrfjlhthibtsm 186 97 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 186 98 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 186 99 clinically clinically RB work_jyzsgzx6ozemtdrfjlhthibtsm 186 100 based base VBN work_jyzsgzx6ozemtdrfjlhthibtsm 186 101 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 187 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 187 2 fact fact NN work_jyzsgzx6ozemtdrfjlhthibtsm 187 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 187 4 it -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 187 5 basically basically RB work_jyzsgzx6ozemtdrfjlhthibtsm 187 6 relies rely VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 187 7 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 187 8 double double JJ work_jyzsgzx6ozemtdrfjlhthibtsm 187 9 reading reading NN work_jyzsgzx6ozemtdrfjlhthibtsm 187 10 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 187 11 nodule nodule JJ work_jyzsgzx6ozemtdrfjlhthibtsm 187 12 detection detection NN work_jyzsgzx6ozemtdrfjlhthibtsm 187 13 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 187 14 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 187 15 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 187 16 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 187 17 operator operator NN work_jyzsgzx6ozemtdrfjlhthibtsm 187 18 ’s ’s POS work_jyzsgzx6ozemtdrfjlhthibtsm 187 19 measurement measurement NN work_jyzsgzx6ozemtdrfjlhthibtsm 187 20 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 187 21 mean mean NNP work_jyzsgzx6ozemtdrfjlhthibtsm 187 22 diameter diameter NN work_jyzsgzx6ozemtdrfjlhthibtsm 187 23 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 187 24 assess assess VB work_jyzsgzx6ozemtdrfjlhthibtsm 187 25 lesion lesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 187 26 growth growth NN work_jyzsgzx6ozemtdrfjlhthibtsm 187 27 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 187 28 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 187 29 visual visual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 187 30 assessment assessment NN work_jyzsgzx6ozemtdrfjlhthibtsm 187 31 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 187 32 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 187 33 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 187 34 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 187 35 uptake uptake NN work_jyzsgzx6ozemtdrfjlhthibtsm 187 36 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 187 37 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 187 38 suspicious suspicious JJ work_jyzsgzx6ozemtdrfjlhthibtsm 187 39 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 187 40 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 187 41 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 187 42 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 187 43 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 187 44 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 187 45 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 187 46 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 187 47 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 187 48 ROSE ROSE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 187 49 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 188 1 Other other JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 2 protocols protocol NNS work_jyzsgzx6ozemtdrfjlhthibtsm 188 3 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 188 4 more more RBR work_jyzsgzx6ozemtdrfjlhthibtsm 188 5 technologically technologically RB work_jyzsgzx6ozemtdrfjlhthibtsm 188 6 oriented orient VBN work_jyzsgzx6ozemtdrfjlhthibtsm 188 7 873Copyright 873copyright JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 8 © © NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 9 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 188 10 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 188 12 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 13 Association Association NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 14 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 188 16 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 17 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 18 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 19 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 20 Journal Journal NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 21 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 22 Thoracic Thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 23 Oncology Oncology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 24 ® ® NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 25     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 188 26 • • NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 27     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 188 28 Volume volume NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 29     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 188 30 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 188 31 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 188 32     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 188 33 Number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 34     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 188 35 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 188 36 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 188 37     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 188 38 July July NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 39     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 188 40 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 188 41 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 42 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 188 43 Nodule Nodule NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 44 Management Management NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 45 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 46 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 47 because because IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 48 they -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 188 49 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 188 50 based base VBN work_jyzsgzx6ozemtdrfjlhthibtsm 188 51 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 52 adoption adoption NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 53 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 54 software software NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 55 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 56 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 57 volumetry18,36 volumetry18,36 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 58 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 188 59 computation computation NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 60 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 61 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 188 62 standardized standardized JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 63 uptake uptake JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 64 value value NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 65 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 66 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 67 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 188 68 PET,18,36,67–69 PET,18,36,67–69 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 69 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 188 70 do do VBP work_jyzsgzx6ozemtdrfjlhthibtsm 188 71 not not RB work_jyzsgzx6ozemtdrfjlhthibtsm 188 72 include include VB work_jyzsgzx6ozemtdrfjlhthibtsm 188 73 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 74 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 188 75 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 188 76 FNAB.18,22,67–69 FNAB.18,22,67–69 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 77 One one CD work_jyzsgzx6ozemtdrfjlhthibtsm 188 78 additional additional JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 79 distinguishing distinguish VBG work_jyzsgzx6ozemtdrfjlhthibtsm 188 80 feature feature NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 81 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 82 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 188 83 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 84 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 85 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 86 compared compare VBN work_jyzsgzx6ozemtdrfjlhthibtsm 188 87 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 88 other other JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 89 observational observational JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 90 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 188 91 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 188 92 RCTs RCTs NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 188 93 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 188 94 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 188 95 adoption adoption NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 96 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 97 antibiotic antibiotic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 98 therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 99 before before IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 100 1-month 1-month CD work_jyzsgzx6ozemtdrfjlhthibtsm 188 101 follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 102 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 188 103 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 188 104 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 105 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 188 106 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 188 107 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 188 108 expected expect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 188 109 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 188 110 decrease decrease VB work_jyzsgzx6ozemtdrfjlhthibtsm 188 111 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 188 112 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 113 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 114 subsequent subsequent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 115 investigations investigation NNS work_jyzsgzx6ozemtdrfjlhthibtsm 188 116 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 117 revealing reveal VBG work_jyzsgzx6ozemtdrfjlhthibtsm 188 118 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 188 119 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 120 inflammatory inflammatory JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 121 nature nature NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 122 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 188 123 especially especially RB work_jyzsgzx6ozemtdrfjlhthibtsm 188 124 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 125 incident incident NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 126 nodules.47,70 nodules.47,70 NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 127 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 188 128 main main JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 129 instrument instrument NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 130 used use VBN work_jyzsgzx6ozemtdrfjlhthibtsm 188 131 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 132 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 133 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 134 suspi- suspi- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 135 cious cious JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 136 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 188 137 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 138 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 188 139 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 140 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 141 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 188 142 follow follow VB work_jyzsgzx6ozemtdrfjlhthibtsm 188 143 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 188 144 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 188 145 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 188 146 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 188 147 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 188 148 accounted account VBD work_jyzsgzx6ozemtdrfjlhthibtsm 188 149 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 150 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 188 151 majority majority NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 152 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 153 further further JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 154 investigations investigation NNS work_jyzsgzx6ozemtdrfjlhthibtsm 188 155 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 188 156 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 188 157 although although IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 158 associated associate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 188 159 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 160 additional additional JJ work_jyzsgzx6ozemtdrfjlhthibtsm 188 161 exposure exposure NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 162 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 188 163 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 188 164 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 188 165 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 166 radiation,49 radiation,49 NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 167 often often RB work_jyzsgzx6ozemtdrfjlhthibtsm 188 168 completed complete VBD work_jyzsgzx6ozemtdrfjlhthibtsm 188 169 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 188 170 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 188 171 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 189 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 2 particular particular JJ work_jyzsgzx6ozemtdrfjlhthibtsm 189 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 189 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 189 5 36 36 CD work_jyzsgzx6ozemtdrfjlhthibtsm 189 6 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 7 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 9 total total JJ work_jyzsgzx6ozemtdrfjlhthibtsm 189 10 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 189 11 partial partial JJ work_jyzsgzx6ozemtdrfjlhthibtsm 189 12 regression regression NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 13 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 14 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 189 15 month month NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 16 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 17 antibiotic antibiotic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 189 18 therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 19 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 20 prevalent prevalent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 189 21 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 189 22 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 23 compared compare VBN work_jyzsgzx6ozemtdrfjlhthibtsm 189 24 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 25 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 189 26 77 77 CD work_jyzsgzx6ozemtdrfjlhthibtsm 189 27 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 28 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 29 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 30 total total JJ work_jyzsgzx6ozemtdrfjlhthibtsm 189 31 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 189 32 partial partial JJ work_jyzsgzx6ozemtdrfjlhthibtsm 189 33 regression regression NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 34 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 35 incident incident NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 36 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 189 37 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 38 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 189 39 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 189 40 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 41 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 189 42 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 43 line line NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 44 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 45 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 189 46 29 29 CD work_jyzsgzx6ozemtdrfjlhthibtsm 189 47 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 48 disappearance disappearance NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 49 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 189 50 reduction reduction NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 51 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 52 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 189 53 month month NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 54 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 55 antibiotic antibiotic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 189 56 therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 57 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 58 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 189 59 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 189 60 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 61 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 62 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 63 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 189 64 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 65 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 189 66 74 74 CD work_jyzsgzx6ozemtdrfjlhthibtsm 189 67 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 68 disappear- disappear- NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 69 ance ance NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 70 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 189 71 reduction reduction NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 72 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 73 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 189 74 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 189 75 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 76 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 189 77 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 78 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 79 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 189 80 ELCAP ELCAP NNP work_jyzsgzx6ozemtdrfjlhthibtsm 189 81 group.70 group.70 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 189 82 This this DT work_jyzsgzx6ozemtdrfjlhthibtsm 189 83 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 189 84 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 85 line line NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 86 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 87 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 189 88 view view NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 89 that that IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 90 prevalent prevalent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 189 91 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 189 92 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 189 93 frequently frequently RB work_jyzsgzx6ozemtdrfjlhthibtsm 189 94 scars scar NNS work_jyzsgzx6ozemtdrfjlhthibtsm 189 95 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 96 benign benign JJ work_jyzsgzx6ozemtdrfjlhthibtsm 189 97 processes process NNS work_jyzsgzx6ozemtdrfjlhthibtsm 189 98 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 189 99 whereas whereas IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 100 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 189 101 incident incident NN work_jyzsgzx6ozemtdrfjlhthibtsm 189 102 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 189 103 frequently frequently RB work_jyzsgzx6ozemtdrfjlhthibtsm 189 104 correspond correspond VBP work_jyzsgzx6ozemtdrfjlhthibtsm 189 105 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 189 106 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 189 107 infective infective JJ work_jyzsgzx6ozemtdrfjlhthibtsm 189 108 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 189 109 inflammatory inflammatory JJ work_jyzsgzx6ozemtdrfjlhthibtsm 189 110 processes process NNS work_jyzsgzx6ozemtdrfjlhthibtsm 189 111 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 190 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 190 2 second second JJ work_jyzsgzx6ozemtdrfjlhthibtsm 190 3 most most RBS work_jyzsgzx6ozemtdrfjlhthibtsm 190 4 frequently frequently RB work_jyzsgzx6ozemtdrfjlhthibtsm 190 5 used use VBN work_jyzsgzx6ozemtdrfjlhthibtsm 190 6 investigation investigation NN work_jyzsgzx6ozemtdrfjlhthibtsm 190 7 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 190 8 nod- nod- DT work_jyzsgzx6ozemtdrfjlhthibtsm 190 9 ule ule NNP work_jyzsgzx6ozemtdrfjlhthibtsm 190 10 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 190 11 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 190 12 our -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 190 13 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 190 14 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 190 15 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 190 16 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 190 17 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 190 18 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 190 19 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 190 20 overall overall RB work_jyzsgzx6ozemtdrfjlhthibtsm 190 21 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 190 22 carried carry VBN work_jyzsgzx6ozemtdrfjlhthibtsm 190 23 out out RP work_jyzsgzx6ozemtdrfjlhthibtsm 190 24 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 190 25 6.5 6.5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 190 26 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 190 27 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 190 28 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 190 29 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 190 30 randomized randomize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 190 31 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 190 32 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 190 33 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 190 34 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 190 35 who who WP work_jyzsgzx6ozemtdrfjlhthibtsm 190 36 underwent undergo VBD work_jyzsgzx6ozemtdrfjlhthibtsm 190 37 baseline baseline JJ work_jyzsgzx6ozemtdrfjlhthibtsm 190 38 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 190 39 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 191 1 This this DT work_jyzsgzx6ozemtdrfjlhthibtsm 191 2 frequency frequency NN work_jyzsgzx6ozemtdrfjlhthibtsm 191 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 191 4 FDG- FDG- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 191 5 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 191 6 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 191 7 higher high JJR work_jyzsgzx6ozemtdrfjlhthibtsm 191 8 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 191 9 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 191 10 other other JJ work_jyzsgzx6ozemtdrfjlhthibtsm 191 11 observational observational JJ work_jyzsgzx6ozemtdrfjlhthibtsm 191 12 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 191 13 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 191 14 RCTs rct NNS work_jyzsgzx6ozemtdrfjlhthibtsm 191 15 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 191 16 range range NN work_jyzsgzx6ozemtdrfjlhthibtsm 191 17 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 191 18 2%–4.5%).18,27,33,42,68,71 2%–4.5%).18,27,33,42,68,71 CD work_jyzsgzx6ozemtdrfjlhthibtsm 191 19 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 191 20 excess excess NN work_jyzsgzx6ozemtdrfjlhthibtsm 191 21 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 191 22 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 191 23 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 191 24 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 191 25 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 191 26 our -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 191 27 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 191 28 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 191 29 related relate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 191 30 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 191 31 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 191 32 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 191 33 number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 191 34 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 191 35 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 191 36 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 191 37 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 191 38 examina- examina- NN work_jyzsgzx6ozemtdrfjlhthibtsm 191 39 tions tion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 191 40 performed perform VBN work_jyzsgzx6ozemtdrfjlhthibtsm 191 41 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 191 42 baseline baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 191 43 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 191 44 59 59 CD work_jyzsgzx6ozemtdrfjlhthibtsm 191 45 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 191 46 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 191 47 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 191 48 whereas whereas IN work_jyzsgzx6ozemtdrfjlhthibtsm 191 49 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 191 50 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 191 51 mean mean JJ work_jyzsgzx6ozemtdrfjlhthibtsm 191 52 number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 191 53 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 191 54 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 191 55 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 191 56 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 191 57 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 191 58 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 191 59 subsequent subsequent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 191 60 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 191 61 repeat repeat NN work_jyzsgzx6ozemtdrfjlhthibtsm 191 62 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 191 63 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 191 64 round round NN work_jyzsgzx6ozemtdrfjlhthibtsm 191 65 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 191 66 13.6 13.6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 191 67 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 191 68 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 192 1 By by IN work_jyzsgzx6ozemtdrfjlhthibtsm 192 2 assimilating assimilate VBG work_jyzsgzx6ozemtdrfjlhthibtsm 192 3 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 192 4 indeterminate indeterminate NN work_jyzsgzx6ozemtdrfjlhthibtsm 192 5 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 192 6 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 192 7 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 192 8 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 192 9 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 192 10 PET pet JJ work_jyzsgzx6ozemtdrfjlhthibtsm 192 11 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 192 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 192 13 we -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 192 14 observed observe VBD work_jyzsgzx6ozemtdrfjlhthibtsm 192 15 overall overall RB work_jyzsgzx6ozemtdrfjlhthibtsm 192 16 84 84 CD work_jyzsgzx6ozemtdrfjlhthibtsm 192 17 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 192 18 sensitiv- sensitiv- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 192 19 ity ity NN work_jyzsgzx6ozemtdrfjlhthibtsm 192 20 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 192 21 90 90 CD work_jyzsgzx6ozemtdrfjlhthibtsm 192 22 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 192 23 specificity specificity NN work_jyzsgzx6ozemtdrfjlhthibtsm 192 24 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 192 25 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 192 26 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 192 27 substantially substantially RB work_jyzsgzx6ozemtdrfjlhthibtsm 192 28 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 192 29 line line NN work_jyzsgzx6ozemtdrfjlhthibtsm 192 30 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 192 31 those those DT work_jyzsgzx6ozemtdrfjlhthibtsm 192 32 previously previously RB work_jyzsgzx6ozemtdrfjlhthibtsm 192 33 reported.37,42,68,69,71 reported.37,42,68,69,71 VB work_jyzsgzx6ozemtdrfjlhthibtsm 192 34 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 192 35 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 192 36 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 192 37 2.4 2.4 CD work_jyzsgzx6ozemtdrfjlhthibtsm 192 38 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 192 39 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 192 40 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 192 41 randomized randomize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 192 42 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 192 43 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 192 44 active active JJ work_jyzsgzx6ozemtdrfjlhthibtsm 192 45 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 192 46 ultimately ultimately RB work_jyzsgzx6ozemtdrfjlhthibtsm 192 47 had have VBD work_jyzsgzx6ozemtdrfjlhthibtsm 192 48 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 192 49 during during IN work_jyzsgzx6ozemtdrfjlhthibtsm 192 50 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 192 51 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 192 52 cycle cycle NN work_jyzsgzx6ozemtdrfjlhthibtsm 192 53 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 192 54 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 192 55 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 192 56 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 192 57 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 192 58 37 37 CD work_jyzsgzx6ozemtdrfjlhthibtsm 192 59 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 192 60 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 192 61 ultrasound ultrasound NN work_jyzsgzx6ozemtdrfjlhthibtsm 192 62 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 192 63 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 192 64 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 192 65 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 192 66 lesion lesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 192 67 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 192 68 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 192 69 part part NN work_jyzsgzx6ozemtdrfjlhthibtsm 192 70 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 192 71 their -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 192 72 diagnostic diagnostic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 192 73 workup workup NN work_jyzsgzx6ozemtdrfjlhthibtsm 192 74 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 192 75 38 38 CD work_jyzsgzx6ozemtdrfjlhthibtsm 192 76 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 192 77 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 192 78 34 34 CD work_jyzsgzx6ozemtdrfjlhthibtsm 192 79 sub- sub- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 192 80 jects ject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 192 81 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 192 82 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 193 1 This this DT work_jyzsgzx6ozemtdrfjlhthibtsm 193 2 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 193 3 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 193 4 similar similar JJ work_jyzsgzx6ozemtdrfjlhthibtsm 193 5 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 193 6 another another DT work_jyzsgzx6ozemtdrfjlhthibtsm 193 7 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 193 8 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 193 9 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 193 10 adopting adopt VBG work_jyzsgzx6ozemtdrfjlhthibtsm 193 11 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 193 12 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 193 13 part part NN work_jyzsgzx6ozemtdrfjlhthibtsm 193 14 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 193 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 193 16 protocol,72 protocol,72 NN work_jyzsgzx6ozemtdrfjlhthibtsm 193 17 but but CC work_jyzsgzx6ozemtdrfjlhthibtsm 193 18 higher high JJR work_jyzsgzx6ozemtdrfjlhthibtsm 193 19 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 193 20 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 193 21 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 193 22 NELSON nelson NN work_jyzsgzx6ozemtdrfjlhthibtsm 193 23 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 193 24 < < XX work_jyzsgzx6ozemtdrfjlhthibtsm 193 25 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 193 26 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 193 27 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 193 28 53 53 CD work_jyzsgzx6ozemtdrfjlhthibtsm 193 29 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 193 30 German German NNP work_jyzsgzx6ozemtdrfjlhthibtsm 193 31 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 193 32 1.5 1.5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 193 33 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 193 34 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 193 35 24 24 CD work_jyzsgzx6ozemtdrfjlhthibtsm 193 36 trials trial NNS work_jyzsgzx6ozemtdrfjlhthibtsm 193 37 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 194 1 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 194 2 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 194 3 majority majority NN work_jyzsgzx6ozemtdrfjlhthibtsm 194 4 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 194 5 89 89 CD work_jyzsgzx6ozemtdrfjlhthibtsm 194 6 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 194 7 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 194 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 194 9 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 194 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 194 11 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 194 12 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 194 13 carried carry VBN work_jyzsgzx6ozemtdrfjlhthibtsm 194 14 out out RP work_jyzsgzx6ozemtdrfjlhthibtsm 194 15 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 194 16 ROSE ROSE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 194 17 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 194 18 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 194 19 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 194 20 associated associate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 194 21 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 194 22 lower low JJR work_jyzsgzx6ozemtdrfjlhthibtsm 194 23 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 194 24 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 194 25 nondiagnostic nondiagnostic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 194 26 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 194 27 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 194 28 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 194 29 our -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 194 30 series series NN work_jyzsgzx6ozemtdrfjlhthibtsm 194 31 it -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 194 32 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 194 33 11 11 CD work_jyzsgzx6ozemtdrfjlhthibtsm 194 34 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 194 35 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 194 36 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 194 37 compared compare VBN work_jyzsgzx6ozemtdrfjlhthibtsm 194 38 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 194 39 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 194 40 alone.73 alone.73 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 194 41 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 194 42 large large JJ work_jyzsgzx6ozemtdrfjlhthibtsm 194 43 majority majority NN work_jyzsgzx6ozemtdrfjlhthibtsm 194 44 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 194 45 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 194 46 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 194 47 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 194 48 32 32 CD work_jyzsgzx6ozemtdrfjlhthibtsm 194 49 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 194 50 38 38 CD work_jyzsgzx6ozemtdrfjlhthibtsm 194 51 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 194 52 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 194 53 whom whom WP work_jyzsgzx6ozemtdrfjlhthibtsm 194 54 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 194 55 primary primary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 194 56 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 194 57 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 194 58 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 194 59 ultimately ultimately RB work_jyzsgzx6ozemtdrfjlhthibtsm 194 60 diagnosed diagnose VBN work_jyzsgzx6ozemtdrfjlhthibtsm 194 61 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 194 62 histological histological JJ work_jyzsgzx6ozemtdrfjlhthibtsm 194 63 exami- exami- NN work_jyzsgzx6ozemtdrfjlhthibtsm 194 64 nation nation NN work_jyzsgzx6ozemtdrfjlhthibtsm 194 65 underwent undergo VBD work_jyzsgzx6ozemtdrfjlhthibtsm 194 66 preliminary preliminary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 194 67 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 194 68 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 195 1 If if IN work_jyzsgzx6ozemtdrfjlhthibtsm 195 2 we -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 195 3 assimilate assimilate VBP work_jyzsgzx6ozemtdrfjlhthibtsm 195 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 195 5 inconclusive inconclusive NN work_jyzsgzx6ozemtdrfjlhthibtsm 195 6 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 195 7 negative negative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 195 8 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 195 9 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 195 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 195 11 we -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 195 12 obtained obtain VBD work_jyzsgzx6ozemtdrfjlhthibtsm 195 13 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 195 14 90 90 CD work_jyzsgzx6ozemtdrfjlhthibtsm 195 15 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 195 16 sensitivity sensitivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 195 17 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 195 18 88 88 CD work_jyzsgzx6ozemtdrfjlhthibtsm 195 19 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 195 20 specificity specificity NN work_jyzsgzx6ozemtdrfjlhthibtsm 195 21 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 196 1 These these DT work_jyzsgzx6ozemtdrfjlhthibtsm 196 2 figures figure NNS work_jyzsgzx6ozemtdrfjlhthibtsm 196 3 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 196 4 better well JJR work_jyzsgzx6ozemtdrfjlhthibtsm 196 5 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 196 6 those those DT work_jyzsgzx6ozemtdrfjlhthibtsm 196 7 reported report VBN work_jyzsgzx6ozemtdrfjlhthibtsm 196 8 both both DT work_jyzsgzx6ozemtdrfjlhthibtsm 196 9 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 196 10 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 196 11 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 196 12 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 13 program program NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 196 15 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 196 16 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 196 17 21 21 CD work_jyzsgzx6ozemtdrfjlhthibtsm 196 18 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 19 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 20 yielded yield VBD work_jyzsgzx6ozemtdrfjlhthibtsm 196 21 unsatisfactory unsatisfactory JJ work_jyzsgzx6ozemtdrfjlhthibtsm 196 22 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 196 23 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 196 24 12 12 CD work_jyzsgzx6ozemtdrfjlhthibtsm 196 25 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 26 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 196 27 were be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 196 28 false false JJ work_jyzsgzx6ozemtdrfjlhthibtsm 196 29 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 196 30 positives positive NNS work_jyzsgzx6ozemtdrfjlhthibtsm 196 31 leading lead VBG work_jyzsgzx6ozemtdrfjlhthibtsm 196 32 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 196 33 surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 34 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 196 35 benign benign JJ work_jyzsgzx6ozemtdrfjlhthibtsm 196 36 pathology,72 pathology,72 NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 37 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 196 38 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 196 39 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 196 40 clinical clinical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 196 41 practice practice NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 42 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 196 43 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 196 44 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 196 45 average average JJ work_jyzsgzx6ozemtdrfjlhthibtsm 196 46 sensitivity sensitivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 47 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 196 48 also also RB work_jyzsgzx6ozemtdrfjlhthibtsm 196 49 90 90 CD work_jyzsgzx6ozemtdrfjlhthibtsm 196 50 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 51 but but CC work_jyzsgzx6ozemtdrfjlhthibtsm 196 52 21 21 CD work_jyzsgzx6ozemtdrfjlhthibtsm 196 53 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 54 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 196 55 FNABs fnab NNS work_jyzsgzx6ozemtdrfjlhthibtsm 196 56 produce produce NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 57 nondiagnostic nondiagnostic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 196 58 results.74 results.74 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 196 59 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 196 60 unique unique JJ work_jyzsgzx6ozemtdrfjlhthibtsm 196 61 false false RB work_jyzsgzx6ozemtdrfjlhthibtsm 196 62 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 196 63 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 196 64 result result NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 65 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 196 66 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 67 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 196 68 our -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 196 69 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 70 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 196 71 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 196 72 led lead VBD work_jyzsgzx6ozemtdrfjlhthibtsm 196 73 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 196 74 surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 75 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 196 76 benign benign JJ work_jyzsgzx6ozemtdrfjlhthibtsm 196 77 pathology pathology NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 78 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 196 79 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 196 80 case case NN work_jyzsgzx6ozemtdrfjlhthibtsm 196 81 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 196 82 AAH AAH NNP work_jyzsgzx6ozemtdrfjlhthibtsm 196 83 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 197 1 This this DT work_jyzsgzx6ozemtdrfjlhthibtsm 197 2 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 197 3 considered consider VBN work_jyzsgzx6ozemtdrfjlhthibtsm 197 4 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 197 5 preneoplastic preneoplastic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 197 6 lesion lesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 7 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 197 8 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 197 9 indistinguishable indistinguishable JJ work_jyzsgzx6ozemtdrfjlhthibtsm 197 10 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 11 cytological cytological JJ work_jyzsgzx6ozemtdrfjlhthibtsm 197 12 examination examination NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 13 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 14 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 197 15 former former JJ work_jyzsgzx6ozemtdrfjlhthibtsm 197 16 category category NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 17 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 18 bron- bron- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 19 chioloalveolar chioloalveolar NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 20 carcinoma,44,46 carcinoma,44,46 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 21 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 197 22 corresponds correspond VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 197 23 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 24 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 197 25 new new JJ work_jyzsgzx6ozemtdrfjlhthibtsm 197 26 category category NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 27 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 28 early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 197 29 AC AC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 30 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 197 31 comprising comprise VBG work_jyzsgzx6ozemtdrfjlhthibtsm 197 32 AC AC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 33 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 34 situ situ NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 35 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 197 36 minimally minimally RB work_jyzsgzx6ozemtdrfjlhthibtsm 197 37 inva- inva- XX work_jyzsgzx6ozemtdrfjlhthibtsm 197 38 sive sive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 197 39 AC AC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 40 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 197 41 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 197 42 lepidic lepidic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 197 43 predominant predominant NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 44 AC.75 AC.75 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 45 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 46 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 197 47 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 48 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 197 49 combination combination NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 50 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 51 volumetry volumetry NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 52 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 53 follow follow VB work_jyzsgzx6ozemtdrfjlhthibtsm 197 54 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 197 55 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 197 56 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 57 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 58 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 59 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 197 60 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 61 improved improve VBD work_jyzsgzx6ozemtdrfjlhthibtsm 197 62 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 197 63 sensitivity sensitivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 64 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 65 diagnosis diagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 66 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 67 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 68 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 69 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 70 71 71 CD work_jyzsgzx6ozemtdrfjlhthibtsm 197 71 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 72 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 197 73 volumetry volumetry NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 74 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 197 75 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 76 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 197 77 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 78 alone alone RB work_jyzsgzx6ozemtdrfjlhthibtsm 197 79 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 197 80 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 81 90 90 CD work_jyzsgzx6ozemtdrfjlhthibtsm 197 82 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 83 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 84 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 197 85 decrease decrease NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 86 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 87 specificity specificity NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 88 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 89 91 91 CD work_jyzsgzx6ozemtdrfjlhthibtsm 197 90 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 91 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 92 82%.37 82%.37 . work_jyzsgzx6ozemtdrfjlhthibtsm 197 93 In in IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 94 our -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 197 95 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 96 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 197 97 combination combination NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 98 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 99 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 197 100 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 101 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 197 102 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 103 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 197 104 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 105 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 197 106 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 197 107 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 108 invariably invariably RB work_jyzsgzx6ozemtdrfjlhthibtsm 197 109 predicted predict VBD work_jyzsgzx6ozemtdrfjlhthibtsm 197 110 primary primary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 197 111 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 197 112 secondary secondary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 197 113 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 114 malig- malig- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 115 nancy nancy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 116 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 197 117 that that RB work_jyzsgzx6ozemtdrfjlhthibtsm 197 118 is is RB work_jyzsgzx6ozemtdrfjlhthibtsm 197 119 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 197 120 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 197 121 100 100 CD work_jyzsgzx6ozemtdrfjlhthibtsm 197 122 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 123 sensitivity sensitivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 197 124 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 197 125 reached reach VBN work_jyzsgzx6ozemtdrfjlhthibtsm 197 126 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 197 127 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 197 128 no no DT work_jyzsgzx6ozemtdrfjlhthibtsm 197 129 double double JJ work_jyzsgzx6ozemtdrfjlhthibtsm 197 130 false false JJ work_jyzsgzx6ozemtdrfjlhthibtsm 197 131 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 197 132 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 197 133 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 197 134 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 197 135 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 136 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 197 137 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 138 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 197 139 FNAB FNAB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 197 140 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 197 141 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 197 142 observed observe VBN work_jyzsgzx6ozemtdrfjlhthibtsm 197 143 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 198 1 These these DT work_jyzsgzx6ozemtdrfjlhthibtsm 198 2 data datum NNS work_jyzsgzx6ozemtdrfjlhthibtsm 198 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 198 4 although although IN work_jyzsgzx6ozemtdrfjlhthibtsm 198 5 obtained obtain VBN work_jyzsgzx6ozemtdrfjlhthibtsm 198 6 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 198 7 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 198 8 relatively relatively RB work_jyzsgzx6ozemtdrfjlhthibtsm 198 9 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 198 10 sample sample NN work_jyzsgzx6ozemtdrfjlhthibtsm 198 11 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 198 12 justify justify VB work_jyzsgzx6ozemtdrfjlhthibtsm 198 13 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 198 14 view view NN work_jyzsgzx6ozemtdrfjlhthibtsm 198 15 that that IN work_jyzsgzx6ozemtdrfjlhthibtsm 198 16 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 198 17 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 198 18 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 198 19 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 198 20 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 198 21 ROSE ROSE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 198 22 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 198 23 very very RB work_jyzsgzx6ozemtdrfjlhthibtsm 198 24 useful useful JJ work_jyzsgzx6ozemtdrfjlhthibtsm 198 25 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 198 26 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 198 27 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 198 28 suspicious suspicious JJ work_jyzsgzx6ozemtdrfjlhthibtsm 198 29 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 198 30 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 198 31 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 198 32 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 198 33 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 198 34 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 198 35 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 198 36 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 199 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 199 2 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 199 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 199 4 surgical surgical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 199 5 curative curative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 199 6 therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 199 7 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 199 8 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 199 9 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 199 10 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 199 11 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 199 12 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 199 13 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 199 14 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 199 15 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 199 16 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 199 17 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 199 18 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 199 19 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 199 20 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 199 21 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 199 22 line line NN work_jyzsgzx6ozemtdrfjlhthibtsm 199 23 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 199 24 previous previous JJ work_jyzsgzx6ozemtdrfjlhthibtsm 199 25 data,12,18,34 data,12,18,34 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 199 26 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 199 27 reflects reflect VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 199 28 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 199 29 early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 199 30 stages stage NNS work_jyzsgzx6ozemtdrfjlhthibtsm 199 31 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 199 32 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 199 33 large large JJ work_jyzsgzx6ozemtdrfjlhthibtsm 199 34 majority majority NN work_jyzsgzx6ozemtdrfjlhthibtsm 199 35 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 199 36 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 199 37 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 199 38 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 199 39 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 199 40 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 199 41 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 200 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 200 2 10 10 CD work_jyzsgzx6ozemtdrfjlhthibtsm 200 3 % % NN work_jyzsgzx6ozemtdrfjlhthibtsm 200 4 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 200 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 6 surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 200 7 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 8 benign benign JJ work_jyzsgzx6ozemtdrfjlhthibtsm 200 9 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 200 10 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 200 12 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 200 13 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 200 14 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 200 15 lower low JJR work_jyzsgzx6ozemtdrfjlhthibtsm 200 16 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 17 those those DT work_jyzsgzx6ozemtdrfjlhthibtsm 200 18 reported report VBN work_jyzsgzx6ozemtdrfjlhthibtsm 200 19 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 20 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 200 21 majority majority NN work_jyzsgzx6ozemtdrfjlhthibtsm 200 22 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 23 other other JJ work_jyzsgzx6ozemtdrfjlhthibtsm 200 24 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 200 25 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 200 26 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 200 27 which which WDT work_jyzsgzx6ozemtdrfjlhthibtsm 200 28 can can MD work_jyzsgzx6ozemtdrfjlhthibtsm 200 29 be be VB work_jyzsgzx6ozemtdrfjlhthibtsm 200 30 as as RB work_jyzsgzx6ozemtdrfjlhthibtsm 200 31 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 200 32 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 33 33%.76 33%.76 ADD work_jyzsgzx6ozemtdrfjlhthibtsm 200 34 This this DT work_jyzsgzx6ozemtdrfjlhthibtsm 200 35 low low JJ work_jyzsgzx6ozemtdrfjlhthibtsm 200 36 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 200 37 supports support VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 200 38 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 200 39 validity validity NN work_jyzsgzx6ozemtdrfjlhthibtsm 200 40 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 41 our -PRON- PRP$ work_jyzsgzx6ozemtdrfjlhthibtsm 200 42 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 200 43 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 200 44 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 200 45 seems seem VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 200 46 noteworthy noteworthy JJ work_jyzsgzx6ozemtdrfjlhthibtsm 200 47 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 200 48 especially especially RB work_jyzsgzx6ozemtdrfjlhthibtsm 200 49 if if IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 50 one one PRP work_jyzsgzx6ozemtdrfjlhthibtsm 200 51 considers consider VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 200 52 that that IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 53 two two CD work_jyzsgzx6ozemtdrfjlhthibtsm 200 54 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 55 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 200 56 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 200 57 cases case NNS work_jyzsgzx6ozemtdrfjlhthibtsm 200 58 referred refer VBN work_jyzsgzx6ozemtdrfjlhthibtsm 200 59 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 60 surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 200 61 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 62 benign benign JJ work_jyzsgzx6ozemtdrfjlhthibtsm 200 63 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 200 64 corresponded correspond VBD work_jyzsgzx6ozemtdrfjlhthibtsm 200 65 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 66 AAH AAH NNP work_jyzsgzx6ozemtdrfjlhthibtsm 200 67 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 200 68 that that IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 69 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 70 three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 200 71 cases case NNS work_jyzsgzx6ozemtdrfjlhthibtsm 200 72 referral referral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 200 73 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 200 74 surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 200 75 followed follow VBD work_jyzsgzx6ozemtdrfjlhthibtsm 200 76 protocol protocol JJ work_jyzsgzx6ozemtdrfjlhthibtsm 200 77 violations violation NNS work_jyzsgzx6ozemtdrfjlhthibtsm 200 78 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 201 1 Strict strict JJ work_jyzsgzx6ozemtdrfjlhthibtsm 201 2 adherence adherence NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 3 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 4 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 201 5 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 6 derived derive VBN work_jyzsgzx6ozemtdrfjlhthibtsm 201 7 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 8 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 201 9 clinical clinical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 201 10 routine routine NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 11 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 201 12 including include VBG work_jyzsgzx6ozemtdrfjlhthibtsm 201 13 follow follow VB work_jyzsgzx6ozemtdrfjlhthibtsm 201 14 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 201 15 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 201 16 LDCT ldct NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 17 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 18 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 201 19 without without IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 20 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 201 21 month month NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 22 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 23 antibiotic antibiotic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 201 24 therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 25 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 201 26 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 201 27 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 201 28 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 201 29 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 201 30 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 201 31 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 201 32 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 201 33 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 201 34 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 35 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 36 ROSE ROSE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 201 37 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 201 38 expected expect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 201 39 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 201 40 further further RB work_jyzsgzx6ozemtdrfjlhthibtsm 201 41 lessen lessen VB work_jyzsgzx6ozemtdrfjlhthibtsm 201 42 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 201 43 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 44 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 45 surgery surgery NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 46 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 47 benign benign JJ work_jyzsgzx6ozemtdrfjlhthibtsm 201 48 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 201 49 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 50 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 201 51 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 52 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 53 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 54 cancer.29 cancer.29 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 201 55 CONCLUSIONS conclusion VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 201 56 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 201 57 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 201 58 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 59 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 201 60 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 201 61 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 62 indicate indicate VBP work_jyzsgzx6ozemtdrfjlhthibtsm 201 63 that that IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 64 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 201 65 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 201 66 risk risk NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 67 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 201 68 recruited recruit VBN work_jyzsgzx6ozemtdrfjlhthibtsm 201 69 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 70 mail mail NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 71 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 201 72 participate participate VB work_jyzsgzx6ozemtdrfjlhthibtsm 201 73 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 74 an an DT work_jyzsgzx6ozemtdrfjlhthibtsm 201 75 RCT RCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 201 76 offering offer VBG work_jyzsgzx6ozemtdrfjlhthibtsm 201 77 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 201 78 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 201 79 usual usual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 201 80 care care NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 81 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 82 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 83 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 84 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 85 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 86 show show VBP work_jyzsgzx6ozemtdrfjlhthibtsm 201 87 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 201 88 lower low JJR work_jyzsgzx6ozemtdrfjlhthibtsm 201 89 adhesion adhesion NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 90 than than IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 91 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 201 92 invited invite VBN work_jyzsgzx6ozemtdrfjlhthibtsm 201 93 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 201 94 undergo undergo VB work_jyzsgzx6ozemtdrfjlhthibtsm 201 95 other other JJ work_jyzsgzx6ozemtdrfjlhthibtsm 201 96 consolidated consolidated JJ work_jyzsgzx6ozemtdrfjlhthibtsm 201 97 population population NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 98 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 201 99 based base VBN work_jyzsgzx6ozemtdrfjlhthibtsm 201 100 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 101 programs program NNS work_jyzsgzx6ozemtdrfjlhthibtsm 201 102 such such JJ work_jyzsgzx6ozemtdrfjlhthibtsm 201 103 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 104 those those DT work_jyzsgzx6ozemtdrfjlhthibtsm 201 105 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 201 106 breast breast NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 107 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 201 108 colorectal colorectal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 201 109 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 201 110 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 202 1 However however RB work_jyzsgzx6ozemtdrfjlhthibtsm 202 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 202 3 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 202 4 adherents adherent NNS work_jyzsgzx6ozemtdrfjlhthibtsm 202 5 randomized randomize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 202 6 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 202 7 receive receive VB work_jyzsgzx6ozemtdrfjlhthibtsm 202 8 four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 202 9 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 202 10 LDCTs LDCTs NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 202 11 show show VBP work_jyzsgzx6ozemtdrfjlhthibtsm 202 12 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 202 13 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 202 14 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 202 15 sustained sustained JJ work_jyzsgzx6ozemtdrfjlhthibtsm 202 16 compli- compli- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 202 17 ance ance NN work_jyzsgzx6ozemtdrfjlhthibtsm 202 18 throughout throughout IN work_jyzsgzx6ozemtdrfjlhthibtsm 202 19 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 202 20 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 202 21 cycle cycle NN work_jyzsgzx6ozemtdrfjlhthibtsm 202 22 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 203 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 203 2 low low JJ work_jyzsgzx6ozemtdrfjlhthibtsm 203 3 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 4 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 203 5 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 6 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 203 7 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 203 8 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 9 cancers cancer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 203 10 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 203 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 203 12 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 203 13 recall recall NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 14 rate rate NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 15 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 203 16 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 203 17 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 203 18 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 19 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 203 20 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 203 21 line line NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 22 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 203 23 those those DT work_jyzsgzx6ozemtdrfjlhthibtsm 203 24 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 203 25 other other JJ work_jyzsgzx6ozemtdrfjlhthibtsm 203 26 observational observational JJ work_jyzsgzx6ozemtdrfjlhthibtsm 203 27 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 203 28 randomized randomized JJ work_jyzsgzx6ozemtdrfjlhthibtsm 203 29 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 203 30 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 203 31 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 203 32 confirm confirm VB work_jyzsgzx6ozemtdrfjlhthibtsm 203 33 that that IN work_jyzsgzx6ozemtdrfjlhthibtsm 203 34 improved improve VBN work_jyzsgzx6ozemtdrfjlhthibtsm 203 35 definition definition NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 36 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 203 37 target target NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 38 population population NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 39 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 203 40 maybe maybe RB work_jyzsgzx6ozemtdrfjlhthibtsm 203 41 inte- inte- IN work_jyzsgzx6ozemtdrfjlhthibtsm 203 42 gration gration NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 43 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 203 44 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 203 45 risk risk NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 46 stratification stratification NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 47 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 203 48 biomarkers biomarker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 203 49 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 203 50 required require VBN work_jyzsgzx6ozemtdrfjlhthibtsm 203 51 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 203 52 increase increase VB work_jyzsgzx6ozemtdrfjlhthibtsm 203 53 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 203 54 cost cost NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 55 effectiveness effectiveness NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 56 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 203 57 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 58 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 59 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 203 60 programs program NNS work_jyzsgzx6ozemtdrfjlhthibtsm 203 61 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 204 1 Adoption adoption NN work_jyzsgzx6ozemtdrfjlhthibtsm 204 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 204 3 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 204 4 shared share VBN work_jyzsgzx6ozemtdrfjlhthibtsm 204 5 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 204 6 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 204 7 nodule nodule JJ work_jyzsgzx6ozemtdrfjlhthibtsm 204 8 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 204 9 derived derive VBN work_jyzsgzx6ozemtdrfjlhthibtsm 204 10 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 204 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 204 12 clinical clinical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 204 13 routine routine NN work_jyzsgzx6ozemtdrfjlhthibtsm 204 14 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 204 15 including include VBG work_jyzsgzx6ozemtdrfjlhthibtsm 204 16 follow follow VB work_jyzsgzx6ozemtdrfjlhthibtsm 204 17 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 204 18 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 204 19 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 20 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 204 21 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 204 22 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 204 23 month month NN work_jyzsgzx6ozemtdrfjlhthibtsm 204 24 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 204 25 antibiotic antibiotic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 204 26 therapy therapy NN work_jyzsgzx6ozemtdrfjlhthibtsm 204 27 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 204 28 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 204 29 measurement measurement NN work_jyzsgzx6ozemtdrfjlhthibtsm 204 30 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 204 31 nodule nodule NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 32 mean mean NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 33 diameter diameter NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 34 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 204 35 visual visual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 204 36 assessment assessment NN work_jyzsgzx6ozemtdrfjlhthibtsm 204 37 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 204 38 FDG FDG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 39 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 204 40 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 41 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 204 42 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 204 43 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 44 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 204 45 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 204 46 FNAB fnab NN work_jyzsgzx6ozemtdrfjlhthibtsm 204 47 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 204 48 ROSE ROSE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 49 yields yield NNS work_jyzsgzx6ozemtdrfjlhthibtsm 204 50 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 204 51 accuracy accuracy NN work_jyzsgzx6ozemtdrfjlhthibtsm 204 52 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 204 53 pre- pre- DT work_jyzsgzx6ozemtdrfjlhthibtsm 204 54 operative operative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 204 55 detection detection NN work_jyzsgzx6ozemtdrfjlhthibtsm 204 56 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 204 57 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 204 58 malignancies malignancy NNS work_jyzsgzx6ozemtdrfjlhthibtsm 204 59 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 204 60 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 204 61 few few JJ work_jyzsgzx6ozemtdrfjlhthibtsm 204 62 surgical surgical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 204 63 874 874 CD work_jyzsgzx6ozemtdrfjlhthibtsm 204 64 Copyright copyright NN work_jyzsgzx6ozemtdrfjlhthibtsm 204 65 © © NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 66 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 204 67 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 204 68 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 204 69 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 70 Association Association NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 71 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 204 72 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 204 73 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 74 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 204 75 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 76 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 77 Pegna Pegna NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 78 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 79 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 204 80 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 205 1 Journal Journal NNP work_jyzsgzx6ozemtdrfjlhthibtsm 205 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 205 3 Thoracic Thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 205 4 Oncology Oncology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 205 5 ® ® NNP work_jyzsgzx6ozemtdrfjlhthibtsm 205 6     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 205 7 • • NN work_jyzsgzx6ozemtdrfjlhthibtsm 205 8     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 205 9 Volume volume NN work_jyzsgzx6ozemtdrfjlhthibtsm 205 10     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 205 11 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 205 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 205 13     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 205 14 Number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 205 15     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 205 16 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 205 17 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 205 18     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 205 19 July July NNP work_jyzsgzx6ozemtdrfjlhthibtsm 205 20     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 205 21 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 205 22 interventions intervention NNS work_jyzsgzx6ozemtdrfjlhthibtsm 205 23 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 205 24 benign benign JJ work_jyzsgzx6ozemtdrfjlhthibtsm 205 25 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 205 26 being be VBG work_jyzsgzx6ozemtdrfjlhthibtsm 205 27 associated associate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 205 28 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 205 29 proto- proto- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 205 30 col col NN work_jyzsgzx6ozemtdrfjlhthibtsm 205 31 violations violation NNS work_jyzsgzx6ozemtdrfjlhthibtsm 205 32 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 206 1 ACKNOWLEDGMENT acknowledgment DT work_jyzsgzx6ozemtdrfjlhthibtsm 206 2 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 206 3 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 206 4 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 206 5 was be VBD work_jyzsgzx6ozemtdrfjlhthibtsm 206 6 entirely entirely RB work_jyzsgzx6ozemtdrfjlhthibtsm 206 7 funded fund VBN work_jyzsgzx6ozemtdrfjlhthibtsm 206 8 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 206 9 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 206 10 Health Health NNP work_jyzsgzx6ozemtdrfjlhthibtsm 206 11 Department Department NNP work_jyzsgzx6ozemtdrfjlhthibtsm 206 12 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 206 13 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 206 14 Tuscany Tuscany NNP work_jyzsgzx6ozemtdrfjlhthibtsm 206 15 Region Region NNP work_jyzsgzx6ozemtdrfjlhthibtsm 206 16 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 206 17 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 206 18 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 206 19 Decision Decision NNP work_jyzsgzx6ozemtdrfjlhthibtsm 206 20 n. n. NNP work_jyzsgzx6ozemtdrfjlhthibtsm 206 21 1014 1014 CD work_jyzsgzx6ozemtdrfjlhthibtsm 206 22 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 206 23 February February NNP work_jyzsgzx6ozemtdrfjlhthibtsm 206 24 25 25 CD work_jyzsgzx6ozemtdrfjlhthibtsm 206 25 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 206 26 2004 2004 CD work_jyzsgzx6ozemtdrfjlhthibtsm 206 27 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 206 28 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 207 1 REFERENCES reference NNS work_jyzsgzx6ozemtdrfjlhthibtsm 207 2 1 1 CD work_jyzsgzx6ozemtdrfjlhthibtsm 207 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 208 1 American American NNP work_jyzsgzx6ozemtdrfjlhthibtsm 208 2 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 208 3 Society Society NNP work_jyzsgzx6ozemtdrfjlhthibtsm 208 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 209 1 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 209 2 Facts Facts NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 209 3 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 209 4 Figures Figures NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 209 5 2012 2012 CD work_jyzsgzx6ozemtdrfjlhthibtsm 209 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 210 1 Atlanta Atlanta NNP work_jyzsgzx6ozemtdrfjlhthibtsm 210 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 210 3 GA GA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 210 4 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 210 5 American American NNP work_jyzsgzx6ozemtdrfjlhthibtsm 210 6 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 210 7 Society Society NNP work_jyzsgzx6ozemtdrfjlhthibtsm 210 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 210 9 2012 2012 CD work_jyzsgzx6ozemtdrfjlhthibtsm 210 10 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 211 1 2 2 LS work_jyzsgzx6ozemtdrfjlhthibtsm 211 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 212 1 Travis Travis NNP work_jyzsgzx6ozemtdrfjlhthibtsm 212 2 WD WD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 212 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 213 1 Pathology pathology NN work_jyzsgzx6ozemtdrfjlhthibtsm 213 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 213 3 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 213 4 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 213 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 214 1 Clin Clin NNP work_jyzsgzx6ozemtdrfjlhthibtsm 214 2 Chest Chest NNP work_jyzsgzx6ozemtdrfjlhthibtsm 214 3 Med Med NNP work_jyzsgzx6ozemtdrfjlhthibtsm 214 4 2012:32:669–692 2012:32:669–692 CD work_jyzsgzx6ozemtdrfjlhthibtsm 214 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 215 1 3 3 LS work_jyzsgzx6ozemtdrfjlhthibtsm 215 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 216 1 AIRTUM AIRTUM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 216 2 Working Working NNP work_jyzsgzx6ozemtdrfjlhthibtsm 216 3 Group Group NNP work_jyzsgzx6ozemtdrfjlhthibtsm 216 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 217 1 Italian italian JJ work_jyzsgzx6ozemtdrfjlhthibtsm 217 2 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 217 3 figures figure NNS work_jyzsgzx6ozemtdrfjlhthibtsm 217 4 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 217 5 report report NN work_jyzsgzx6ozemtdrfjlhthibtsm 217 6 2009 2009 CD work_jyzsgzx6ozemtdrfjlhthibtsm 217 7 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 217 8 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 217 9 trend trend NN work_jyzsgzx6ozemtdrfjlhthibtsm 217 10 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 217 11 1998–2005 1998–2005 CD work_jyzsgzx6ozemtdrfjlhthibtsm 217 12 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 217 13 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 218 1 Epidemiol Epidemiol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 218 2 Prev Prev NNP work_jyzsgzx6ozemtdrfjlhthibtsm 218 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 219 1 2009;33(XX 2009;33(xx CD work_jyzsgzx6ozemtdrfjlhthibtsm 219 2 Suppl Suppl NNP work_jyzsgzx6ozemtdrfjlhthibtsm 219 3 1):1–168 1):1–168 CD work_jyzsgzx6ozemtdrfjlhthibtsm 219 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 220 1 4 4 LS work_jyzsgzx6ozemtdrfjlhthibtsm 220 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 221 1 Howlander howlander NN work_jyzsgzx6ozemtdrfjlhthibtsm 221 2 N n CD work_jyzsgzx6ozemtdrfjlhthibtsm 221 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 221 4 Noone Noone NNP work_jyzsgzx6ozemtdrfjlhthibtsm 221 5 AM am NN work_jyzsgzx6ozemtdrfjlhthibtsm 221 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 221 7 Krapcho Krapcho NNP work_jyzsgzx6ozemtdrfjlhthibtsm 221 8 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 221 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 221 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 221 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 221 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 222 1 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 222 2 Eds Eds NNP work_jyzsgzx6ozemtdrfjlhthibtsm 222 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 222 4 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 223 1 SEER SEER NNP work_jyzsgzx6ozemtdrfjlhthibtsm 223 2 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 223 3 Statistics Statistics NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 223 4 Review Review NNP work_jyzsgzx6ozemtdrfjlhthibtsm 223 5 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 223 6 1975–2009 1975–2009 CD work_jyzsgzx6ozemtdrfjlhthibtsm 223 7 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 224 1 Bethesda Bethesda NNP work_jyzsgzx6ozemtdrfjlhthibtsm 224 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 224 3 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 224 4 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 224 5 National National NNP work_jyzsgzx6ozemtdrfjlhthibtsm 224 6 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 224 7 Institutehttp://seer Institutehttp://seer NNS work_jyzsgzx6ozemtdrfjlhthibtsm 224 8 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 225 1 cancer.gov/csr/1975_2009_pops09/. cancer.gov/csr/1975_2009_pops09/. NN work_jyzsgzx6ozemtdrfjlhthibtsm 226 1 Accessed access VBN work_jyzsgzx6ozemtdrfjlhthibtsm 226 2 April April NNP work_jyzsgzx6ozemtdrfjlhthibtsm 226 3 2012 2012 CD work_jyzsgzx6ozemtdrfjlhthibtsm 226 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 227 1 5 5 CD work_jyzsgzx6ozemtdrfjlhthibtsm 227 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 228 1 AIRTUM AIRTUM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 228 2 Working Working NNP work_jyzsgzx6ozemtdrfjlhthibtsm 228 3 Group Group NNP work_jyzsgzx6ozemtdrfjlhthibtsm 228 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 229 1 Italian italian JJ work_jyzsgzx6ozemtdrfjlhthibtsm 229 2 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 229 3 figures figure NNS work_jyzsgzx6ozemtdrfjlhthibtsm 229 4 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 229 5 report report VB work_jyzsgzx6ozemtdrfjlhthibtsm 229 6 2011 2011 CD work_jyzsgzx6ozemtdrfjlhthibtsm 229 7 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 229 8 survival survival NN work_jyzsgzx6ozemtdrfjlhthibtsm 229 9 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 229 10 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 229 11 patients patient NNS work_jyzsgzx6ozemtdrfjlhthibtsm 229 12 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 229 13 Italy Italy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 229 14 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 230 1 Epidemiol Epidemiol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 230 2 Prev Prev NNP work_jyzsgzx6ozemtdrfjlhthibtsm 230 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 231 1 2011;35:1–200 2011;35:1–200 CD work_jyzsgzx6ozemtdrfjlhthibtsm 231 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 232 1 6 6 CD work_jyzsgzx6ozemtdrfjlhthibtsm 232 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 233 1 Midthun Midthun NNP work_jyzsgzx6ozemtdrfjlhthibtsm 233 2 DE DE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 233 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 233 4 Jett Jett NNP work_jyzsgzx6ozemtdrfjlhthibtsm 233 5 JR JR NNP work_jyzsgzx6ozemtdrfjlhthibtsm 233 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 233 7 Ross Ross NNP work_jyzsgzx6ozemtdrfjlhthibtsm 233 8 ME ME NNP work_jyzsgzx6ozemtdrfjlhthibtsm 233 9 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 234 1 Overview overview NN work_jyzsgzx6ozemtdrfjlhthibtsm 234 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 234 3 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 234 4 risk risk NN work_jyzsgzx6ozemtdrfjlhthibtsm 234 5 factors factor NNS work_jyzsgzx6ozemtdrfjlhthibtsm 234 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 234 7 pathology pathology NN work_jyzsgzx6ozemtdrfjlhthibtsm 234 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 234 9 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 234 10 clinical clinical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 234 11 manifestations manifestation NNS work_jyzsgzx6ozemtdrfjlhthibtsm 234 12 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 234 13 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 234 14 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 234 15 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 235 1 2012 2012 CD work_jyzsgzx6ozemtdrfjlhthibtsm 235 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 236 1 Available available JJ work_jyzsgzx6ozemtdrfjlhthibtsm 236 2 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 236 3 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 236 4 http://www http://www ADD work_jyzsgzx6ozemtdrfjlhthibtsm 236 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 237 1 uptodate.com uptodate.com ADD work_jyzsgzx6ozemtdrfjlhthibtsm 237 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 238 1 Accessed access VBN work_jyzsgzx6ozemtdrfjlhthibtsm 238 2 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 238 3 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 238 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 239 1 Kubík Kubík NNP work_jyzsgzx6ozemtdrfjlhthibtsm 239 2 AK AK NNP work_jyzsgzx6ozemtdrfjlhthibtsm 239 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 239 4 Parkin Parkin NNP work_jyzsgzx6ozemtdrfjlhthibtsm 239 5 DM DM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 239 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 239 7 Zatloukal Zatloukal NNP work_jyzsgzx6ozemtdrfjlhthibtsm 239 8 P. P. NNP work_jyzsgzx6ozemtdrfjlhthibtsm 239 9 Czech Czech NNP work_jyzsgzx6ozemtdrfjlhthibtsm 239 10 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 239 11 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 239 12 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 239 13 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 239 14 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 239 15 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 239 16 post post JJ work_jyzsgzx6ozemtdrfjlhthibtsm 239 17 - - JJ work_jyzsgzx6ozemtdrfjlhthibtsm 239 18 trial trial JJ work_jyzsgzx6ozemtdrfjlhthibtsm 239 19 follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 239 20 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 239 21 up up NN work_jyzsgzx6ozemtdrfjlhthibtsm 239 22 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 239 23 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 239 24 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 239 25 deaths death NNS work_jyzsgzx6ozemtdrfjlhthibtsm 239 26 up up IN work_jyzsgzx6ozemtdrfjlhthibtsm 239 27 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 239 28 year year NN work_jyzsgzx6ozemtdrfjlhthibtsm 239 29 15 15 CD work_jyzsgzx6ozemtdrfjlhthibtsm 239 30 since since IN work_jyzsgzx6ozemtdrfjlhthibtsm 239 31 enrollment enrollment NN work_jyzsgzx6ozemtdrfjlhthibtsm 239 32 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 240 1 Cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 240 2 2000;89(11 2000;89(11 CD work_jyzsgzx6ozemtdrfjlhthibtsm 240 3 Suppl):2363–2368 suppl):2363–2368 IN work_jyzsgzx6ozemtdrfjlhthibtsm 240 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 241 1 8 8 LS work_jyzsgzx6ozemtdrfjlhthibtsm 241 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 242 1 Parkin Parkin NNP work_jyzsgzx6ozemtdrfjlhthibtsm 242 2 DM DM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 242 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 242 4 Moss Moss NNP work_jyzsgzx6ozemtdrfjlhthibtsm 242 5 SM SM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 242 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 243 1 Lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 243 2 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 243 3 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 243 4 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 243 5 improved improved JJ work_jyzsgzx6ozemtdrfjlhthibtsm 243 6 survival survival NN work_jyzsgzx6ozemtdrfjlhthibtsm 243 7 but but CC work_jyzsgzx6ozemtdrfjlhthibtsm 243 8 no no DT work_jyzsgzx6ozemtdrfjlhthibtsm 243 9 reduction reduction NN work_jyzsgzx6ozemtdrfjlhthibtsm 243 10 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 243 11 deaths death NNS work_jyzsgzx6ozemtdrfjlhthibtsm 243 12 – – : work_jyzsgzx6ozemtdrfjlhthibtsm 243 13 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 243 14 role role NN work_jyzsgzx6ozemtdrfjlhthibtsm 243 15 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 243 16 “ " `` work_jyzsgzx6ozemtdrfjlhthibtsm 243 17 overdiagnosis overdiagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 243 18 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 243 19 ” " '' work_jyzsgzx6ozemtdrfjlhthibtsm 243 20 Cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 243 21 2000;89(11 2000;89(11 CD work_jyzsgzx6ozemtdrfjlhthibtsm 243 22 Suppl):2369–2376 suppl):2369–2376 NN work_jyzsgzx6ozemtdrfjlhthibtsm 243 23 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 244 1 9 9 CD work_jyzsgzx6ozemtdrfjlhthibtsm 244 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 245 1 Marcus Marcus NNP work_jyzsgzx6ozemtdrfjlhthibtsm 245 2 PM PM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 245 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 245 4 Bergstralh Bergstralh NNP work_jyzsgzx6ozemtdrfjlhthibtsm 245 5 EJ EJ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 245 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 245 7 Zweig Zweig NNP work_jyzsgzx6ozemtdrfjlhthibtsm 245 8 MH MH NNP work_jyzsgzx6ozemtdrfjlhthibtsm 245 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 245 10 Harris Harris NNP work_jyzsgzx6ozemtdrfjlhthibtsm 245 11 A A NNP work_jyzsgzx6ozemtdrfjlhthibtsm 245 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 245 13 Offord Offord NNP work_jyzsgzx6ozemtdrfjlhthibtsm 245 14 KP KP NNP work_jyzsgzx6ozemtdrfjlhthibtsm 245 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 245 16 Fontana Fontana NNP work_jyzsgzx6ozemtdrfjlhthibtsm 245 17 RS RS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 245 18 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 246 1 Extended extended JJ work_jyzsgzx6ozemtdrfjlhthibtsm 246 2 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 246 3 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 246 4 incidence incidence NN work_jyzsgzx6ozemtdrfjlhthibtsm 246 5 follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 246 6 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 246 7 up up NN work_jyzsgzx6ozemtdrfjlhthibtsm 246 8 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 246 9 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 246 10 Mayo Mayo NNP work_jyzsgzx6ozemtdrfjlhthibtsm 246 11 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 246 12 Project Project NNP work_jyzsgzx6ozemtdrfjlhthibtsm 246 13 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 246 14 overdiagnosis overdiagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 246 15 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 247 1 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 247 2 Natl Natl NNP work_jyzsgzx6ozemtdrfjlhthibtsm 247 3 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 247 4 Inst Inst NNP work_jyzsgzx6ozemtdrfjlhthibtsm 247 5 2006;98:748–756 2006;98:748–756 CD work_jyzsgzx6ozemtdrfjlhthibtsm 247 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 248 1 10 10 CD work_jyzsgzx6ozemtdrfjlhthibtsm 248 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 249 1 Oken Oken NNP work_jyzsgzx6ozemtdrfjlhthibtsm 249 2 MM MM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 249 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 249 4 Hocking Hocking NNP work_jyzsgzx6ozemtdrfjlhthibtsm 249 5 WG WG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 249 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 249 7 Kvale Kvale NNP work_jyzsgzx6ozemtdrfjlhthibtsm 249 8 PA PA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 249 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 249 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 249 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 249 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 250 1 Screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 250 2 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 250 3 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 250 4 radiograph radiograph NN work_jyzsgzx6ozemtdrfjlhthibtsm 250 5 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 250 6 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 250 7 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 250 8 mortality mortality NN work_jyzsgzx6ozemtdrfjlhthibtsm 250 9 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 251 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 251 2 Prostate Prostate NNP work_jyzsgzx6ozemtdrfjlhthibtsm 251 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 251 4 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 251 5 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 251 6 Colorectal Colorectal NNP work_jyzsgzx6ozemtdrfjlhthibtsm 251 7 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 251 8 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 251 9 Ovarian Ovarian NNP work_jyzsgzx6ozemtdrfjlhthibtsm 251 10 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 251 11 PLCO PLCO NNP work_jyzsgzx6ozemtdrfjlhthibtsm 251 12 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 251 13 randomized randomize VBD work_jyzsgzx6ozemtdrfjlhthibtsm 251 14 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 251 15 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 252 1 JAMA JAMA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 252 2 2011;306:1865–1873 2011;306:1865–1873 CD work_jyzsgzx6ozemtdrfjlhthibtsm 252 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 253 1 11 11 CD work_jyzsgzx6ozemtdrfjlhthibtsm 253 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 254 1 Henschke Henschke NNP work_jyzsgzx6ozemtdrfjlhthibtsm 254 2 CI CI NNP work_jyzsgzx6ozemtdrfjlhthibtsm 254 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 254 4 McCauley McCauley NNP work_jyzsgzx6ozemtdrfjlhthibtsm 254 5 DI DI NNP work_jyzsgzx6ozemtdrfjlhthibtsm 254 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 254 7 Yankelevitz Yankelevitz NNP work_jyzsgzx6ozemtdrfjlhthibtsm 254 8 DF DF NNP work_jyzsgzx6ozemtdrfjlhthibtsm 254 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 254 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 254 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 254 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 255 1 Early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 255 2 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 255 3 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 255 4 Action Action NNP work_jyzsgzx6ozemtdrfjlhthibtsm 255 5 Project Project NNP work_jyzsgzx6ozemtdrfjlhthibtsm 255 6 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 255 7 overall overall JJ work_jyzsgzx6ozemtdrfjlhthibtsm 255 8 design design NN work_jyzsgzx6ozemtdrfjlhthibtsm 255 9 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 255 10 findings finding NNS work_jyzsgzx6ozemtdrfjlhthibtsm 255 11 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 255 12 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 255 13 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 255 14 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 256 1 Lancet Lancet NNP work_jyzsgzx6ozemtdrfjlhthibtsm 256 2 1999;354:99–105 1999;354:99–105 CD work_jyzsgzx6ozemtdrfjlhthibtsm 256 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 257 1 12 12 CD work_jyzsgzx6ozemtdrfjlhthibtsm 257 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 258 1 Bach Bach NNP work_jyzsgzx6ozemtdrfjlhthibtsm 258 2 PB PB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 258 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 258 4 Mirkin Mirkin NNP work_jyzsgzx6ozemtdrfjlhthibtsm 258 5 JN JN NNP work_jyzsgzx6ozemtdrfjlhthibtsm 258 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 258 7 Oliver Oliver NNP work_jyzsgzx6ozemtdrfjlhthibtsm 258 8 TK TK NNP work_jyzsgzx6ozemtdrfjlhthibtsm 258 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 258 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 258 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 258 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 259 1 Benefits benefit NNS work_jyzsgzx6ozemtdrfjlhthibtsm 259 2 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 259 3 harms harm NNS work_jyzsgzx6ozemtdrfjlhthibtsm 259 4 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 259 5 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 259 6 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 259 7 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 259 8 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 259 9 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 259 10 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 259 11 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 259 12 systematic systematic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 259 13 review review NN work_jyzsgzx6ozemtdrfjlhthibtsm 259 14 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 260 1 JAMA JAMA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 260 2 2012;307:2418–2429 2012;307:2418–2429 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 260 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 261 1 13 13 CD work_jyzsgzx6ozemtdrfjlhthibtsm 261 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 261 3 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 261 4 Early Early NNP work_jyzsgzx6ozemtdrfjlhthibtsm 261 5 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 261 6 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 261 7 Action Action NNP work_jyzsgzx6ozemtdrfjlhthibtsm 261 8 Program Program NNP work_jyzsgzx6ozemtdrfjlhthibtsm 261 9 Investigators Investigators NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 261 10 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 262 1 Survival survival NN work_jyzsgzx6ozemtdrfjlhthibtsm 262 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 262 3 patients patient NNS work_jyzsgzx6ozemtdrfjlhthibtsm 262 4 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 262 5 stage stage NN work_jyzsgzx6ozemtdrfjlhthibtsm 262 6 I -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 262 7 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 262 8 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 262 9 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 262 10 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 262 11 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 262 12 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 262 13 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 263 1 N N NNP work_jyzsgzx6ozemtdrfjlhthibtsm 263 2 Engl Engl NNP work_jyzsgzx6ozemtdrfjlhthibtsm 263 3 J j NN work_jyzsgzx6ozemtdrfjlhthibtsm 263 4 Med Med NNP work_jyzsgzx6ozemtdrfjlhthibtsm 263 5 2006;355:1763–1771 2006;355:1763–1771 CD work_jyzsgzx6ozemtdrfjlhthibtsm 263 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 264 1 14 14 CD work_jyzsgzx6ozemtdrfjlhthibtsm 264 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 265 1 Patz Patz NNP work_jyzsgzx6ozemtdrfjlhthibtsm 265 2 EF EF NNP work_jyzsgzx6ozemtdrfjlhthibtsm 265 3 Jr Jr NNP work_jyzsgzx6ozemtdrfjlhthibtsm 265 4 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 265 5 Goodman Goodman NNP work_jyzsgzx6ozemtdrfjlhthibtsm 265 6 PC PC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 265 7 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 265 8 Bepler Bepler NNP work_jyzsgzx6ozemtdrfjlhthibtsm 265 9 G. G. NNP work_jyzsgzx6ozemtdrfjlhthibtsm 265 10 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 265 11 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 265 12 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 265 13 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 265 14 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 266 1 N N NNP work_jyzsgzx6ozemtdrfjlhthibtsm 266 2 Engl Engl NNP work_jyzsgzx6ozemtdrfjlhthibtsm 266 3 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 266 4 Med Med NNP work_jyzsgzx6ozemtdrfjlhthibtsm 266 5 2000;343:1627–1633 2000;343:1627–1633 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 266 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 267 1 15 15 CD work_jyzsgzx6ozemtdrfjlhthibtsm 267 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 268 1 Bach Bach NNP work_jyzsgzx6ozemtdrfjlhthibtsm 268 2 PB PB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 268 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 268 4 Jett Jett NNP work_jyzsgzx6ozemtdrfjlhthibtsm 268 5 JR JR NNP work_jyzsgzx6ozemtdrfjlhthibtsm 268 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 268 7 Pastorino Pastorino NNP work_jyzsgzx6ozemtdrfjlhthibtsm 268 8 U U NNP work_jyzsgzx6ozemtdrfjlhthibtsm 268 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 268 10 Tockman Tockman NNP work_jyzsgzx6ozemtdrfjlhthibtsm 268 11 MS MS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 268 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 268 13 Swensen Swensen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 268 14 SJ SJ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 268 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 268 16 Begg Begg NNP work_jyzsgzx6ozemtdrfjlhthibtsm 268 17 CB CB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 268 18 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 269 1 Computed compute VBN work_jyzsgzx6ozemtdrfjlhthibtsm 269 2 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 269 3 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 269 4 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 269 5 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 269 6 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 269 7 outcomes outcome NNS work_jyzsgzx6ozemtdrfjlhthibtsm 269 8 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 270 1 JAMA JAMA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 270 2 2007;297:953–961 2007;297:953–961 CD work_jyzsgzx6ozemtdrfjlhthibtsm 270 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 271 1 16 16 CD work_jyzsgzx6ozemtdrfjlhthibtsm 271 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 272 1 Paci Paci NNP work_jyzsgzx6ozemtdrfjlhthibtsm 272 2 E. E. NNP work_jyzsgzx6ozemtdrfjlhthibtsm 272 3 Observational Observational NNP work_jyzsgzx6ozemtdrfjlhthibtsm 272 4 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 272 5 one one CD work_jyzsgzx6ozemtdrfjlhthibtsm 272 6 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 272 7 arm arm NN work_jyzsgzx6ozemtdrfjlhthibtsm 272 8 studies study NNS work_jyzsgzx6ozemtdrfjlhthibtsm 272 9 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 272 10 randomized randomized JJ work_jyzsgzx6ozemtdrfjlhthibtsm 272 11 population population NN work_jyzsgzx6ozemtdrfjlhthibtsm 272 12 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 272 13 based base VBN work_jyzsgzx6ozemtdrfjlhthibtsm 272 14 trials trial NNS work_jyzsgzx6ozemtdrfjlhthibtsm 272 15 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 272 16 evaluation evaluation NN work_jyzsgzx6ozemtdrfjlhthibtsm 272 17 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 272 18 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 272 19 efficacy efficacy NN work_jyzsgzx6ozemtdrfjlhthibtsm 272 20 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 272 21 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 272 22 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 272 23 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 272 24 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 273 1 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 273 2 Thorac Thorac NNP work_jyzsgzx6ozemtdrfjlhthibtsm 273 3 Oncol Oncol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 273 4 2007;2(5 2007;2(5 VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 273 5 Suppl):S45–S46 Suppl):S45–S46 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 273 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 274 1 17 17 CD work_jyzsgzx6ozemtdrfjlhthibtsm 274 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 275 1 Gohagan Gohagan NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 2 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 275 4 Marcus Marcus NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 5 P P NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 275 7 Fagerstrom Fagerstrom NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 8 R R NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 275 10 Pinsky Pinsky NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 11 P P NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 275 13 Kramer Kramer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 14 B B NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 275 16 Prorok Prorok NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 17 P P NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 18 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 275 19 Writing Writing NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 20 Committee Committee NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 21 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 275 22 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 23 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 24 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 25 Research Research NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 26 Group Group NNP work_jyzsgzx6ozemtdrfjlhthibtsm 275 27 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 276 1 Baseline baseline JJ work_jyzsgzx6ozemtdrfjlhthibtsm 276 2 findings finding NNS work_jyzsgzx6ozemtdrfjlhthibtsm 276 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 276 4 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 276 5 randomized randomized JJ work_jyzsgzx6ozemtdrfjlhthibtsm 276 6 feasibility feasibility NN work_jyzsgzx6ozemtdrfjlhthibtsm 276 7 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 276 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 276 9 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 276 10 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 276 11 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 276 12 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 276 13 spiral spiral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 276 14 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 276 15 scan scan NNP work_jyzsgzx6ozemtdrfjlhthibtsm 276 16 vs vs IN work_jyzsgzx6ozemtdrfjlhthibtsm 276 17 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 276 18 radiograph radiograph NN work_jyzsgzx6ozemtdrfjlhthibtsm 276 19 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 276 20 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 276 21 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 276 22 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 276 23 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 276 24 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 276 25 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 276 26 National National NNP work_jyzsgzx6ozemtdrfjlhthibtsm 276 27 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 276 28 Institute Institute NNP work_jyzsgzx6ozemtdrfjlhthibtsm 276 29 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 277 1 Chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 277 2 2004;126:114–121 2004;126:114–121 CD work_jyzsgzx6ozemtdrfjlhthibtsm 277 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 278 1 18 18 CD work_jyzsgzx6ozemtdrfjlhthibtsm 278 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 279 1 Pastorino pastorino JJ work_jyzsgzx6ozemtdrfjlhthibtsm 279 2 U U NNP work_jyzsgzx6ozemtdrfjlhthibtsm 279 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 279 4 Rossi Rossi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 279 5 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 279 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 279 7 Rosato Rosato NNP work_jyzsgzx6ozemtdrfjlhthibtsm 279 8 V V NNP work_jyzsgzx6ozemtdrfjlhthibtsm 279 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 279 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 279 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 279 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 280 1 Annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 280 2 or or CC work_jyzsgzx6ozemtdrfjlhthibtsm 280 3 biennial biennial JJ work_jyzsgzx6ozemtdrfjlhthibtsm 280 4 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 280 5 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 280 6 versus versus FW work_jyzsgzx6ozemtdrfjlhthibtsm 280 7 observation observation NN work_jyzsgzx6ozemtdrfjlhthibtsm 280 8 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 280 9 heavy heavy JJ work_jyzsgzx6ozemtdrfjlhthibtsm 280 10 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 280 11 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 280 12 5-year 5-year CD work_jyzsgzx6ozemtdrfjlhthibtsm 280 13 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 280 14 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 280 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 280 16 MILD MILD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 280 17 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 280 18 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 281 1 Eur Eur NNP work_jyzsgzx6ozemtdrfjlhthibtsm 281 2 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 281 3 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 281 4 Prev Prev NNP work_jyzsgzx6ozemtdrfjlhthibtsm 281 5 2012;21:308–315 2012;21:308–315 CD work_jyzsgzx6ozemtdrfjlhthibtsm 281 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 282 1 19 19 CD work_jyzsgzx6ozemtdrfjlhthibtsm 282 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 282 3 van van NNP work_jyzsgzx6ozemtdrfjlhthibtsm 282 4 Iersel Iersel NNP work_jyzsgzx6ozemtdrfjlhthibtsm 282 5 CA CA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 282 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 282 7 de de NNP work_jyzsgzx6ozemtdrfjlhthibtsm 282 8 Koning Koning NNP work_jyzsgzx6ozemtdrfjlhthibtsm 282 9 HJ HJ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 282 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 282 11 Draisma Draisma NNP work_jyzsgzx6ozemtdrfjlhthibtsm 282 12 G G NNP work_jyzsgzx6ozemtdrfjlhthibtsm 282 13 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 282 14 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 282 15 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 282 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 283 1 Risk risk NN work_jyzsgzx6ozemtdrfjlhthibtsm 283 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 283 3 based base VBN work_jyzsgzx6ozemtdrfjlhthibtsm 283 4 selection selection NN work_jyzsgzx6ozemtdrfjlhthibtsm 283 5 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 283 6 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 283 7 general general JJ work_jyzsgzx6ozemtdrfjlhthibtsm 283 8 population population NN work_jyzsgzx6ozemtdrfjlhthibtsm 283 9 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 283 10 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 283 11 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 283 12 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 283 13 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 283 14 selection selection NN work_jyzsgzx6ozemtdrfjlhthibtsm 283 15 criteria criterion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 283 16 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 283 17 recruitment recruitment NN work_jyzsgzx6ozemtdrfjlhthibtsm 283 18 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 283 19 power power NN work_jyzsgzx6ozemtdrfjlhthibtsm 283 20 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 283 21 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 283 22 Dutch dutch JJ work_jyzsgzx6ozemtdrfjlhthibtsm 283 23 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 283 24 Belgian belgian JJ work_jyzsgzx6ozemtdrfjlhthibtsm 283 25 randomised randomise VBN work_jyzsgzx6ozemtdrfjlhthibtsm 283 26 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 283 27 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 283 28 multi multi JJ work_jyzsgzx6ozemtdrfjlhthibtsm 283 29 - - JJ work_jyzsgzx6ozemtdrfjlhthibtsm 283 30 slice slice JJ work_jyzsgzx6ozemtdrfjlhthibtsm 283 31 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 283 32 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 283 33 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 283 34 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 283 35 NELSON NELSON NNP work_jyzsgzx6ozemtdrfjlhthibtsm 283 36 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 283 37 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 284 1 Int Int NNP work_jyzsgzx6ozemtdrfjlhthibtsm 284 2 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 284 3 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 284 4 2007;120:868–874 2007;120:868–874 CD work_jyzsgzx6ozemtdrfjlhthibtsm 284 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 285 1 20 20 CD work_jyzsgzx6ozemtdrfjlhthibtsm 285 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 286 1 Lopes Lopes NNP work_jyzsgzx6ozemtdrfjlhthibtsm 286 2 Pegna Pegna NNP work_jyzsgzx6ozemtdrfjlhthibtsm 286 3 A A NNP work_jyzsgzx6ozemtdrfjlhthibtsm 286 4 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 286 5 Picozzi Picozzi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 286 6 G G NNP work_jyzsgzx6ozemtdrfjlhthibtsm 286 7 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 286 8 Mascalchi Mascalchi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 286 9 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 286 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 286 11 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 286 12 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 286 13 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 287 1 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 287 2 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 287 3 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 287 4 Research Research NNP work_jyzsgzx6ozemtdrfjlhthibtsm 287 5 Group Group NNP work_jyzsgzx6ozemtdrfjlhthibtsm 287 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 288 1 Design design NN work_jyzsgzx6ozemtdrfjlhthibtsm 288 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 288 3 recruitment recruitment NN work_jyzsgzx6ozemtdrfjlhthibtsm 288 4 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 288 5 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 288 6 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 288 7 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 288 8 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 288 9 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 288 10 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 288 11 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 288 12 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 288 13 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 288 14 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 288 15 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 288 16 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 288 17 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 288 18 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 288 19 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 288 20 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 289 1 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 289 2 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 289 3 2009;64:34–40 2009;64:34–40 CD work_jyzsgzx6ozemtdrfjlhthibtsm 289 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 290 1 21 21 CD work_jyzsgzx6ozemtdrfjlhthibtsm 290 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 291 1 Infante Infante NNP work_jyzsgzx6ozemtdrfjlhthibtsm 291 2 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 291 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 291 4 Lutman Lutman NNP work_jyzsgzx6ozemtdrfjlhthibtsm 291 5 FR FR NNP work_jyzsgzx6ozemtdrfjlhthibtsm 291 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 291 7 Cavuto Cavuto NNP work_jyzsgzx6ozemtdrfjlhthibtsm 291 8 S S NNP work_jyzsgzx6ozemtdrfjlhthibtsm 291 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 291 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 291 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 291 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 292 1 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 292 2 DANTE DANTE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 292 3 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 292 4 Group Group NNP work_jyzsgzx6ozemtdrfjlhthibtsm 292 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 293 1 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 293 2 can- can- NN work_jyzsgzx6ozemtdrfjlhthibtsm 293 3 cer cer NN work_jyzsgzx6ozemtdrfjlhthibtsm 293 4 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 293 5 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 293 6 spiral spiral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 293 7 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 293 8 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 293 9 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 293 10 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 293 11 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 293 12 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 293 13 randomized randomized JJ work_jyzsgzx6ozemtdrfjlhthibtsm 293 14 DANTE DANTE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 293 15 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 293 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 294 1 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 294 2 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 294 3 2008;59:355–363 2008;59:355–363 VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 294 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 295 1 22 22 CD work_jyzsgzx6ozemtdrfjlhthibtsm 295 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 296 1 Pedersen Pedersen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 296 2 JH JH NNP work_jyzsgzx6ozemtdrfjlhthibtsm 296 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 296 4 Ashraf Ashraf NNP work_jyzsgzx6ozemtdrfjlhthibtsm 296 5 H H NNP work_jyzsgzx6ozemtdrfjlhthibtsm 296 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 296 7 Dirksen Dirksen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 296 8 A A NNP work_jyzsgzx6ozemtdrfjlhthibtsm 296 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 296 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 296 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 296 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 297 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 297 2 Danish Danish NNP work_jyzsgzx6ozemtdrfjlhthibtsm 297 3 randomized randomized JJ work_jyzsgzx6ozemtdrfjlhthibtsm 297 4 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 297 5 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 297 6 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 297 7 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 297 8 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 297 9 – – : work_jyzsgzx6ozemtdrfjlhthibtsm 297 10 overall overall JJ work_jyzsgzx6ozemtdrfjlhthibtsm 297 11 design design NN work_jyzsgzx6ozemtdrfjlhthibtsm 297 12 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 297 13 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 297 14 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 297 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 297 16 prevalence prevalence NN work_jyzsgzx6ozemtdrfjlhthibtsm 297 17 round round RB work_jyzsgzx6ozemtdrfjlhthibtsm 297 18 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 298 1 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 298 2 Thorac Thorac NNP work_jyzsgzx6ozemtdrfjlhthibtsm 298 3 Oncol Oncol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 298 4 2009;4:608–614 2009;4:608–614 CD work_jyzsgzx6ozemtdrfjlhthibtsm 298 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 299 1 23 23 CD work_jyzsgzx6ozemtdrfjlhthibtsm 299 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 300 1 Croswell Croswell NNP work_jyzsgzx6ozemtdrfjlhthibtsm 300 2 JM JM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 300 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 300 4 Baker Baker NNP work_jyzsgzx6ozemtdrfjlhthibtsm 300 5 SG SG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 300 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 300 7 Marcus Marcus NNP work_jyzsgzx6ozemtdrfjlhthibtsm 300 8 PM PM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 300 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 300 10 Clapp Clapp NNP work_jyzsgzx6ozemtdrfjlhthibtsm 300 11 JD JD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 300 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 300 13 Kramer Kramer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 300 14 BS BS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 300 15 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 301 1 Cumulative cumulative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 301 2 incidence incidence NN work_jyzsgzx6ozemtdrfjlhthibtsm 301 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 301 4 false false JJ work_jyzsgzx6ozemtdrfjlhthibtsm 301 5 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 301 6 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 301 7 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 301 8 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 301 9 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 301 10 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 301 11 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 301 12 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 301 13 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 301 14 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 301 15 ran- ran- RB work_jyzsgzx6ozemtdrfjlhthibtsm 301 16 domized domize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 301 17 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 301 18 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 302 1 Ann Ann NNP work_jyzsgzx6ozemtdrfjlhthibtsm 302 2 Intern Intern NNP work_jyzsgzx6ozemtdrfjlhthibtsm 302 3 Med Med NNP work_jyzsgzx6ozemtdrfjlhthibtsm 302 4 2010;152:505–12 2010;152:505–12 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 302 5 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 302 6 W176 W176 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 302 7 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 303 1 24 24 CD work_jyzsgzx6ozemtdrfjlhthibtsm 303 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 304 1 Becker Becker NNP work_jyzsgzx6ozemtdrfjlhthibtsm 304 2 N N NNP work_jyzsgzx6ozemtdrfjlhthibtsm 304 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 304 4 Motsch Motsch NNP work_jyzsgzx6ozemtdrfjlhthibtsm 304 5 E E NNP work_jyzsgzx6ozemtdrfjlhthibtsm 304 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 304 7 Gross Gross NNP work_jyzsgzx6ozemtdrfjlhthibtsm 304 8 ML ML NNP work_jyzsgzx6ozemtdrfjlhthibtsm 304 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 304 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 304 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 304 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 305 1 Randomized randomized JJ work_jyzsgzx6ozemtdrfjlhthibtsm 305 2 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 305 3 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 305 4 early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 305 5 detec- detec- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 305 6 tion tion NN work_jyzsgzx6ozemtdrfjlhthibtsm 305 7 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 305 8 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 305 9 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 305 10 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 305 11 MSCT MSCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 305 12 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 305 13 Germany Germany NNP work_jyzsgzx6ozemtdrfjlhthibtsm 305 14 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 305 15 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 305 16 design design NN work_jyzsgzx6ozemtdrfjlhthibtsm 305 17 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 305 18 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 305 19 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 305 20 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 305 21 first first JJ work_jyzsgzx6ozemtdrfjlhthibtsm 305 22 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 305 23 round round NN work_jyzsgzx6ozemtdrfjlhthibtsm 305 24 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 306 1 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 306 2 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 306 3 Res Res NNP work_jyzsgzx6ozemtdrfjlhthibtsm 306 4 Clin Clin NNP work_jyzsgzx6ozemtdrfjlhthibtsm 306 5 Oncol Oncol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 306 6 2012;138:1475–1486 2012;138:1475–1486 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 306 7 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 307 1 25 25 CD work_jyzsgzx6ozemtdrfjlhthibtsm 307 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 308 1 Baldwin Baldwin NNP work_jyzsgzx6ozemtdrfjlhthibtsm 308 2 DR DR NNP work_jyzsgzx6ozemtdrfjlhthibtsm 308 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 308 4 Duffy Duffy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 308 5 SW SW NNP work_jyzsgzx6ozemtdrfjlhthibtsm 308 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 308 7 Wald Wald NNP work_jyzsgzx6ozemtdrfjlhthibtsm 308 8 NJ NJ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 308 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 308 10 Page Page NNP work_jyzsgzx6ozemtdrfjlhthibtsm 308 11 R R NNP work_jyzsgzx6ozemtdrfjlhthibtsm 308 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 308 13 Hansell Hansell NNP work_jyzsgzx6ozemtdrfjlhthibtsm 308 14 DM DM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 308 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 308 16 Field field NN work_jyzsgzx6ozemtdrfjlhthibtsm 308 17 JK jk NN work_jyzsgzx6ozemtdrfjlhthibtsm 308 18 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 309 1 UK UK NNP work_jyzsgzx6ozemtdrfjlhthibtsm 309 2 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 309 3 Screen Screen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 309 4 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 309 5 UKLS UKLS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 309 6 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 309 7 nodule nodule VBP work_jyzsgzx6ozemtdrfjlhthibtsm 309 8 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 309 9 protocol protocol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 309 10 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 309 11 modelling modelling NN work_jyzsgzx6ozemtdrfjlhthibtsm 309 12 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 309 13 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 309 14 single single JJ work_jyzsgzx6ozemtdrfjlhthibtsm 309 15 screen screen NN work_jyzsgzx6ozemtdrfjlhthibtsm 309 16 randomised randomise VBN work_jyzsgzx6ozemtdrfjlhthibtsm 309 17 controlled controlled JJ work_jyzsgzx6ozemtdrfjlhthibtsm 309 18 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 309 19 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 309 20 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 309 21 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 309 22 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 309 23 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 309 24 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 309 25 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 309 26 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 309 27 can- can- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 309 28 cer cer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 309 29 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 310 1 Thorax Thorax NNP work_jyzsgzx6ozemtdrfjlhthibtsm 310 2 2011;66:308–313 2011;66:308–313 CD work_jyzsgzx6ozemtdrfjlhthibtsm 310 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 311 1 26 26 CD work_jyzsgzx6ozemtdrfjlhthibtsm 311 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 312 1 National National NNP work_jyzsgzx6ozemtdrfjlhthibtsm 312 2 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 312 3 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 312 4 Trial Trial NNP work_jyzsgzx6ozemtdrfjlhthibtsm 312 5 Research Research NNP work_jyzsgzx6ozemtdrfjlhthibtsm 312 6 Team Team NNP work_jyzsgzx6ozemtdrfjlhthibtsm 312 7 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 313 1 Baseline baseline JJ work_jyzsgzx6ozemtdrfjlhthibtsm 313 2 characteristics characteristic NNS work_jyzsgzx6ozemtdrfjlhthibtsm 313 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 313 4 participants participant NNS work_jyzsgzx6ozemtdrfjlhthibtsm 313 5 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 313 6 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 313 7 randomized randomized JJ work_jyzsgzx6ozemtdrfjlhthibtsm 313 8 national national JJ work_jyzsgzx6ozemtdrfjlhthibtsm 313 9 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 313 10 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 313 11 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 313 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 314 1 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 314 2 Natl Natl NNP work_jyzsgzx6ozemtdrfjlhthibtsm 314 3 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 314 4 Inst Inst NNP work_jyzsgzx6ozemtdrfjlhthibtsm 314 5 2010;102(23):1771–1779 2010;102(23):1771–1779 CD work_jyzsgzx6ozemtdrfjlhthibtsm 314 6 27 27 CD work_jyzsgzx6ozemtdrfjlhthibtsm 314 7 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 315 1 National National NNP work_jyzsgzx6ozemtdrfjlhthibtsm 315 2 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 315 3 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 315 4 Trial Trial NNP work_jyzsgzx6ozemtdrfjlhthibtsm 315 5 Research Research NNP work_jyzsgzx6ozemtdrfjlhthibtsm 315 6 Team Team NNP work_jyzsgzx6ozemtdrfjlhthibtsm 315 7 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 316 1 Reduced reduce VBN work_jyzsgzx6ozemtdrfjlhthibtsm 316 2 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 316 3 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 316 4 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 316 5 mortality mortality NN work_jyzsgzx6ozemtdrfjlhthibtsm 316 6 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 316 7 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 316 8 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 316 9 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 316 10 computed compute VBN work_jyzsgzx6ozemtdrfjlhthibtsm 316 11 tomographic tomographic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 316 12 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 316 13 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 317 1 N N NNP work_jyzsgzx6ozemtdrfjlhthibtsm 317 2 Engl Engl NNP work_jyzsgzx6ozemtdrfjlhthibtsm 317 3 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 317 4 Med Med NNP work_jyzsgzx6ozemtdrfjlhthibtsm 317 5 2011;365:395–409 2011;365:395–409 NN work_jyzsgzx6ozemtdrfjlhthibtsm 317 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 318 1 28 28 CD work_jyzsgzx6ozemtdrfjlhthibtsm 318 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 319 1 Sox Sox NNP work_jyzsgzx6ozemtdrfjlhthibtsm 319 2 HC HC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 319 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 320 1 Better well JJR work_jyzsgzx6ozemtdrfjlhthibtsm 320 2 evidence evidence NN work_jyzsgzx6ozemtdrfjlhthibtsm 320 3 about about IN work_jyzsgzx6ozemtdrfjlhthibtsm 320 4 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 320 5 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 320 6 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 320 7 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 320 8 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 321 1 N N NNP work_jyzsgzx6ozemtdrfjlhthibtsm 321 2 Engl Engl NNP work_jyzsgzx6ozemtdrfjlhthibtsm 321 3 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 321 4 Med Med NNP work_jyzsgzx6ozemtdrfjlhthibtsm 321 5 2011;365:455–457 2011;365:455–457 CD work_jyzsgzx6ozemtdrfjlhthibtsm 321 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 322 1 Accessed access VBN work_jyzsgzx6ozemtdrfjlhthibtsm 322 2 December December NNP work_jyzsgzx6ozemtdrfjlhthibtsm 322 3 28 28 CD work_jyzsgzx6ozemtdrfjlhthibtsm 322 4 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 322 5 2012 2012 CD work_jyzsgzx6ozemtdrfjlhthibtsm 322 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 323 1 29 29 CD work_jyzsgzx6ozemtdrfjlhthibtsm 323 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 324 1 Wood wood NN work_jyzsgzx6ozemtdrfjlhthibtsm 324 2 DE DE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 324 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 325 1 Maximizing maximize VBG work_jyzsgzx6ozemtdrfjlhthibtsm 325 2 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 325 3 benefit benefit NN work_jyzsgzx6ozemtdrfjlhthibtsm 325 4 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 325 5 minimizing minimize VBG work_jyzsgzx6ozemtdrfjlhthibtsm 325 6 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 325 7 risks risk NNS work_jyzsgzx6ozemtdrfjlhthibtsm 325 8 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 325 9 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 325 10 can- can- NN work_jyzsgzx6ozemtdrfjlhthibtsm 325 11 cer cer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 325 12 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 325 13 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 326 1 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 326 2 Thorac Thorac NNP work_jyzsgzx6ozemtdrfjlhthibtsm 326 3 Imaging Imaging NNP work_jyzsgzx6ozemtdrfjlhthibtsm 326 4 2012;27:211–212 2012;27:211–212 CD work_jyzsgzx6ozemtdrfjlhthibtsm 326 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 327 1 30 30 CD work_jyzsgzx6ozemtdrfjlhthibtsm 327 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 328 1 Zompatori Zompatori NNP work_jyzsgzx6ozemtdrfjlhthibtsm 328 2 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 328 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 328 4 Mascalchi Mascalchi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 328 5 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 328 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 328 7 Ciccarese Ciccarese NNP work_jyzsgzx6ozemtdrfjlhthibtsm 328 8 F F NNP work_jyzsgzx6ozemtdrfjlhthibtsm 328 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 328 10 Sverzellati Sverzellati NNP work_jyzsgzx6ozemtdrfjlhthibtsm 328 11 N N NNP work_jyzsgzx6ozemtdrfjlhthibtsm 328 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 328 13 Pastorino Pastorino NNP work_jyzsgzx6ozemtdrfjlhthibtsm 328 14 U. U. NNP work_jyzsgzx6ozemtdrfjlhthibtsm 329 1 Screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 329 2 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 329 3 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 329 4 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 329 5 using use VBG work_jyzsgzx6ozemtdrfjlhthibtsm 329 6 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 329 7 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 329 8 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 329 9 spiral spiral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 329 10 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 329 11 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 329 12 10 10 CD work_jyzsgzx6ozemtdrfjlhthibtsm 329 13 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 329 14 later later RB work_jyzsgzx6ozemtdrfjlhthibtsm 329 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 329 16 state state NN work_jyzsgzx6ozemtdrfjlhthibtsm 329 17 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 329 18 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 329 19 art art NN work_jyzsgzx6ozemtdrfjlhthibtsm 329 20 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 330 1 Radiol Radiol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 330 2 Med Med NNP work_jyzsgzx6ozemtdrfjlhthibtsm 330 3 2013;118:51–61 2013;118:51–61 CD work_jyzsgzx6ozemtdrfjlhthibtsm 330 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 331 1 31 31 CD work_jyzsgzx6ozemtdrfjlhthibtsm 331 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 332 1 American American NNP work_jyzsgzx6ozemtdrfjlhthibtsm 332 2 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 332 3 Association Association NNP work_jyzsgzx6ozemtdrfjlhthibtsm 332 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 333 1 Providing provide VBG work_jyzsgzx6ozemtdrfjlhthibtsm 333 2 guidance guidance NN work_jyzsgzx6ozemtdrfjlhthibtsm 333 3 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 333 4 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 333 5 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 333 6 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 333 7 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 333 8 patients patient NNS work_jyzsgzx6ozemtdrfjlhthibtsm 333 9 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 333 10 physicians physician NNS work_jyzsgzx6ozemtdrfjlhthibtsm 333 11 April April NNP work_jyzsgzx6ozemtdrfjlhthibtsm 333 12 23 23 CD work_jyzsgzx6ozemtdrfjlhthibtsm 333 13 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 333 14 2012 2012 CD work_jyzsgzx6ozemtdrfjlhthibtsm 333 15 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 334 1 Available available JJ work_jyzsgzx6ozemtdrfjlhthibtsm 334 2 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 334 3 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 334 4 http://www http://www ADD work_jyzsgzx6ozemtdrfjlhthibtsm 334 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 335 1 lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/ lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 335 2 Accessed Accessed NNP work_jyzsgzx6ozemtdrfjlhthibtsm 335 3 April April NNP work_jyzsgzx6ozemtdrfjlhthibtsm 335 4 23 23 CD work_jyzsgzx6ozemtdrfjlhthibtsm 335 5 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 335 6 2012 2012 CD work_jyzsgzx6ozemtdrfjlhthibtsm 335 7 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 336 1 32 32 CD work_jyzsgzx6ozemtdrfjlhthibtsm 336 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 337 1 NCCN NCCN NNP work_jyzsgzx6ozemtdrfjlhthibtsm 337 2 Clinical Clinical NNP work_jyzsgzx6ozemtdrfjlhthibtsm 337 3 Practice practice NN work_jyzsgzx6ozemtdrfjlhthibtsm 337 4 Guidelines Guidelines NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 337 5 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 337 6 Oncology Oncology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 337 7 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 338 1 Lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 338 2 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 338 3 screen- screen- NN work_jyzsgzx6ozemtdrfjlhthibtsm 338 4 ing ing NNP work_jyzsgzx6ozemtdrfjlhthibtsm 338 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 339 1 Version version NN work_jyzsgzx6ozemtdrfjlhthibtsm 339 2 1.2013 1.2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 339 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 340 1 Available available JJ work_jyzsgzx6ozemtdrfjlhthibtsm 340 2 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 340 3 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 340 4 http://www.nccn.org http://www.nccn.org NNP work_jyzsgzx6ozemtdrfjlhthibtsm 340 5 Accessed Accessed NNP work_jyzsgzx6ozemtdrfjlhthibtsm 340 6 June June NNP work_jyzsgzx6ozemtdrfjlhthibtsm 340 7 15 15 CD work_jyzsgzx6ozemtdrfjlhthibtsm 340 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 340 9 2012 2012 CD work_jyzsgzx6ozemtdrfjlhthibtsm 340 10 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 341 1 33 33 CD work_jyzsgzx6ozemtdrfjlhthibtsm 341 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 342 1 Infante Infante NNP work_jyzsgzx6ozemtdrfjlhthibtsm 342 2 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 342 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 342 4 Cavuto Cavuto NNP work_jyzsgzx6ozemtdrfjlhthibtsm 342 5 S S NNP work_jyzsgzx6ozemtdrfjlhthibtsm 342 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 342 7 Lutman Lutman NNP work_jyzsgzx6ozemtdrfjlhthibtsm 342 8 FR FR NNP work_jyzsgzx6ozemtdrfjlhthibtsm 342 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 342 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 342 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 342 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 343 1 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 343 2 DANTE DANTE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 343 3 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 343 4 Group Group NNP work_jyzsgzx6ozemtdrfjlhthibtsm 343 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 344 1 A a DT work_jyzsgzx6ozemtdrfjlhthibtsm 344 2 ran- ran- RB work_jyzsgzx6ozemtdrfjlhthibtsm 344 3 domized domize VBN work_jyzsgzx6ozemtdrfjlhthibtsm 344 4 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 344 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 344 6 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 344 7 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 344 8 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 344 9 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 344 10 spiral spiral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 344 11 computed compute VBD work_jyzsgzx6ozemtdrfjlhthibtsm 344 12 tomogra- tomogra- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 344 13 phy phy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 344 14 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 344 15 three three CD work_jyzsgzx6ozemtdrfjlhthibtsm 344 16 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 344 17 year year NN work_jyzsgzx6ozemtdrfjlhthibtsm 344 18 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 344 19 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 344 20 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 344 21 DANTE DANTE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 344 22 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 344 23 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 345 1 Am Am NNP work_jyzsgzx6ozemtdrfjlhthibtsm 345 2 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 345 3 Respir Respir NNP work_jyzsgzx6ozemtdrfjlhthibtsm 345 4 Crit Crit NNP work_jyzsgzx6ozemtdrfjlhthibtsm 345 5 Care Care NNP work_jyzsgzx6ozemtdrfjlhthibtsm 345 6 Med Med NNP work_jyzsgzx6ozemtdrfjlhthibtsm 345 7 2009;180:445–453 2009;180:445–453 CD work_jyzsgzx6ozemtdrfjlhthibtsm 345 8 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 346 1 34 34 CD work_jyzsgzx6ozemtdrfjlhthibtsm 346 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 347 1 Saghir Saghir NNP work_jyzsgzx6ozemtdrfjlhthibtsm 347 2 Z Z NNP work_jyzsgzx6ozemtdrfjlhthibtsm 347 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 347 4 Dirksen Dirksen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 347 5 A A NNP work_jyzsgzx6ozemtdrfjlhthibtsm 347 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 347 7 Ashraf Ashraf NNP work_jyzsgzx6ozemtdrfjlhthibtsm 347 8 H H NNP work_jyzsgzx6ozemtdrfjlhthibtsm 347 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 347 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 347 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 347 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 348 1 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 348 2 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 348 3 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 348 4 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 348 5 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 348 6 brings bring VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 348 7 forward forward RP work_jyzsgzx6ozemtdrfjlhthibtsm 348 8 early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 348 9 disease disease NN work_jyzsgzx6ozemtdrfjlhthibtsm 348 10 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 349 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 349 2 randomised randomised JJ work_jyzsgzx6ozemtdrfjlhthibtsm 349 3 Danish Danish NNP work_jyzsgzx6ozemtdrfjlhthibtsm 349 4 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 349 5 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 349 6 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 349 7 Trial Trial NNP work_jyzsgzx6ozemtdrfjlhthibtsm 349 8 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 349 9 status status NN work_jyzsgzx6ozemtdrfjlhthibtsm 349 10 after after IN work_jyzsgzx6ozemtdrfjlhthibtsm 349 11 five five CD work_jyzsgzx6ozemtdrfjlhthibtsm 349 12 annual annual JJ work_jyzsgzx6ozemtdrfjlhthibtsm 349 13 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 349 14 rounds round NNS work_jyzsgzx6ozemtdrfjlhthibtsm 349 15 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 349 16 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 349 17 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 349 18 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 349 19 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 349 20 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 349 21 Thorax Thorax NNP work_jyzsgzx6ozemtdrfjlhthibtsm 349 22 2012;67:296–301 2012;67:296–301 CD work_jyzsgzx6ozemtdrfjlhthibtsm 349 23 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 350 1 35 35 CD work_jyzsgzx6ozemtdrfjlhthibtsm 350 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 351 1 Henschke Henschke NNP work_jyzsgzx6ozemtdrfjlhthibtsm 351 2 CI CI NNP work_jyzsgzx6ozemtdrfjlhthibtsm 351 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 352 1 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 352 2 Early Early NNP work_jyzsgzx6ozemtdrfjlhthibtsm 352 3 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 352 4 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 352 5 Action Action NNP work_jyzsgzx6ozemtdrfjlhthibtsm 352 6 Program Program NNP work_jyzsgzx6ozemtdrfjlhthibtsm 352 7 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 352 8 enrol- enrol- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 352 9 ment ment NN work_jyzsgzx6ozemtdrfjlhthibtsm 352 10 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 352 11 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 352 12 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 352 13 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 353 1 Available available JJ work_jyzsgzx6ozemtdrfjlhthibtsm 353 2 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 353 3 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 353 4 http://www.IELCAP.org http://www.ielcap.org ADD work_jyzsgzx6ozemtdrfjlhthibtsm 353 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 354 1 Accessed Accessed NNP work_jyzsgzx6ozemtdrfjlhthibtsm 354 2 March March NNP work_jyzsgzx6ozemtdrfjlhthibtsm 354 3 17 17 CD work_jyzsgzx6ozemtdrfjlhthibtsm 354 4 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 354 5 2004 2004 CD work_jyzsgzx6ozemtdrfjlhthibtsm 354 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 355 1 36 36 CD work_jyzsgzx6ozemtdrfjlhthibtsm 355 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 356 1 Xu Xu NNP work_jyzsgzx6ozemtdrfjlhthibtsm 356 2 DM DM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 356 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 356 4 Gietema Gietema NNP work_jyzsgzx6ozemtdrfjlhthibtsm 356 5 H H NNP work_jyzsgzx6ozemtdrfjlhthibtsm 356 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 356 7 de de NNP work_jyzsgzx6ozemtdrfjlhthibtsm 356 8 Koning Koning NNP work_jyzsgzx6ozemtdrfjlhthibtsm 356 9 H H NNP work_jyzsgzx6ozemtdrfjlhthibtsm 356 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 356 11 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 356 12 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 356 13 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 357 1 Nodule nodule IN work_jyzsgzx6ozemtdrfjlhthibtsm 357 2 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 357 3 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 357 4 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 357 5 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 357 6 NELSON NELSON NNP work_jyzsgzx6ozemtdrfjlhthibtsm 357 7 randomised randomise VBN work_jyzsgzx6ozemtdrfjlhthibtsm 357 8 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 357 9 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 357 10 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 357 11 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 357 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 358 1 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 358 2 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 358 3 2006;54:177–184 2006;54:177–184 CD work_jyzsgzx6ozemtdrfjlhthibtsm 358 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 359 1 37 37 CD work_jyzsgzx6ozemtdrfjlhthibtsm 359 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 360 1 Ashraf Ashraf NNP work_jyzsgzx6ozemtdrfjlhthibtsm 360 2 H H NNP work_jyzsgzx6ozemtdrfjlhthibtsm 360 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 360 4 Dirksen Dirksen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 360 5 A A NNP work_jyzsgzx6ozemtdrfjlhthibtsm 360 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 360 7 Loft Loft NNP work_jyzsgzx6ozemtdrfjlhthibtsm 360 8 A A NNP work_jyzsgzx6ozemtdrfjlhthibtsm 360 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 360 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 360 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 360 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 361 1 Combined combine VBN work_jyzsgzx6ozemtdrfjlhthibtsm 361 2 use use NN work_jyzsgzx6ozemtdrfjlhthibtsm 361 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 361 4 positron positron JJ work_jyzsgzx6ozemtdrfjlhthibtsm 361 5 emission emission NN work_jyzsgzx6ozemtdrfjlhthibtsm 361 6 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 361 7 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 361 8 volume volume NN work_jyzsgzx6ozemtdrfjlhthibtsm 361 9 doubling double VBG work_jyzsgzx6ozemtdrfjlhthibtsm 361 10 time time NN work_jyzsgzx6ozemtdrfjlhthibtsm 361 11 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 361 12 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 361 13 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 361 14 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 361 15 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 361 16 low- low- NN work_jyzsgzx6ozemtdrfjlhthibtsm 361 17 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 361 18 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 361 19 scanning scanning NN work_jyzsgzx6ozemtdrfjlhthibtsm 361 20 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 362 1 Thorax Thorax NNP work_jyzsgzx6ozemtdrfjlhthibtsm 362 2 2011;66:315–319 2011;66:315–319 CD work_jyzsgzx6ozemtdrfjlhthibtsm 362 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 363 1 38 38 CD work_jyzsgzx6ozemtdrfjlhthibtsm 363 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 364 1 Gohagan gohagan JJ work_jyzsgzx6ozemtdrfjlhthibtsm 364 2 JK jk NN work_jyzsgzx6ozemtdrfjlhthibtsm 364 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 364 4 Marcus Marcus NNP work_jyzsgzx6ozemtdrfjlhthibtsm 364 5 PM PM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 364 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 364 7 Fagerstrom Fagerstrom NNP work_jyzsgzx6ozemtdrfjlhthibtsm 364 8 RM RM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 364 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 364 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 364 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 364 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 365 1 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 365 2 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 365 3 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 365 4 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 365 5 Research Research NNP work_jyzsgzx6ozemtdrfjlhthibtsm 365 6 Group Group NNP work_jyzsgzx6ozemtdrfjlhthibtsm 365 7 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 366 1 Final final JJ work_jyzsgzx6ozemtdrfjlhthibtsm 366 2 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 366 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 366 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 366 5 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 366 6 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 366 7 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 366 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 366 9 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 366 10 random- random- VBG work_jyzsgzx6ozemtdrfjlhthibtsm 366 11 ized ized JJ work_jyzsgzx6ozemtdrfjlhthibtsm 366 12 feasibility feasibility NN work_jyzsgzx6ozemtdrfjlhthibtsm 366 13 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 366 14 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 366 15 spiral spiral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 366 16 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 366 17 versus versus IN work_jyzsgzx6ozemtdrfjlhthibtsm 366 18 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 366 19 X x NN work_jyzsgzx6ozemtdrfjlhthibtsm 366 20 - - NN work_jyzsgzx6ozemtdrfjlhthibtsm 366 21 ray ray NN work_jyzsgzx6ozemtdrfjlhthibtsm 366 22 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 366 23 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 366 24 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 366 25 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 366 26 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 367 1 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 367 2 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 367 3 2005;47:9–15 2005;47:9–15 CD work_jyzsgzx6ozemtdrfjlhthibtsm 367 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 368 1 39 39 CD work_jyzsgzx6ozemtdrfjlhthibtsm 368 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 369 1 Field field NN work_jyzsgzx6ozemtdrfjlhthibtsm 369 2 JK JK NNP work_jyzsgzx6ozemtdrfjlhthibtsm 369 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 369 4 Smith Smith NNP work_jyzsgzx6ozemtdrfjlhthibtsm 369 5 RA RA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 369 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 369 7 Duffy Duffy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 369 8 SW SW NNP work_jyzsgzx6ozemtdrfjlhthibtsm 369 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 369 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 369 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 369 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 370 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 370 2 Liverpool Liverpool NNP work_jyzsgzx6ozemtdrfjlhthibtsm 370 3 Statement Statement NNP work_jyzsgzx6ozemtdrfjlhthibtsm 370 4 2005 2005 CD work_jyzsgzx6ozemtdrfjlhthibtsm 370 5 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 370 6 priorities priority NNS work_jyzsgzx6ozemtdrfjlhthibtsm 370 7 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 370 8 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 370 9 European European NNP work_jyzsgzx6ozemtdrfjlhthibtsm 370 10 Union Union NNP work_jyzsgzx6ozemtdrfjlhthibtsm 370 11 / / SYM work_jyzsgzx6ozemtdrfjlhthibtsm 370 12 United United NNP work_jyzsgzx6ozemtdrfjlhthibtsm 370 13 States States NNP work_jyzsgzx6ozemtdrfjlhthibtsm 370 14 spiral spiral NN work_jyzsgzx6ozemtdrfjlhthibtsm 370 15 computed compute VBD work_jyzsgzx6ozemtdrfjlhthibtsm 370 16 tomog- tomog- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 370 17 raphy raphy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 370 18 collaborative collaborative JJ work_jyzsgzx6ozemtdrfjlhthibtsm 370 19 group group NN work_jyzsgzx6ozemtdrfjlhthibtsm 370 20 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 371 1 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 371 2 Thorac Thorac NNP work_jyzsgzx6ozemtdrfjlhthibtsm 371 3 Oncol Oncol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 371 4 2006;1:497–498 2006;1:497–498 CD work_jyzsgzx6ozemtdrfjlhthibtsm 371 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 372 1 40 40 CD work_jyzsgzx6ozemtdrfjlhthibtsm 372 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 373 1 Carozzi Carozzi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 373 2 FM FM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 373 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 373 4 Bisanzi Bisanzi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 373 5 S S NNP work_jyzsgzx6ozemtdrfjlhthibtsm 373 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 373 7 Falini Falini NNP work_jyzsgzx6ozemtdrfjlhthibtsm 373 8 P P NNP work_jyzsgzx6ozemtdrfjlhthibtsm 373 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 373 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 373 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 373 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 374 1 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 374 2 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 374 3 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 374 4 Research Research NNP work_jyzsgzx6ozemtdrfjlhthibtsm 374 5 Group Group NNP work_jyzsgzx6ozemtdrfjlhthibtsm 374 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 375 1 Molecular molecular JJ work_jyzsgzx6ozemtdrfjlhthibtsm 375 2 profile profile NN work_jyzsgzx6ozemtdrfjlhthibtsm 375 3 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 375 4 body body NN work_jyzsgzx6ozemtdrfjlhthibtsm 375 5 fluids fluid NNS work_jyzsgzx6ozemtdrfjlhthibtsm 375 6 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 375 7 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 375 8 enrolled enrol VBN work_jyzsgzx6ozemtdrfjlhthibtsm 375 9 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 375 10 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 375 11 randomised randomised JJ work_jyzsgzx6ozemtdrfjlhthibtsm 375 12 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 375 13 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 375 14 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 375 15 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 375 16 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 375 17 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 375 18 perspectives perspective NNS work_jyzsgzx6ozemtdrfjlhthibtsm 375 19 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 375 20 integrated integrate VBN work_jyzsgzx6ozemtdrfjlhthibtsm 375 21 strategies strategy NNS work_jyzsgzx6ozemtdrfjlhthibtsm 375 22 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 375 23 early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 375 24 diagnosis diagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 375 25 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 376 1 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 376 2 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 376 3 2010;68:216–221 2010;68:216–221 CD work_jyzsgzx6ozemtdrfjlhthibtsm 376 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 377 1 41 41 CD work_jyzsgzx6ozemtdrfjlhthibtsm 377 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 378 1 Wormanns Wormanns NNP work_jyzsgzx6ozemtdrfjlhthibtsm 378 2 D d NN work_jyzsgzx6ozemtdrfjlhthibtsm 378 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 378 4 Ludwig Ludwig NNP work_jyzsgzx6ozemtdrfjlhthibtsm 378 5 K K NNP work_jyzsgzx6ozemtdrfjlhthibtsm 378 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 378 7 Beyer Beyer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 378 8 F F NNP work_jyzsgzx6ozemtdrfjlhthibtsm 378 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 378 10 Heindel Heindel NNP work_jyzsgzx6ozemtdrfjlhthibtsm 378 11 W W NNP work_jyzsgzx6ozemtdrfjlhthibtsm 378 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 378 13 Diederich Diederich NNP work_jyzsgzx6ozemtdrfjlhthibtsm 378 14 S. S. NNP work_jyzsgzx6ozemtdrfjlhthibtsm 378 15 Detection Detection NNP work_jyzsgzx6ozemtdrfjlhthibtsm 378 16 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 378 17 pulmonary pulmonary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 378 18 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 378 19 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 378 20 multirow multirow NN work_jyzsgzx6ozemtdrfjlhthibtsm 378 21 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 378 22 detector detector NN work_jyzsgzx6ozemtdrfjlhthibtsm 378 23 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 378 24 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 378 25 effectiveness effectiveness NN work_jyzsgzx6ozemtdrfjlhthibtsm 378 26 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 378 27 double double JJ work_jyzsgzx6ozemtdrfjlhthibtsm 378 28 reading reading NN work_jyzsgzx6ozemtdrfjlhthibtsm 378 29 to to TO work_jyzsgzx6ozemtdrfjlhthibtsm 378 30 improve improve VB work_jyzsgzx6ozemtdrfjlhthibtsm 378 31 sensitivity sensitivity NN work_jyzsgzx6ozemtdrfjlhthibtsm 378 32 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 378 33 standard standard NN work_jyzsgzx6ozemtdrfjlhthibtsm 378 34 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 378 35 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 378 36 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 378 37 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 378 38 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 378 39 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 378 40 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 378 41 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 378 42 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 378 43 Eur Eur NNP work_jyzsgzx6ozemtdrfjlhthibtsm 378 44 Radiol Radiol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 378 45 2005;15:14–22 2005;15:14–22 CD work_jyzsgzx6ozemtdrfjlhthibtsm 378 46 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 379 1 42 42 CD work_jyzsgzx6ozemtdrfjlhthibtsm 379 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 380 1 Bastarrika Bastarrika NNP work_jyzsgzx6ozemtdrfjlhthibtsm 380 2 G G NNP work_jyzsgzx6ozemtdrfjlhthibtsm 380 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 380 4 García García NNP work_jyzsgzx6ozemtdrfjlhthibtsm 380 5 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 380 6 Velloso Velloso NNP work_jyzsgzx6ozemtdrfjlhthibtsm 380 7 MJ MJ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 380 8 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 380 9 Lozano Lozano NNP work_jyzsgzx6ozemtdrfjlhthibtsm 380 10 MD MD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 380 11 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 380 12 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 380 13 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 380 14 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 381 1 Early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 381 2 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 381 3 can- can- NN work_jyzsgzx6ozemtdrfjlhthibtsm 381 4 cer cer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 381 5 detection detection NN work_jyzsgzx6ozemtdrfjlhthibtsm 381 6 using use VBG work_jyzsgzx6ozemtdrfjlhthibtsm 381 7 spiral spiral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 381 8 computed compute VBD work_jyzsgzx6ozemtdrfjlhthibtsm 381 9 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 381 10 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 381 11 positron positron NNP work_jyzsgzx6ozemtdrfjlhthibtsm 381 12 emission emission NN work_jyzsgzx6ozemtdrfjlhthibtsm 381 13 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 381 14 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 382 1 Am Am NNP work_jyzsgzx6ozemtdrfjlhthibtsm 382 2 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 382 3 Respir Respir NNP work_jyzsgzx6ozemtdrfjlhthibtsm 382 4 Crit Crit NNP work_jyzsgzx6ozemtdrfjlhthibtsm 382 5 Care care VB work_jyzsgzx6ozemtdrfjlhthibtsm 382 6 Med Med NNP work_jyzsgzx6ozemtdrfjlhthibtsm 382 7 2005;171:1378–1383 2005;171:1378–1383 NNS work_jyzsgzx6ozemtdrfjlhthibtsm 382 8 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 383 1 43 43 CD work_jyzsgzx6ozemtdrfjlhthibtsm 383 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 384 1 Lindell Lindell NNP work_jyzsgzx6ozemtdrfjlhthibtsm 384 2 RM RM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 384 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 384 4 Hartman Hartman NNP work_jyzsgzx6ozemtdrfjlhthibtsm 384 5 TE TE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 384 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 384 7 Swensen Swensen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 384 8 SJ SJ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 384 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 384 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 384 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 384 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 385 1 Lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 385 2 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 385 3 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 385 4 expe- expe- XX work_jyzsgzx6ozemtdrfjlhthibtsm 385 5 rience rience NN work_jyzsgzx6ozemtdrfjlhthibtsm 385 6 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 385 7 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 385 8 retrospective retrospective JJ work_jyzsgzx6ozemtdrfjlhthibtsm 385 9 review review NN work_jyzsgzx6ozemtdrfjlhthibtsm 385 10 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 385 11 PET PET NNP work_jyzsgzx6ozemtdrfjlhthibtsm 385 12 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 385 13 22 22 CD work_jyzsgzx6ozemtdrfjlhthibtsm 385 14 non non JJ work_jyzsgzx6ozemtdrfjlhthibtsm 385 15 - - JJ work_jyzsgzx6ozemtdrfjlhthibtsm 385 16 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 385 17 cell cell NN work_jyzsgzx6ozemtdrfjlhthibtsm 385 18 lung lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 385 19 carcino- carcino- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 385 20 mas mas NNP work_jyzsgzx6ozemtdrfjlhthibtsm 385 21 detected detect VBD work_jyzsgzx6ozemtdrfjlhthibtsm 385 22 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 385 23 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 385 24 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 385 25 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 385 26 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 385 27 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 385 28 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 385 29 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 385 30 risk risk NN work_jyzsgzx6ozemtdrfjlhthibtsm 385 31 population population NN work_jyzsgzx6ozemtdrfjlhthibtsm 385 32 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 386 1 AJR AJR NNP work_jyzsgzx6ozemtdrfjlhthibtsm 386 2 Am Am NNP work_jyzsgzx6ozemtdrfjlhthibtsm 386 3 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 386 4 Roentgenol Roentgenol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 386 5 2005;185:126–131 2005;185:126–131 CD work_jyzsgzx6ozemtdrfjlhthibtsm 386 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 387 1 http://www.uptodate.com http://www.uptodate.com ADD work_jyzsgzx6ozemtdrfjlhthibtsm 387 2 http://www.uptodate.com http://www.uptodate.com ADD work_jyzsgzx6ozemtdrfjlhthibtsm 387 3 http://www.lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/ http://www.lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/ VB work_jyzsgzx6ozemtdrfjlhthibtsm 387 4 http://www.lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/ http://www.lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/ FW work_jyzsgzx6ozemtdrfjlhthibtsm 387 5 http://www.nccn.org http://www.nccn.org ADD work_jyzsgzx6ozemtdrfjlhthibtsm 387 6 http://www.IELCAP.org http://www.ielcap.org JJ work_jyzsgzx6ozemtdrfjlhthibtsm 387 7 875Copyright 875copyright CD work_jyzsgzx6ozemtdrfjlhthibtsm 387 8 © © CD work_jyzsgzx6ozemtdrfjlhthibtsm 387 9 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 387 10 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 387 11 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 387 12 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 387 13 Association Association NNP work_jyzsgzx6ozemtdrfjlhthibtsm 387 14 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 387 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 387 16 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 387 17 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 387 18 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 387 19 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 387 20 Journal Journal NNP work_jyzsgzx6ozemtdrfjlhthibtsm 387 21 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 387 22 Thoracic Thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 387 23 Oncology Oncology NNP work_jyzsgzx6ozemtdrfjlhthibtsm 387 24 ® ® NNP work_jyzsgzx6ozemtdrfjlhthibtsm 387 25     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 387 26 • • NN work_jyzsgzx6ozemtdrfjlhthibtsm 387 27     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 387 28 Volume volume NN work_jyzsgzx6ozemtdrfjlhthibtsm 387 29     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 387 30 8 8 CD work_jyzsgzx6ozemtdrfjlhthibtsm 387 31 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 387 32     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 387 33 Number number NN work_jyzsgzx6ozemtdrfjlhthibtsm 387 34     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 387 35 7 7 CD work_jyzsgzx6ozemtdrfjlhthibtsm 387 36 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 387 37     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 387 38 July July NNP work_jyzsgzx6ozemtdrfjlhthibtsm 387 39     _SP work_jyzsgzx6ozemtdrfjlhthibtsm 387 40 2013 2013 CD work_jyzsgzx6ozemtdrfjlhthibtsm 387 41 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 387 42 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 387 43 Nodule Nodule NNP work_jyzsgzx6ozemtdrfjlhthibtsm 387 44 Management Management NNP work_jyzsgzx6ozemtdrfjlhthibtsm 387 45 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 387 46 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 387 47 44 44 CD work_jyzsgzx6ozemtdrfjlhthibtsm 387 48 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 388 1 Vazquez Vazquez NNP work_jyzsgzx6ozemtdrfjlhthibtsm 388 2 MF MF NNP work_jyzsgzx6ozemtdrfjlhthibtsm 388 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 388 4 Flieder Flieder NNP work_jyzsgzx6ozemtdrfjlhthibtsm 388 5 DB DB NNP work_jyzsgzx6ozemtdrfjlhthibtsm 388 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 389 1 Small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 389 2 peripheral peripheral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 389 3 glandular glandular JJ work_jyzsgzx6ozemtdrfjlhthibtsm 389 4 lesions lesion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 389 5 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 389 6 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 389 7 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 389 8 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 389 9 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 389 10 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 389 11 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 389 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 390 1 A a DT work_jyzsgzx6ozemtdrfjlhthibtsm 390 2 diagnostic diagnostic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 390 3 dilemma dilemma NN work_jyzsgzx6ozemtdrfjlhthibtsm 390 4 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 390 5 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 390 6 pathologist pathologist NN work_jyzsgzx6ozemtdrfjlhthibtsm 390 7 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 391 1 Radiol Radiol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 391 2 Clin Clin NNP work_jyzsgzx6ozemtdrfjlhthibtsm 391 3 North North NNP work_jyzsgzx6ozemtdrfjlhthibtsm 391 4 Am Am NNP work_jyzsgzx6ozemtdrfjlhthibtsm 391 5 2000;38:579–589 2000;38:579–589 CD work_jyzsgzx6ozemtdrfjlhthibtsm 391 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 392 1 45 45 CD work_jyzsgzx6ozemtdrfjlhthibtsm 392 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 393 1 Vazquez Vazquez NNP work_jyzsgzx6ozemtdrfjlhthibtsm 393 2 MF MF NNP work_jyzsgzx6ozemtdrfjlhthibtsm 393 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 393 4 Koizumi Koizumi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 393 5 JH JH NNP work_jyzsgzx6ozemtdrfjlhthibtsm 393 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 393 7 Henschke Henschke NNP work_jyzsgzx6ozemtdrfjlhthibtsm 393 8 CI CI NNP work_jyzsgzx6ozemtdrfjlhthibtsm 393 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 393 10 Yankelevitz Yankelevitz NNP work_jyzsgzx6ozemtdrfjlhthibtsm 393 11 DF DF NNP work_jyzsgzx6ozemtdrfjlhthibtsm 393 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 394 1 Reliability reliability NN work_jyzsgzx6ozemtdrfjlhthibtsm 394 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 394 3 cytologic cytologic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 394 4 diagnosis diagnosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 394 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 394 6 early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 394 7 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 394 8 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 394 9 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 395 1 Cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 395 2 2007;111:252–258 2007;111:252–258 CD work_jyzsgzx6ozemtdrfjlhthibtsm 395 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 396 1 46 46 CD work_jyzsgzx6ozemtdrfjlhthibtsm 396 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 397 1 Picozzi Picozzi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 397 2 G G NNP work_jyzsgzx6ozemtdrfjlhthibtsm 397 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 397 4 Diciotti Diciotti NNP work_jyzsgzx6ozemtdrfjlhthibtsm 397 5 S S NNP work_jyzsgzx6ozemtdrfjlhthibtsm 397 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 397 7 Falchini Falchini NNP work_jyzsgzx6ozemtdrfjlhthibtsm 397 8 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 397 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 397 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 397 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 397 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 398 1 Operator operator NN work_jyzsgzx6ozemtdrfjlhthibtsm 398 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 398 3 dependent dependent JJ work_jyzsgzx6ozemtdrfjlhthibtsm 398 4 reproduc- reproduc- FW work_jyzsgzx6ozemtdrfjlhthibtsm 398 5 ibility ibility NN work_jyzsgzx6ozemtdrfjlhthibtsm 398 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 398 7 size size NN work_jyzsgzx6ozemtdrfjlhthibtsm 398 8 measurements measurement NNS work_jyzsgzx6ozemtdrfjlhthibtsm 398 9 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 398 10 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 398 11 phantoms phantom NNS work_jyzsgzx6ozemtdrfjlhthibtsm 398 12 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 398 13 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 398 14 nodules nodule VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 398 15 exam- exam- RB work_jyzsgzx6ozemtdrfjlhthibtsm 398 16 ined ine VBN work_jyzsgzx6ozemtdrfjlhthibtsm 398 17 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 398 18 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 398 19 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 398 20 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 398 21 thin thin JJ work_jyzsgzx6ozemtdrfjlhthibtsm 398 22 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 398 23 section section NN work_jyzsgzx6ozemtdrfjlhthibtsm 398 24 computed compute VBD work_jyzsgzx6ozemtdrfjlhthibtsm 398 25 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 398 26 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 399 1 Invest invest VB work_jyzsgzx6ozemtdrfjlhthibtsm 399 2 Radiol Radiol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 399 3 2006;41:831–839 2006;41:831–839 CD work_jyzsgzx6ozemtdrfjlhthibtsm 399 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 400 1 47 47 CD work_jyzsgzx6ozemtdrfjlhthibtsm 400 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 401 1 Libby Libby NNP work_jyzsgzx6ozemtdrfjlhthibtsm 401 2 DM DM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 401 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 401 4 Smith Smith NNP work_jyzsgzx6ozemtdrfjlhthibtsm 401 5 JP JP NNP work_jyzsgzx6ozemtdrfjlhthibtsm 401 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 401 7 Altorki Altorki NNP work_jyzsgzx6ozemtdrfjlhthibtsm 401 8 NK NK NNP work_jyzsgzx6ozemtdrfjlhthibtsm 401 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 401 10 Pasmantier Pasmantier NNP work_jyzsgzx6ozemtdrfjlhthibtsm 401 11 MW MW NNP work_jyzsgzx6ozemtdrfjlhthibtsm 401 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 401 13 Yankelevitz Yankelevitz NNP work_jyzsgzx6ozemtdrfjlhthibtsm 401 14 D D NNP work_jyzsgzx6ozemtdrfjlhthibtsm 401 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 401 16 Henschke Henschke NNP work_jyzsgzx6ozemtdrfjlhthibtsm 401 17 CI CI NNP work_jyzsgzx6ozemtdrfjlhthibtsm 401 18 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 402 1 Managing manage VBG work_jyzsgzx6ozemtdrfjlhthibtsm 402 2 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 402 3 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 402 4 pulmonary pulmonary NN work_jyzsgzx6ozemtdrfjlhthibtsm 402 5 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 402 6 discovered discover VBN work_jyzsgzx6ozemtdrfjlhthibtsm 402 7 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 402 8 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 402 9 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 403 1 Chest Chest NNP work_jyzsgzx6ozemtdrfjlhthibtsm 403 2 2004;125:1522–1529 2004;125:1522–1529 CD work_jyzsgzx6ozemtdrfjlhthibtsm 403 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 404 1 48 48 CD work_jyzsgzx6ozemtdrfjlhthibtsm 404 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 405 1 Travis Travis NNP work_jyzsgzx6ozemtdrfjlhthibtsm 405 2 WD WD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 405 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 405 4 Brambilla Brambilla NNP work_jyzsgzx6ozemtdrfjlhthibtsm 405 5 E E NNP work_jyzsgzx6ozemtdrfjlhthibtsm 405 6 Müller Müller NNP work_jyzsgzx6ozemtdrfjlhthibtsm 405 7 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 405 8 Hermelink Hermelink NNP work_jyzsgzx6ozemtdrfjlhthibtsm 405 9 HK HK NNP work_jyzsgzx6ozemtdrfjlhthibtsm 405 10 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 405 11 Harris Harris NNP work_jyzsgzx6ozemtdrfjlhthibtsm 405 12 CC CC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 405 13 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 405 14 Eds Eds NNP work_jyzsgzx6ozemtdrfjlhthibtsm 405 15 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 405 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 406 1 World World NNP work_jyzsgzx6ozemtdrfjlhthibtsm 406 2 Health Health NNP work_jyzsgzx6ozemtdrfjlhthibtsm 406 3 Organization Organization NNP work_jyzsgzx6ozemtdrfjlhthibtsm 406 4 Classification Classification NNP work_jyzsgzx6ozemtdrfjlhthibtsm 406 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 406 6 Tumours Tumours NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 406 7 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 407 1 Pathology pathology NN work_jyzsgzx6ozemtdrfjlhthibtsm 407 2 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 407 3 Genetics Genetics NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 407 4 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 407 5 Tumours tumour NNS work_jyzsgzx6ozemtdrfjlhthibtsm 407 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 407 7 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 407 8 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 407 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 407 10 pleura pleura NNP work_jyzsgzx6ozemtdrfjlhthibtsm 407 11 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 407 12 thymus thymus NN work_jyzsgzx6ozemtdrfjlhthibtsm 407 13 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 407 14 heart heart NN work_jyzsgzx6ozemtdrfjlhthibtsm 407 15 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 408 1 Lyon Lyon NNP work_jyzsgzx6ozemtdrfjlhthibtsm 408 2 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 408 3 France France NNP work_jyzsgzx6ozemtdrfjlhthibtsm 408 4 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 408 5 IARC IARC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 408 6 Press Press NNP work_jyzsgzx6ozemtdrfjlhthibtsm 408 7 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 408 8 2004 2004 CD work_jyzsgzx6ozemtdrfjlhthibtsm 408 9 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 409 1 49 49 CD work_jyzsgzx6ozemtdrfjlhthibtsm 409 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 410 1 Mascalchi Mascalchi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 410 2 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 410 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 410 4 Mazzoni Mazzoni NNP work_jyzsgzx6ozemtdrfjlhthibtsm 410 5 LN LN NNP work_jyzsgzx6ozemtdrfjlhthibtsm 410 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 410 7 Falchini Falchini NNP work_jyzsgzx6ozemtdrfjlhthibtsm 410 8 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 410 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 410 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 410 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 410 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 411 1 Dose dose VB work_jyzsgzx6ozemtdrfjlhthibtsm 411 2 exposure exposure NN work_jyzsgzx6ozemtdrfjlhthibtsm 411 3 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 411 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 411 5 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 411 6 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 411 7 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 411 8 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 411 9 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 411 10 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 411 11 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 411 12 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 411 13 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 411 14 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 411 15 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 411 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 411 17 Br Br NNP work_jyzsgzx6ozemtdrfjlhthibtsm 411 18 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 411 19 Radiol Radiol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 411 20 2012;85:1134–1139 2012;85:1134–1139 CD work_jyzsgzx6ozemtdrfjlhthibtsm 411 21 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 412 1 50 50 CD work_jyzsgzx6ozemtdrfjlhthibtsm 412 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 413 1 Giordano Giordano NNP work_jyzsgzx6ozemtdrfjlhthibtsm 413 2 L L NNP work_jyzsgzx6ozemtdrfjlhthibtsm 413 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 413 4 Giorgi Giorgi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 413 5 D D NNP work_jyzsgzx6ozemtdrfjlhthibtsm 413 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 413 7 Ventura Ventura NNP work_jyzsgzx6ozemtdrfjlhthibtsm 413 8 L L NNP work_jyzsgzx6ozemtdrfjlhthibtsm 413 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 413 10 Castagno Castagno NNP work_jyzsgzx6ozemtdrfjlhthibtsm 413 11 R R NNP work_jyzsgzx6ozemtdrfjlhthibtsm 413 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 413 13 Paci Paci NNP work_jyzsgzx6ozemtdrfjlhthibtsm 413 14 E E NNP work_jyzsgzx6ozemtdrfjlhthibtsm 413 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 413 16 Segnan Segnan NNP work_jyzsgzx6ozemtdrfjlhthibtsm 413 17 N. N. NNP work_jyzsgzx6ozemtdrfjlhthibtsm 413 18 Time Time NNP work_jyzsgzx6ozemtdrfjlhthibtsm 413 19 trends trend NNS work_jyzsgzx6ozemtdrfjlhthibtsm 413 20 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 413 21 process process NN work_jyzsgzx6ozemtdrfjlhthibtsm 413 22 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 413 23 impact impact NN work_jyzsgzx6ozemtdrfjlhthibtsm 413 24 indicators indicator NNS work_jyzsgzx6ozemtdrfjlhthibtsm 413 25 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 413 26 Italian italian JJ work_jyzsgzx6ozemtdrfjlhthibtsm 413 27 breast breast NN work_jyzsgzx6ozemtdrfjlhthibtsm 413 28 screen- screen- NN work_jyzsgzx6ozemtdrfjlhthibtsm 413 29 ing ing NN work_jyzsgzx6ozemtdrfjlhthibtsm 413 30 programmes programme NNS work_jyzsgzx6ozemtdrfjlhthibtsm 413 31 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 413 32 1999–2009 1999–2009 CD work_jyzsgzx6ozemtdrfjlhthibtsm 413 33 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 413 34 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 414 1 Epidemiol Epidemiol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 414 2 Prev Prev NNP work_jyzsgzx6ozemtdrfjlhthibtsm 414 3 2011;35(5–6 2011;35(5–6 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 414 4 Suppl Suppl NNP work_jyzsgzx6ozemtdrfjlhthibtsm 414 5 5):28–38 5):28–38 NNS work_jyzsgzx6ozemtdrfjlhthibtsm 414 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 415 1 51 51 CD work_jyzsgzx6ozemtdrfjlhthibtsm 415 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 416 1 Sali Sali NNP work_jyzsgzx6ozemtdrfjlhthibtsm 416 2 L L NNP work_jyzsgzx6ozemtdrfjlhthibtsm 416 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 416 4 Grazzini Grazzini NNP work_jyzsgzx6ozemtdrfjlhthibtsm 416 5 G G NNP work_jyzsgzx6ozemtdrfjlhthibtsm 416 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 416 7 Ventura Ventura NNP work_jyzsgzx6ozemtdrfjlhthibtsm 416 8 L L NNP work_jyzsgzx6ozemtdrfjlhthibtsm 416 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 416 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 416 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 416 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 417 1 Computed compute VBN work_jyzsgzx6ozemtdrfjlhthibtsm 417 2 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 417 3 colonography colonography NN work_jyzsgzx6ozemtdrfjlhthibtsm 417 4 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 417 5 subjects subject NNS work_jyzsgzx6ozemtdrfjlhthibtsm 417 6 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 417 7 positive positive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 417 8 faecal faecal JJ work_jyzsgzx6ozemtdrfjlhthibtsm 417 9 occult occult NN work_jyzsgzx6ozemtdrfjlhthibtsm 417 10 blood blood NN work_jyzsgzx6ozemtdrfjlhthibtsm 417 11 test test NN work_jyzsgzx6ozemtdrfjlhthibtsm 417 12 refusing refuse VBG work_jyzsgzx6ozemtdrfjlhthibtsm 417 13 optical optical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 417 14 colonos- colonos- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 417 15 copy copy NNP work_jyzsgzx6ozemtdrfjlhthibtsm 417 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 418 1 Digest Digest NNP work_jyzsgzx6ozemtdrfjlhthibtsm 418 2 Liver Liver NNP work_jyzsgzx6ozemtdrfjlhthibtsm 418 3 Dis Dis NNP work_jyzsgzx6ozemtdrfjlhthibtsm 418 4 December December NNP work_jyzsgzx6ozemtdrfjlhthibtsm 418 5 19 19 CD work_jyzsgzx6ozemtdrfjlhthibtsm 418 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 418 7 2012 2012 CD work_jyzsgzx6ozemtdrfjlhthibtsm 418 8 [ [ -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 418 9 Epub Epub NNP work_jyzsgzx6ozemtdrfjlhthibtsm 418 10 ahead ahead RB work_jyzsgzx6ozemtdrfjlhthibtsm 418 11 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 418 12 print print NN work_jyzsgzx6ozemtdrfjlhthibtsm 418 13 ] ] -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 418 14 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 419 1 52 52 CD work_jyzsgzx6ozemtdrfjlhthibtsm 419 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 420 1 Blanchon Blanchon NNP work_jyzsgzx6ozemtdrfjlhthibtsm 420 2 T T NNP work_jyzsgzx6ozemtdrfjlhthibtsm 420 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 420 4 Bréchot Bréchot NNP work_jyzsgzx6ozemtdrfjlhthibtsm 420 5 JM JM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 420 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 420 7 Grenier Grenier NNP work_jyzsgzx6ozemtdrfjlhthibtsm 420 8 PA PA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 420 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 420 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 420 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 420 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 421 1 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 421 2 Dépiscan Dépiscan NNP work_jyzsgzx6ozemtdrfjlhthibtsm 421 3 Group Group NNP work_jyzsgzx6ozemtdrfjlhthibtsm 421 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 422 1 Baseline baseline JJ work_jyzsgzx6ozemtdrfjlhthibtsm 422 2 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 422 3 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 422 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 422 5 Depiscan depiscan JJ work_jyzsgzx6ozemtdrfjlhthibtsm 422 6 study study NN work_jyzsgzx6ozemtdrfjlhthibtsm 422 7 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 422 8 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 422 9 French French NNP work_jyzsgzx6ozemtdrfjlhthibtsm 422 10 randomized randomized JJ work_jyzsgzx6ozemtdrfjlhthibtsm 422 11 pilot pilot NN work_jyzsgzx6ozemtdrfjlhthibtsm 422 12 trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 422 13 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 422 14 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 422 15 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 422 16 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 422 17 comparing compare VBG work_jyzsgzx6ozemtdrfjlhthibtsm 422 18 low low NN work_jyzsgzx6ozemtdrfjlhthibtsm 422 19 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 422 20 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 422 21 scan scan NNP work_jyzsgzx6ozemtdrfjlhthibtsm 422 22 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 422 23 LDCT LDCT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 422 24 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 422 25 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 422 26 chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 422 27 X x NN work_jyzsgzx6ozemtdrfjlhthibtsm 422 28 - - NN work_jyzsgzx6ozemtdrfjlhthibtsm 422 29 ray ray NN work_jyzsgzx6ozemtdrfjlhthibtsm 422 30 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 422 31 CXR CXR NNP work_jyzsgzx6ozemtdrfjlhthibtsm 422 32 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 422 33 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 423 1 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 423 2 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 423 3 2007;58:50–58 2007;58:50–58 CD work_jyzsgzx6ozemtdrfjlhthibtsm 423 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 424 1 53 53 CD work_jyzsgzx6ozemtdrfjlhthibtsm 424 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 424 3 van van NNP work_jyzsgzx6ozemtdrfjlhthibtsm 424 4 Klaveren Klaveren NNP work_jyzsgzx6ozemtdrfjlhthibtsm 424 5 RJ RJ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 424 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 424 7 Oudkerk Oudkerk NNP work_jyzsgzx6ozemtdrfjlhthibtsm 424 8 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 424 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 424 10 Prokop Prokop NNP work_jyzsgzx6ozemtdrfjlhthibtsm 424 11 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 424 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 424 13 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 424 14 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 424 15 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 425 1 Management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 425 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 425 3 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 425 4 nod- nod- NN work_jyzsgzx6ozemtdrfjlhthibtsm 425 5 ules ule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 425 6 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 425 7 by by IN work_jyzsgzx6ozemtdrfjlhthibtsm 425 8 volume volume NN work_jyzsgzx6ozemtdrfjlhthibtsm 425 9 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 425 10 scanning scanning NN work_jyzsgzx6ozemtdrfjlhthibtsm 425 11 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 426 1 N N NNP work_jyzsgzx6ozemtdrfjlhthibtsm 426 2 Engl Engl NNP work_jyzsgzx6ozemtdrfjlhthibtsm 426 3 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 426 4 Med Med NNP work_jyzsgzx6ozemtdrfjlhthibtsm 426 5 2009;361:2221–2229 2009;361:2221–2229 CD work_jyzsgzx6ozemtdrfjlhthibtsm 426 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 427 1 54 54 CD work_jyzsgzx6ozemtdrfjlhthibtsm 427 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 428 1 MacRedmond MacRedmond NNP work_jyzsgzx6ozemtdrfjlhthibtsm 428 2 R R NNP work_jyzsgzx6ozemtdrfjlhthibtsm 428 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 428 4 McVey McVey NNP work_jyzsgzx6ozemtdrfjlhthibtsm 428 5 G G NNP work_jyzsgzx6ozemtdrfjlhthibtsm 428 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 428 7 Lee Lee NNP work_jyzsgzx6ozemtdrfjlhthibtsm 428 8 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 428 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 428 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 428 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 428 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 429 1 Screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 429 2 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 429 3 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 429 4 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 429 5 using use VBG work_jyzsgzx6ozemtdrfjlhthibtsm 429 6 low low JJ work_jyzsgzx6ozemtdrfjlhthibtsm 429 7 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 429 8 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 429 9 scanning scanning NN work_jyzsgzx6ozemtdrfjlhthibtsm 429 10 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 429 11 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 429 12 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 429 13 2 2 CD work_jyzsgzx6ozemtdrfjlhthibtsm 429 14 year year NN work_jyzsgzx6ozemtdrfjlhthibtsm 429 15 follow follow VB work_jyzsgzx6ozemtdrfjlhthibtsm 429 16 up up RP work_jyzsgzx6ozemtdrfjlhthibtsm 429 17 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 430 1 Thorax thorax NN work_jyzsgzx6ozemtdrfjlhthibtsm 430 2 2006;61:54–56 2006;61:54–56 CD work_jyzsgzx6ozemtdrfjlhthibtsm 430 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 431 1 55 55 CD work_jyzsgzx6ozemtdrfjlhthibtsm 431 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 432 1 Patz Patz NNP work_jyzsgzx6ozemtdrfjlhthibtsm 432 2 EF EF NNP work_jyzsgzx6ozemtdrfjlhthibtsm 432 3 Jr Jr NNP work_jyzsgzx6ozemtdrfjlhthibtsm 432 4 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 432 5 Swensen Swensen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 432 6 SJ SJ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 432 7 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 432 8 Herndon Herndon NNP work_jyzsgzx6ozemtdrfjlhthibtsm 432 9 JE JE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 432 10 2nd 2nd NN work_jyzsgzx6ozemtdrfjlhthibtsm 432 11 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 433 1 Estimate estimate NN work_jyzsgzx6ozemtdrfjlhthibtsm 433 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 433 3 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 433 4 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 433 5 mortality mortality NN work_jyzsgzx6ozemtdrfjlhthibtsm 433 6 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 433 7 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 433 8 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 433 9 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 433 10 spiral spiral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 433 11 computed compute VBD work_jyzsgzx6ozemtdrfjlhthibtsm 433 12 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 433 13 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 433 14 trials trial NNS work_jyzsgzx6ozemtdrfjlhthibtsm 433 15 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 433 16 implications implication NNS work_jyzsgzx6ozemtdrfjlhthibtsm 433 17 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 433 18 current current JJ work_jyzsgzx6ozemtdrfjlhthibtsm 433 19 mass mass NN work_jyzsgzx6ozemtdrfjlhthibtsm 433 20 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 433 21 recommendations recommendation NNS work_jyzsgzx6ozemtdrfjlhthibtsm 433 22 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 434 1 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 434 2 Clin Clin NNP work_jyzsgzx6ozemtdrfjlhthibtsm 434 3 Oncol Oncol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 434 4 2004;22:2202–2206 2004;22:2202–2206 CD work_jyzsgzx6ozemtdrfjlhthibtsm 434 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 435 1 56 56 CD work_jyzsgzx6ozemtdrfjlhthibtsm 435 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 436 1 Swensen Swensen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 436 2 SJ SJ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 436 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 436 4 Jett Jett NNP work_jyzsgzx6ozemtdrfjlhthibtsm 436 5 JR JR NNP work_jyzsgzx6ozemtdrfjlhthibtsm 436 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 436 7 Hartman Hartman NNP work_jyzsgzx6ozemtdrfjlhthibtsm 436 8 TE TE NNP work_jyzsgzx6ozemtdrfjlhthibtsm 436 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 436 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 436 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 436 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 437 1 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 437 2 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 437 3 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 437 4 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 437 5 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 437 6 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 437 7 five five CD work_jyzsgzx6ozemtdrfjlhthibtsm 437 8 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 437 9 year year NN work_jyzsgzx6ozemtdrfjlhthibtsm 437 10 prospective prospective JJ work_jyzsgzx6ozemtdrfjlhthibtsm 437 11 experience experience NN work_jyzsgzx6ozemtdrfjlhthibtsm 437 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 438 1 Radiology radiology NN work_jyzsgzx6ozemtdrfjlhthibtsm 438 2 2005;235:259–265 2005;235:259–265 CD work_jyzsgzx6ozemtdrfjlhthibtsm 438 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 439 1 57 57 CD work_jyzsgzx6ozemtdrfjlhthibtsm 439 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 440 1 Das Das NNP work_jyzsgzx6ozemtdrfjlhthibtsm 440 2 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 440 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 440 4 Mühlenbruch Mühlenbruch NNP work_jyzsgzx6ozemtdrfjlhthibtsm 440 5 G g NN work_jyzsgzx6ozemtdrfjlhthibtsm 440 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 440 7 Mahnken Mahnken NNP work_jyzsgzx6ozemtdrfjlhthibtsm 440 8 AH AH NNP work_jyzsgzx6ozemtdrfjlhthibtsm 440 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 440 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 440 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 440 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 441 1 Asbestos Asbestos NNP work_jyzsgzx6ozemtdrfjlhthibtsm 441 2 Surveillance Surveillance NNP work_jyzsgzx6ozemtdrfjlhthibtsm 441 3 Program Program NNP work_jyzsgzx6ozemtdrfjlhthibtsm 441 4 Aachen Aachen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 441 5 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 441 6 ASPA ASPA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 441 7 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 441 8 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 441 9 initial initial JJ work_jyzsgzx6ozemtdrfjlhthibtsm 441 10 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 441 11 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 441 12 baseline baseline NN work_jyzsgzx6ozemtdrfjlhthibtsm 441 13 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 441 14 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 441 15 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 441 16 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 441 17 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 441 18 asbestos asbestos NN work_jyzsgzx6ozemtdrfjlhthibtsm 441 19 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 441 20 exposed expose VBN work_jyzsgzx6ozemtdrfjlhthibtsm 441 21 high high JJ work_jyzsgzx6ozemtdrfjlhthibtsm 441 22 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 441 23 risk risk NN work_jyzsgzx6ozemtdrfjlhthibtsm 441 24 individuals individual NNS work_jyzsgzx6ozemtdrfjlhthibtsm 441 25 using use VBG work_jyzsgzx6ozemtdrfjlhthibtsm 441 26 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 441 27 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 441 28 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 441 29 multide- multide- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 441 30 tector tector NN work_jyzsgzx6ozemtdrfjlhthibtsm 441 31 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 441 32 row row NN work_jyzsgzx6ozemtdrfjlhthibtsm 441 33 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 441 34 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 441 35 Eur Eur NNP work_jyzsgzx6ozemtdrfjlhthibtsm 441 36 Radiol Radiol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 441 37 2007;17:1193–1199 2007;17:1193–1199 CD work_jyzsgzx6ozemtdrfjlhthibtsm 441 38 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 442 1 58 58 CD work_jyzsgzx6ozemtdrfjlhthibtsm 442 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 443 1 Carrozzi Carrozzi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 443 2 L L NNP work_jyzsgzx6ozemtdrfjlhthibtsm 443 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 443 4 Viegi Viegi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 443 5 G. G. NNP work_jyzsgzx6ozemtdrfjlhthibtsm 443 6 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 443 7 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 443 8 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 443 9 chronic chronic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 443 10 obstructive obstructive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 443 11 pulmonary pulmonary NN work_jyzsgzx6ozemtdrfjlhthibtsm 443 12 dis- dis- IN work_jyzsgzx6ozemtdrfjlhthibtsm 443 13 ease ease NN work_jyzsgzx6ozemtdrfjlhthibtsm 443 14 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 443 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 443 16 story story NN work_jyzsgzx6ozemtdrfjlhthibtsm 443 17 goes go VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 443 18 on on RP work_jyzsgzx6ozemtdrfjlhthibtsm 443 19 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 444 1 Radiology radiology NN work_jyzsgzx6ozemtdrfjlhthibtsm 444 2 2011;261:688–691 2011;261:688–691 CD work_jyzsgzx6ozemtdrfjlhthibtsm 444 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 445 1 59 59 CD work_jyzsgzx6ozemtdrfjlhthibtsm 445 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 446 1 Sozzi Sozzi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 446 2 G G NNP work_jyzsgzx6ozemtdrfjlhthibtsm 446 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 446 4 Pastorino Pastorino NNP work_jyzsgzx6ozemtdrfjlhthibtsm 446 5 U U NNP work_jyzsgzx6ozemtdrfjlhthibtsm 446 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 446 7 Croce Croce NNP work_jyzsgzx6ozemtdrfjlhthibtsm 446 8 CM CM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 446 9 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 447 1 MicroRNAs MicroRNAs NNP work_jyzsgzx6ozemtdrfjlhthibtsm 447 2 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 447 3 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 447 4 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 447 5 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 447 6 from from IN work_jyzsgzx6ozemtdrfjlhthibtsm 447 7 markers marker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 447 8 to to IN work_jyzsgzx6ozemtdrfjlhthibtsm 447 9 targets target NNS work_jyzsgzx6ozemtdrfjlhthibtsm 447 10 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 448 1 Cell cell NN work_jyzsgzx6ozemtdrfjlhthibtsm 448 2 Cycle Cycle NNP work_jyzsgzx6ozemtdrfjlhthibtsm 448 3 2011;10:2045–2046 2011;10:2045–2046 CD work_jyzsgzx6ozemtdrfjlhthibtsm 448 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 449 1 60 60 CD work_jyzsgzx6ozemtdrfjlhthibtsm 449 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 450 1 Boeri Boeri NNP work_jyzsgzx6ozemtdrfjlhthibtsm 450 2 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 450 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 450 4 Verri Verri NNP work_jyzsgzx6ozemtdrfjlhthibtsm 450 5 C C NNP work_jyzsgzx6ozemtdrfjlhthibtsm 450 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 450 7 Conte Conte NNP work_jyzsgzx6ozemtdrfjlhthibtsm 450 8 D D NNP work_jyzsgzx6ozemtdrfjlhthibtsm 450 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 450 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 450 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 450 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 451 1 MicroRNA microrna NN work_jyzsgzx6ozemtdrfjlhthibtsm 451 2 signatures signature NNS work_jyzsgzx6ozemtdrfjlhthibtsm 451 3 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 451 4 tissues tissue NNS work_jyzsgzx6ozemtdrfjlhthibtsm 451 5 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 451 6 plasma plasma NN work_jyzsgzx6ozemtdrfjlhthibtsm 451 7 predict predict VBP work_jyzsgzx6ozemtdrfjlhthibtsm 451 8 development development NN work_jyzsgzx6ozemtdrfjlhthibtsm 451 9 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 451 10 prognosis prognosis NN work_jyzsgzx6ozemtdrfjlhthibtsm 451 11 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 451 12 computed compute VBN work_jyzsgzx6ozemtdrfjlhthibtsm 451 13 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 451 14 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 451 15 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 451 16 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 451 17 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 452 1 Proc Proc NNP work_jyzsgzx6ozemtdrfjlhthibtsm 452 2 Natl Natl NNP work_jyzsgzx6ozemtdrfjlhthibtsm 452 3 Acad Acad NNP work_jyzsgzx6ozemtdrfjlhthibtsm 452 4 Sci Sci NNP work_jyzsgzx6ozemtdrfjlhthibtsm 452 5 USA USA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 452 6 2011;108:3713–3718 2011;108:3713–3718 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 452 7 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 453 1 61 61 CD work_jyzsgzx6ozemtdrfjlhthibtsm 453 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 454 1 Early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 454 2 warnings warning NNS work_jyzsgzx6ozemtdrfjlhthibtsm 454 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 455 1 Screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 455 2 programmes programme NNS work_jyzsgzx6ozemtdrfjlhthibtsm 455 3 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 455 4 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 455 5 detection detection NN work_jyzsgzx6ozemtdrfjlhthibtsm 455 6 are be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 455 7 not not RB work_jyzsgzx6ozemtdrfjlhthibtsm 455 8 always always RB work_jyzsgzx6ozemtdrfjlhthibtsm 455 9 as as RB work_jyzsgzx6ozemtdrfjlhthibtsm 455 10 effective effective JJ work_jyzsgzx6ozemtdrfjlhthibtsm 455 11 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 455 12 saving save VBG work_jyzsgzx6ozemtdrfjlhthibtsm 455 13 lives life NNS work_jyzsgzx6ozemtdrfjlhthibtsm 455 14 as as IN work_jyzsgzx6ozemtdrfjlhthibtsm 455 15 might may MD work_jyzsgzx6ozemtdrfjlhthibtsm 455 16 be be VB work_jyzsgzx6ozemtdrfjlhthibtsm 455 17 hoped hope VBN work_jyzsgzx6ozemtdrfjlhthibtsm 455 18 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 456 1 Improving improve VBG work_jyzsgzx6ozemtdrfjlhthibtsm 456 2 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 456 3 situation situation NN work_jyzsgzx6ozemtdrfjlhthibtsm 456 4 will will MD work_jyzsgzx6ozemtdrfjlhthibtsm 456 5 require require VB work_jyzsgzx6ozemtdrfjlhthibtsm 456 6 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 456 7 concerted concerted JJ work_jyzsgzx6ozemtdrfjlhthibtsm 456 8 effort effort NN work_jyzsgzx6ozemtdrfjlhthibtsm 456 9 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 456 10 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 456 11 broad broad JJ work_jyzsgzx6ozemtdrfjlhthibtsm 456 12 front front NN work_jyzsgzx6ozemtdrfjlhthibtsm 456 13 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 456 14 Editorial Editorial NNP work_jyzsgzx6ozemtdrfjlhthibtsm 456 15 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 456 16 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 457 1 Nature nature NN work_jyzsgzx6ozemtdrfjlhthibtsm 457 2 2009;458:679 2009;458:679 CD work_jyzsgzx6ozemtdrfjlhthibtsm 457 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 458 1 62 62 CD work_jyzsgzx6ozemtdrfjlhthibtsm 458 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 459 1 Wilson Wilson NNP work_jyzsgzx6ozemtdrfjlhthibtsm 459 2 DO DO NNP work_jyzsgzx6ozemtdrfjlhthibtsm 459 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 459 4 Weissfeld Weissfeld NNP work_jyzsgzx6ozemtdrfjlhthibtsm 459 5 JL JL NNP work_jyzsgzx6ozemtdrfjlhthibtsm 459 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 459 7 Fuhrman Fuhrman NNP work_jyzsgzx6ozemtdrfjlhthibtsm 459 8 CR CR NNP work_jyzsgzx6ozemtdrfjlhthibtsm 459 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 459 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 459 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 459 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 460 1 The the DT work_jyzsgzx6ozemtdrfjlhthibtsm 460 2 Pittsburgh Pittsburgh NNP work_jyzsgzx6ozemtdrfjlhthibtsm 460 3 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 460 4 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 460 5 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 460 6 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 460 7 PLuSS PLuSS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 460 8 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 460 9 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 460 10 outcomes outcome NNS work_jyzsgzx6ozemtdrfjlhthibtsm 460 11 within within IN work_jyzsgzx6ozemtdrfjlhthibtsm 460 12 3 3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 460 13 years year NNS work_jyzsgzx6ozemtdrfjlhthibtsm 460 14 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 460 15 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 460 16 first first JJ work_jyzsgzx6ozemtdrfjlhthibtsm 460 17 computed compute VBN work_jyzsgzx6ozemtdrfjlhthibtsm 460 18 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 460 19 scan scan NNP work_jyzsgzx6ozemtdrfjlhthibtsm 460 20 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 461 1 Am Am NNP work_jyzsgzx6ozemtdrfjlhthibtsm 461 2 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 461 3 Respir Respir NNP work_jyzsgzx6ozemtdrfjlhthibtsm 461 4 Crit Crit NNP work_jyzsgzx6ozemtdrfjlhthibtsm 461 5 Care Care NNP work_jyzsgzx6ozemtdrfjlhthibtsm 461 6 Med Med NNP work_jyzsgzx6ozemtdrfjlhthibtsm 461 7 2008;178:956–961 2008;178:956–961 CD work_jyzsgzx6ozemtdrfjlhthibtsm 461 8 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 462 1 63 63 CD work_jyzsgzx6ozemtdrfjlhthibtsm 462 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 463 1 Swensen Swensen NNP work_jyzsgzx6ozemtdrfjlhthibtsm 463 2 SJ SJ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 463 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 463 4 Jett Jett NNP work_jyzsgzx6ozemtdrfjlhthibtsm 463 5 JR JR NNP work_jyzsgzx6ozemtdrfjlhthibtsm 463 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 463 7 Sloan Sloan NNP work_jyzsgzx6ozemtdrfjlhthibtsm 463 8 JA JA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 463 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 463 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 463 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 463 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 464 1 Screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 464 2 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 464 3 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 464 4 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 464 5 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 464 6 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 464 7 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 464 8 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 464 9 spiral spiral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 464 10 computed compute VBD work_jyzsgzx6ozemtdrfjlhthibtsm 464 11 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 464 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 465 1 Am Am NNP work_jyzsgzx6ozemtdrfjlhthibtsm 465 2 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 465 3 Respir Respir NNP work_jyzsgzx6ozemtdrfjlhthibtsm 465 4 Crit Crit NNP work_jyzsgzx6ozemtdrfjlhthibtsm 465 5 Care Care NNP work_jyzsgzx6ozemtdrfjlhthibtsm 465 6 Med Med NNP work_jyzsgzx6ozemtdrfjlhthibtsm 465 7 2002;165:508–513 2002;165:508–513 NNS work_jyzsgzx6ozemtdrfjlhthibtsm 465 8 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 466 1 64 64 CD work_jyzsgzx6ozemtdrfjlhthibtsm 466 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 467 1 Diederich Diederich NNP work_jyzsgzx6ozemtdrfjlhthibtsm 467 2 S S NNP work_jyzsgzx6ozemtdrfjlhthibtsm 467 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 467 4 Wormanns Wormanns NNP work_jyzsgzx6ozemtdrfjlhthibtsm 467 5 D d NN work_jyzsgzx6ozemtdrfjlhthibtsm 467 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 467 7 Semik Semik NNP work_jyzsgzx6ozemtdrfjlhthibtsm 467 8 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 467 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 467 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 467 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 467 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 468 1 Screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 468 2 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 468 3 early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 468 4 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 468 5 can- can- NN work_jyzsgzx6ozemtdrfjlhthibtsm 468 6 cer cer NN work_jyzsgzx6ozemtdrfjlhthibtsm 468 7 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 468 8 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 468 9 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 468 10 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 468 11 spiral spiral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 468 12 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 468 13 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 468 14 prevalence prevalence NN work_jyzsgzx6ozemtdrfjlhthibtsm 468 15 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 468 16 817 817 CD work_jyzsgzx6ozemtdrfjlhthibtsm 468 17 asymptomatic asymptomatic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 468 18 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 468 19 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 469 1 Radiology radiology NN work_jyzsgzx6ozemtdrfjlhthibtsm 469 2 2002;222:773–781 2002;222:773–781 CD work_jyzsgzx6ozemtdrfjlhthibtsm 469 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 470 1 65 65 CD work_jyzsgzx6ozemtdrfjlhthibtsm 470 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 471 1 Kido Kido NNP work_jyzsgzx6ozemtdrfjlhthibtsm 471 2 S S NNP work_jyzsgzx6ozemtdrfjlhthibtsm 471 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 471 4 Kuriyama Kuriyama NNP work_jyzsgzx6ozemtdrfjlhthibtsm 471 5 K K NNP work_jyzsgzx6ozemtdrfjlhthibtsm 471 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 471 7 Higashiyama Higashiyama NNP work_jyzsgzx6ozemtdrfjlhthibtsm 471 8 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 471 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 471 10 Kasugai Kasugai NNP work_jyzsgzx6ozemtdrfjlhthibtsm 471 11 T T NNP work_jyzsgzx6ozemtdrfjlhthibtsm 471 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 471 13 Kuroda Kuroda NNP work_jyzsgzx6ozemtdrfjlhthibtsm 471 14 C. C. NNP work_jyzsgzx6ozemtdrfjlhthibtsm 471 15 Fractal Fractal NNP work_jyzsgzx6ozemtdrfjlhthibtsm 471 16 anal- anal- JJ work_jyzsgzx6ozemtdrfjlhthibtsm 471 17 ysis ysis NN work_jyzsgzx6ozemtdrfjlhthibtsm 471 18 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 471 19 small small JJ work_jyzsgzx6ozemtdrfjlhthibtsm 471 20 peripheral peripheral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 471 21 pulmonary pulmonary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 471 22 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 471 23 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 471 24 thin thin JJ work_jyzsgzx6ozemtdrfjlhthibtsm 471 25 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 471 26 section section NN work_jyzsgzx6ozemtdrfjlhthibtsm 471 27 CT ct NN work_jyzsgzx6ozemtdrfjlhthibtsm 471 28 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 471 29 evaluation evaluation NN work_jyzsgzx6ozemtdrfjlhthibtsm 471 30 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 471 31 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 471 32 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 471 33 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 471 34 nodule nodule NN work_jyzsgzx6ozemtdrfjlhthibtsm 471 35 interfaces interface NNS work_jyzsgzx6ozemtdrfjlhthibtsm 471 36 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 472 1 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 472 2 Comput Comput NNP work_jyzsgzx6ozemtdrfjlhthibtsm 472 3 Assist Assist NNP work_jyzsgzx6ozemtdrfjlhthibtsm 472 4 Tomogr Tomogr NNP work_jyzsgzx6ozemtdrfjlhthibtsm 472 5 2002;26:573–578 2002;26:573–578 CD work_jyzsgzx6ozemtdrfjlhthibtsm 472 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 473 1 66 66 CD work_jyzsgzx6ozemtdrfjlhthibtsm 473 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 474 1 Wang Wang NNP work_jyzsgzx6ozemtdrfjlhthibtsm 474 2 H H NNP work_jyzsgzx6ozemtdrfjlhthibtsm 474 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 474 4 Guo Guo NNP work_jyzsgzx6ozemtdrfjlhthibtsm 474 5 XH xh NN work_jyzsgzx6ozemtdrfjlhthibtsm 474 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 474 7 Jia Jia NNP work_jyzsgzx6ozemtdrfjlhthibtsm 474 8 ZW ZW NNP work_jyzsgzx6ozemtdrfjlhthibtsm 474 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 474 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 474 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 474 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 475 1 Multilevel multilevel JJ work_jyzsgzx6ozemtdrfjlhthibtsm 475 2 binomial binomial JJ work_jyzsgzx6ozemtdrfjlhthibtsm 475 3 logistic logistic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 475 4 prediction prediction NN work_jyzsgzx6ozemtdrfjlhthibtsm 475 5 model model NN work_jyzsgzx6ozemtdrfjlhthibtsm 475 6 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 475 7 malignant malignant JJ work_jyzsgzx6ozemtdrfjlhthibtsm 475 8 pulmonary pulmonary NN work_jyzsgzx6ozemtdrfjlhthibtsm 475 9 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 475 10 based base VBN work_jyzsgzx6ozemtdrfjlhthibtsm 475 11 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 475 12 texture texture NN work_jyzsgzx6ozemtdrfjlhthibtsm 475 13 features feature NNS work_jyzsgzx6ozemtdrfjlhthibtsm 475 14 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 475 15 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 475 16 image image NN work_jyzsgzx6ozemtdrfjlhthibtsm 475 17 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 476 1 Eur Eur NNP work_jyzsgzx6ozemtdrfjlhthibtsm 476 2 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 476 3 Radiol Radiol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 476 4 2010;74:124–129 2010;74:124–129 CD work_jyzsgzx6ozemtdrfjlhthibtsm 476 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 477 1 67 67 CD work_jyzsgzx6ozemtdrfjlhthibtsm 477 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 478 1 Veronesi veronesi JJ work_jyzsgzx6ozemtdrfjlhthibtsm 478 2 G g NN work_jyzsgzx6ozemtdrfjlhthibtsm 478 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 478 4 Bellomi Bellomi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 478 5 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 478 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 478 7 Mulshine Mulshine NNP work_jyzsgzx6ozemtdrfjlhthibtsm 478 8 JL JL NNP work_jyzsgzx6ozemtdrfjlhthibtsm 478 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 478 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 478 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 478 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 479 1 Lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 479 2 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 479 3 screening screen VBG work_jyzsgzx6ozemtdrfjlhthibtsm 479 4 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 479 5 low low RB work_jyzsgzx6ozemtdrfjlhthibtsm 479 6 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 479 7 dose dose NN work_jyzsgzx6ozemtdrfjlhthibtsm 479 8 computed computed JJ work_jyzsgzx6ozemtdrfjlhthibtsm 479 9 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 479 10 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 479 11 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 479 12 non non JJ work_jyzsgzx6ozemtdrfjlhthibtsm 479 13 - - JJ work_jyzsgzx6ozemtdrfjlhthibtsm 479 14 invasive invasive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 479 15 diagnostic diagnostic JJ work_jyzsgzx6ozemtdrfjlhthibtsm 479 16 protocol protocol NN work_jyzsgzx6ozemtdrfjlhthibtsm 479 17 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 479 18 baseline baseline NNP work_jyzsgzx6ozemtdrfjlhthibtsm 479 19 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 479 20 nodules nodule VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 479 21 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 480 1 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 480 2 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 480 3 2008;61:340–349 2008;61:340–349 CD work_jyzsgzx6ozemtdrfjlhthibtsm 480 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 481 1 68 68 CD work_jyzsgzx6ozemtdrfjlhthibtsm 481 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 482 1 Veronesi veronesi JJ work_jyzsgzx6ozemtdrfjlhthibtsm 482 2 G g NN work_jyzsgzx6ozemtdrfjlhthibtsm 482 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 482 4 Bellomi Bellomi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 482 5 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 482 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 482 7 Veronesi Veronesi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 482 8 U U NNP work_jyzsgzx6ozemtdrfjlhthibtsm 482 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 482 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 482 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 482 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 483 1 Role role NN work_jyzsgzx6ozemtdrfjlhthibtsm 483 2 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 483 3 positron positron NNP work_jyzsgzx6ozemtdrfjlhthibtsm 483 4 emission emission NN work_jyzsgzx6ozemtdrfjlhthibtsm 483 5 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 483 6 scanning scanning NN work_jyzsgzx6ozemtdrfjlhthibtsm 483 7 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 483 8 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 483 9 management management NN work_jyzsgzx6ozemtdrfjlhthibtsm 483 10 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 483 11 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 483 12 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 483 13 detected detect VBD work_jyzsgzx6ozemtdrfjlhthibtsm 483 14 at at IN work_jyzsgzx6ozemtdrfjlhthibtsm 483 15 base- base- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 483 16 line line NN work_jyzsgzx6ozemtdrfjlhthibtsm 483 17 computed compute VBD work_jyzsgzx6ozemtdrfjlhthibtsm 483 18 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 483 19 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 483 20 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 484 1 Ann Ann NNP work_jyzsgzx6ozemtdrfjlhthibtsm 484 2 Thorac Thorac NNP work_jyzsgzx6ozemtdrfjlhthibtsm 484 3 Surg Surg NNP work_jyzsgzx6ozemtdrfjlhthibtsm 484 4 2007;84:959–65 2007;84:959–65 CD work_jyzsgzx6ozemtdrfjlhthibtsm 484 5 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 484 6 discussion discussion NN work_jyzsgzx6ozemtdrfjlhthibtsm 484 7 965 965 CD work_jyzsgzx6ozemtdrfjlhthibtsm 484 8 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 485 1 69 69 CD work_jyzsgzx6ozemtdrfjlhthibtsm 485 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 486 1 Veronesi veronesi JJ work_jyzsgzx6ozemtdrfjlhthibtsm 486 2 G g NN work_jyzsgzx6ozemtdrfjlhthibtsm 486 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 486 4 Bellomi Bellomi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 486 5 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 486 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 486 7 Scanagatta Scanagatta NNP work_jyzsgzx6ozemtdrfjlhthibtsm 486 8 P P NNP work_jyzsgzx6ozemtdrfjlhthibtsm 486 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 486 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 486 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 486 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 487 1 Difficulties difficulty NNS work_jyzsgzx6ozemtdrfjlhthibtsm 487 2 encountered encounter VBD work_jyzsgzx6ozemtdrfjlhthibtsm 487 3 managing managing NN work_jyzsgzx6ozemtdrfjlhthibtsm 487 4 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 487 5 detected detect VBN work_jyzsgzx6ozemtdrfjlhthibtsm 487 6 during during IN work_jyzsgzx6ozemtdrfjlhthibtsm 487 7 a a DT work_jyzsgzx6ozemtdrfjlhthibtsm 487 8 computed computed JJ work_jyzsgzx6ozemtdrfjlhthibtsm 487 9 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 487 10 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 487 11 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 487 12 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 487 13 program program NN work_jyzsgzx6ozemtdrfjlhthibtsm 487 14 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 488 1 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 488 2 Thorac Thorac NNP work_jyzsgzx6ozemtdrfjlhthibtsm 488 3 Cardiovasc Cardiovasc NNP work_jyzsgzx6ozemtdrfjlhthibtsm 488 4 Surg Surg NNP work_jyzsgzx6ozemtdrfjlhthibtsm 488 5 2008;136:611–617 2008;136:611–617 CD work_jyzsgzx6ozemtdrfjlhthibtsm 488 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 489 1 70 70 CD work_jyzsgzx6ozemtdrfjlhthibtsm 489 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 490 1 Libby Libby NNP work_jyzsgzx6ozemtdrfjlhthibtsm 490 2 DM DM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 490 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 490 4 Wu Wu NNP work_jyzsgzx6ozemtdrfjlhthibtsm 490 5 N N NNP work_jyzsgzx6ozemtdrfjlhthibtsm 490 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 490 7 Lee Lee NNP work_jyzsgzx6ozemtdrfjlhthibtsm 490 8 IJ IJ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 490 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 490 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 490 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 490 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 491 1 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 491 2 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 491 3 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 491 4 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 491 5 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 491 6 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 491 7 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 491 8 value value NN work_jyzsgzx6ozemtdrfjlhthibtsm 491 9 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 491 10 short short JJ work_jyzsgzx6ozemtdrfjlhthibtsm 491 11 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 491 12 term term NN work_jyzsgzx6ozemtdrfjlhthibtsm 491 13 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 491 14 follow follow NN work_jyzsgzx6ozemtdrfjlhthibtsm 491 15 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 491 16 up up NN work_jyzsgzx6ozemtdrfjlhthibtsm 491 17 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 492 1 Chest Chest NNP work_jyzsgzx6ozemtdrfjlhthibtsm 492 2 2006;129:1039–1042 2006;129:1039–1042 CD work_jyzsgzx6ozemtdrfjlhthibtsm 492 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 493 1 71 71 CD work_jyzsgzx6ozemtdrfjlhthibtsm 493 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 494 1 Pastorino pastorino JJ work_jyzsgzx6ozemtdrfjlhthibtsm 494 2 U u NN work_jyzsgzx6ozemtdrfjlhthibtsm 494 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 494 4 Bellomi Bellomi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 494 5 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 494 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 494 7 Landoni Landoni NNP work_jyzsgzx6ozemtdrfjlhthibtsm 494 8 C C NNP work_jyzsgzx6ozemtdrfjlhthibtsm 494 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 494 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 494 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 494 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 495 1 Early early JJ work_jyzsgzx6ozemtdrfjlhthibtsm 495 2 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 495 3 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 495 4 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 495 5 detection detection NN work_jyzsgzx6ozemtdrfjlhthibtsm 495 6 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 495 7 spiral spiral JJ work_jyzsgzx6ozemtdrfjlhthibtsm 495 8 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 495 9 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 495 10 positron positron NNP work_jyzsgzx6ozemtdrfjlhthibtsm 495 11 emission emission NN work_jyzsgzx6ozemtdrfjlhthibtsm 495 12 tomography tomography NN work_jyzsgzx6ozemtdrfjlhthibtsm 495 13 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 495 14 heavy heavy JJ work_jyzsgzx6ozemtdrfjlhthibtsm 495 15 smokers smoker NNS work_jyzsgzx6ozemtdrfjlhthibtsm 495 16 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 495 17 2-year 2-year CD work_jyzsgzx6ozemtdrfjlhthibtsm 495 18 results result NNS work_jyzsgzx6ozemtdrfjlhthibtsm 495 19 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 496 1 Lancet Lancet NNP work_jyzsgzx6ozemtdrfjlhthibtsm 496 2 2003;362:593–597 2003;362:593–597 CD work_jyzsgzx6ozemtdrfjlhthibtsm 496 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 497 1 72 72 CD work_jyzsgzx6ozemtdrfjlhthibtsm 497 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 498 1 Wagnetz wagnetz NN work_jyzsgzx6ozemtdrfjlhthibtsm 498 2 U u NN work_jyzsgzx6ozemtdrfjlhthibtsm 498 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 498 4 Menezes Menezes NNP work_jyzsgzx6ozemtdrfjlhthibtsm 498 5 RJ RJ NNP work_jyzsgzx6ozemtdrfjlhthibtsm 498 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 498 7 Boerner Boerner NNP work_jyzsgzx6ozemtdrfjlhthibtsm 498 8 S S NNP work_jyzsgzx6ozemtdrfjlhthibtsm 498 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 498 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 498 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 498 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 499 1 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 499 2 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 499 3 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 499 4 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 499 5 can- can- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 499 6 cer cer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 499 7 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 499 8 implication implication NN work_jyzsgzx6ozemtdrfjlhthibtsm 499 9 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 499 10 lung lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 499 11 biopsy biopsy NN work_jyzsgzx6ozemtdrfjlhthibtsm 499 12 recommendations recommendation NNS work_jyzsgzx6ozemtdrfjlhthibtsm 499 13 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 500 1 AJR AJR NNP work_jyzsgzx6ozemtdrfjlhthibtsm 500 2 Am Am NNP work_jyzsgzx6ozemtdrfjlhthibtsm 500 3 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 500 4 Roentgenol Roentgenol NNP work_jyzsgzx6ozemtdrfjlhthibtsm 500 5 2012;198:351–358 2012;198:351–358 CD work_jyzsgzx6ozemtdrfjlhthibtsm 500 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 501 1 73 73 CD work_jyzsgzx6ozemtdrfjlhthibtsm 501 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 502 1 Fassina Fassina NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 2 A A NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 502 4 Corradin Corradin NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 5 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 502 7 Zardo Zardo NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 8 D D NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 502 10 Cappellesso Cappellesso NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 11 R R NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 502 13 Corbetti Corbetti NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 14 F F NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 15 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 502 16 Fassan Fassan NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 17 M. M. NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 18 Role Role NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 19 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 502 20 accuracy accuracy NN work_jyzsgzx6ozemtdrfjlhthibtsm 502 21 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 502 22 rapid rapid JJ work_jyzsgzx6ozemtdrfjlhthibtsm 502 23 on on IN work_jyzsgzx6ozemtdrfjlhthibtsm 502 24 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 502 25 site site NN work_jyzsgzx6ozemtdrfjlhthibtsm 502 26 evaluation evaluation NN work_jyzsgzx6ozemtdrfjlhthibtsm 502 27 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 502 28 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 29 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 502 30 guided guide VBN work_jyzsgzx6ozemtdrfjlhthibtsm 502 31 f f NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 32 ine ine NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 33 needle needle NNP work_jyzsgzx6ozemtdrfjlhthibtsm 502 34 aspiration aspiration NN work_jyzsgzx6ozemtdrfjlhthibtsm 502 35 cytology cytology NN work_jyzsgzx6ozemtdrfjlhthibtsm 502 36 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 502 37 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 502 38 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 502 39 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 503 1 Cytopathology cytopathology NN work_jyzsgzx6ozemtdrfjlhthibtsm 503 2 2011;22:306–312 2011;22:306–312 CD work_jyzsgzx6ozemtdrfjlhthibtsm 503 3 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 504 1 74 74 CD work_jyzsgzx6ozemtdrfjlhthibtsm 504 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 505 1 Wahidi Wahidi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 505 2 MM MM NNP work_jyzsgzx6ozemtdrfjlhthibtsm 505 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 505 4 Govert Govert NNP work_jyzsgzx6ozemtdrfjlhthibtsm 505 5 JA JA NNP work_jyzsgzx6ozemtdrfjlhthibtsm 505 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 505 7 Goudar Goudar NNP work_jyzsgzx6ozemtdrfjlhthibtsm 505 8 RK RK NNP work_jyzsgzx6ozemtdrfjlhthibtsm 505 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 505 10 Gould Gould NNP work_jyzsgzx6ozemtdrfjlhthibtsm 505 11 MK MK NNP work_jyzsgzx6ozemtdrfjlhthibtsm 505 12 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 505 13 McCrory McCrory NNP work_jyzsgzx6ozemtdrfjlhthibtsm 505 14 DC DC NNP work_jyzsgzx6ozemtdrfjlhthibtsm 505 15 ; ; : work_jyzsgzx6ozemtdrfjlhthibtsm 505 16 American American NNP work_jyzsgzx6ozemtdrfjlhthibtsm 505 17 College College NNP work_jyzsgzx6ozemtdrfjlhthibtsm 505 18 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 505 19 Chest Chest NNP work_jyzsgzx6ozemtdrfjlhthibtsm 505 20 Physicians Physicians NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 505 21 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 506 1 Evidence evidence NN work_jyzsgzx6ozemtdrfjlhthibtsm 506 2 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 506 3 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 506 4 treatment treatment NN work_jyzsgzx6ozemtdrfjlhthibtsm 506 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 506 6 patients patient NNS work_jyzsgzx6ozemtdrfjlhthibtsm 506 7 with with IN work_jyzsgzx6ozemtdrfjlhthibtsm 506 8 pulmonary pulmonary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 506 9 nodules nodule NNS work_jyzsgzx6ozemtdrfjlhthibtsm 506 10 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 506 11 when when WRB work_jyzsgzx6ozemtdrfjlhthibtsm 506 12 is be VBZ work_jyzsgzx6ozemtdrfjlhthibtsm 506 13 it -PRON- PRP work_jyzsgzx6ozemtdrfjlhthibtsm 506 14 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 506 15 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 506 16 ? ? . work_jyzsgzx6ozemtdrfjlhthibtsm 507 1 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 507 2 ACCP ACCP NNP work_jyzsgzx6ozemtdrfjlhthibtsm 507 3 evi- evi- CC work_jyzsgzx6ozemtdrfjlhthibtsm 507 4 dence dence NN work_jyzsgzx6ozemtdrfjlhthibtsm 507 5 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 507 6 based base VBN work_jyzsgzx6ozemtdrfjlhthibtsm 507 7 clinical clinical JJ work_jyzsgzx6ozemtdrfjlhthibtsm 507 8 practice practice NN work_jyzsgzx6ozemtdrfjlhthibtsm 507 9 guidelines guideline NNS work_jyzsgzx6ozemtdrfjlhthibtsm 507 10 ( ( -LRB- work_jyzsgzx6ozemtdrfjlhthibtsm 507 11 2nd 2nd NNP work_jyzsgzx6ozemtdrfjlhthibtsm 507 12 edition edition NNP work_jyzsgzx6ozemtdrfjlhthibtsm 507 13 ) ) -RRB- work_jyzsgzx6ozemtdrfjlhthibtsm 507 14 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 508 1 Chest chest NN work_jyzsgzx6ozemtdrfjlhthibtsm 508 2 2007;132(3 2007;132(3 CD work_jyzsgzx6ozemtdrfjlhthibtsm 508 3 Suppl):94S–107S. Suppl):94S–107S. NNP work_jyzsgzx6ozemtdrfjlhthibtsm 509 1 75 75 CD work_jyzsgzx6ozemtdrfjlhthibtsm 509 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 510 1 Travis Travis NNP work_jyzsgzx6ozemtdrfjlhthibtsm 510 2 WD WD NNP work_jyzsgzx6ozemtdrfjlhthibtsm 510 3 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 510 4 Brambilla Brambilla NNP work_jyzsgzx6ozemtdrfjlhthibtsm 510 5 E E NNP work_jyzsgzx6ozemtdrfjlhthibtsm 510 6 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 510 7 Noguchi Noguchi NNP work_jyzsgzx6ozemtdrfjlhthibtsm 510 8 M M NNP work_jyzsgzx6ozemtdrfjlhthibtsm 510 9 , , , work_jyzsgzx6ozemtdrfjlhthibtsm 510 10 et et NNP work_jyzsgzx6ozemtdrfjlhthibtsm 510 11 al al NNP work_jyzsgzx6ozemtdrfjlhthibtsm 510 12 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 511 1 American American NNP work_jyzsgzx6ozemtdrfjlhthibtsm 511 2 Thoracic Thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 511 3 Society Society NNP work_jyzsgzx6ozemtdrfjlhthibtsm 511 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 512 1 International International NNP work_jyzsgzx6ozemtdrfjlhthibtsm 512 2 Association Association NNP work_jyzsgzx6ozemtdrfjlhthibtsm 512 3 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 512 4 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 512 5 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 512 6 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 512 7 Lung Lung NNP work_jyzsgzx6ozemtdrfjlhthibtsm 512 8 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 512 9 / / SYM work_jyzsgzx6ozemtdrfjlhthibtsm 512 10 American American NNP work_jyzsgzx6ozemtdrfjlhthibtsm 512 11 Thoracic Thoracic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 512 12 Society Society NNP work_jyzsgzx6ozemtdrfjlhthibtsm 512 13 / / SYM work_jyzsgzx6ozemtdrfjlhthibtsm 512 14 European European NNP work_jyzsgzx6ozemtdrfjlhthibtsm 512 15 Respiratory Respiratory NNP work_jyzsgzx6ozemtdrfjlhthibtsm 512 16 Society Society NNP work_jyzsgzx6ozemtdrfjlhthibtsm 512 17 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 512 18 international international JJ work_jyzsgzx6ozemtdrfjlhthibtsm 512 19 multidisci- multidisci- NNP work_jyzsgzx6ozemtdrfjlhthibtsm 512 20 plinary plinary JJ work_jyzsgzx6ozemtdrfjlhthibtsm 512 21 classification classification NN work_jyzsgzx6ozemtdrfjlhthibtsm 512 22 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 512 23 lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 512 24 adenocarcinoma adenocarcinoma NN work_jyzsgzx6ozemtdrfjlhthibtsm 512 25 : : : work_jyzsgzx6ozemtdrfjlhthibtsm 512 26 executive executive JJ work_jyzsgzx6ozemtdrfjlhthibtsm 512 27 summary summary NN work_jyzsgzx6ozemtdrfjlhthibtsm 512 28 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 513 1 Proc Proc NNP work_jyzsgzx6ozemtdrfjlhthibtsm 513 2 Am be VBP work_jyzsgzx6ozemtdrfjlhthibtsm 513 3 Thorac Thorac NNP work_jyzsgzx6ozemtdrfjlhthibtsm 513 4 Soc Soc NNP work_jyzsgzx6ozemtdrfjlhthibtsm 513 5 2011;8:381–385 2011;8:381–385 CD work_jyzsgzx6ozemtdrfjlhthibtsm 513 6 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 514 1 76 76 CD work_jyzsgzx6ozemtdrfjlhthibtsm 514 2 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 515 1 Pastorino Pastorino NNP work_jyzsgzx6ozemtdrfjlhthibtsm 515 2 U. U. NNP work_jyzsgzx6ozemtdrfjlhthibtsm 516 1 Lung lung NN work_jyzsgzx6ozemtdrfjlhthibtsm 516 2 cancer cancer NN work_jyzsgzx6ozemtdrfjlhthibtsm 516 3 screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 516 4 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 517 1 Br br IN work_jyzsgzx6ozemtdrfjlhthibtsm 517 2 J J NNP work_jyzsgzx6ozemtdrfjlhthibtsm 517 3 Cancer Cancer NNP work_jyzsgzx6ozemtdrfjlhthibtsm 517 4 2010;102:1681–1686 2010;102:1681–1686 NNP work_jyzsgzx6ozemtdrfjlhthibtsm 517 5 . . . work_jyzsgzx6ozemtdrfjlhthibtsm 518 1 Four four CD work_jyzsgzx6ozemtdrfjlhthibtsm 518 2 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 518 3 Year Year NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 4 Results Results NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 518 5 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 518 6 Low Low NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 7 - - HYPH work_jyzsgzx6ozemtdrfjlhthibtsm 518 8 Dose Dose NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 9 CT CT NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 10 Screening screening NN work_jyzsgzx6ozemtdrfjlhthibtsm 518 11 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 518 12 Nodule Nodule NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 13 Management Management NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 14 in in IN work_jyzsgzx6ozemtdrfjlhthibtsm 518 15 the the DT work_jyzsgzx6ozemtdrfjlhthibtsm 518 16 ITALUNG ITALUNG NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 17 Trial trial NN work_jyzsgzx6ozemtdrfjlhthibtsm 518 18 MATERIALS material NNS work_jyzsgzx6ozemtdrfjlhthibtsm 518 19 AND and CC work_jyzsgzx6ozemtdrfjlhthibtsm 518 20 METHODS METHODS NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 21 Selection Selection NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 22 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 518 23 Randomization Randomization NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 24 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 518 25 Study Study NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 26 Participants Participants NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 27 Procedure Procedure NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 28 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 518 29 Instrument Instrument NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 30 of of IN work_jyzsgzx6ozemtdrfjlhthibtsm 518 31 Screening Screening NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 32 Criteria Criteria NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 33 for for IN work_jyzsgzx6ozemtdrfjlhthibtsm 518 34 Positive Positive NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 35 Test Test NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 36 and and CC work_jyzsgzx6ozemtdrfjlhthibtsm 518 37 Further Further NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 38 Diagnostic Diagnostic NNP work_jyzsgzx6ozemtdrfjlhthibtsm 518 39 Investigations Investigations NNPS work_jyzsgzx6ozemtdrfjlhthibtsm 518 40 RESULTS results VB work_jyzsgzx6ozemtdrfjlhthibtsm 518 41 DISCUSSION discussion NN work_jyzsgzx6ozemtdrfjlhthibtsm 518 42 CONCLUSIONS conclusion NNS work_jyzsgzx6ozemtdrfjlhthibtsm 518 43 ACKNOWLEDGMENT acknowledgment DT work_jyzsgzx6ozemtdrfjlhthibtsm 518 44 REFERENCES reference NNS